000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|7048|11199|lyfalmen|V0457|8760|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7048||7048|11199||2|0|E|0|||0
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|NED|0|0|0|100|XEU|21642|30646|lyfalmen|V0475|9452|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21642||21642|30646||2|0|E|0|||0
000193|N05AH0302|Zyprexa Velotab|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|27954|38630|lyfalmen|V0540|20624|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||27954||27954|38630||2|0||0|||0
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|4420|7582|lyfalmen|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4420||4420|7582||1|H|0|0|||0
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|4223|8182|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||4223||4223|8182||1|0||0|||0
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|0|0|FER|0|0|0|100|DKK|11752|17673|lyfalmen|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11752||11752|17673||1|H|0|0|||0
000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|2768|5308|lyfalmen|V0942|4816|1|6|0|6,0000|Icepharma hf|Merck AB|Prógesterón||2768||2768|5308||2|0|G|0|||0
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3802|6731|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3802||3802|6731||1|0||0|||0
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2829|5392|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2829||2829|5392||1|0|G|0|||0
000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|1|G|0|MEC|0|0|0|100|SEK|7660|12041|lyfalmen|V0942|12041|1|15|0|15,0000|Icepharma hf|Merck AB|Prógesterón||7660||7660|12041||2|0|G|0|||0
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3110|5779|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3110||3110|5779||1|0||0|||0
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1|0||0|||0
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|1|G|0|MRP|0|0|0|100|SEK|86712|112947|lyfalmen|||1|6|0|122,7907|Icepharma hf|Merck Europe B.V.|Interferón beta-1a||86712||86712|112947||2|0|G|0|||0
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14632|21637|lyfalmen|V0115|7967|1|100|0|400,0000|Icepharma hf|Upjohn EESV|Atorvastatín||14632||14632|21637||1|0|E|0|||0
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1689|3823|lyfalmen|V0050|2485|1|100|0|15,8333|Vistor hf|Recordati Ireland Limited|Metóprólól||1689||1689|3823||1|0|G|0|||0
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5188|8639|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5188||5188|8639||1|0|G|0|||0
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2593|5067|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2593||2593|5067||1|0|G|0|||0
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|17733|25906|lyfalmen|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||17733||17733|25906||1|0|0|0|||0
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|G|0|VIF|0|0|1|100|CHF|12134|18199|lyfalmen|V0637|18198|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||12134||12134|18199||1|0|G|0|||0
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|FKA|0|0|0|100|DKK|24174|33849|lyfalmen|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||24174||24174|33849||1|0|0|0|||0
001870|QP54AA0601|Slice vet.|forbl|0,2|% w/w|2,5|kg|1|þpakki|duft|QP54AA06|01.02.2019||R|0|0|0|0|0|IBV|0|0|0|100|DKK|127721|205886|veteldis|||0|2,5|0||Vistor hf|Intervet International BV|emamektín||127721||127721|205886||1|0||0|||0
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|HES|0|0|0|100|DKK|2281|4637|lyfalmen|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2281||2281|4637||1|H|0|0|||0
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|4260|7361|lyfalmen|||1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||4260||4260|7361||1|0|G|0|||0
001905|N03AX0901|Lamictal|dreifit.|2|mg|30|stk|1|glas||N03AX09|01.08.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|479|2157|lyfalmen|||1|30|0|0,2000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||479||479|2157||1|0|G|0|||0
001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1633|2529|lyfalmen|V0291|2273|2|60|0|12,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||749||749|2529||1|0|G|0|||0
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|BIG|0|0|1|100|SEK|3202|5905|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3202||3202|5905||2|0|E|0|||0
001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2851|3557|lyfalmen|V0292|3494|2|60|0|24,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||1496||1496|3557||1|0|G|0|||0
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|1518|3587|lyfalmen|V0004|2839|1|28|0|18,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||1518||1518|3587||1|0|E|0|||0
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|GRH|0|0|1|100|DKK|3091|5752|lyfalmen|V0005|2874|1|28|0|37,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3091||3091|5752||1|0|E|0|||0
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|FKA|0|0|0|100|DKK|20591|29317|lyfalmen|||1|5760|0||Vistor hf|Fresenius Kabi AB|Blöndur||20591||20591|29317||2|0|0|0|||0
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2721|5243|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2721||2721|5243||1|0|G|0|||0
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11646|17527|lyfalmen|V0492|15905|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||11646||11646|17527||1|0|G|0|||0
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||||1|0||0|||0
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lóratadín|||||2728||1|0|G|0|||0
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|1|0|0|LPT|0|0|0|100|XEU|28519|32724|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||23285||23285|32724||1|0|0|0|||0
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11083|14753|lyfalmen|V0089|3631|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9630||9630|14753||1|0|G|0|||0
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|7552|11892|lyfalmen|V0515|5198|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||7552||7552|11892||1|0|G|0|||0
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|10485|15929|lyfalmen|V0253|4878|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||10485||10485|15929||1|0|G|0|||0
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|G|0|UCB|0|0|0|100|DKK|20349|29011|lyfalmen|V0516|12509|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||20349||20349|29011||1|0|G|0|||0
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|7984|12487|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||7984||7984|12487||1|0|G|0|||0
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|1|G|0|PFP|0|0|0|100|DKK|11789|17724|lyfalmen|V0992|15243|1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11789||11789|17724||1|0|G|0|||0
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5667|9298|lyfalmen|V0971|9297|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5667||5667|9298||1|0|G|0|||0
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|G|0|AZD|0|0|0|100|SEK|6747|10784|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6747||6747|10784||1|0|G|0|||0
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2854|5426|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2854||2854|5426||1|0|G|0|||0
003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|0|0|SGB|0|0|0|100|XEU|31265|42818|lyfalmen|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||31265||31265|42818||1|H|0|0|||0
003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|1883|3176|lyfalmen|||2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1219||1219|3176||1|0|G|0|||0
003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|G|0|ATE|0|0|0|100|XEU|23287|25588|lyfalmen|||2|500|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||17502||17502|25588||1|0|G|0|||0
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|ATE|0|0|0|100|XEU|994|2638|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||828||828|2638||1|0|E|0|||0
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2110|3278|lyfalmen|V0322|2858|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||1293||1293|3278||1|0|G|0|||0
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|17431|25490|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17431||17431|25490||1|H|0|0|||0
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|G|0|HES|0|0|0|100|DKK|7288|11529|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7288||7288|11529||1|0|G|0|||0
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3970|6962|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3970||3970|6962||1|0|G|0|||0
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5336|8842|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5336||5336|8842||1|0|G|0|||0
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|PEU|0|0|0|100|DKK|15980|23493|lyfalmen|||1|1|0|0,5000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||15980||15980|23493||1|H|0|0|||0
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6704|12889|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Fenetamathýdrójoðíð í blöndum með öðrum sýklalyfjum||6704||6704|12889||1|0||0|||0
004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2311|4679|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2311||2311|4679||1|0||0|||0
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2627|2706|lyfalmen|V0494|2706|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||878||878|2706||1|0|G|0|||0
004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2810|5366|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2810||2810|5366||1|0||0|||0
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3817|4269|lyfalmen|V0320|4251|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cítalópram||2013||2013|4269||1|0|G|0|||0
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|G|0|SDH|0|0|0|100|XEU|7575|11924|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7575||7575|11924||1|0|G|0|||0
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|773|2562|lyfalmen|||2|24|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||773||773|2562||1|0||0|||0
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3878|6836|lyfalmen|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||3878||3878|6836||1|0|0|0|||0
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|ATE|0|0|1|100|DKK|332|1955|lyfalmen|||2|8|0|2,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||332||332|1955||1|0||0|||0
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|850|2668|lyfalmen|||2|14|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||850||850|2668||1|0||0|||0
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1455|3501|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól||1455||1455|3501||1|0||0|||0
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2372|4763|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2372||2372|4763||1|0||0|||0
005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|8065|7151|lyfalmen|V0148|4237|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4107||4107|7151||1|0|G|0|||0
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2409|4161|lyfalmen|V0337|3948|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díkloxacillín||1935||1935|4161||1|0|E|0|||0
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|G|0|AZD|0|0|0|100|SEK|17001|24898|lyfalmen|V0356|24898|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17001||17001|24898||1|0|G|0|||0
005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|G|0|BOI|0|0|0|100|DKK|1647|3765|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1647||1647|3765||1|0|G|0|||0
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4487|7674|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4487||4487|7674||1|0|G|0|||0
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|G|0|BII|0|0|0|100|DKK|4526|7728|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4526||4526|7728||1|0|G|0|||0
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1724|3871|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1724||1724|3871||2|0|G|0|||0
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|5415|8951|lyfalmen|V0020|7004|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5415||5415|8951||2|0|G|0|||0
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|G|0|LLS|0|0|0|100|DKK|3955|6942|lyfalmen|V0020|3502|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3955||3955|6942||2|0|G|0|||0
005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4312|7433|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Europe B.V.|Cetrorelix||4312||4312|7433||2|0|G|0|||0
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|G|0|LBK|0|0|0|100|DKK|5011|8395|lyfalmen|V0324|3838|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5011||5011|8395||1|0|G|0|||0
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|8043|12568|lyfalmen|V0325|4526|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8043||8043|12568||1|0|E|0|||0
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|G|0|NED|0|0|0|100|XEU|2525|4973|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2525||2525|4973||2|0|G|0|||0
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|13512|19993|lyfalmen|V0326|5352|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13437||13437|19993||1|0|E|0|||0
005963|J01CR0204|Amoxin comp|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RHA|0|0|1|100|IKR|1834|2668|lyfalmen|V0169|2530|2|14|0|8,1667|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||850||850|2668||2|0|E|0|||0
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5073|8480|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5073||5073|8480||1|0|G|0|||0
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|92349|120077|lyfalmen|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||92349||92349|120077||1|H|0|0|||0
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4845|8167|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4845||4845|8167||1|0|G|0|||0
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|70553|92509|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||70553||70553|92509||1|H|0|0|||0
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|BOI|1|0|0|100|DKK|3281|6395|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|Meloxícam||||3281|6395||1|0||0|||0
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12471|18663|lyfalmen|V1030|16089|1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12471||12471|18663||1|0|G|0|||0
006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|411630|518464|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||411630||411630|518464||1|H|L|0|||0
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|G|0|MSD|0|0|0|100|DKK|12541|18759|lyfalmen|V0099|14341|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||12541||12541|18759||1|0|G|0|||0
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|10969|16596|lyfalmen|V0117|4773|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||10969||10969|16596||1|0|E|0|||0
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|15708|23118|lyfalmen|V0118|7656|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15708||15708|23118||1|0|E|0|||0
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|AZD|0|0|0|100|SEK|18677|27205|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||18677||18677|27205||1|0|E|0|||0
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|77398|101167|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||77398||77398|101167||1|0|L|0|||0
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|1|0|0|PLS|0|1|0|100|DKK|197881|252620|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||197881||197881|252620||1|0|L|0|||0
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|2104|4394|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Tímólól í blöndum||2104||2104|4394||1|0|G|0|||0
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|BAM|0|0|0|100|SEK|6896|10990|lyfalmen|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||6896||6896|10990||2|0|0|0|||0
007449|V03AB3402|Fomepizol EUSA Pharma|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|SER|0|0|0|100|XEU|89535|116517|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||89535||89535|116517||3|H|0|0|||0
007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|ABV|0|0|0|100|DKK|21247|30147|lyfalmen|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21247||21247|30147||1|H|0|0|||0
007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5574|9170|lyfalmen|||1|30|0|15,0000|Icepharma hf|Upjohn EESV|Tólteródín||5574||5574|9170||1|0|G|0|||0
007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|0|0|SHG|0|1|0|100|XEU|227577|289553|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||227577|289553||1|H|L|0|||0
007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|4528|7730|lyfalmen|||1|30|0|30,0000|Icepharma hf|Upjohn EESV|Tólteródín||4528||4528|7730||1|0|G|0|||0
007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|14290|21167|lyfalmen|||1|100|0|100,0000|Icepharma hf|Upjohn EESV|Tólteródín||14290||14290|21167||1|0|G|0|||0
007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1561|2689|lyfalmen|V0290|2689|2|60|0|6,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Risperídón||865||865|2689||1|0|G|0|||0
007852|G02BB0101|NuvaRing|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst.|G02BB01|01.11.2002||R|0|0|0|0|0|DSM|0|0|0|100|DKK|3683|5879|lyfalm11|V0983|5196|1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3683||3683|5879||1|0||0|||1
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|NEL|0|0|0|100|DKK|1268|3243|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1268||1268|3243||1|0||0|||0
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|G|0|MCK|0|0|0|100|SEK|319|1937|lyfalmen|V0502|1034|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||319||319|1937||2|0|G|0|||0
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|1|100|XEU|823|2247|lyfalmen|V0226|2247|2|20|0|6,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||544||544|2247||1|0|G|1|30|dagar|0
008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|G|0|GPH|0|0|1|100|DKK|967|2829|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||967||967|2829||1|0|G|0|||0
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2625|4492|lyfalmen|V0227|4388|2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2175||2175|4492||1|0|G|1|30|dagar|0
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3735|5308|lyfalmen|V0228|5214|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||2768||2768|5308||1|0|G|1|30|dagar|0
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4377|6669|lyfalmen|V0224|6591|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||3757||3757|6669||1|0|G|1|30|dagar|0
008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|0|0|GEB|0|0|0|100|XEU|116384|151260|lyfalmen|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||116384||116384|151260||1|H|0|0|||0
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|CHP|0|0|0|100|IKR|8120|13996|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |Fenbendazolum||8120||8120|13996||2|0||0|||0
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|CHP|1|0|0|100|XEU|10914|20877|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||10914||10914|20877||2|0||0|||0
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2651||2|0|G|0|||0
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2579|5048|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2579||2579|5048||1|0|G|0|||0
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012|31.07.2021|L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|RRG|0|0|0|100|DKK|91135|118541|lyfalmen|||1|2|0|20,7700|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||91135||91135|118541||2|0|G|0|||0
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|1|G|0|RRG|0|0|0|100|DKK|106690|139204|lyfalmen|||1|2|0|27,6900|Icepharma hf|Roche Registration GmbH|Peginterferón alfa 2a||106690||106690|139204||2|0|G|0|||0
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6495|10438|lyfalmen|V0145|3558|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||6495|10438||2|0|E|0|||0
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|12879|19225|lyfalmen|V0145|7115|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||12879|19225||2|0|E|0|||0
008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4383|7531|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4383||4383|7531||2|0|G|0|||0
009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8006|12517|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8006||8006|12517||2|0|0|0|||0
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4944|8303|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||4944||4944|8303||2|0|G|0|||0
009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8006|12517|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8006||8006|12517||2|0|0|0|||0
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|PEU|0|0|1|100|DKK|10117|15423|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Europe MA EEIG|Parekoxíb||10117||10117|15423||1|0||0|||0
009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5897|9615|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5897||5897|9615||2|0|0|0|||0
009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2|0||0|||0
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20125|28728|lyfalmen|V1033|15993|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20125||20125|28728||1|0|G|0|||0
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1050|2943|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1050||1050|2943||1|0|G|0|||0
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1158|3092|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1158||1158|3092||1|0|G|0|||0
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1339|3341|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1339||1339|3341||1|0|G|0|||0
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1678|3808|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1678||1678|3808||1|0|G|0|||0
009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|NOK|6107|9904|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6107||6107|9904||2|0|0|0|||0
009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|8006|12517|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8006||8006|12517||2|0|0|0|||0
009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|NOK|6107|9904|lyfalmen|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6107||6107|9904||2|0|0|0|||0
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|1|0|0|GII|0|1|0|100|DKK|52025|69075|lyfsjukr|||1|30|0|30,0000|Gilead Sciences International Ltd|Gilead Sciences Ireland UC|Tenófóvír dísóproxíl||52025||52025|69075||2|0|L|0|||0
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8633|13380|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8633||8633|13380||1|0||0|||0
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9867|15079|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9867||9867|15079||1|0||0|||0
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9125|14058|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9125||9125|14058||1|0||0|||0
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9867|15079|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9867||9867|15079||1|0||0|||0
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|9125|14058|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||9125||9125|14058||1|0||0|||0
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|DPL|0|0|1|100|XEU|8633|13380|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8633||8633|13380||1|0||0|||0
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|0|0|MSD|0|0|0|100|DKK|5464|9019|lyfalmen|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5464||5464|9019||1|H|0|0|||0
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|G|0|LUN|0|0|0|100|DKK|14696|21725|lyfalmen|V0605|2874|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||14696||14696|21725||1|0|G|0|||0
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|7409|11696|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||7409||7409|11696||1|0|E|0|||0
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|FKA|0|0|0|100|DKK|9075|13989|lyfalmen|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||9075||9075|13989||1|H|0|0|||0
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|SAO|0|0|1|100|XEU|1279|3258|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1279||1279|3258||2|0||0|||0
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|244004|309984|lyfsjukr|||1|56|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||244004||244004|309984||3|0|L|0|||0
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|0|1|0|0|JCI|0|1|0|100|SEK|244635|310769|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Bósentan||244635||244635|310769||3|0|L|0|||0
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|1|0|0|PEU|0|1|0|100|DKK|652166|817623|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||652166||652166|817623||1|0|L|0|||0
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|0|0|BAM|0|0|0|100|SEK|39181|52830|lyfalmen|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||39181||39181|52830||2|H|0|0|||0
010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2548|2679|lyfalmen|V0058|2679|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||858||858|2679||2|0|G|0|||0
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|18623|27131|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||18623||18623|27131||1|0|E|0|||0
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|12547|18768|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||12547||12547|18768||1|0||0|||0
010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|3502|3090|lyfalmen|V0059|3090|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||1157||1157|3090||2|0|G|0|||0
010989|R06AE0707|Cetirizin STADA|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.05.2018||L|1|0|0|G|0|ASR|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cetirizín|||||1677||2|0|G|0|||0
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|OPC|0|0|0|100|DKK|28608|39457|lyfalmen|V0683|3375|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||28608||28608|39457||1|0|E|0|||0
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|G|0|OPC|0|0|0|100|DKK|23114|32508|lyfalmen|V0684|3375|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||23114||23114|32508||1|0|G|0|||0
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3325|6074|lyfalmen|V0825|2811|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3325||3325|6074||1|0|G|0|||0
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3441|6234|lyfalmen|V0826|3647|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3441||3441|6234||1|0|G|0|||0
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|LBK|0|0|0|100|DKK|14745|21793|lyfalmen|V0327|6315|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14745||14745|21793||1|0|E|0|||0
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|1083|2989|lyfalmen|V0827|2186|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1083||1083|2989||1|0|G|0|||0
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|G|0|GPA|0|0|0|100|XEU|2068|2907|lyfalmen|V0069|2884|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1024||1024|2907||1|0|G|0|||0
011397|J01CA0102|Doktacillin|stl/irs|||1|g|10|hgl||J01CA01|01.03.2020||R|0|0|0|0|0|MEA|0|0|1|100|SEK|13699|20353|lyfalmen|||1|10|0|1,6667|Icepharma hf|Meda AB|Ampicillín||13699||13699|20353||2|0|0|0|||0
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|G|0|AZD|0|0|0|100|SEK|5592|9195|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5592||5592|9195||1|0|G|0|||0
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|5037|8431|lyfalmen|V0691|5572|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5037||5037|8431||1|0|E|1|30|dagar|0
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|0|0|0|JAS|0|0|0|100|SEK|6443|7909|lyfalmen|V0624|5357|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4658||4658|7909||1|0|E|1|30|dagar|0
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|CHP|1|0|0|100|XEU|1778|3494|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |Xylazinum||1778||1778|3494||2|0||0|||0
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3505|6322|lyfalmen|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3505||3505|6322||1|H|0|1|30|dagar|0
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|OCO|0|0|0|100|DKK|4123|7993|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||4123||4123|7993||2|0||0|||0
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3359|4906|lyfalmen|V0323|4166|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Sertralín||2476||2476|4906||1|0|G|0|||0
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|3565|6405|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3565||3565|6405||2|H|0|0|||0
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|MAR|0|0|0|100|DKK|1878|4083|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1878||1878|4083||2|H|0|0|||0
012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|1|0|0|MSD|0|1|0|100|DKK|26023|36187|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26023||26023|36187||1|0|L|0|||0
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3426|6213|lyfalmen|V0909|2771|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3426||3426|6213||1|0|G|0|||0
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|6250|10100|lyfalmen|V0924|6005|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||6250||6250|10100||2|0|E|0|||0
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|0|0|0|JAS|0|0|0|100|SEK|8432|10125|lyfalmen|V0622|6132|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6268||6268|10125||1|0|E|1|30|dagar|0
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|GPH|0|0|1|100|DKK|879|2708|lyfalmen|||1|80|0|2,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||879||879|2708||1|0|E|0|||0
012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|JCI|0|0|0|100|SEK|4103|6396|lyfalm11|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4103||4103|6396||1|0||0|||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki|hlaup til notkunar um húð|G03BA03|01.12.2003||R|0|0|0|G|0|LBI|0|0|0|100|DKK|5510|9082|lyfalmen|||1|30|0|30,0000|Vistor hf|Laboratoires Besins International|Testósterón||5510||5510|9082||1|0|G|0|||0
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||950||950|2806||2|0|G|0|||0
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2941|3425|lyfalmen|V0251|3150|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||1400||1400|3425||2|0|G|0|||0
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|6106|8399|lyfalmen|V0959|4529|1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5014||5014|8399||1|0|E|1|30|dagar|0
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|8795|12359|lyfalmen|V0996|6950|1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7891||7891|12359||1|0|E|1|30|dagar|0
013172|J06BB0101|Rhophylac|stl|300|mcg|2|ml|1|áfspr||J06BB01|01.02.2004||R|0|0|0|0|0|CSB|0|0|0|100|SEK|7165|11360|lyfalmen|||1|2|0||Icepharma hf|CSL Behring GmbH|And-D(rh) immúnóglóbúlín||7165||7165|11360||2|H|0|0|||0
013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2767|4805|lyfalmen|V0042|4116|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxazósín||2403||2403|4805||1|0|G|0|||0
013347|L01EB0101|Iressa|töflur|250|mg|30|stk|1|þpakki||L01EB01|01.03.2010||R|0|0|1|0|0|AZE|0|1|0|100|SEK|290511|367826|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Gefitinib||290511||290511|367826||1|0|L|0|||0
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1175|3115|lyfalmen|||1|5|0|1,6700|Icepharma hf|Mundipharma A/S|Oxýcódon||1175||1175|3115||2|0|E|1|30|dagar|0
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|763|2402|lyfalmen|V0562|2402|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Íbúprófen||657||657|2402||2|0|G|0|||0
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2258|4606|lyfalmen|||1|10|0|3,3300|Icepharma hf|Mundipharma A/S|Oxýcódon||2258||2258|4606||2|0|E|1|30|dagar|0
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5686|9324|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5686||5686|9324||1|0|G|0|||0
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2097|4384|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2097||2097|4384||1|0|G|0|||0
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4376|7521|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4376||4376|7521||1|0|G|0|||0
013971|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.06.2012||R|0|0|1|0|0|NEL|0|1|0|100|DKK|93397|121402|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||93397||93397|121402||1|0|L|0|||0
013982|L01EA0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.05.2004||R|0|0|1|0|0|NEL|0|1|0|100|DKK|185940|237769|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatinib||185940||185940|237769||1|0|L|0|||0
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2264|4614|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2264||2264|4614||1|0|G|0|||0
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|GRH|0|0|1|100|DKK|5997|9752|lyfalmen|||1|50|0|13,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||5997||5997|9752||1|0|0|0|||0
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|G|0|UCB|0|0|0|100|DKK|14999|22143|lyfalmen|V1000|16638|1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||14999||14999|22143||1|0|G|0|||0
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|NED|0|0|0|100|XEU|47693|63596|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||47693||47693|63596||2|0|E|0|||0
014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1253|3223|lyfalmen|V0479|2936|2|60|0|4,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1253||1253|3223||1|0|E|0|||0
014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|SHS|0|0|1|100|DKK|1625|3735|lyfalmen|||2|100|0|6,6667|Artasan ehf|Sandoz A/S|Amoxicillín||1625||1625|3735||1|0|E|0|||0
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|G|0|AZD|0|0|0|100|SEK|16777|24590|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||16777||16777|24590||1|0|G|0|||0
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|366|1823|lyfalmen|V0563|1823|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Íbúprófen||236||236|1823||2|0|G|0|||0
014435|QM01AE0303|Dolovet vet.|duft|160|mg/g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|VET|0|0|0|100|XEU|2334|4587|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|Ketóprófen||2334||2334|4587||2|0||0|||0
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|1|0|0|GEI|0|1|0|100|DKK|71041|93126|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Adefovír||||71041|93126||2|0|L|0|||0
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|994|2265|lyfalmen|V0564|2265|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Íbúprófen||557||557|2265||2|0|G|0|||0
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|22040|31150|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||22040||22040|31150||1|0|G|0|||0
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|61064|80507|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||61064||61064|80507||1|0|G|0|||0
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|1|G|0|HES|0|0|0|100|DKK|40707|54760|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||40707||40707|54760||1|0|G|0|||0
014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OUS|0|0|0|100|XEU|666901|835949|lyfalmen|||1|60|0|60,0000|Recordati AB|Orphan Europe SARL|Carglumicsýra||666901||666901|835949||3|0|E|0|||0
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2426|4186|lyfalmen|V0673|4186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1953||1953|4186||1|0|G|0|||0
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|G|0|NAS|0|0|0|100|DKK|7018|11157|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7018||7018|11157||1|0|G|0|||0
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|G|0|NAA|0|0|0|100|DKK|1007|2884|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1007||1007|2884||1|0|G|0|||0
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1679|2806|lyfalmen|V0234|1694|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||950||950|2806||1|0|G|0|||0
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2397|2806|lyfalmen|V0233|2195|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||950||950|2806||1|0|G|0|||0
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|G|0|NAS|0|0|0|100|DKK|8165|12736|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8165||8165|12736||1|0|G|0|||0
015460|H01AC0114|Norditropin NordiFlex|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|13744|20415|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||13744||13744|20415||1|0|L|0|||0
015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|PAM|0|1|0|100|DKK|282401|357739|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||282401||282401|357739|31.5.2021|3|H|L|0|||0
015591|H01AC0114|Norditropin NordiFlex|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|27486|38038|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||27486||27486|38038||1|0|L|0|||0
015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|0|0|PAM|0|1|0|100|DKK|75264|98468|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||75264|98468|31.5.2021|3|H|L|0|||0
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11128|16814|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11128||11128|16814||1|0|G|0|||0
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|11064|16726|lyfalmen|V0900|16724|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11064||11064|16726||1|0|G|0|||0
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|G|0|COR|0|0|0|100|DKK|9667|14804|lyfalmen|V0829|14801|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9667||9667|14804||1|0|G|0|||0
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|16932|16971|lyfalmen|V0470|16971|1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||11242||11242|16971||1|0|G|0|||0
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|1|G|0|HES|0|0|0|100|DKK|33823|31676|lyfalmen|V1008|31676|1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||22456||22456|31676||1|0|G|0|||0
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3650|6291|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3650||3650|6291||2|0||0|||0
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5611|9671|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5611||5611|9671||2|0||0|||0
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3035|5231|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3035||3035|5231||2|0||0|||0
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|3080|5309|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||3080||3080|5309||2|0||0|||0
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5386|9283|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||5386||5386|9283||2|0||0|||0
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|0|0|0|ETH|0|0|1|100|GBP|1403|3429|lyfalmen|||2|10|0|3,3300|Icepharma hf|Ethypharm|Morfín||1403||1403|3429||2|0|E|1|30|dagar|0
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2961|5104|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|Moxidectinum í blöndum||2961||2961|5104||2|0||0|||0
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|1499|3561|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1499||1499|3561||1|0|E|0|||0
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2299|4662|lyfalmen|||1|14|0|7,0000|Icepharma hf|Upjohn EESV|Pregabalín||2299||2299|4662||1|0|E|0|||0
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|4881|8216|lyfalmen|V0686|1925|1|56|0|14,0000|Icepharma hf|Upjohn EESV|Pregabalín||4881||4881|8216||1|0|E|0|||0
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8608|13346|lyfalmen|V0687|2612|1|56|0|28,0000|Icepharma hf|Upjohn EESV|Pregabalín||8608||8608|13346||1|0|E|0|||0
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1511|3578|lyfalmen|||1|14|0|3,5000|Icepharma hf|Upjohn EESV|Pregabalín||1511||1511|3578||1|0|E|0|||0
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10843|16422|lyfalmen|V0689|3390|1|56|0|56,0000|Icepharma hf|Upjohn EESV|Pregabalín||10843||10843|16422||1|0|E|0|||0
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|PEU|0|0|1|100|DKK|86656|112876|lyfalmen|||1|70|0|7,0000|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||86656||86656|112876||1|0|0|0|||0
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3022|5657|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3022||3022|5657||1|H|0|0|||0
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|2212|4543|lyfalmen|V0685|2129|1|56|0|4,6667|Icepharma hf|Upjohn EESV|Pregabalín||2212||2212|4543||1|0|E|0|||0
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|15264|22507|lyfalmen|V0690|6125|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||15264||15264|22507||1|0|E|0|||0
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7838||1|0|E|0|||0
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|OPC|0|0|0|100|DKK|25206|35154|lyfalmen|V0682|3375|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||25206||25206|35154||1|0|E|0|||0
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.02.2004||R|1|1|0|0|0|HES|0|0|0|100|DKK|7270|9941|lyfalmen|V0960|5368|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6134||6134|9941||1|0|E|1|30|dagar|0
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|G|0|LVR|0|0|0|100|DKK|2752|5286|lyfalmen|V0240|5286|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2752||2752|5286||3|0|G|0|||0
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|47569|63439|lyfalmen|V0721|11682|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||47569||47569|63439||1|0||0|||0
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|70082|91913|lyfalmen|V0722|43747|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||70082||70082|91913||1|0||0|||0
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|AEB|0|0|0|100|DKK|26055|36228|lyfalmen|V0720|8288|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26055||26055|36228||1|0||0|||0
016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|0|0|GEB|0|1|0|100|XEU|59954|79103|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||59954||59954|79103||1|H|L|0|||0
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1450|3494|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1450|3494||1|0|E|0|||0
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|1|0|0|GEI|0|1|0|100|DKK|29686|40820|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín||29686||29686|40820||2|0|L|0|||0
016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|1912|4130|lyfalmen|V0943|3885|1|4|0|2,8000|Icepharma hf|Mundipharma A/S|Búprenorfín||1912||1912|4130||2|0|G|1|30|dagar|0
017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|G|0|PLS|0|0|0|100|DKK|962|2526|lyfalm11|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||962||962|2526||1|0|G|0|||1
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|ATE|0|0|0|100|XEU|5992|9745|lyfalmen|||2|500|0|333,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||5992||5992|9745||1|0||2|225|mg|0
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|ATE|0|0|0|100|SEK|6661|10666|lyfalmen|||2|500|0|500,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Zópíklón||6661||6661|10666||1|0||2|225|mg|0
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|1|G|0|BNB|0|0|0|100|XEU|83627|109045|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||83627||83627|109045||2|0|G|0|||0
017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|3427|6215|lyfalmen|V0944|5774|1|4|0|5,6000|Icepharma hf|Mundipharma A/S|Búprenorfín||3427||3427|6215||2|0|G|1|30|dagar|0
017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|0|G|0|MUP|0|0|0|100|DKK|6106|9902|lyfalmen|V0945|4174|1|4|0|11,2000|Icepharma hf|Mundipharma A/S|Búprenorfín||6106||6106|9902||2|0|G|1|30|dagar|0
017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|G|0|MSD|0|0|1|100|DKK|7096|11265|lyfalmen|V0986|9302|1|3|0|1,7273|Vistor hf|M.S.D.|Aprepitant||7096||7096|11265||1|0|G|0|||0
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|G|0|MEA|0|0|1|100|DKK|2513|4957|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2513||2513|4957||2|0|G|0|||0
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|BOI|0|0|0|100|DKK|6642|12772|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|Meloxícam||6642||6642|12772||1|0||0|||0
017668|J02AC0107|Fluconazol Krka|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1500|2186|lyfalmen|V0556|2186|2|4|0|3,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||500||500|2186||2|0||0|||0
017679|J02AC0107|Fluconazol Krka|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.12.2018||L|1|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól|||||||2|0||0|||0
017701|J02AC0107|Fluconazol Krka|hylki|150|mg|6|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2300|3563|lyfalmen|V0556|3279|2|6|0|4,5000|LYFIS ehf|Krka Sverige AB|Flúkónazól||1500||1500|3563||2|0||0|||0
017712|J02AC0107|Fluconazol Krka|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1271|2117|lyfalmen|V0551|2095|2|7|0|1,7500|LYFIS ehf|Krka Sverige AB|Flúkónazól||450||450|2117||2|0||0|||0
017745|J02AC0107|Fluconazol Krka|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|3500|2599|lyfalmen|V0552|2555|2|28|0|7,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||800||800|2599||2|0||0|||0
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|8234|12831|lyfalmen|V0107|2530|1|30|0|15,0000|Icepharma hf|Upjohn EESV|Eplerenón||8234||8234|12831||1|0|0|0|||0
018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||800||800|2599||2|0|G|0|||0
018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2107|3356|lyfalmen|V0947|3356|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1350||1350|3356||2|0|G|0|||0
018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2975|3631|lyfalmen|V0948|3631|2|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1550||1550|3631||2|0|G|0|||0
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|G|0|GPH|0|0|0|100|DKK|808|2273|lyfalmen|V0243|2062|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||563||563|2273||1|0|G|0|||0
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|6124|9927|lyfalmen|V0985|7087|1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6124||6124|9927||1|0|G|0|||0
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|17116|25056|lyfalmen|V0441|11163|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17116||17116|25056||1|0|G|0|||0
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|G|0|MEC|0|0|1|100|SEK|1066|2965|lyfalmen|V0414|2965|1|100|0|50,0000|Icepharma hf|Merck AB|Prednisólón||1066||1066|2965||2|0|G|0|||0
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|5106|8526|lyfalmen|V0438|4580|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5106||5106|8526||1|0|G|0|||0
018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|4458|7634|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||4458||4458|7634||1|0|E|0|||0
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|G|0|ASP|0|0|0|100|XEU|12913|19271|lyfalmen|V0440|8889|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||12913||12913|19271||1|0|G|0|||0
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|29692|40828|lyfalmen|V0111|6315|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Eplerenón||29692||29692|40828||1|0|E|0|||0
018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|0|0|WIL|0|0|0|100|XEU|92350|120078|lyfalmen|||1|3|0|21,0000|Williams & Halls efh|medac Gesellschaft|BCG bóluefni||92350||92350|120078||2|H|0|0|||0
018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|1|SPP|0|1|0|100|XEU|9305|14305|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||9305||9305|14305||2|H|L|0|||0
018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|COR|0|0|1|100|DKK|717|2485|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||717||717|2485||1|0|E|0|||0
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|1|G|0|TGM|0|0|0|100|NOK|76396|99899|lyfalmen|||1|28|0|28,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||76396||76396|99899||1|0|G|0|||0
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|5439|8984|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||5439||5439|8984||2|H|0|0|||0
019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|194191|248030|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||194191||194191|248030||2|H|L|0|||0
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|16535|24257|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||16535||16535|24257||2|H|0|0|||0
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|19776|28718|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Iohexol||19776||19776|28718||2|H|0|0|||0
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|17781|25972|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||17781||17781|25972||2|H|0|0|||0
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|23930|33540|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||23930||23930|33540||2|H|0|0|||0
019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|97078|126058|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||97078||97078|126058||2|H|L|0|||0
019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|48541|64668|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||48541||48541|64668||2|H|L|0|||0
019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|SPP|0|1|0|100|IKR|24272|33973|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||24272||24272|33973||2|H|L|0|||0
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|5862|11292|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||5862||5862|11292||1|0||0|||0
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|456|2017|lyfalmen|V0633|2017|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||377||377|2017||1|0|G|0|||0
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|CAR|0|0|0|100|DKK|32058|60991|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||32058||32058|60991||1|0||0|||0
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|6111|9909|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6111||6111|9909||2|0|E|0|||0
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|45534|60865|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||45534||45534|60865||2|H|L|0|||0
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|NED|0|0|0|100|XEU|5708|9354|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5708||5708|9354||2|0|E|0|||0
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|0|0|RRG|0|1|0|100|DKK|172406|220936|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration GmbH|Bevacizúmab||172406||172406|220936||2|H|L|0|||0
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|MYL|0|0|1|100|SEK|895|2417|lyfalmen|V0159|2306|2|20|0|6,6667|Icepharma hf|Mylan AB|Amoxicillín||668||668|2417||2|0|E|0|||0
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|0|0|NED|0|1|0|100|XEU|152688|196412|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||152688||152688|196412||2|H|L|0|||0
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11935|17925|lyfalmen|V0812|3197|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11935||11935|17925||2|0|E|0|||0
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11935|17925|lyfalmen|V0813|3197|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11935||11935|17925||2|0|E|0|||0
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11272|17013|lyfalmen|V0814|3197|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11272||11272|17013||2|0|E|0|||0
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11272|17013|lyfalmen|V0815|3197|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11272||11272|17013||2|0|E|0|||0
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|DAN|0|0|0|100|XEU|11272|17013|lyfalmen|V0816|3325|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11272||11272|17013||2|0|E|0|||0
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|0|1|0|0|VIC|0|1|0|100|DKK|56857|75186|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín og abacavír||56857||56857|75186||1|0|L|0|||0
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1112|2811|lyfalmen|V0160|2748|2|30|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||954||954|2811||2|0|E|0|||0
020011|N06AB0405|Citalopram PCD|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.04.2018||R|1|0|0|G|0|PDA|0|0|0|100|IKR|4500|4251|lyfalmen|V0320|4251|2|100|0|200,0000|LYFIS ehf|PharmaCoDane ApS|Cítalópram||2000||2000|4251||2|0|G|0|||0
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1|0||0|||0
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|29344|40388|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||29344||29344|40388||1|0||0|||0
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|LVR|0|0|0|100|NOK|2609|5089|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2609||2609|5089||3|0|E|0|||0
020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|1|0|0|RPR|0|1|0|100|XEU|89990|117093|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|HRA Pharma Rare Diseases|Mitotanum||89990||89990|117093||0|0|L|0|||0
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|45018|60212|lyfalmen|||1|2|0|155,7500|Vistor hf|Recordati Ireland Limited|Leuprórelín||45018||45018|60212||1|0|G|0|||0
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|1|G|0|REI|0|0|0|100|DKK|20860|29657|lyfalmen|||1|2|0|51,9400|Vistor hf|Recordati Ireland Limited|Leuprórelín||20860||20860|29657||1|0|G|0|||0
020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6080|9866|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||6080||6080|9866||2|0|G|0|||0
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|BOA|0|0|0|100|XEU|2055|3542|vetorma|||0|7,74|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum í blöndum||2055||2055|3542||1|0||0|||0
020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|0|0|UCC|0|0|0|100|DKK|46136|61626|lyfalmen|||1|180|0|12,0000|Vistor hf|UCB Pharma S.A.|sodium oxybate||||46136|61626||1|0|E|3|||0
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|LLS|0|0|0|100|DKK|2408|4812|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2408||2408|4812||2|0||0|||0
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|GAN|0|0|0|100|XEU|1878|4083|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1878||1878|4083||2|0||0|||0
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|IKR|633|2357|lyfalmen|V0188|2193|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||624||624|2357||1|0|G|0|||0
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1306|2739|lyfalmen|V0189|2668|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||902||902|2739||1|0|G|0|||0
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|G|0|MSD|0|0|0|100|DKK|11846|17803|lyfalmen|V0490|14769|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||11846||11846|17803||1|0|G|0|||0
021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1|0||0|||0
021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|32621|44533|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||32621||32621|44533||3|0|G|0|||0
021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|G|0|URE|0|0|0|100|XEU|59760|78858|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||59760||59760|78858||3|0|G|0|||0
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3707|6600|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3707||3707|6600||1|0|G|0|||0
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12373|18528|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12373||12373|18528||1|0|G|0|||0
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|AZD|0|0|0|100|SEK|11631|17507|lyfalmen|V0214|4512|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11631||11631|17507||1|0|E|0|||0
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|6178|10001|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6178||6178|10001||1|0|G|0|||0
021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|G|0|FER|0|0|0|100|DKK|13591|20205|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13591||13591|20205||1|0|G|0|||0
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|14631|21636|lyfalmen|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||14631||14631|21636||1|H|0|0|||0
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|G|0|FEL|0|0|0|100|DKK|17360|25392|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||17360||17360|25392||1|0|G|0|||0
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|22520|31757|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22520||22520|31757||1|0|G|0|||0
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|FKA|0|0|0|100|DKK|8412|13076|lyfalmen|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||8412||8412|13076||1|H|0|0|||0
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|PLS|0|0|1|100|DKK|4026|7039|lyfalmen|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4026||4026|7039||1|0|0|0|||0
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|18030|26314|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18030||18030|26314||1|0|G|0|||0
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|3138|5817|lyfalmen|V0692|2242|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3138||3138|5817||2|0|E|0|||0
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|4409|7566|lyfalmen|V0693|3453|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4409||4409|7566||2|0|E|0|||0
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|NED|0|0|0|100|XEU|11517|17350|lyfalmen|V0694|3861|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||11517||11517|17350||2|0|E|0|||0
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|1|G|0|SCL|0|0|0|100|DKK|23873|33468|lyfalmen|V1034|33468|1|100|0||Shire Sweden AB |Shire Pharmaceuticals Ireland Limited|Anagrelidum||23873||23873|33468||1|0|G|0|||0
022050|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|VIN|0|0|1|100|XEU|2555|5015|lyfalmen|V1053|5015|1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2555||2555|5015||2|0|0|0|||0
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|AXA|0|0|0|100|DKK|96836|125752|lyfalmen|||1|1200|0||Baxalta Innovations GmbH|Baxalta Innovations GmbH|albumin||96836||96836|125752||1|H|0|0|||0
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4119|7167|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4119||4119|7167||1|0|G|0|||0
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|1|0|0|LPT|0|0|0|100|XEU|14441|21375|lyfalmen|||1|1|0||Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||14441||14441|21375||1|0||0|||0
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|2101|3621|vetorma|||0|2,24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||2101||2101|3621||2|0||0|||0
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|3519|3115|lyfalmen|V0056|2207|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Amlódipín||1175||1175|3115||1|0|G|0|||0
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|6238|4053|lyfalmen|V0057|2207|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Amlódipín||1856||1856|4053||1|0|G|0|||0
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1990|3430|vetorma|||0|1,4|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1990||1990|3430||2|0||0|||0
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1288|2220|vetorma|||0|0,7|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1288||1288|2220||2|0||0|||0
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1852|3901|lyfalmen|V0321|3901|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paroxetín||1746||1746|3901||1|0|G|0|||0
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4066||2|0|G|0|||0
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|2098|4386|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2098||2098|4386||1|0|G|0|||0
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|1|G|0|ATE|0|0|0|30|XEU|3118|4834|lyfalmen|V0125|3777|2|30|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísótretínóín||2424||2424|4834||1|0|G|0|||0
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|1|0|0|GEI|0|1|0|100|DKK|61881|81541|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír dísóproxíl og emtrícítabín||61881||61881|81541||2|0|L|0|||0
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|22204|31357|lyfalmen|||1|90|0|20,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||22204||22204|31357||1|0||0|||0
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|1|0|0|SHE|0|0|0|100|DKK|34068|46363|lyfalmen|||1|90|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|Lanthanum karbónat||34068||34068|46363||1|0||0|||0
023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|3000|3907|lyfalmen|V0125|3777|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1750||1750|3907||2|0|G|0|||0
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|12542|18761|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||12542||12542|18761||1|0|G|0|||0
023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|1|G|0|RTH|0|0|0|30|IKR|5231|7554|lyfalmen|V0125|7554|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||4400||4400|7554||2|0|G|0|||0
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|G|0|ZRP|0|0|0|100|DKK|14853|21942|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|zr pharma& GmbH|Darífenacín||14853||14853|21942||1|0|G|0|||0
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2189|3031|lyfalmen|V0250|2453|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1114||1114|3031||2|0|G|0|||0
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2825|3521|lyfalmen|V0251|3150|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1470||1470|3521||2|0|G|0|||0
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|G|0|SGB|0|0|0|100|XEU|15927|23420|lyfalmen|V0029|5655|1|100|0|100,0000|Vistor hf|Sanofi-aventis groupe|Klópídógrel||15927||15927|23420||1|0|G|0|||0
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|G|0|SAO|0|0|0|100|XEU|1897|4109|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1897||1897|4109||2|0|G|0|||0
023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|115746|150467|lyfalmen|||2|1500|0||Icepharma hf|Baxter Medical AB|Sevóflúran||115746||115746|150467||2|H|0|0|||0
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|900|2737|lyfalmen|V0066|2662|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2737||2|0|G|0|||0
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1050|2943|lyfalmen|V0449|2943|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2943||2|0|G|0|||0
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|750|2530|lyfalmen|V0448|2288|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||750||750|2530||2|0|G|0|||0
023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|6144|9955|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6144||6144|9955||2|0|G|0|||0
023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2327|4701|lyfalmen|V0673|4186|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||2327||2327|4701||2|0|G|0|||0
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|25456|35470|lyfalmen|V0984|27989|1|90|0|36,0000|Icepharma hf|Upjohn EESV|Síldenafíl||25456||25456|35470||1|0|G|0|||0
023993|A02BC0308|Lansoprazol Krka|sþ-hylki|30|mg|98|stk|1|ílát||A02BC03|01.08.2018||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3500|4939|lyfalmen|V0007|4939|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól||2500||2500|4939||2|0|G|0|||0
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2476|4906|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2476||2476|4906||1|0|G|0|||0
024040|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6000|9756|lyfalmen|V0384|9756|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||6000||6000|9756||2|0|G|0|||0
024053|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|2992|4526|lyfalmen|V0381|4526|2|10|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2200||2200|4526||2|0|G|0|||0
024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|1|0|0|OUS|0|0|0|100|XEU|57606|76134|lyfalmen|||1|5|0|5,0000|Recordati AB|Orphan Europe SARL|Carglumicsýra||57606||57606|76134||3|0|E|0|||0
024276|N06AB0607|Sertralin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3264|4251|lyfalmen|V0323|4251|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Sertralín||2000||2000|4251||2|0|G|0|||0
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|64980|85460|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||64980||64980|85460||1|0|G|0|||0
024366|N06AB0607|Sertralin Krka|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.07.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1926|3012|lyfalmen|V0322|2916|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Sertralín||1100||1100|3012||2|0|G|0|||0
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11617|17488|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11617||11617|17488||1|0||0|||0
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|11432|17233|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11432||11432|17233||1|0||0|||0
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9121|14052|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9121||9121|14052||1|0||0|||0
024603|V04CL0001|Soluprick  Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2267|4618|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2267||2267|4618||1|0||0|||0
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9121|14052|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9121||9121|14052||1|0||0|||0
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|9258|14241|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9258||9258|14241||1|0||0|||0
024681|V04CL0002|Soluprick  Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|ALK|0|0|0|100|DKK|2267|4618|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||2267||2267|4618||1|0||0|||0
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1820|4003|lyfalmen|||2|100|0|66,6667|Alvogen|ratiopharm GmbH|Metóprólól||1820||1820|4003||2|0|G|0|||0
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|50644|67328|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||50644||50644|67328||1|0|G|0|||0
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|1547|3627|lyfalmen|||2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||1547||1547|3627||2|0|G|0|||0
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|1|0|0|BSP|0|1|0|100|DKK|52676|69898|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||52676||52676|69898||1|0|L|0|||0
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|BOI|1|0|0|100|DKK|8934|17120|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|Meloxícam||8934||8934|17120||1|0||0|||0
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|14007|20777|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||14007||14007|20777||1|0|E|0|||0
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|4892|8231|lyfalmen|V0205|1279|1|1|0|30,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||4892||4892|8231||2|0|E|0|||0
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|ATP|0|0|0|100|DKK|13111|19544|lyfalmen|V0205|3838|1|3|0|90,0000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13111||13111|19544||2|0|E|0|||0
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|1|0|0|ALK|0|0|0|100|DKK|40637|54671|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||40637||40637|54671||1|0|E|0|||0
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|MAR|0|0|0|100|DKK|5784|9459|lyfalmen|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5784||5784|9459||2|H|0|0|||0
025814|H01AC0114|Norditropin NordiFlex|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|41241|55435|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||41241||41241|55435||1|0|L|0|||0
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|65311|85879|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||65311||65311|85879||1|0|G|0|||0
025911|QD11AH9102|Cytopoint|stl|10|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11035|21106|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||11035||11035|21106||2|0||0|||0
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|1|0|0|CPV|0|1|0|100|DKK|48052|64050|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Thalidómíde||||48052|64050||2|0|L|0|||0
025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|26589|36903|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||26589||26589|36903||1|0||0|||0
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|3617|6234|vetorma|||0|1|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||3617||3617|6234||1|0||0|||0
025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|1|G|0|ZET|0|0|0|100|XEU|85634|85029|lyfalmen|||2|28|0|28,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||64639||64639|85029||2|0|G|0|||0
025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||2|0||0|||0
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|2037|4004|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2037||2037|4004||1|0||0|||0
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|BOA|0|0|0|100|XEU|8630|14875|vetorma|||0|2,5|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||8630||8630|14875||1|0||0|||0
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|50974|67746|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||50974||50974|67746||1|0|G|0|||0
026490|L04AD0204|Dailiport|forðahlk|2|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|15543|22891|lyfalmen|||2|50|0|20,0000|Artasan ehf|Sandoz A/S|Tacrolimus||15543||15543|22891||1|0|G|0|||0
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|1694|3830|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1694|3830||1|0|G|0|||0
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|6689|10705|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6689|10705||1|0|G|0|||0
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|3347|6105|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3347|6105||1|0|G|0|||0
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|13061|19475|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||13061|19475||1|0|G|0|||0
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|19498|28335|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||19498|28335||1|0|G|0|||0
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|G|0|UCB|0|0|0|100|DKK|25882|36009|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||25882|36009||1|0|G|0|||0
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|1223|3181|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1223||1223|3181||2|0|0|0|||0
026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|DKK|9544|14634|lyfalmen|V0099|14634|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||9544||9544|14634||2|0|G|0|||0
027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7860|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7860||2|0|E|1|30|dagar|0
027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|16568|24302|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16568||16568|24302||1|0|G|0|||0
027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2043|4310|lyfalmen|V0823|3743|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||2043||2043|4310||2|0|G|0|||0
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|MEA|0|0|1|100|DKK|859|2680|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||859||859|2680||2|0||0|||0
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2002|4253|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2002||2002|4253||1|0|G|0|||0
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|12302|10813|lyfalmen|||2|100|0|66,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6768||6768|10813||1|0|G|0|||0
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|11845|10813|lyfalmen|V0342|10813|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||6768||6768|10813||1|0|G|0|||0
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|BAM|0|0|1|100|SEK|2303|4668|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2303||2303|4668||2|0|0|0|||0
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|G|0|EIG|0|0|0|100|SEK|5922|9649|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai GmbH|Zonisamíð||5922||5922|9649||1|0|G|0|||0
027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|0|G|0|MYL|0|0|0|100|SEK|3892|4174|lyfalmen|V0945|4174|2|4|0|11,2000|Icepharma hf|Mylan AB|Búprenorfín||1944||1944|4174||2|0|G|1|30|dagar|0
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|G|0|OHS|0|0|0|100|DKK|562|2271|lyfalmen|||2|100|0|33,3300|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||562||562|2271||1|0|G|0|||0
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|G|0|OHS|0|0|0|100|DKK|648|2390|lyfalmen|||2|100|0|66,6667|Vistor hf|Orifarm Healthcare A/S|Levótýroxínnatríum||648||648|2390||1|0|G|0|||0
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|19120|27815|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19120||19120|27815||1|0|E|0|||0
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|28439|39243|lyfalmen|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28439||28439|39243||2|H|0|0|||0
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|OPC|0|0|0|100|DKK|21683|30698|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||21683||21683|30698||1|0|E|0|||0
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|34015|46296|lyfalmen|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||34015||34015|46296||2|H|0|0|||0
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|NED|0|0|0|100|XEU|45829|61238|lyfalmen|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||45829||45829|61238||2|H|0|0|||0
028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|BAB|0|0|0|100|DKK|4005|6275|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||4005||4005|6275||2|0||0|||1
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16525|24243|lyfalmen|V0387|24243|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16525||16525|24243||1|0|G|0|||0
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2943||2|0||0|||0
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16071|23618|lyfalmen|V0386|23618|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||16071||16071|23618||1|0|G|0|||0
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|46009|61466|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||46009||46009|61466||1|0|L|0|||0
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2867|5444|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir  mótefnavakar||2867||2867|5444||1|0||0|||0
028342|J07BL0101|Stamaril|sts|||0,5|ml|1|hgl|+1 áf.spr.með leysi+2 nálar|J07BL01|01.04.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|3934|6913|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Gulusótt, veikluð veira||3934||3934|6913||1|0||0|||0
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|39344|53036|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||39344|53036||1|0||0|||0
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|2316|4413|lyfalmen|V0202|4157|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||2118||2118|4413||2|0|G|0|||0
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1715|3858|lyfalmen|V0428|3088|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1715||1715|3858||2|0|G|0|||0
028497|N04BC0505|Oprymea|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|800|2530|lyfalmen|V0266|2503|2|30|0|1,5000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||750||750|2530||2|0|G|0|||0
028519|N04BC0505|Oprymea|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2582|4388|lyfalmen|V0267|4277|2|100|0|10,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||2100||2100|4388||2|0|G|0|||0
028531|N04BC0505|Oprymea|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2018||R|1|0|0|G|0|KAN|0|0|0|100|IKR|14853|21942|lyfalmen|||2|100|0|40,0000|Krka Sverige AB|Krka d.d. Novo mesto|Pramipexól||14853||14853|21942||2|0|G|0|||0
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|5675|4935|lyfalmen|V0245|4599|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2497||2497|4935||1|0|G|0|||0
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|G|0|GPH|0|0|0|100|DKK|10691|10862|lyfalmen|V0232|9557|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||6803||6803|10862||1|0|G|0|||0
028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|742|2503|lyfalmen|V0266|2503|2|30|0|1,5000|Alvogen|Alvogen|Pramipexól||730||730|2503||2|0|G|0|||0
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|OCO|1|0|0|100|DKK|7415|14238|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||7415||7415|14238||2|0||0|||0
028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|G|0|POF|0|0|0|100|XEU|2779|4277|lyfalmen|V0267|4277|2|100|0|10,0000|Alvogen|Alvogen|Pramipexól||2019||2019|4277||2|0|G|0|||0
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|G|0|GCA|0|0|1|100|DKK|1126|2929|lyfalmen|V0625|2190|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Flútíkasón||1040||1040|2929||1|0|G|0|||0
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|5794|9473|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5794||5794|9473||2|0||0|||0
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|LLS|0|0|0|100|DKK|15938|23435|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||15938||15938|23435||2|0||0|||0
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1|0|0|0|||0
029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|32888|44870|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||32888||32888|44870||2|0|E|1|30|dagar|0
029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|32888|44870|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||32888||32888|44870||2|0|E|1|30|dagar|0
029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|10945|16563|lyfalmen|V0801|14934|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||10945||10945|16563||2|0|E|1|30|dagar|0
029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|CAM|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|CampusPharma AB|CampusPharma AB|Meklózín|||||||1|0||0|||0
029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|32834|44802|lyfalmen|V0801|44802|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||32834||32834|44802||2|0|E|1|30|dagar|0
029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|10963|16587|lyfalmen|||1|10|0|3,3300|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||10963||10963|16587||2|0|E|1|30|dagar|0
029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|32888|44870|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||32888||32888|44870||2|0|E|1|30|dagar|0
029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|0|0|0|KWA|0|0|0|100|DKK|32888|44870|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Fentanýl||32888||32888|44870||2|0|E|1|30|dagar|0
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|0|0|EIG|0|1|0|100|SEK|47325|63130|lyfsjukr|||1|2|0||Vistor hf|Eisai GmbH|Eribulin||47325||47325|63130||1|H|L|0|||0
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|GAN|0|0|1|100|XEU|5405|8937|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5405||5405|8937||2|0|E|0|||0
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2806|lyfalmen|V0168|2806|2|20|0|6,6667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||950||950|2806||2|0|E|0|||0
030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|PEU|0|0|0|100|DKK|7657|12037|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7657||7657|12037||1|0||0|||0
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|15330|26423|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||15330||15330|26423||2|0||0|||0
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|G|0|NED|0|0|0|100|XEU|2554|5013|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2554||2554|5013||2|0|G|0|||0
031140|N06AX2701|Spravato|nefúði|28|mg|28|mg|2|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|62812|82718|lyfsjukr|||1|56|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||62812||62812|82718||1|H|L|1|30|dagar|0
031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2378|4771|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2378||2378|4771||2|0|G|0|||0
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5352|8864|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5352||5352|8864||1|0|G|0|||0
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|FEL|0|0|0|100|DKK|17891|26123|lyfalmen|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||17891||17891|26123||1|H|0|0|||0
032257|C01CA1703|Hypotron|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.10.2018|30.06.2021|R|1|0|0|G|0|RET|0|0|0|100|IKR|8875|13713|lyfalmen|||2|50|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||8875||8875|13713||1|0|G|0|||0
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|G|0|OPC|0|0|0|100|DKK|19713|28631|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||19713||19713|28631||1|0|G|0|||0
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|BOA|1|0|0|100|DKK|14347|24728|vetorma|||0|200|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||14347||14347|24728||1|0||0|||0
032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2100|3170|lyfalmen|V0069|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1215||1215|3170||2|0|G|0|||0
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|20813|29598|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||20813||20813|29598||1|0|G|0|||0
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|1|G|0|FER|0|0|0|100|DKK|38000|51336|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||38000|51336||1|0|G|0|||0
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|1274|2196|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||1274||1274|2196||2|0||0|||0
033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|2879|5461|lyfalmen|V1004|4538|1|28|0|3,7400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||2879||2879|5461||2|0|E|1|30|dagar|0
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|8554|16399|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8554|16399||2|0||0|||0
033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|9876|15091|lyfalmen|V1005|13114|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||9876||9876|15091||2|0|E|1|30|dagar|0
033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5763|9430|lyfalmen|V1006|7909|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5763||5763|9430||2|0|E|1|30|dagar|0
033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|18874|27476|lyfalmen|||1|98|0|26,1400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||18874||18874|27476||2|0|E|1|30|dagar|0
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|G|0|HES|0|0|1|100|DKK|1432|3469|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1432||1432|3469||1|0|G|0|||0
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|1391|2767|lyfalmen|V0189|2668|2|100|0|50,0000|Alvogen|Alvogen ehf|Díklófenak||922||922|2767||2|0|G|0|||0
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|G|0|GOV|0|0|1|100|XEU|618|2349|lyfalmen|V0188|2193|2|30|0|15,0000|Alvogen|Alvogen ehf|Díklófenak||618||618|2349||2|0|G|0|||0
033644|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|8397|13056|lyfalmen|||1|100|0|80,0000|Icepharma hf|Abcur AB|Metadón||8397||8397|13056||2|0|G|1|30|dagar|0
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|15306|22565|lyfalmen|V0185|21514|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||15306||15306|22565||2|0|G|0|||0
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|1|0|0|JCI|0|1|0|100|SEK|75709|99030|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||75709||75709|99030||1|0|L|0|||0
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|2318|4556|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2318|4556||2|0||0|||0
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|XEU|1967|2559|lyfalmen|V0098|2556|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||771||771|2559||2|0|G|0|||0
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|21991|31088|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||21991||21991|31088||2|H|L|0|||0
034613|N02AB0310|Fentanyl Alvogen|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|3360|5967|lyfalmen|V0220|5967|2|5|0|15,0000|Alvogen|Alvogen|Fentanýl||3247||3247|5967||2|0|G|1|30|dagar|0
034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3882|4377|lyfalmen|V0323|4251|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||2092||2092|4377||1|0|G|0|||0
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|1034|2921|lyfalmen|||1|6|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||1034||1034|2921||1|0|G|0|||0
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|2416|4823|lyfalmen|||1|12|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||2416||2416|4823||1|0|G|0|||0
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|LEP|0|0|1|100|DKK|6612|10599|lyfalmen|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6612||6612|10599||1|0|0|0|||0
035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1896|4108|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1896||1896|4108||1|H|0|0|||0
035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|2334|4710|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||2334|4710||1|0|G|0|||0
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|14579|21564|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14579||14579|21564||1|0|G|0|||0
035495|N02AJ0602|Parkodin forte|filmhtfl|530|mg|20|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|598|2321|lyfalmen|||2|20|0|6,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||598||598|2321||1|0|E|3|||0
035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|2334|3012|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|ratiopharm GmbH|Metóprólól||1100||1100|3012||2|0|G|0|||0
035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|G|0|RTH|0|0|0|100|IKR|4390|5571|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|ratiopharm GmbH|Metóprólól||2959||2959|5571||2|0|G|0|||0
035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2766|3293|lyfalmen|V0233|3293|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1304||1304|3293||1|0|G|0|||0
035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
035982|B01AF0102|Rivaroxaban WH|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|30365|41679|lyfalmen|V0975|41679|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||30365||30365|41679||2|0|G|0|||0
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|GEB|0|0|0|100|XEU|22797|32107|lyfalmen|V0680|14915|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22797||22797|32107||1|0||0|||0
036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7757|12175|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7757|12175||2|0|G|0|||0
036339|N02BE5107|Paradorm|filmhtfl|525|mg|10|stk|1|þpakki|500+25 mg|N02BE51|01.09.2020||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6666|Acare ehf|Acare ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||2|0|0|0|||0
036353|R06AX2708|Dasergin|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|G|0|KAN|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||2979||2|0|G|0|||0
036431|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.09.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1402|3428|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer Aps|Metýlprednisólón||||1402|3428||1|0|G|0|||0
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|694|2453|lyfalmen|||1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||694||694|2453||2|0|E|0|||0
036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|16200|23796|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16200||16200|23796||1|0|G|0|||0
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|BIV|0|0|0|100|DKK|1436|2475|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1436||1436|2475||1|0||0|||0
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1|0||0|||0
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2409|4814|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2409||2409|4814||2|0|E|0|||0
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|MEA|0|0|1|100|DKK|915|2757|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||915||915|2757||2|0|E|0|||0
036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|G|0|VAL|0|0|1|100|IKR|342|1969|lyfalmen|V0006|1312|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||342||342|1969||2|0|G|0|||0
037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|6287|7298|lyfalmen|V0532|6717|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4214||4214|7298||1|0|G|0|||0
037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|11757|10186|lyfalmen|V0533|9317|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6312||6312|10186||1|0|G|0|||0
037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|G|0|GPH|0|0|0|100|DKK|16253|18980|lyfalmen|V0534|17196|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||12701||12701|18980||1|0|G|0|||0
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2320|4691|lyfalmen|V0434|4598|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2320||2320|4691||2|0|G|0|||0
037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3533|4939|lyfalmen|V0054|4939|2|100|0|133,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2500||2500|4939||2|0|G|0|||0
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1047|2697|0|100|0|25,0000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||2697||2|0|G|0|||0
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|G|0|KPA|0|0|0|100|DKK|||lyfalmen|V1048|4668|0|250|0|62,5000|Alvogen|Karo Pharma AB|Kalíumklóríð|||||4668||2|0|G|0|||0
037992|J06BA0210|Octagam 10%|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|337729|426552|lyfsjukr|||1|300|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||337729||337729|426552||1|H|L|0|||0
038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|G|0|GPH|0|0|0|100|DKK|3264|4182|lyfalmen|V0321|3901|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1950||1950|4182||1|0|G|0|||0
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1595|2742|lyfalmen|V0110|2576|2|100|0|133,3333|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||904||904|2742||1|0|G|0|||0
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|13435|19990|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||13435|19990||2|0|G|0|||0
039145|L01XC0303|Trazimera|st/irþ|420|mg|420|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|212721|271077|lyfsjukr|||1|420|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||212721||212721|271077||1|H|L|0|||0
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|1|0|0|PSS|0|0|0|100|SEK|27083|37528|lyfalmen|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||27083||27083|37528||2|0|0|0|||0
039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|11559|16334|lyfalmen|V0388|15262|2|50|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||10779||10779|16334||1|0|G|0|||0
039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|1532|3607|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1532||1532|3607||2|0|G|0|||0
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|GBI|0|0|0|100|DKK|5353|8866|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5353||5353|8866||1|0||0|||0
039441|A09AA0217|Creon 10.000 (Lyfjaver)|sþ-hylki|||100|stk|1|tfílát||A09AA02|01.12.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|3492|6304|lyfalmen|V0706|6304|3|100|0|16,6700|Lyfjaver ehf|Lyfjaver ehf|Hvatablöndur (lípasi, próteasi o.s.frv.)||3492||3492|6304||3|0|G|0|||0
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|1|0|0|SGB|0|0|0|100|XEU|17545|25647|lyfalmen|V1027|17117|1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||17545||17545|25647||1|0|E|0|||0
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4197|7275|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||4197||4197|7275||2|0|G|0|||0
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1039|2928|lyfalmen|||2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||1039||1039|2928||2|0|G|0|||0
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1042|2932|lyfalmen|||2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||1042||1042|2932||2|0|G|0|||0
039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|PLS|0|0|1|100|DKK|686|2442|lyfalmen|V0821|2186|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||686||686|2442||1|0|E|0|||0
039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1444|3485|lyfalmen|V0822|2874|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1444||1444|3485||1|0|E|0|||0
039829|L04AX0402|Lenalidomid Alvogen|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|701811|864546|lyfsjukr|||2|21|0|52,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||689894||689894|864546||2|0|L|0|||0
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1960|2576|lyfalmen|V0110|2524|2|98|0|130,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||783||783|2576||1|0|G|0|||0
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|G|0|ATE|0|0|1|100|XEU|6190|4189|lyfalmen|V0182|4189|2|42|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír||1955||1955|4189||1|0|G|0|||0
040092|N02AX0213|Tramadol Krka|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|2200|4388|lyfalmen|V0227|4388|2|100|0|33,3300|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2100||2100|4388||2|0|G|1|30|dagar|0
040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|G|0|RTH|0|0|0|100|XEU|2645|5138|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2645||2645|5138||2|0|G|0|||0
040771|N06AX2701|Spravato|nefúði|28|mg|28|mg|3|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|94218|122441|lyfsjukr|||1|84|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||94218||94218|122441||1|H|L|1|30|dagar|0
040823|A06AD6503|Movicol Junior Neutral|mixtduft|6,9|g|30|pokar|1|pakki|lausn|A06AD65|01.11.2018||L|0|0|0|0|0|NOG|0|0|0|100|IKR|||lyfalmen|||0|30|0||Vistor hf|Norgine BV|Makrógól 3350|||||3874||1|0|E|0|||0
040977|J01DD0402|Ceftriaxona Normon|sts|1000|mg|100|stk|1|hgl|+ 100 lykjur með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|217605|277151|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||217605||217605|277151||2|0|0|0|||0
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7781|12208|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7781||7781|12208||2|0|E|0|||0
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|LLS|0|0|0|100|DKK|7781|12208|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7781||7781|12208||2|0|E|0|||0
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|IBV|0|0|0|100|DKK|3780|6515|vetbolu|||0|100|0||Vistor hf|Intervet International BV|Clostridíum bóluefni||3780||3780|6515||1|0||0|||0
041816|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4730|3375|lyfalmen|V0682|3375|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1281|3261|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||1281||1281|3261||2|0|G|0|||0
041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8106|11133|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7000||7000|11133||2|0|G|0|||0
041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|8023|11354|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||7161||7161|11354||2|0|G|0|||0
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1|0||0|||0
042157|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1146|3075|lyfalmen|V0449|2943|2|100|0|200,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||1146||1146|3075||1|0|G|0|||0
042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5841|8720|lyfalmen|V0737|8720|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5247||5247|8720||2|0|E|0|||0
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2242|4584|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2242||2242|4584||1|0|0|0|||0
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3313|6058|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3313||3313|6058||1|0|0|0|||0
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|2001|4252|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2001||2001|4252||1|0|0|0|||0
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1931|4156|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1931||1931|4156||1|0|0|0|||0
042500|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|1 innöndunartæk+3 rörlykjur|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|12394|18326|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||12226||12226|18326||1|0|G|0|||0
042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|SSS|0|0|0|100|XEU|2128|4427|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||2128||2128|4427||1|0||0|||0
042628|N06AX2108|Aritavi|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.07.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6433|5262|lyfalmen|V0811|5262|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||2735||2735|5262||1|0|E|0|||0
042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1312|3304|lyfalmen|V0560|3304|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1312||1312|3304||2|0||0|||0
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|PLS|0|0|1|100|DKK|491|2174|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||491||491|2174||1|0||2|60|töflur|0
043965|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4990|5357|lyfalmen|V0624|5357|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2804||2804|5357||1|0|E|1|30|dagar|0
044065|H02AB0804|Kenacort-T|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2019||R|0|0|0|0|0|BBB|0|0|1|100|DKK|683|2438|lyfalmen|||0|1|0|5,3330|Vistor hf|Bristol-Myers Squibb AB|Tríamcínólón||683||683|2438||1|0||0|||0
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|G|0|LVR|0|0|1|100|CHF|12133|18198|lyfalmen|V0637|18198|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12133||12133|18198||3|0|G|0|||0
044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|0|0|NGV|0|0|0|100|DKK|13029|19431|lyfalmen|||1|8|0|1,0000|Norgine BV|Norgine B.V.|Misóprostól||13029||13029|19431||1|H|0|0|||0
044532|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8866|13701|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||8866||8866|13701||2|0||0|||0
044560|J05AB0105|Zovirax|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|4871|8202|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4871||4871|8202||1|0|G|0|||0
044580|L01EG0201|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|319516|403900|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||319516||319516|403900||1|0|L|0|||0
044591|L01EG0201|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01EG02|01.09.2011||R|0|0|1|0|0|NEL|0|1|0|100|DKK|447439|563000|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolimus||447439||447439|563000||1|0|L|0|||0
044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|G|0|BAM|0|0|0|100|SEK|5024|8413|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5024||5024|8413||2|0|G|0|||0
045202|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|29469|40546|lyfalmen|V0976|40273|2|98|0|73,5000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||29469||29469|40546||2|0|G|0|||0
045332|V03AN0502|Airapy|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|6866|10948|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6866||6866|10948||1|0|G|0|||0
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1263|2376|lyfalmen|V0109|2287|2|98|0|65,3400|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||638||638|2376||1|0|G|0|||0
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1044|2310|lyfalmen|V0108|2150|2|98|0|32,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Simvastatín||590||590|2310||1|0|G|0|||0
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|G|0|ATE|0|0|0|100|SEK|3673|6553|lyfalmen|||2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||3673||3673|6553||1|0|G|0|||0
046155|L01AD0105|Carmustine Obvius|sts|100|mg|1|hgl|1|pakki|1 lykja m. 3 ml leysi|L01AD01|01.03.2019||R|0|0|0|0|0|OBV|0|1|0|100|NOK|171145|219368|lyfsjukr|||2|1|0||Oresund Pharma ApS|Obvius Investment B.V.|Carmustine ||171145||171145|219368||2|H|L|0|||0
046188|M01AH0108|Celecoxib Medical|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|2075|4354|lyfalmen|V0429|4073|2|100|0|50,0000|LYFIS ehf|Medical ehf|Celekoxíb||2075||2075|4354||2|0|G|0|||0
046214|J02AC0107|Fluconazol Krka|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.09.2018||R|1|0|0|0|0|KRK|0|0|1|100|IKR|14206|10582|lyfalmen|V0419|9845|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Flúkónazól||6600||6600|10582||2|0||0|||0
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|1337|3338|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1337|3338||1|0|G|0|||0
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|926|2772|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||926||926|2772||1|0|G|0|||0
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|484|2090|lyfalmen|V0021|1992|2|90|0|45,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||430||430|2090||1|0|G|0|||0
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|745|2390|lyfalmen|V0022|2285|2|90|0|90,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||648||648|2390||1|0|G|0|||0
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|954|2642|lyfalmen|V0023|2518|2|90|0|135,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||831||831|2642||1|0|G|0|||0
046625|N06AB1008|Escitalopram STADA|filmhtfl|5|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|3838|lyfalmen|V0324|3838|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||1700||1700|3838||2|0|0|0|||0
046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|G|0|TSA|0|0|1|100|IKR|1563|2737|lyfalmen|V0625|2737|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||900||900|2737||2|0|G|0|||0
046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|G|0|POF|0|0|0|100|IKR|6568|3838|lyfalmen|V0205|3838|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1700||1700|3838||2|0|G|0|||0
047108|QA14AB0101|Myodine vet|stl|25|mg/ml|10|ml|1|hgl|lausn|QA14AB01|01.04.2019||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3385|6593|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Nandrolone||3385||3385|6593||2|0|0|0|||0
047154|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2933|4355|lyfalmen|V1010|2956|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||2076||2076|4355||2|0|G|0|||0
047238|C01BD0703|Dronedarone Teva|filmhtfl|400|mg|100|stk|1|stsk.þ||C01BD07|01.06.2021||R|1|1|1|0|0|TVI|0|0|0|100|XEU|14883|17117|lyfalmen|V1027|17117|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Dronedarón||11348||11348|17117||1|0|E|0|||0
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|34237|46577|lyfalmen|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||34237||34237|46577||5|H|0|0|||0
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|143635|185153|lyfalmen|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||143635||143635|185153||5|H|0|0|||0
047709|J05AB1403|Valganciclovir Medical Valley|filmhtfl|450|mg|60|stk|1|glas||J05AB14|01.06.2020||R|1|0|0|0|0|VAL|0|1|1|100|XEU|36627|49599|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Valgancíklóvír||36627||36627|49599||2|0|L|0|||0
047840|C02CA0408|Doxazosin Krka|forðatfl|4|mg|120|stk|1|þpakki||C02CA04|01.10.2020||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3622|4939|lyfalmen|V0042|4939|2|120|0|120,0000|Krka Sverige AB|Krka d.d. Novo mesto|Doxazósín||2500||2500|4939||2|0|G|0|||0
048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|4078|7111|lyfalmen|||1|250|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||4078||4078|7111||1|H|0|0|||0
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|7503|11825|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7503||7503|11825||1|0|0|0|||0
048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|BTP|0|0|0|100|DKK|6616|10604|lyfalmen|||1|100|0||Takeda Pharma A/S|Baxalta Innovations GmbH|albumin||6616||6616|10604||1|H|0|0|||0
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1791|3963|lyfalmen|V0324|3838|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1791||1791|3963||1|0|G|0|||0
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1053|2947|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||1053||1053|2947||1|0|E|0|||0
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2502|4942|lyfalmen|V0325|4526|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||2502||2502|4942||1|0|G|0|||0
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3378|6147|lyfalmen|V0326|5352|2|100|0|150,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||3378||3378|6147||1|0|G|0|||0
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5243|7862|lyfalmen|V0327|6315|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Escítalópram||4624||4624|7862||1|0|G|0|||0
048196|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5160|7444|lyfalmen|||2|120|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4320||4320|7444||2|0|G|0|||0
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|G|0|MEA|0|0|0|100|DKK|1984|4229|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||1984||1984|4229||2|0|G|2|100|töflur|0
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|0|0|GEB|0|1|0|100|XEU|801164|1002935|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||801164||801164|1002935||1|H|L|0|||0
048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|GCA|0|0|1|100|DKK|382|2024|lyfalmen|V0230|2024|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||382||382|2024||1|0|E|0|||0
048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|0|0|GAA|0|0|0|100|SEK|4913|8260|lyfalmen|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4913||4913|8260||2|H|0|0|||0
048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|35386|48030|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||35386||35386|48030||3|0|L|0|||0
048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4320|4237|lyfalmen|V0148|4237|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1990||1990|4237||2|0|G|0|||0
049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|6702|10723|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||6702||6702|10723||1|0|G|0|||0
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|4942|8300|lyfalmen|V0376|4972|1|7,5|0|75,0000|Icepharma hf|Upjohn EESV|Latanóprost||||4942|8300||1|0|G|0|||0
049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|270621|343088|lyfsjukr|||1|1|0|16,6700|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||270621||270621|343088||1|0|L|0|||0
049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|852|2671|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||852||852|2671||1|0|G|0|||0
049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|5008|8391|lyfalmen|||1|7|0|1,7500|Eisai AB|Eisai GmbH|Perampanel||5008||5008|8391||1|0|G|0|||0
049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2265|2287|lyfalmen|V0109|2287|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||573||573|2287||2|0|G|0|||0
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|993|2865|lyfalmen|||2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||993||993|2865||1|0|G|0|||0
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1695|3831|lyfalmen|||2|100|0|400,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ramipríl||1695||1695|3831||1|0|G|0|||0
049696|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|3600|4388|lyfalmen|V0384|3252|2|10|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||2100||2100|4388||2|0|G|0|||0
049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||1938|30.6.2021|1|0|E|0|||0
049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|0|0|WPA|0|0|0|100|DKK|70215|92082|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma (International) B.V|Cannabinoids||70215||70215|92082||1|0|E|1|30|dagar|0
049906|N02CC0106|Sumatriptan Apofri|filmhtfl|50|mg|2|stk|1|þpakki||N02CC01|01.06.2020||L|1|0|0|0|0|APO|0|0|0|100|IKR|||lyflausa|||0|2|0||LYFIS ehf|Apofri AB|Súmatriptan|||||||2|0||0|||0
049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|1|0|0|MBV|0|1|0|100|DKK|1047181|1308911|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme B.V.|Elbasvir og grazoprevir||1047181||1047181|1308911||1|0|L|0|||0
050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|8380|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||5000||5000|8380||2|0|E|0|||0
050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3995||1|0|G|0|||0
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|G|0|RTH|0|0|0|100|XEU|6977|11101|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||6977||6977|11101||2|0|G|0|||0
050323|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9201|14162|lyfalmen|V0925|14162|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||||9201|14162||2|0|E|0|||0
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|61697|81308|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||61697|81308||1|0|L|0|||0
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2750|5283|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||2750||2750|5283||2|0|G|0|||0
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10571|16048|lyfalmen|V0688|12655|1|56|0|42,0000|Icepharma hf|Upjohn EESV|Pregabalín||10571||10571|16048||1|0|E|0|||0
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5131|5418|lyfalmen|V0042|4116|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Doxazósín||2848||2848|5418|||0|G|0|||0
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|0|ATE|0|0|1|100|IKR|4615|7082|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||4057||4057|7082||1|0|0|0|||0
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|4360|2324|lyfalmen|V0006|2186|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||600||600|2324||1|0|G|0|||0
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|G|0|ATE|0|0|1|100|IKR|6304|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||1000||1000|2874||1|0|G|0|||0
051109|V03AN0502|Airapy|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1025|2698|lyfalmen|V0363|2698|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||872||872|2698||2|0|G|0|||0
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3154|5147|lyfalmen|V0365|5147|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2651||2651|5147||2|0|G|0|||0
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|UCB|0|0|0|100|DKK|16012|23537|lyfalmen|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||16012||16012|23537||1|H|0|0|||0
052210|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|4985|3885|lyfalmen|V0144|3885|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1734||1734|3885||2|0|E|0|||0
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|176|1740|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||176||176|1740|31.7.2021|2|0||2|120|töflur|0
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|672|2303|lyfalmen|V0305|1245|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||585||585|2303||2|0||2|120|töflur|0
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|MYL|0|0|1|100|SEK|267|1865|lyfalmen|||2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||267||267|1865|31.5.2021|2|0|0|2|60|töflur|0
052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|598|2321|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||598||598|2321||2|0||2|60|töflur|0
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|MYL|0|0|0|100|SEK|827|2489|lyfalmen|V0305|2489|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||720||720|2489||2|0||2|120|töflur|0
052360|L01EA0201|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01EA02|01.09.2007||R|0|0|1|0|0|BMS|0|1|0|100|DKK|540803|679119|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatinib||540803||540803|679119||1|0|L|0|||0
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|G|0|AGC|0|0|0|100|XEU|3144|5825|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Tímólól í blöndum||3144||3144|5825||1|0|G|0|||0
052414|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|3|glös||S01ED51|01.04.2018||R|0|0|0|G|0|TIC|0|0|0|100|XEU|7573|11921|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||7573||7573|11921||1|0|G|0|||0
052467|N06AX1615|Venlafaxine Alvogen|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2018||R|1|0|0|G|0|POF|0|0|0|100|IKR|7035|2874|lyfalmen|V0335|2568|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|28628|39482|lyfalmen|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||28628||28628|39482||1|0|0|0|||0
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23274|32711|lyfalmen|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||23274||23274|32711||1|0|0|0|||0
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23928|33538|lyfalmen|||1|7680|0||Vistor hf|Fresenius Kabi AB|Blöndur||23928||23928|33538||2|0|0|0|||0
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|FKA|0|0|0|100|DKK|20980|29809|lyfalmen|||1|7200|0||Vistor hf|Fresenius Kabi AB|Blöndur||20980||20980|29809||2|0|0|0|||0
052677|N02AB0310|Fentanyl Alvogen|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.09.2020||R|0|0|0|G|0|POF|0|0|0|100|XEU|2220|4554|lyfalmen|||2|5|0|3,6000|Alvogen|Alvogen|Fentanýl||2220||2220|4554||2|0|G|1|30|dagar|0
052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4448|3934|lyfalmen|V0682|3375|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|NAS|0|0|0|100|DKK|13985|20747|lyfalmen|||1|6|0|24,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||13985||13985|20747||1|0|E|0|||0
053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|39124|52758|lyfalmen|V1007|44998|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||39124||39124|52758||2|0|E|1|30|dagar|0
053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|5644|9266|lyfalmen|V1003|8163|1|98|0|6,5400|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||5644||5644|9266||2|0|E|1|30|dagar|0
053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|0|0|0|MUP|0|0|0|100|DKK|1655|3766|lyfalmen|V1002|3173|1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxycodonum í blöndum||1648||1648|3766||2|0|E|1|30|dagar|0
053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|6489|7967|lyfalmen|V0115|7967|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||4700||4700|7967||2|0|E|0|||0
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|1|G|0|SDH|0|0|0|100|XEU|24701|34515|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||24701||24701|34515||1|0|G|0|||0
053846|M05BA0602|Bonviva|stl|3|mg|3|ml|1|áfspr||M05BA06|01.11.2019||R|0|1|0|0|0|ATP|0|0|0|100|DKK|13222|19697|lyfalmen|V0957|16820|1|3|0|0,5000|Pharmanovia A/S|Atnahs Pharma Netherlands B.V.|Íbandrónsýra||13222||13222|19697||2|0|E|0|||0
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|0|0|0|ETH|0|0|0|100|GBP|10520|15978|lyfalmen|||2|10|0|50,0000|Icepharma hf|Ethypharm|Hýdrómorphón||10520||10520|15978||2|0||1|30|dagar|0
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|OPC|0|0|0|100|DKK|1395|3418|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Netherlands B.V.|Aripiprazól||1395||1395|3418||1|0|E|0|||0
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1872|4075|lyfalmen|||1|15|0|10,0000|Alvogen|Karo Pharma AB|Pívmecillínam||1872||1872|4075||2|0|E|0|||0
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|KPA|0|0|1|100|DKK|2639|5130|lyfalmen|||1|20|0|13,3300|Alvogen|Karo Pharma AB|Pívmecillínam||2639||2639|5130||2|0|E|0|||0
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|UCN|0|0|1|100|SEK|1076|2979|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1076||1076|2979||1|0||0|||0
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|UCN|0|0|0|100|SEK|1157|3090|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1157||1157|3090||1|0||0|||0
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|1462|3510|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||1462||1462|3510|30.6.2021|1|0|E|0|||0
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|0|0|0|CES|1|0|0|100|DKK|5265|10159|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||5265||5265|10159||2|0||1|30|dagar|0
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|10431|15855|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||10431||10431|15855||2|0|G|0|||0
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|1|1|G|0|TAB|0|0|0|100|XEU|6472|10406|lyfalmen|||2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||6472||6472|10406||2|0|G|0|||0
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|HES|0|0|1|100|DKK|1931|4156|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1931|4156||1|0||0|||0
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|8709|13485|lyfalmen|||1|100|0|60,0000|Icepharma hf|Mundipharma A/S|Morfín||8709||8709|13485||2|0|G|1|30|dagar|0
055372|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2726|2825|lyfalmen|V0334|2825|2|110|0|82,5000|Acare ehf|Medical Valley Invest AB|Venlafaxín||964||964|2825||2|0|G|0|||0
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|1768|3550|lyfalmen|V0467|2772|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1491||1491|3550||1|0|E|0|||0
055825|J02AC0402|Posaconazol Alvogen|sþ-tfl|100|mg|24|stk|1|stsk.þ||J02AC04|01.01.2021||R|0|0|1|0|0|ALE|0|1|0|100|DKK|90236|117404|lyfsjukr|||1|24|0|8,0000|Alvogen|Alvogen Pharma Trading Europe EOOD|Posacónazól||90236||90236|117404||2|0|L|0|||0
055873|N05AX1304|Paliperidon Krka|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|10082|15375|lyfalmen|V0965|15375|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||10082||10082|15375||2|0|G|0|||0
055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|2978|5597|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2978||2978|5597||1|0|G|0|||0
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2462|2916|lyfalmen|V0112|2733|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1030||1030|2916||1|0|G|0|||0
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3743|3169|lyfalmen|V0113|2735|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1214||1214|3169||1|0|G|0|||0
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5438|3169|lyfalmen|V0114|2736|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atorvastatín||1214||1214|3169||1|0|G|0|||0
056196|L01XC0501|Mylotarg|st/irþ|5|mg|1|hgl|1|pakki|lausn|L01XC05|01.06.2019||R|0|0|0|0|0|PEU|0|1|0|100|DKK|1026552|1283254|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Gemtuzumab ozogamicin||1026552||1026552|1283254||2|H|L|0|||0
056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|22343|31533|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||22343||22343|31533||2|0|E|0|||0
056339|C09BA0203|Enalapril-Hydrochlorthiazid Krka|töflur|32,5|mg|110|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2943|lyfalmen|V0098|2812|2|110|0|110,0000|LYFIS ehf|Krka Sverige AB|Enalapríl og þvagræsilyf||1050||1050|2943||2|0|G|0|||0
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|CES|1|0|0|100|XEU|25448|43862|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25448||25448|43862||2|0||0|||0
056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|3182|5878|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||3182||3182|5878||1|0|G|0|||0
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986|31.07.2021|R|1|0|0|0|0|MEA|0|0|1|100|DKK|1884|4091|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1884||1884|4091||2|0|E|0|||0
056858|L04AD0204|Dailiport|forðahlk|5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|44654|59752|lyfalmen|||2|50|0|50,0000|Artasan ehf|Sandoz A/S|Tacrolimus||44654||44654|59752||1|0|G|0|||0
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|0|0|BNB|0|1|0|100|XEU|202901|258863|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Netherlands B.V.|Natalizumab||202901||202901|258863||2|H|L|0|||0
057304|V03AN0502|Airapy|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3245|5964|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3245||3245|5964||2|0|0|0|||0
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|3348|6106|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3348||3348|6106||1|0|L|0|||0
057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2859|2874|lyfalmen|V0334|2568|2|100|0|75,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|3700|2874|lyfalmen|V0335|2568|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2874||2|0|G|0|||0
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|HES|0|1|0|100|DKK|2333|4709|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2333||2333|4709||1|0|L|0|||0
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|9877|6341|lyfalmen|V0607|3019|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3519||3519|6341||2|0|G|0|||0
057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|87430|113855|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||87430|113855||2|0|L|0|||0
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19051|27720|lyfalmen|V1050|27720|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19051|27720||1|0||0|||0
058199|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|100|stk|1|tfílát||N02AA05|01.10.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4592|7750|lyfalmen|V0585|7750|2|100|0|26,6666|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4542||4542|7750||1|0|G|1|30|dagar|0
058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|345790|436577|lyfsjukr|||1|1|0|33,3300|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||345790||345790|436577||1|0|L|0|||0
058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|152892|263525|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||152892|263525||2|0||0|||0
058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|LOH|0|0|0|100|XEU|232258|400320|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|chicken anaemia virus||||232258|400320||2|0||0|||0
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|MEA|0|0|1|100|DKK|2022|4281|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||2022||2022|4281||2|0|E|0|||0
058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|35315|47940|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35315||35315|47940||1|0|E|0|||0
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4769|8062|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4769||4769|8062||2|0|0|0|||0
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1128|3050|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1128||1128|3050||1|0|G|0|||0
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1625|3735|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1625||1625|3735||1|0|G|0|||0
059012|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki|stakskammtaþynna|A06AH03|01.10.2018||R|1|0|0|0|0|KWA|0|0|0|100|XEU|11389|17174|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Holdings B.V.|Naloxegol||11389||11389|17174||2|0|0|0|||0
059059|N06DA0405|Galantamin STADA|forðahlk|16|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|14895|21999|lyfalmen|||2|84|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||14895||14895|21999||2|0|G|0|||0
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|G|0|ATE|0|0|1|100|IKR|2374|2737|lyfalmen|V0006|1224|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól||900||900|2737||1|0|G|0|||0
059211|L01XC2801|Imfinzi|irþ|50|mg/ml|10|ml|1|hgl|500 mg/10 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|431037|542601|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Durvalumab||||431037|542601||1|H|L|0|||0
059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013|31.05.2021|R|0|0|0|0|0|HBP|0|0|0|100|DKK|10971|16598|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||10971||10971|16598||3|H|E|0|||0
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|1|G|0|REI|0|0|0|100|DKK|88774|115555|lyfalmen|||1|2|0|311,1900|Vistor hf|Recordati Ireland Limited|Leuprórelín||88774||88774|115555||1|0|G|0|||0
059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|0|0|PEU|0|0|0|100|DKK|55731|73762|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer Europe MA EEIG|Anidulafungin||55731||55731|73762||1|H|0|0|||0
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|G|0|BPC|0|0|0|100|SEK|23733|33291|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||23733||23733|33291||1|0|G|0|||0
059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|G|0|BAB|0|0|0|100|DKK|4362|7502|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4362|7502||2|0|G|0|||0
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|8430|13101|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8430||8430|13101||1|0|E|0|||0
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|1|0|0|ASP|0|0|0|100|XEU|42153|56589|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||42153||42153|56589||1|0|E|0|||0
059976|J01DD0402|Ceftriaxona Normon|irs|2000|mg|1|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|3061|5711|lyfalmen|||2|1|0|1,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||3061||3061|5711||2|0|0|0|||0
060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20568|29288|lyfalmen|V0713|29288|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20568||20568|29288||1|0|G|0|||0
060930|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|100|stk|1|þpakki||J01AA02|01.07.2018||R|1|0|0|0|0|EQL|0|0|1|100|IKR|5000|8380|lyfalmen|||2|100|0|100,0000|LYFIS ehf|EQL Pharma AB|Doxýcýklín||5000||5000|8380||2|0|E|0|||0
061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|1|0|0|SGB|0|1|0|100|XEU|96456|125271|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||96456||96456|125271||1|0|L|0|||0
061147|N05CF0201|Stilnoct|filmhtfl|10|mg|28|stk|1|þpakki||N05CF02|01.04.2021||R|1|0|0|0|0|SNP|0|0|1|100|XEU|297|1907|lyfalmen|V0060|1822|1|28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||297||297|1907||1|0||2|30|töflur|0
061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1994|2806|lyfalmen|V0112|2733|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|G|0|MBV|0|0|0|100|DKK|4813|8123|lyfalmen|||1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4813||4813|8123||1|0|G|0|||0
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|HES|0|0|0|100|DKK|3621|6482|lyfalmen|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3621||3621|6482||1|H|0|0|||0
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|13607|20227|lyfalmen|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||13607||13607|20227||1|0|0|0|||0
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|1|0|0|MLD|0|0|0|100|DKK|18259|26630|lyfalmen|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||18259||18259|26630||1|0|0|0|||0
062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|15000|18015|lyfalmen|V0924|18015|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||12000||12000|18015||2|0|E|0|||0
062544|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.11.2019||R|1|0|0|G|0|PIX|0|0|1|100|NOK|5581|9180|lyfalmen|||1|10|0|1,6667|Phoenix Labs|Phoenix Labs|Famcíclóvír||5581||5581|9180||2|0|G|0|||0
062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|1|0|0|GSE|0|1|0|100|XEU|1938668|2417671|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir||||1938668|2417671||1|0|L|0|||0
062662|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|úðaílá|HFA 134a|R03AC12|01.09.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|3569|6410|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3569||3569|6410||1|0|G|0|||0
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|874|2701|lyfalmen|V0308|2677|1|60|0|30,0000|Icepharma hf|Upjohn EESV|Alprazólam||874||874|2701||1|0||2|60|mg|0
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|BAN|0|0|0|100|DKK|16997|29296|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Phoximum||16997||16997|29296||2|0||0|||0
062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|73481|62490|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||46819||46819|62490||2|0|L|0|||0
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|GBI|0|0|0|100|DKK|11133|14987|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||9800||9800|14987||1|0||0|||0
062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|GBI|0|0|0|100|DKK|112326|146213|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||112326||112326|146213||1|0||0|||0
063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1725|3176|lyfalmen|V0276|3176|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||1219||1219|3176||1|0|G|0|||0
063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5323|6189|lyfalmen|V0277|6189|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klózapín||3408||3408|6189||1|0|G|0|||0
063426|L02BB0601|Nubeqa|filmhtfl|300|mg|112|stk|1|þpakki||L02BB06|01.01.2021||R|1|0|0|0|0|BAB|0|1|0|100|DKK|420377|529343|lyfsjukr|||1|112|0||Icepharma hf|Bayer AB|Darolutamide||420377||420377|529343||2|0|L|0|||0
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3367||2|0|E|0|||0
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2049|3545|lyfalmen|V0123|3545|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||1487||1487|3545||1|0|E|0|||0
063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|1|0|0|RRG|0|1|0|100|DKK|135979|175631|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||135979||135979|175631||2|0|L|0|||0
063940|N05CD0806|Buccolam|munnh.l|2,5|mg|0,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12389|18550|lyfalmen|||2|2|0|1,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12389||12389|18550||3|H|E|2|450|mg|0
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|911|2752|lyfalmen|V0310|2752|1|60|0|60,0000|Icepharma hf|Upjohn EESV|Alprazólam||911||911|2752||1|0||2|60|mg|0
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|883370|1105176|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||883370|1105176||2|H|L|0|||0
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|350259|442135|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||350259|442135||2|H|L|0|||0
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3027983|3772474|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||3027983|3772474||2|H|L|0|||0
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1569143|1958086|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||||1569143|1958086||2|H|L|0|||0
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1929|4153|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1929||1929|4153||2|0|G|0|||0
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|6153|5655|lyfalmen|V0029|5655|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3020||3020|5655||2|0|G|0|||0
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1117|2195|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Oxytetracyclinum||1117||1117|2195||1|0||0|||0
064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|6375|10988|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6375|10988||1|0||0|||0
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|OCT|0|1|0|100|DKK|30653|42044|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||30653||30653|42044||1|H|L|0|||0
064809|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.03.2020||R|1|0|0|G|0|ATE|0|0|0|100|IKR|4118|3904|lyfalmen|V0679|3904|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1748||1748|3904||1|0|G|0|||0
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|G|0|ASS|0|0|1|100|DKK|784|2577|lyfalmen|||2|50|0|16,6667|Vistor hf|Takeda AS|Metóklópramíð||784||784|2577||1|0|G|0|||0
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|G|0|ASS|0|0|1|100|DKK|1054|2949|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||1054||1054|2949||1|0|G|0|||0
064963|L01ED0401|Alunbrig|filmhtfl|90|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|494260|621232|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||494260||494260|621232||1|0|L|0|||0
065012|C07AB0215|Metoprolol Alvogen|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.02.2021||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2334|2910|lyfalmen|V0049|2910|2|100|0|63,3333|Alvogen|Alvogen ehf|Metóprólól||1026||1026|2910||2|0|G|0|||0
065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4698|9084|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketóprófen||4698||4698|9084||2|0||0|||0
065093|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.07.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3822|6346|lyfalmen|V0437|5268|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3522||3522|6346||2|0|G|0|||0
065200|J01DB0402|Cefazolina Normon|sts|1|g|1|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|524|2219|lyfalmen|||2|1|0|0,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||524||524|2219||2|0|0|0|||0
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|G|0|FEL|0|0|0|100|DKK|14827|21906|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||14827||14827|21906||1|0|G|0|||0
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|9572|14673|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9572||9572|14673||2|H|0|0|||0
065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5183|7140|lyfalmen|V0830|6864|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4099||4099|7140||2|0|G|0|||0
065583|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|112|stk|1|þpakki||C10AX09|01.07.2019||R|0|0|0|0|0|VAL|0|0|0|100|DKK|8696|6816|lyfalmen|V0954|6816|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3864||3864|6816||2|0|0|0|||0
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|1|G|0|LVR|0|0|0|100|SEK|47672|62258|lyfalmen|V0451|52775|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||46635||46635|62258||3|0|G|0|||0
065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065751|J01CR0204|Amoxin comp|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1923|4145|lyfalmen|||2|70|0|3,7333|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||1923||1923|4145||2|0|E|0|||0
065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|ílát|10+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|2669|5172|lyfalmen|||2|200|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||2669||2669|5172||1|0|E|1|||0
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|3024|5660|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Iohexol||3024||3024|5660||2|H|0|0|||0
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|1508|3574|lyfalmen|||2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||1508||1508|3574||1|0|G|0|||0
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|2759|5295|lyfalmen|||2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||2759||2759|5295||1|0|G|0|||0
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|G|0|ATE|0|0|0|100|SEK|4742|7624|lyfalmen|||2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lerkanidipín||4451||4451|7624||1|0|G|0|||0
066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|OUS|0|0|0|100|XEU|11395|17182|lyfalmen|||1|20|0|5,0000|Recordati AB|Orphan Europe SARL|Tocofersolanum||11395||11395|17182||3|0|E|0|||0
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|DOR|1|0|0|100|DKK|4240|8215|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Meloxícam||4240||4240|8215||2|0||0|||0
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|GOG|0|0|1|100|DKK|827|2636|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||827||827|2636||2|0||0|||0
066497|N05AH0415|Quetiapin Krka|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|7500|8930|lyfalmen|V0272|8917|2|100|0|75,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||5400||5400|8930||2|0|G|0|||0
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ómeprazól|||||||1|0||0|||0
066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|0|0|ATE|0|0|0|100|XEU|11942|17935|lyfalmen|||2|50|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paklítaxel||||11942|17935||1|H|0|0|||0
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|7730|12137|lyfalmen|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7730||7730|12137||1|0|0|0|||0
067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|1|0|0|GSU|0|1|0|100|DKK|102571|134081|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland UC|Emtricitabine, tenofovir alafenamide og rilpivirine||||102571|134081||2|0|L|0|||0
067394|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.05.2019||R|1|0|0|0|0|LVR|0|0|1|100|DKK|10794|15464|lyfalmen|V0012|5765|3|100|0|133,3300|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||10147||10147|15464||3|0|0|0|||0
067829|QA04AD9002|Prevomax|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|8069|15479|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|maropitant||||8069|15479||2|0||0|||0
067848|QN02BG9102|Librela|stl|30|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|16727|31905|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||16727||16727|31905||2|0||2|||0
067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2281|4637|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2281|4637||2|0|0|0|||0
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|1|G|0|MEA|0|0|0|100|DKK|4355|7492|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4355||4355|7492||2|0|G|0|||0
068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3123||2|0|G|0|||0
068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|8530|13239|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8530||8530|13239||1|0|G|0|||0
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014|31.07.2021|L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2947|5554|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2947||2947|5554||2|0|G|0|||0
068860|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||||2|0||0|||0
068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|2552|5010|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2552||2552|5010||2|H|0|0|||0
068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|3253|5975|lyfalmen|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||3253||3253|5975||2|H|0|0|||0
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3622||2|0||0|||0
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3805||2|0||0|||0
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3576||2|0||0|||0
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3755||2|0||0|||0
069030|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.08.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|14868|21962|lyfalmen|V0651|21962|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||14868||14868|21962||3|0|G|0|||0
069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|12321|18457|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12321||12321|18457||1|0|G|0|||0
069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|G|0|FEL|0|0|0|100|DKK|35654|48369|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||35654||35654|48369||1|0|G|0|||0
069177|C10AA0704|Rosuvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|9540|10169|lyfalmen|V0195|10169|2|100|0|400,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|365854|461531|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||365854||365854|461531||1|0|L|0|||0
069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
069536|L04AA0607|Mycofenolsýra Accord|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|14420|17376|lyfalmen|V0470|16971|2|120|0|10,8000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||11536||11536|17376||1|0|G|0|||0
069596|A02BC0308|Lansoprazol Krka|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.08.2018||L|1|0|0|G|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Lansóprazól|||||3284||2|0|G|0|||0
069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|1|0|0|GEI|0|1|0|100|DKK|63152|83148|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland|Tenófóvír alafenamíð||||63152|83148||2|0|L|0|||0
070203|N05CF0107|Imomed|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2020||R|1|0|0|0|0|DIC|0|0|0|100|IKR|450|2117|lyfalmen|V0312|2117|2|30|0|30,0000|LYFIS ehf|Medical ehf|Zópíklón||450||450|2117||2|0||2|30|töflur|0
070512|L01EB0401|Tagrisso|filmhtfl|40|mg|30|stk|1|stsk.þ||L01EB04|01.07.2020||R|0|0|1|0|0|AZE|0|1|0|100|SEK|865163|1082532|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||865163||865163|1082532||1|0|L|0|||0
070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|20559|29277|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||20559||20559|29277||2|0|L|0|||0
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|G|0|JAS|0|0|0|100|SEK|9339|14352|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9339||9339|14352||1|0|G|0|||0
070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|CZV|1|0|0|100|XEU|7138|12303|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||7138||7138|12303||1|0||0|||0
071450|J01FA1008|Azitromicina Normon|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.03.2019||R|1|0|0|0|0|WEH|0|0|1|100|IKR|1100|3012|lyfalmen|V0174|2599|2|3|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Azitrómýcín||1100||1100|3012||2|0||0|||0
071784|A10BD2401|Steglujan|filmhtfl|105|mg|98|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|34530|46750|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||34374||34374|46750||1|0|G|0|||0
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|1|0|0|GEB|0|0|0|100|XEU|71591|93822|lyfalmen|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||71591|93822||1|0|0|0|||0
072103|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|0|0|ATE|0|0|0|100|XEU|13195|11259|lyfalmen|||2|56|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||7092||7092|11259||1|0|E|0|||0
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|ORF|1|0|0|100|DKK|6625|12739|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|Detomidinum||6625||6625|12739||1|0||0|||0
072374|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|300|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|5175|8621|lyfalmen|V1029|8621|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||5175||5175|8621||3|0|E|0|||0
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|G|0|PSA|0|0|0|100|XEU|6153|5655|lyfalmen|V0029|5655|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3020||3020|5655||2|0|G|0|||0
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|202539|258413|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||202539||202539|258413||5|H|0|0|||0
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|215442|274461|lyfalmen|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||215442||215442|274461||5|H|0|0|||0
072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|11133|lyfalmen|||2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||7000||7000|11133||2|0|G|0|||0
072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2859|5433|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2859||2859|5433||2|0|G|0|||0
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|0|0|0|PBV|0|0|0|100|SEK|501|2187|lyfalmen|||1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Súfentaníl||501||501|2187||1|0|0|1|30|dagar|0
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|1|0|0|JCI|0|1|0|100|SEK|52814|70073|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||52814||52814|70073||1|0|L|0|||0
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8352|5611|lyfalmen|V0286|5611|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||2988||2988|5611||1|0|G|0|||0
073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|G|0|SHS|0|0|0|100|DKK|437|2099|lyfalmen|V0500|2048|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||437||437|2099||1|0|G|0|||0
073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|1|0|0|JCI|0|1|0|100|SEK|331672|419018|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Macitentan||||331672|419018||1|0|L|0|||0
073313|L01ED0101|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|486993|612194|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||486993||486993|612194||1|0|L|0|||0
073495|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|38 mg/8 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2688|4633|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2688||2688|4633||1|0||0|||0
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2947|5554|lyfalmen|V1010|2956|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2947||2947|5554||1|0|G|0|||0
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|15306|21514|lyfalmen|V0185|21514|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Letrózól||14542||14542|21514||1|0|G|0|||0
073728|L01CB0105|Etópósíð Accord|irþ|20|mg/ml|25|ml|1|hgl||L01CB01|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|8715|13493|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Etoposíð||8715||8715|13493||1|H|0|0|||0
073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|7967|lyfalmen|V0924|6005|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4700||4700|7967||2|0|E|0|||0
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|904|2742|lyfalmen|V0305|2489|1|100|0|25,0000|Icepharma hf|Upjohn EESV|Alprazólam||904||904|2742||1|0||2|120|töflur|0
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|1|100|DKK|486|2167|lyfalmen|||1|20|0|10,0000|Icepharma hf|Upjohn EESV|Alprazólam||486||486|2167||1|0||2|60|töflur|0
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|1322|3318|lyfalmen|||1|100|0|50,0000|Icepharma hf|Upjohn EESV|Alprazólam||1322||1322|3318||1|0||2|60|töflur|0
073885|N05CF0201|Stilnoct|filmhtfl|10|mg|150|stk|1|þpakki||N05CF02|01.05.2021||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1793|3966|lyfalmen|||1|150|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1793||1793|3966||1|0||2|30|töflur|0
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1342|3345|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1342||1342|3345||2|0|G|0|||0
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|IKR|3687|6355|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||3687||3687|6355||2|0||0|||0
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|870|2695|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||870||870|2695||2|0|G|0|||0
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|NEL|0|0|0|100|DKK|2810|5366|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2810||2810|5366||1|0|E|0|||0
074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20031|28609|lyfalmen|||1|28|0|28,0000|Eisai AB|Eisai GmbH|Perampanel||20031||20031|28609||1|0|G|0|||0
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|1014|2894|lyfalmen|||2|25|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1014||1014|2894||1|0||2|50|töflur|0
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2|0||0|||0
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|ATE|0|0|0|100|DKK|863|2686|lyfalmen|||2|50|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||863||863|2686||1|0||2|50|töflur|0
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1378|3395|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1378||1378|3395||1|0||2|50|töflur|0
074664|N06AB1008|Escitalopram STADA|filmhtfl|15|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2800|5352|lyfalmen|V0326|5352|2|100|0|150,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2800||2800|5352||2|0|0|0|||0
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|G|0|AEP|0|0|0|100|DKK|644|2384|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||644||644|2384||2|0|G|0|||0
074927|C02AC0201|Intuniv|forðatfl|2|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|10127|15437|lyfalmen|||1|28|0|18,6666|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||10127||10127|15437||1|0|E|0|||0
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|G|0|AEP|0|0|0|100|DKK|2104|4394|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||2104||2104|4394||2|0|G|0|||0
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|4953|8315|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4953||4953|8315||1|0|G|0|||0
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|14517|21479|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14517||14517|21479||1|0|G|0|||0
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|5221|8684|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5221||5221|8684||1|0|G|0|||0
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1078|2982|lyfalmen|V0363|2698|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1078||1078|2982||1|0|G|0|||0
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|G|0|NEL|0|0|1|100|DKK|15282|22532|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15282||15282|22532||1|0|G|0|||0
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|NIE|0|0|0|100|DKK|||lyfalmen|||1|4|0||Artasan ehf|Norgine B.V.|Hægðalyf með osmótíska verkun|||||4708||1|0|E|0|||0
075451|G04CB0106|Finasteride Alvogen|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|G|0|POF|0|0|0|100|IKR|5987|3563|lyfalmen|V0445|2884|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1500||1500|3563||2|0|G|0|||0
075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|12030|10407|lyfalmen|V0440|8889|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||6473||6473|10407||2|0|G|0|||0
075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5419|8957|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5419||5419|8957||2|0|0|0|||0
075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|5419|8957|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5419||5419|8957||2|0|0|0|||0
075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|FMC|0|0|0|100|XEU|6231|10074|lyfalmen|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6231||6231|10074||2|0|0|0|||0
075921|N02AA0507|OxyContin Depot|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|3868|6822|lyfalmen|V0598|5246|1|98|0|13,0700|Icepharma hf|Mundipharma A/S|Oxýcódon||3868||3868|6822||2|0|G|1|30|dagar|0
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4649|7897|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||4649||4649|7897||1|0|G|0|||0
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|G|0|MBV|0|0|0|100|DKK|16159|23739|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||||16159|23739||1|0|G|0|||0
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14356|21258|lyfalmen|||1|98|0|24,5000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14356||14356|21258||1|0|G|0|||0
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|G|0|MBV|0|0|0|100|DKK|14494|21447|lyfalmen|V0982|21446|1|98|0|49,0000|Vistor hf|Merck Sharp & Dohme B.V.|Sítagliptín||14494||14494|21447||1|0|G|0|||0
076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1605|2461|lyfalmen|V0143|1126|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2461||2|0|E|0|||0
076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2971|3571|lyfalmen|V0143|2252|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3571||2|0|E|0|||0
076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3742|3604|lyfalmen|V0143|3378|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3604||2|0|E|0|||0
076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1667|2613|lyfalmen|V0144|1295|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2613||2|0|E|0|||0
076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3208|3897|lyfalmen|V0144|2590|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3897||2|0|E|0|||0
076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|7023|4182|lyfalmen|V0144|3885|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1950||1950|4182||2|0|E|0|||0
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1944|2273|lyfalmen|V0291|2273|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||563||563|2273||2|0|G|0|||0
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|dropaí||S01GX08|01.06.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen|||||3399||1|0|G|0|||0
076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2737|lyfalmen|V0290|2689|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2737||2|0|G|0|||0
076657|N05AH0416|Quetiapin Medical Valley|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|6400|5008|lyfalmen|V0273|5008|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||2550||2550|5008||2|0|0|0|||0
076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|227864|289910|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||227864||227864|289910||1|0|L|0|||0
076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|132096|170802|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||132096||132096|170802||1|0|L|0|||0
076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|66048|86811|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||66048||66048|86811||1|0|L|0|||0
076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|37978|51308|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||37978||37978|51308||1|0|L|0|||0
076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2725|5249|lyfalmen|V0598|5246|2|98|0|13,0700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||2725||2725|5249||1|0|G|1|30|dagar|0
076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|79512|103840|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||79512||79512|103840||2|0|L|0|||0
077085|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|105|stk|1|glas||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|7330|11587|lyfalmen|||2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||7330||7330|11587||2|0|E|0|||0
077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|0|0|SPP|0|1|0|100|XEU|50223|66796|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||50223||50223|66796||2|H|L|0|||0
077555|N07BC0102|Buvidal|stl|8|mg|0,16|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13061|19475|lyfsjukr|||1|0,16|0|3,8095|Vistor hf|Camurus AB|Búprenorfín||13061||13061|19475||1|H|L|1|30|dagar|0
077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2625|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2625||2|0|E|1|30|dagar|0
077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2701|lyfalmen|V0671|2701|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2701||2|0|E|1|30|dagar|0
077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4697|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4697||2|0|E|1|30|dagar|0
077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|6040|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8380|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8380||2|0|E|1|30|dagar|0
077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10169|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12674|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12674||2|0|E|1|30|dagar|0
077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|G|0|TVA|0|0|0|100|IKR|5017|5352|lyfalmen|V0275|4788|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||2800||2800|5352||2|0|G|0|||0
078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9545|14636|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9545||9545|14636||1|0|G|0|||0
078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|37152|70655|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||37152||37152|70655||2|0||0|||0
078674|N06BA1201|Elvanse Adult|hylki|50|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|12768|19072|lyfalmen|||1|30|0|50,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||12768||12768|19072||1|0|E|1|30|dagar|0
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|G|0|MSD|0|0|0|100|DKK|7964|6336|lyfalmen|V0069|2884|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3515||3515|6336||1|0|G|0|||0
079195|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|4985|3885|lyfalmen|V0144|3885|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1734||1734|3885||2|0|E|0|||0
079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2071|3975|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3975||2|0|G|0|||0
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3791|6716|lyfalmen|V0315|6716|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúoxetín||3791||3791|6716||1|0|G|0|||0
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|G|0|TSA|0|0|0|100|XEU|10088|12793|lyfalmen|V0184|12793|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||8206||8206|12793||2|0|G|0|||0
079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1|0||0|||0
079885|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5618|9231|lyfalmen|V0025|9231|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5618||5618|9231||1|0|G|0|||0
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|473|2149|lyfalmen|||2|10|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||473||473|2149||1|0|E|0|||0
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|ATE|0|0|1|100|XEU|767|2430|lyfalmen|V0418|2430|2|20|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||677||677|2430||1|0|E|0|||0
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|778|2442|lyfalmen|V0177|2442|2|10|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||686||686|2442||1|0|E|0|||0
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1355|3199|lyfalmen|V0411|3199|2|20|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cíprófloxacín||1236||1236|3199||1|0|E|0|||0
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Cloprostenolum||4985||4985|9628||2|0||0|||0
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|ANI|1|0|0|100|XEU|3763|7310|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3763|7310||2|0||2|||0
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
080431|H02AB0207|Dexamethasone Krka|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|3000|3287|lyfalmen|V0422|3287|2|20|0|53,3300|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||1300||1300|3287||2|0|G|0|||0
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|VEO|0|0|0|100|DKK|12278|21162|vetorma|||0|24|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||12278||12278|21162||2|0||0|||0
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|G|0|BLS|0|0|0|100|XEU|6528|6845|lyfalmen|||2|30|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Letrózól||3885||3885|6845||1|0|G|0|||0
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|G|0|LBK|0|0|0|100|DKK|2150|4457|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2150||2150|4457||1|0|G|0|||0
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5177|8624|lyfalmen|V1029|8621|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5177||5177|8624||1|0|E|0|||0
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|GPH|0|0|0|100|DKK|2455|4877|lyfalmen|V1028|4876|1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2455||2455|4877||1|0|E|0|||0
080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|31819|43518|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||31819||31819|43518||1|0|G|0|||0
080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|0|0|AMR|0|0|0|100|XEU|3744|6651|lyfalmen|||1|1|0|1,0000|Alvogen|Amring|Mifepriston||3744||3744|6651||2|H|0|0|||0
081038|QI01AN0101|Evalon|innúðal|||1000|skammtar|1|hgl|+50ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|22950|39557|vetorma|||0|1000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||22950||22950|39557||2|0|0|0|||0
081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0815|3197|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
081305|L01ED0101|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01ED01|01.05.2013||R|1|1|1|0|0|PEU|0|1|0|100|DKK|608740|763613|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Europe MA EEIG|Crizotinib||608740||608740|763613||1|0|L|0|||0
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klórhexidín|||||||1|0||0|||0
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081626|N06AX2108|Aritavi|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1842|2402|lyfalmen|V0692|2402|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||657||657|2402||1|0|E|0|||0
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Bauluventill.|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|4225|7313|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4225||4225|7313||1|0|G|0|||0
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi. Kranaventill|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
081681|N06DA0304|Nimvastid|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|6070|9853|lyfalmen|||2|28|0|4,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||6070||6070|9853||2|0|G|0|||0
081821|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|lykjur|innr.lyf, fleyti|N01AX10|01.11.2019||R|0|0|0|0|0|FKA|0|0|0|100|DKK|1463|3512|lyfalmen|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1463||1463|3512||1|H|0|0|||0
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|4680|7939|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||4680||4680|7939||1|0|G|0|||0
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|G|0|SDH|0|0|0|100|XEU|6332|10213|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6332||6332|10213||1|0|G|0|||0
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|26352|36604|lyfalmen|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||26352||26352|36604||2|H|0|0|||0
082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|12860|22165|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||12860||12860|22165||1|0||0|||0
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|VIR|1|0|0|100|XEU|54001|93076|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||54001||54001|93076||1|0||0|||0
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|623|2355|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||623||623|2355||1|0|G|0|||0
082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2876|5456|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2876||2876|5456||1|0|G|0|||0
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2589|5061|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2589||2589|5061||1|0|G|0|||0
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3626|6489|lyfalmen|V0080|6198|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3626||3626|6489||1|0|G|0|||0
083019|L01EB0202|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.04.2018||R|1|1|1|0|0|ALO|0|1|0|100|XEU|259762|294815|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlotinib||231808||231808|294815||2|0|L|0|||0
083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||L|1|0|0|G|0|MYL|0|0|0|100|DKK|||lyfalmen|V0706|6304|1|100|0|16,6700|Icepharma hf|Mylan AB|Hvatablöndur (lípasi, próteasi o.s.frv.)|||||6306||2|0|G|0|||0
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|G|0|AZD|0|0|0|100|SEK|3267|5995|lyfalmen|V0701|5352|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3267||3267|5995||1|0|G|0|||0
083209|QN02BG9102|Librela|stl|5|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9659|18496|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||9659||9659|18496||2|0||2|||0
083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|4825|3437|lyfalmen|V0686|3437|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1409||1409|3437||1|0|E|0|||0
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|5781|11138|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5781||5781|11138||2|0||0|||0
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|GCA|0|0|1|100|DKK|835|2555|lyfalmen|V0231|2555|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||768||768|2555||1|0|E|0|||0
083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4818|5368|lyfalmen|V0624|5357|2|30|0|36,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||2812||2812|5368||1|0|E|1|30|dagar|0
083966|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4393|7544|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4393||4393|7544||1|0|G|0|||0
084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|158823|204043|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||158823||158823|204043||1|0||0|||0
084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2430|4843|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||2430||2430|4843||2|0||2|60|mg|0
084252|C03EA0115|Amiloride/HCT Alvogen|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|1345|3349|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||1345||1345|3349||2|0|G|0|||0
084454|G04CA5203|Dutasteride/Tamsulosin Teva|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.05.2020||R|0|0|0|G|0|TVI|0|0|0|100|XEU|2770|4355|lyfalmen|V1010|2956|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Dútasteríð og tamsúlósínhýdroklóríð||2076||2076|4355||1|0|G|0|||0
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|57907|76514|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||57907||57907|76514||1|0|L|0|||0
084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|5569|9163|lyfalmen|||2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5569||5569|9163||2|0|G|0|||0
084866|N02AJ0602|Parkodin forte|filmhtfl|530|mg|40|stk|1|þpakki|30+500 mg|N02AJ06|01.05.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1181|3123|lyfalmen|||2|40|0|13,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1181||1181|3123||1|0|E|3|||0
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|1|0|0|MSD|0|1|0|100|DKK|35500|48174|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||35500||35500|48174||1|0|L|0|||0
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|0|G|0|MDI|0|0|0|100|DKK|11909|17889|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mundipharma A/S|Morfín||11909||11909|17889||2|0|G|1|30|dagar|0
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|1|G|0|GAN|0|0|0|100|XEU|34174|46497|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||34174||34174|46497||2|0|G|0|||0
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,3|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|SAO|0|0|1|100|XEU|2437|4852|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Levófloxacín||2437||2437|4852||2|0||0|||0
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|G|0|GPH|0|0|1|100|DKK|768|2555|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||768||768|2555||1|0|G|0|||0
085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl||B01AB04|01.05.2018||R|0|0|0|0|0|PLS|0|0|0|100|DKK|11517|17350|lyfalmen|||1|4|0|40,0000|Icepharma hf|Pfizer Aps|Dalteparín||11517||11517|17350||1|H|0|0|||0
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4116|7163|lyfalmen|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4116||4116|7163||2|0|0|0|||0
085515|G04CB0105|Finasterid STADA|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4051|3563|lyfalmen|V0445|2943|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||1500||1500|3563||2|0|G|0|||0
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ 5x1ml lykja m.leysi|G03GA02|01.03.2001||R|0|0|1|G|0|FEL|0|0|0|100|DKK|19334|28109|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||19334||19334|28109||1|0|G|0|||0
085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|16264|22683|lyfalmen|V0652|22520|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||15392||15392|22683||1|0|G|0|||0
085584|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|75|pokar|lausn|B05BB01|01.01.2019||R|0|0|0|0|0|BAM|0|0|1|100|SEK|8421|13089|lyfalmen|||1|3750|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8421||8421|13089||2|0|0|0|||0
085627|G03AA0708|Melleva|filmhtfl|||63|stk|1|þpakki|150mcg/30mcg|G03AA07|01.04.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|858|1867|lyfalm11|V0545|1867|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Levónorgestrel og ethinylestradíól||427||427|1867||2|0||0|||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|1|G|0|NED|0|0|0|100|XEU|79367|103657|lyfalmen|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||79367||79367|103657||2|0|G|0|||0
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|1|G|0|ATE|0|0|0|100|SEK|20430|29113|lyfalmen|V0579|29113|2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rílúzól||20430||20430|29113||1|0|G|0|||0
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|AEB|0|0|0|100|DKK|29050|40016|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||29050||29050|40016||1|0|E|0|||0
085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|7952|12443|lyfalmen|||2|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Karbóplatín||7952||7952|12443||1|H|0|0|||0
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|2510|4953|lyfalmen|||1|3|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||2510||2510|4953||1|0|G|0|||0
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|G|0|TIC|0|0|0|100|XEU|6100|9894|lyfalmen|||1|9|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Bimatóprost||6100||6100|9894||1|0|G|0|||0
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|SNP|0|0|1|100|XEU|356|1988|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||356||356|1988||1|0||2|45|töflur|0
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1804|3981|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1804||1804|3981||1|0|G|0|||0
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|G|0|SNP|0|0|1|100|XEU|2940|5545|lyfalmen|V0365|5147|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2940||2940|5545||1|0|G|0|||0
086118|L04AA3301|Entyvio|stl|108|mg|1|áf-penni|1|pakki||L04AA33|01.03.2021||R|0|1|0|0|0|TPA|0|1|0|100|DKK|74102|96998|lyfsjukr|||1|1|0|20,0000|Vistor hf|Takeda Pharma A/S|Vedolizumab||74102||74102|96998||1|0|L|0|||0
086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|1|0|0|BNB|0|0|0|100|XEU|38793|52339|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Fampridine||38793||38793|52339||2|0|E|0|||0
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|GPH|0|0|1|100|DKK|7869|12329|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7869||7869|12329||1|0|0|0|||0
086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|10147|15464|lyfalmen|V0012|5765|1|100|0|133,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||10147||10147|15464||1|0|E|0|||0
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|26648|36978|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||26648|36978||1|0|G|0|||0
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|1|G|0|FEL|0|0|0|100|DKK|46580|62188|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||46580|62188||1|0|G|0|||0
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|0|0|BSP|0|1|0|100|DKK|48084|64090|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||48084||48084|64090||1|H|L|0|||0
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|15743|20738|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||15743|20738||2|0|E|0|||1
086649|L01XG0301|Ninlaro|hylki|3|mg|1|stk|3|þpakki|Hver hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|784553|982275|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||784553||784553|982275||1|0|L|0|||0
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|ROA|0|1|1|100|DKK|42174|56615|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||42174||42174|56615||2|0|L|0|||0
087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1|0||0|||0
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1|0||0|||0
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|SNP|0|0|1|100|XEU|330|1952|lyfalmen|V0060|1952|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||330||330|1952||1|0||2|30|töflur|0
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|223|1805|lyfalmen|V0312|706|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||223||223|1805||1|0||2|30|töflur|0
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|589|2309|lyfalmen|V0312|2117|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||589||589|2309||1|0||2|30|töflur|0
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|SNP|0|0|0|100|XEU|1655|3776|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1655||1655|3776||1|0||2|30|töflur|0
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14603|21597|lyfalmen|||2|250|0|166,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14603||14603|21597||1|0|G|0|||0
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|G|0|ATE|0|0|0|100|XEU|14603|21597|lyfalmen|||2|250|0|333,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dónepezíl||14603||14603|21597||1|0|G|0|||0
087572|G04BD0801|Vesicare|mixtúra|1|mg/ml|150|ml|1|glas||G04BD08|01.08.2019||R|0|0|0|G|0|ASP|0|0|0|100|XEU|5340|8848|lyfalmen|||1|150|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5340||5340|8848||1|0|G|0|||0
087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1415|3446|lyfalmen|V0952|3242|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1415||1415|3446||1|0|G|0|||0
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|CHP|0|0|0|100|XEU|32330|55724|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||32330||32330|55724||2|0||0|||0
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1|0||0|||0
087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4609|8915|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4609||4609|8915||1|0||0|||0
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|CES|1|0|0|100|SEK|22761|39231|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||22761||22761|39231||2|0||0|||0
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2923|4942|lyfalm11|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2923||2923|4942||2|0||0|||1
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|G|0|RGP|0|0|1|100|DKK|997|2870|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Flútíkasón fúróat||997||997|2870||1|0|G|0|||0
088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3011|5642|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3011||3011|5642||2|0|G|0|||0
088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|7196|3934|lyfalmen|V0684|3375|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|7666|12049|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||7666||7666|12049||1|0||0|||0
088677|N07BC0102|Buvidal|stl|24|mg|0,48|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13061|19475|lyfsjukr|||1|0,48|0|11,4286|Vistor hf|Camurus AB|Búprenorfín||13061||13061|19475||1|H|L|1|30|dagar|0
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|4420|7582|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4420||4420|7582||1|0|G|0|||0
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|G|0|LEP|0|0|0|100|DKK|7639|12012|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7639||7639|12012||1|0|G|0|||0
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|G|0|LEP|0|0|0|100|DKK|12529|18743|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12529||12529|18743||1|0|G|0|||0
088817|A10BD2301|Segluromet|filmhtfl|1002,5|mg|56|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5727|9381|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5727||5727|9381||1|0|G|0|||0
088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|410136|516606|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||410136||410136|516606||1|H|L|0|||0
088961|N02AA0507|OxyContin Depot|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|20560|29278|lyfalmen|V0588|25058|1|98|0|104,5300|Icepharma hf|Mundipharma A/S|Oxýcódon||20560||20560|29278||2|0|G|1|30|dagar|0
088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1379|3040|lyfalm11|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||||1379|3040||1|0||0|||1
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|MPS|0|0|0|100|DKK|21830|30884|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||21830||21830|30884||1|0|0|0|||0
089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|127915|165602|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||127915||127915|165602||1|0|L|0|||0
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6222||1|0||0|||0
089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|18216|26570|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||18216||18216|26570||1|0|L|0|||0
089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|1|0|0|PLS|0|1|0|100|DKK|39620|53385|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||39620||39620|53385||1|0|L|0|||0
089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|1419|3287|lyfalmen|V0048|2993|2|100|0|33,3333|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1300||1300|3287||2|0|G|0|||0
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22182|31329|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22182||22182|31329||1|0|G|0|||0
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|G|0|PAC|0|0|1|100|DKK|88728|115497|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||88728||88728|115497||1|0|G|0|||0
090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|15006|17485|lyfalmen|||2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||11615||11615|17485||1|0|G|0|||0
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|2308|4675|lyfalmen|||1|20|0|5,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||2308||2308|4675||2|0|E|0|||0
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4617|7853|lyfalmen|||1|40|0|10,0000|Icepharma hf|STADA Nordic ApS.|Cefalexín||4617||4617|7853||2|0|E|0|||0
090257|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3332|4509|lyfalmen|||2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||2188||2188|4509||3|0|G|0|||0
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|STA|0|0|1|100|DKK|699|2460|lyfalmen|||1|100|0|2,5000|Icepharma hf|STADA Nordic ApS.|Cefalexín||699||699|2460||2|0|E|0|||0
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|STA|0|0|1|100|DKK|4125|7176|lyfalmen|||1|10|0|3,3333|Icepharma hf|STADA Nordic ApS.|Cefazólín||4125||4125|7176||2|0|0|0|||0
090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1765|3927|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1765||1765|3927||1|0|G|0|||0
090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|765|2551|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai GmbH|Rúfínamíð||765||765|2551||1|0|G|0|||0
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|0|0|AAS|0|0|0|100|XEU|19556|28415|lyfalmen|||1|60|0||Alcon Danmark A/S|Alcon Nordic A/S|Flúorescein||19556||19556|28415||1|H|0|0|||0
091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1084|2990|lyfalmen|V0333|2990|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1084||1084|2990||2|0|E|0|||0
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2438|4854|lyfalmen|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2438||2438|4854||1|H|0|0|||0
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4217|7302|lyfalmen|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4217||4217|7302||1|H|0|0|||0
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|PLS|0|0|0|100|DKK|12379|18536|lyfalmen|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12379||12379|18536||1|H|0|0|||0
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.03.2011||R|1|1|0|0|0|HES|0|0|0|100|DKK|3311|5865|lyfalmen|V0958|5696|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3173||3173|5865||1|0|E|1|30|dagar|0
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|5810|9495|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5810||5810|9495||1|0|G|0|||0
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|sk-ílá|lausn|S01BA01|01.05.2011||R|0|0|0|G|0|TAE|0|0|1|100|SEK|3459|6259|lyfalmen|||1|30|0||Alvogen|Trimb Healthcare AB|Dexametasón||3459||3459|6259||2|0|G|0|||0
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|965|1992|lyfalmen|V0021|1992|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||359||359|1992||1|0|G|0|||0
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1668|2285|lyfalmen|V0022|2285|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||572||572|2285||1|0|G|0|||0
091804|L01EM0301|Piqray|filmhtfl|150|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|242042|307544|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||242042||242042|307544||1|0|L|0|||0
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1083|2989|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||1083||1083|2989||1|0|G|0|||0
092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8537|16367|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||8537||8537|16367||2|0||0|||0
092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2|0||0|||0
092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|V0004|2839|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2839||2|0|E|0|||0
092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2060|4251|lyfalmen|V0011|2686|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|3453|4939|lyfalmen|V0011|4700|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2500||2500|4939||2|0|G|0|||0
092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1510|2874|lyfalmen|V0005|2874|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2874||2|0|E|0|||0
092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|KRK|0|0|1|100|IKR|2400|4251|lyfalmen|V0012|3228|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4251||2|0|E|0|||0
092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|G|0|KRK|0|0|1|100|IKR|4794|5765|lyfalmen|V0012|5650|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3100||3100|5765||2|0|G|0|||0
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
092620|H01AC0113|Norditropin FlexPro|stl|5|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|29658|40785|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||29658||29658|40785||1|0|L|0|||0
092631|H01AC0113|Norditropin FlexPro|stl|10|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|59532|78570|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||59532||59532|78570||1|0|L|0|||0
092644|H01AC0113|Norditropin FlexPro|stl|15|mg|1,5|ml|1|áfpen||H01AC01|01.04.2021||R|0|0|1|0|0|NAS|0|1|0|100|DKK|89299|116219|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||89299||89299|116219||1|0|L|0|||0
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2115|4409|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2115||2115|4409||1|0|G|0|||0
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|G|0|WEH|0|0|0|100|IKR|1863|4026|lyfalmen|V0203|4026|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1837||1837|4026||2|0|G|0|||0
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|1067|2967|lyfalmen|||1|28|0|1,8700|Icepharma hf|Mundipharma A/S|Oxýcódon||1067||1067|2967||2|0|E|1|30|dagar|0
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|2129|4428|lyfalmen|||1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||2129||2129|4428||2|0|E|1|30|dagar|0
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|0|0|0|MUP|0|0|0|100|DKK|4140|7196|lyfalmen|||1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||4140||4140|7196||2|0|E|1|30|dagar|0
093072|L01EX0301|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|314452|397601|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||314452||314452|397601||1|0|L|0|||0
093083|L01EX0301|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01EX03|01.01.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|419467|528211|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazopanib||419467||419467|528211||1|0|L|0|||0
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4583|7806|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4583||4583|7806||1|0|G|0|||0
093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5073|8480|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5073||5073|8480||1|0|G|0|||0
093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|1|0|0|ERZ|0|0|0|100|XEU|22903|30138|lyfalmen|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||21240||21240|30138||2|0|0|0|||0
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|G|0|HES|0|0|0|100|DKK|1798|3973|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1798||1798|3973||1|0|G|0|||0
093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|5100|8518|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5100||5100|8518||2|0|G|0|||0
093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|G|0|TIL|0|0|0|100|DKK|3777|6697|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3777||3777|6697||2|0|G|0|||0
093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2274|4628|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||2274||2274|4628||2|0||0|||0
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|G|0|ABC|0|0|0|100|SEK|31752|43434|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||31752||31752|43434||2|0|G|0|||0
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|391173|493021|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||391173||391173|493021||1|0|L|0|||0
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|0|1|0|0|JCI|0|1|0|100|SEK|391173|493021|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||391173||391173|493021||1|0|L|0|||0
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|G|0|AAC|0|0|0|100|DKK|5145|8579|lyfalmen|||1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||5145||5145|8579||2|0|G|0|||0
094132|QM01AC0604|Metacam handa köttum og naggrísum|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|1657|3257|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|Meloxícam||1657||1657|3257||1|0||0|||0
094146|L04AA2901|Xeljanz|forðatfl|11|mg|28|stk|1|þpakki||L04AA29|01.06.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|113001|147053|lyfsjukr|||1|28|0|30,8000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||113001||113001|147053||1|0|L|0|||0
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1702|3841|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||1702||1702|3841||2|0|G|0|||0
094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|G|0|BLS|0|0|0|100|IKR|1955|4189|lyfalmen|V0324|3761|2|98|0|49,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||1955||1955|4189||1|0|0|0|||0
094757|N04BC0408|Ropinirole Alvogen|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|12391|17196|lyfalmen|V0534|17196|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||11405||11405|17196||2|0|G|0|||0
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|1|0|0|VIC|0|1|0|100|DKK|70679|92668|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín, lamívúdín og abacavír||70679||70679|92668||1|0|L|0|||0
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|HAL|0|0|1|100|DKK|42426|56934|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||42426|56934||1|0|E|0|||0
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6001|10343|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6001||6001|10343||2|0||0|||0
094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1|0||0|||0
094971|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|100|stk|1|þpakki||R06AX27|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|100|0|100,0000|Alvogen|Alvogen|Deslóratadín|||||||2|0||0|||0
095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|0|0|TAG|0|0|0|100|DKK|40184|54098|lyfalmen|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||40184||40184|54098||1|H|0|0|||0
095314|N04BA0211|Duodopa|hlaup|||100|ml|7|askja||N04BA02|01.10.2018||R|0|1|0|0|0|AIS|0|1|0|100|DKK|94398|122668|lyfsjukr|||1|700|0||Vistor hf|AbbVie A/S|Levódópa og dópadekarboxýl­asa­hemill||94398||94398|122668||1|0|L|0|||0
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|G|0|ATE|0|0|0|100|DKK|8135|12695|lyfalmen|||1|50|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Dísúlfíram||8135||8135|12695||1|0|G|0|||0
095621|L04AX0306|Metojectpen|stl|20|mg|0,4|ml|6|áfpen||L04AX03|01.11.2019||R|0|0|0|G|0|WIL|0|0|0|100|XEU|14270|21139|lyfalmen|||1|2,4|0|48,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||14270||14270|21139||2|0|G|0|||0
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|14738|21783|lyfalmen|V0963|14969|1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14738||14738|21783||1|0|E|0|||0
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|JCI|0|0|0|100|SEK|14958|22086|lyfalmen|V0964|16808|1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14958||14958|22086||1|0|E|0|||0
095682|N06BA0408|Methylphenidate Teva|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|4878|4529|lyfalmen|V0959|4529|2|30|0|20,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2202||2202|4529||1|0|E|1|30|dagar|0
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|G|0|JCI|0|0|0|100|SEK|17414|25467|lyfalmen|V0965|15375|1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17414||17414|25467||1|0|G|0|||0
095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|1793|3966|lyfalmen|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1793|3966||2|H|0|0|||0
095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|GOV|0|0|0|100|XEU|3117|5788|lyfalmen|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3117|5788||2|H|0|0|||0
095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|5352|lyfalmen|V0701|5352|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||2800||2800|5352||2|0|G|0|||0
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|4999|9655|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||4999||4999|9655||2|0|0|0|||0
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6184|10677|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||5538||5538|10677||2|0|0|0|||0
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|CHP|0|0|0|100|IKR|11467|21926|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Vedaprofenum||11467||11467|21926||2|0|0|0|||0
096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|RRG|0|1|0|100|DKK|681412|853997|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||681412||681412|853997||2|H|L|0|||0
096223|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|830|2599|lyfalmen|V0685|2129|2|56|0|4,6667|Acare ehf|Medical Valley Invest AB|Pregabalín||800||800|2599||2|0|E|0|||0
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|9019|13912|lyfalmen|||1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||9019||9019|13912||1|0|G|0|||0
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|649134|813852|lyfsjukr|||1|21|0|10,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||649134||649134|813852||2|0|L|0|||0
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|595826|747552|lyfsjukr|||1|21|0|21,0000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||595826||595826|747552||2|0|L|0|||0
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|627174|786540|lyfsjukr|||1|21|0|31,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||627174||627174|786540||2|0|L|0|||0
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|689870|864516|lyfsjukr|||1|21|0|52,5000|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||689870||689870|864516||2|0|L|0|||0
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008|30.06.2021|R|0|1|0|G|0|NEL|0|0|0|100|DKK|8443|13119|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8443||8443|13119||1|0|G|0|||0
096703|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.02.2019||R|0|0|0|0|0|ATE|0|0|0|100|GBP|9384|14414|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Epírúbicín||||9384|14414||1|H|0|0|||0
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|ELC|0|0|0|100|DKK|68156|117474|vetorma|||1|1000|0||Elanco Denmark ApS|Elanco GmbH|Óvirkar bakteríur í bóluefnum||68156||68156|117474||2|0||0|||0
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|VMD|1|0|0|100|XEU|7497|14394|vetalmen|||0|10|0||Icepharma hf|V.M.D. n.v.|Bútorfanóltartrat||||7497|14394||2|0||2|||0
097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10307|15684|lyfalmen|V0334|2517|1|98|0|73,5000|Icepharma hf|Upjohn EESV|Venlafaxín||10307||10307|15684||1|0|E|0|||0
097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|19176|27892|lyfalmen|V0335|2517|1|98|0|147,0000|Icepharma hf|Upjohn EESV|Venlafaxín||||19176|27892||1|0|E|0|||0
097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|32419|44277|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||32419||32419|44277||1|0|E|0|||0
097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|5746|11072|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5746||5746|11072||2|0||0|||0
097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|DSM|0|0|0|100|DKK|16428|21582|lyfalm11|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||16428||16428|21582||1|0||0|||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|G|0|SNP|0|0|0|100|XEU|2394|2518|lyfalmen|V0023|2518|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||741||741|2518||1|0|G|0|||0
097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|VIN|0|0|1|100|DKK|2883|5466|lyfalmen|||2|2000|0|5,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2883|5466|30.6.2021|2|0|0|0|||0
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1487|3545|lyfalmen|||2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1487||1487|3545||1|0|E|0|||0
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|G|0|ATE|0|0|0|100|IKR|2976|3563|lyfalmen|V0678|3563|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan||1500||1500|3563||1|0|G|0|||0
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|G|0|BIG|0|0|1|100|SEK|553|2259|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||553||553|2259||2|0|G|0|||0
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|G|0|BIG|0|0|1|100|SEK|553|2259|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||553||553|2259||2|0|G|0|||0
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2|0||0|||0
098363|L04AA4201|Mayzent|filmhtfl|0,25|mg|120|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|237401|301772|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Limited|Siponimod||237401||237401|301772||1|0|L|0|||0
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|897|2455|lyfalmen|V0243|2455|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||695||695|2455||2|0|G|0|||0
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|1556|2896|lyfalmen|V0244|2686|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1016||1016|2896||2|0|G|0|||0
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|4146|4693|lyfalmen|V0245|4693|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||2321||2321|4693||2|0|G|0|||0
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|G|0|RTH|0|0|0|100|DKK|7222|9752|lyfalmen|V0232|9752|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||5997||5997|9752||2|0|G|0|||0
098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|2502|4741|lyfalmen|V0381|4526|2|10|0|2,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2356||2356|4741||1|0|G|0|||0
099100|C03DA0407|Eplerenon Krka|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2991|2530|lyfalmen|V0107|2530|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||750||750|2530||2|0||0|||0
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|AZA|0|0|0|100|SEK|80091|104573|lyfalmen|||1|10|0|60,2400|Vistor hf|AstraZeneca AB|Fulvestrant||80091||80091|104573||1|0|0|0|||0
099327|B02BB0102|Fibryga|sts/irs|1|g|1|g|1|glas|leysir,lausn|B02BB01|01.04.2021||R|0|0|0|0|0|OCT|0|1|0|100|DKK|65341|85917|lyfsjukr|||1|1|0|0,2000|Vistor hf|Octapharma AB|Manna Fíbrínógen||65341||65341|85917||1|H|L|0|||0
099436|L01EM0301|Piqray|filmhtfl|||56|stk|1|þpakki|28x50 mg + 28x200 mg|L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|484186|608703|lyfsjukr|||1|56|0|23,3333|Vistor hf|Novartis Europharm Limited|Alpelisib||484186||484186|608703||1|0|L|0|||0
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2293|2324|lyfalmen|V0284|2324|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||600||600|2324||2|0|G|0|||0
099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017|31.07.2021|R|1|1|0|G|0|SSA|0|0|0|100|DKK|10529|12908|lyfalmen|||2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||8290||8290|12908||1|0|G|0|||0
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|4284|4161|lyfalmen|V0285|3261|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1935||1935|4161||2|0|G|0|||0
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|G|0|MYL|0|0|0|100|SEK|7667|7127|lyfalmen|V0286|5611|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4090||4090|7127||2|0|G|0|||0
099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|2708|3801|lyfalmen|V0685|3801|2|100|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||1673||1673|3801||1|0|E|0|||0
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1544|3623|lyfalmen|V0247|3623|2|60|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1544||1544|3623||1|0|G|0|||0
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2557|5017|lyfalmen|V0248|5017|2|60|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||2557||2557|5017||1|0|G|0|||0
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5324|4248|lyfalmen|V0249|4248|2|60|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tópíramat||1998||1998|4248||1|0|G|0|||0
099863|L01EX0101|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01EX01|01.12.2012||R|1|0|1|0|0|PEU|0|1|0|100|DKK|156719|201426|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||156719||156719|201426||1|0|L|0|||0
099872|L01EX0101|Sutent|hylki|25|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|312740|395472|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||312740||312740|395472||1|0|L|0|||0
099881|L01EX0101|Sutent|hylki|50|mg|28|stk|1|þpakki||L01EX01|01.03.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|625458|784406|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Sunitinib||625458||625458|784406||1|0|L|0|||0
099959|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|storn f. innr.þykkni lausn|L01BA04|01.04.2018||R|0|0|0|0|0|CLU|0|1|0|100|XEU|137475|177492|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||137475||137475|177492||1|H|L|0|||0
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|NED|0|0|0|100|XEU|10750|16294|lyfalmen|V0925|14162|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||10750|16294||2|0|E|0|||0
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2083|3743|lyfalmen|V0823|3743|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||1631||1631|3743||1|0|G|0|||0
100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|322|1842|lyfalmen|V0563|1823|2|30|0|15,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||250||250|1842||2|0|G|0|||0
100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|1000|2874|lyfalmen|V0685|2129|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1000||1000|2874||2|0|E|0|||0
100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2186|lyfalmen|V0821|2186|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||500||500|2186||2|0|E|0|||0
100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2874|lyfalmen|V0822|2874|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2874||2|0|E|0|||0
100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|ATE|0|0|1|100|XEU|3443|6237|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lymecycline||3443||3443|6237||1|0|E|0|||0
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|9287|12999|lyfalmen|V0254|11495|1|100|0|33,3300|Icepharma hf|Upjohn EESV|Gabapentín||8356||8356|12999||1|0|G|0|||0
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|13257|19745|lyfalmen|V0256|18827|1|100|0|44,4400|Icepharma hf|Upjohn EESV|Gabapentín||13257||13257|19745||1|0|G|0|||0
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|PHA|0|0|0|100|NOK|56431|83669|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||51904||51904|83669||1|0||0|||0
101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5189||5189|10015||2|0||0|||0
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1777|3944|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||1777|3944||1|0||0|||0
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3065|5717|lyfalmen|||2|96|0|96,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||||3065|5717||1|0|G|0|||0
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|BOI|0|0|0|100|DKK|12005|22946|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|Meloxícam||12005||12005|22946||1|0||0|||0
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5723|9375|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5723||5723|9375||2|0|E|0|||0
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|16979|24868|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||16979||16979|24868||2|0|E|0|||0
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|995|2867|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||995||995|2867||1|0|G|0|||0
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1501|3564|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1501||1501|3564||1|0|G|0|||0
102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|5421|8959|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5421||5421|8959||2|H|0|0|||0
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|387|2031|lyfalmen|V0230|2024|2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||387||387|2031||1|0|E|0|||0
102249|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|2|glas|2 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|400|0|13,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7781|3375|lyfalmen|V0684|3375|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1364||1364|3375||2|0|G|0|||0
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|G|0|TOG|0|0|0|100|SEK|3016|5649|lyfalmen|V0041|3704|1|98|0|147,0000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||3016||3016|5649||1|0|G|0|||0
102952|G04BD0805|Solifenacin Alvogen|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|14785|13462|lyfalmen|V0441|11163|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||8692||8692|13462||2|0|G|0|||0
103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|WEH|0|0|1|100|IKR|321|1940|lyfalmen|||2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1940|30.6.2021|2|0||2|30|töflur|0
103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2444|4862|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2444||2444|4862||2|0|G|0|||0
103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|1|0|0|PMA|0|0|0|100|DKK|6937|9158|lyfalmen|V0657|8655|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||5565||5565|9158||1|0|E|2|||0
103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|1|0|0|TBB|0|1|0|100|NOK|91394|118869|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Teva B.V.|Lipegfilgrastim||91394||91394|118869||1|0|L|0|||0
103444|L04AB0404|IDACIO|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|33574|45738|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||33574||33574|45738||1|0|L|0|||0
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2030|3161|lyfalmen|V0088|3108|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3161||2|0|G|0|||0
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|2590|3747|lyfalmen|V0089|3631|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3747||2|0|G|0|||0
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|G|0|GOV|0|0|0|100|IKR|1845|3934|lyfalmen|V0069|2884|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3934||2|0|G|0|||0
103678|N06AX1615|Venlafaxine Alvogen|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|G|0|POF|0|0|0|100|IKR|5678|2874|lyfalmen|V0334|2568|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1000||1000|2874||2|0|G|0|||0
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|278411|352777|lyfalmen|||1|40|0||Icepharma hf|Baxter Medical AB|Blöndur||278411||278411|352777||2|H|0|0|||0
103854|L01EK0101|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|98250|127540|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||98250||98250|127540||1|0|L|0|||0
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|DEC|0|0|0|100|DKK|3691|7173|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3691||3691|7173||1|0||0|||0
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2366||1|0|E|0|||0
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|GEH|0|0|0|100|NOK|8180|12757|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8180||8180|12757||2|H|0|0|||0
104401|N06AB0607|Sertralin Krka|filmhtfl|50|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5696|7004|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Sertralín||4000||4000|7004||2|0|G|0|||0
104482|L01CA0403|Vinorelbine Alvogen|hylki|30|mg|1|stk|1|þpakki|mjúkt|L01CA04|01.10.2019||R|0|0|1|G|0|ALE|0|0|0|100|SEK|11186|15243|lyfalmen|V0992|15243|2|1|0||Alvogen|Alvogen Pharma Trading Europe EOOD|Vínorelbín||9986||9986|15243||2|0|G|0|||0
104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|9861|15071|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||9861||9861|15071||1|0|E|0|||0
104688|N05AH0415|Quetiapin Krka|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|4500|4801|lyfalmen|V0275|4788|2|100|0|12,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||2400||2400|4801||2|0|G|0|||0
104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|G|0|FER|0|0|0|100|DKK|6654|10656|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6654||6654|10656||1|0|G|0|||0
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|G|0|FER|0|0|0|100|DKK|3475|6281|lyfalmen|V0017|5558|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3475||3475|6281||1|0|G|0|||0
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|G|0|FER|0|0|0|100|DKK|5553|9141|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5553||5553|9141||1|0|G|0|||0
104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|4224|7312|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4224||4224|7312||2|0|G|0|||0
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|95649|124250|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||95649|124250||1|0|L|0|||0
105331|N02AE0105|Buprenorphine Alvogen|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|3107|5774|lyfalmen|V0944|5774|2|4|0|5,6000|Alvogen|Alvogen|Búprenorfín||3107||3107|5774||2|0|G|1|30|dagar|0
105363|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|3105|3128|lyfalmen|V0107|2530|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||1184||1184|3128||1|0|E|0|||0
105621|N02BE0127|Dolorin Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
105669|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1958|4193|lyfalmen|||1|20|0|16,0000|Icepharma hf|Abcur AB|Metadón||1958||1958|4193||2|0|G|1|30|dagar|0
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2770|5311|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2770||2770|5311||2|0||0|||0
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3323|6072|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||3323||3323|6072||2|0||0|||0
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|1823|4007|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1823||1823|4007||2|0||0|||0
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|RRG|0|0|0|100|DKK|2971|4008|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration GmbH|Oseltamivír||1824||1824|4008||2|0||0|||0
106390|L01EJ0101|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01EJ01|01.03.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|424361|534298|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||424361||424361|534298||1|0|L|0|||0
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|16335|23981|lyfalmen|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||16335||16335|23981||1|H|0|0|||0
106602|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6358|10249|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Navamedic ASA|Cíprófloxacín||6358||6358|10249||2|0|0|0|||0
106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|3359|2541|lyfalmen|V0107|2530|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||758||758|2541||2|0|E|0|||0
107002|R07AA0201|Curosurf|innönddr|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|116437|151326|lyfalmen|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||116437||116437|151326||1|H|0|0|||0
107194|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|75 mg/15 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3003|5176|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3003||3003|5176||1|0||0|||0
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1459|3506|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1459||1459|3506||1|0|G|0|||0
107322|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|5841|8720|lyfalmen|V0737|8720|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5247||5247|8720||2|0|E|0|||0
107464|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|G|0|POF|0|0|0|100|XEU|4319|4580|lyfalmen|V0438|4580|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||2239||2239|4580||2|0|G|0|||0
107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|PBV|0|0|0|100|XEU|18605|25592|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17505||17505|25592||2|H|0|0|||0
107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|11917|3240|lyfalmen|V0814|3197|2|28|0|8,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1266||1266|3240||1|0|E|0|||0
107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5625|3934|lyfalmen|V0683|3375|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||1770||1770|3934||2|0|G|0|||0
107785|L01EF0201|Kisqali|filmhtfl|200|mg|42|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|278198|352512|lyfsjukr|||1|42|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||278198||278198|352512||1|0|L|0|||0
107918|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040|30.6.2021|2|0|E|1|30|dagar|0
107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2|0||1|30|dagar|0
108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2|0||1|30|dagar|0
108413|C10AX1401|Praluent|stl|75|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|67990|89267|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||67990||67990|89267||1|0|E|0|||0
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|G|0|NEL|0|0|0|100|DKK|8610|13349|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8610||8610|13349||1|0|G|0|||0
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|1|0|0|OUS|0|0|0|100|XEU|78108|102065|lyfalmen|||1|180|0|30,0000|Recordati AB|Orphan Europe SARL|Betain anhydrous||78108||78108|102065||3|0|E|0|||0
109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||500||500|2186||2|0|G|0|||0
109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|5340|7622|lyfalmen|V0585|7595|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||4449||4449|7622||2|0|G|1|30|dagar|0
109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|3869|6823|lyfalmen|||2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||3869||3869|6823||2|0|G|1|30|dagar|0
109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|0|G|0|RTH|0|0|0|100|XEU|9754|13484|lyfalmen|V0587|13484|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||8708||8708|13484||2|0|G|1|30|dagar|0
109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|XEU|18909|25153|lyfalmen|||2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||17186||17186|25153||2|0|G|1|30|dagar|0
110001|N03AX1602|Lyrica (Lyfjaver)|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|8715|13493|lyfalmen|V0686|3437|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||8715||8715|13493||3|0|E|0|||0
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2|0||0|||0
110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|1744|3898|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1744||1744|3898||1|0|G|0|||0
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|1500|2461|lyfalmen|V0291|2273|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||700||700|2461||2|0|G|0|||0
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2608|3494|lyfalmen|V0292|3494|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1450||1450|3494||2|0|G|0|||0
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4870|8201|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4870||4870|8201||2|0|G|0|||0
110341|A10BJ0601|Ozempic|stl|0,25|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18238|26601|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18238||18238|26601||1|0|E|0|||0
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5000|8380|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8380||2|0|G|0|||0
110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1428|3100|lyfalm11|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1428||1428|3100||1|0||0|||1
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|G|0|COR|0|0|0|100|DKK|5165|8607|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||5165||5165|8607||1|0|G|0|||0
110750|J05AJ0101|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AJ01|01.04.2012||R|1|0|1|0|0|MBV|0|1|0|100|DKK|85562|111492|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Raltegravír||85562||85562|111492||1|0|L|0|||0
110958|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|8097|12643|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8097||8097|12643||1|0|L|0|||0
111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|GED|0|0|0|100|XEU|13506|16812|lyfalm11|||2|1|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||12557||12557|16812||1|0|E|0|||1
111479|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|G|0|POF|0|0|0|100|XEU|4464|4803|lyfalmen|V0373|4803|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2401||2401|4803||2|0|G|0|||0
111775|G03AA1209|Asubtela|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.11.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|2469|4383|lyfalm11|V0993|4383|2|63|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Dróspírenón og ethinylestradíól||2469||2469|4383||2|0||0|||1
111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|GCA|0|0|1|100|DKK|651|2394|lyfalmen|||1|100|0|33,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól||651||651|2394||1|0|E|0|||0
112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|lausn|V03AB33|01.05.2019||R|0|0|0|0|0|SEB|0|0|0|100|XEU|126065|163301|lyfalmen|||2|1|0||Swedish Orphan Biovitrum A/S|SERB S.A.|Hydroxocobalamin||126065||126065|163301||3|H|0|0|||0
112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|182928|234022|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||182928||182928|234022||1|0|L|0|||0
112345|J01FF0104|Clindamycin EQL Pharma|hylki|150|mg|32|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|1500|3563|lyfalmen|||2|32|0|4,0000|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
112704|N05AH0415|Quetiapin Krka|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|1800|2599|lyfalmen|V0284|2324|2|100|0|6,2500|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||800||800|2599||2|0|G|0|||0
112713|N05AH0415|Quetiapin Krka|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3800|3287|lyfalmen|V0285|3261|2|100|0|25,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||1300||1300|3287||2|0|G|0|||0
112732|N05AH0415|Quetiapin Krka|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|5000|5627|lyfalmen|V0286|5611|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Quetíapín||3000||3000|5627||2|0|G|0|||0
112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3737|lyfalmen|||2|100|0|3,3333|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3737||2|0|E|0|||0
113088|M05BA0802|Aclasta|irl|5|mg|100|ml|1|glas|lausn|M05BA08|01.04.2019||R|0|1|0|0|0|NEL|0|0|0|100|DKK|50313|66909|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||50313||50313|66909||1|0|E|0|||0
113179|S01LA0601|Beovu|stl|120|mg/ml|0,165|ml|1|áfspr|lausn|S01LA06|01.06.2020||R|0|1|0|0|0|NEP|0|1|0|100|DKK|110525|143973|lyfsjukr|||1|0,165|0||Vistor hf|Novartis Europharm Limited|Brolucizumab||110525||110525|143973||1|H|L|0|||0
113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014|31.07.2021|L|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||5077||2|0|E|0|||0
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6408|10318|lyfalmen|V0024|10318|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6408||6408|10318||1|0|G|0|||0
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|1|0|0|G|0|NEL|0|0|0|100|DKK|5618|9231|lyfalmen|V0025|9231|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5618||5618|9231||1|0|G|0|||0
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|2790|5338|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||2790||2790|5338||2|H|0|0|||0
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|3313|6058|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3313||3313|6058||1|0|G|0|||0
113566|C07AB0215|Metoprolol Alvogen|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1246|2993|lyfalmen|V0048|2993|2|100|0|31,6667|Alvogen|Alvogen ehf|Metóprólól||1086||1086|2993||2|0|G|0|||0
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|G|0|SNP|0|0|1|100|XEU|4608|7840|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4608||4608|7840||1|0|G|0|||0
113818|L01EA0301|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01EA03|01.06.2008||R|0|1|1|0|0|NEL|0|1|0|100|DKK|473745|595717|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||473745||473745|595717||1|0|L|0|||0
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|563|2273|lyfalmen|||1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||563||563|2273||2|0|E|0|||0
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|818|2624|lyfalmen|||1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||818||818|2624||2|0|E|0|||0
114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5000|8380|lyfalmen|V0145|3558|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||5000||5000|8380||2|0|E|0|||0
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1|0||0|||0
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|32747|44692|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||32747|44692||2|0|L|0|||0
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|G|0|MSD|0|0|1|100|DKK|3528|6354|lyfalmen|V0824|3968|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3528||3528|6354||1|0|G|0|||0
114505|C07AB0215|Metoprolol Alvogen|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|4390|4939|lyfalmen|V0054|4939|2|100|0|126,6667|Alvogen|Alvogen|Metóprólól||2500||2500|4939||2|0|G|0|||0
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6061|9840|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||6061||6061|9840||2|0|G|0|||0
114605|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|8263|11806|lyfalmen|V0973|11806|2|100|0|60,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||7489||7489|11806||2|0|G|0|||0
114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|G|0|MED|0|0|0|100|IKR|14000|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0
114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5620|9687|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5620||5620|9687||2|0||0|||0
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|1948|3726|lyfalmen|V0278|3726|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1619||1619|3726||2|0|G|0|||0
114950|L01BC0702|Azacitidine Accord|sts|25|mg/ml|100|mg|1|hgl||L01BC07|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|48355|64433|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Azasitidín||48355||48355|64433||1|H|L|0|||0
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2626|3663|lyfalmen|V0279|3663|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1573||1573|3663||2|0|G|0|||0
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|7815|6725|lyfalmen|V0280|6725|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3798||3798|6725||2|0|G|0|||0
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|10799|6725|lyfalmen|V0282|6725|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3798||3798|6725||2|0|G|0|||0
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|0|KNM|0|0|0|100|IKR|5276|8760|lyfalmen|V0457|8760|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8760||2|0|G|0|||0
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12539|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12539||2|0|G|0|||0
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9452|lyfalmen|V0475|9452|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9452||2|0|G|0|||0
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20624|lyfalmen|V0540|20624|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20624||2|0|G|0|||0
115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|82027|107021|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||82027||82027|107021||1|H|L|0|||0
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|RAU|0|0|1|100|XEU|7226|11444|lyfalmen|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7226||7226|11444||2|0|0|0|||0
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1079|2983|lyfalmen|V0158|2983|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||1079||1079|2983||2|0|E|0|||0
115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|1741|3287|lyfalmen|V0276|3176|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1300||1300|3287||2|0|G|0|||0
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|10566|16041|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10566||10566|16041||1|0|G|0|||0
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|G|0|BII|0|0|0|100|DKK|9098|14020|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9098||9098|14020||1|0|G|0|||0
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|42244|56704|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||42244||42244|56704||1|0|G|0|||0
115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|STE|0|0|0|100|DKK|3373|6141|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||3373||3373|6141||1|0|0|0|||0
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|GPH|0|0|1|100|DKK|3259|5984|lyfalmen|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3259||3259|5984||1|0|0|0|||0
116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1704|3843|lyfalmen|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1704||1704|3843||1|0|0|0|||0
116551|M01AE0102|Ibufen|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116573|M01AE0102|Ibufen|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
116584|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|791|2468|lyfalmen|V0562|2402|2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||705||705|2468||1|0|G|0|||0
116595|M01AE0102|Ibufen|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|403|1978|lyfalmen|V0563|1823|2|30|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||349||349|1978||1|0|G|0|||0
116606|M01AE0102|Ibufen|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|G|0|ATE|0|0|1|100|XEU|841|2636|lyfalmen|V0564|2265|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen||827||827|2636||1|0|G|0|||0
116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|13805|20499|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||13805||13805|20499||1|0|G|0|||0
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4143|6632|lyfalmen|V0081|6391|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan||3730||3730|6632||1|0|G|0|||0
116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5381|8904|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5381||5381|8904||1|0|G|0|||0
116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|5859|9562|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||5859||5859|9562||1|0|G|0|||0
116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|G|0|PEU|0|0|0|100|DKK|15037|22195|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Europe MA EEIG|Fesóteródín||15037||15037|22195||1|0|G|0|||0
117103|QN01AX0305|Ketabel vet.|stl|100|mg/ml|25|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|2997|5856|vetalmen|||0|25|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||2997||2997|5856||2|0|0|1|30|dagar|0
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|KEL|1|0|0|100|XEU|9059|17357|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9059||9059|17357||2|0||0|||0
117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|G|0|SNP|0|0|1|100|XEU|1452|3496|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1452||1452|3496||1|0|G|0|||0
117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|ASZ|0|0|0|100|SEK|10916|15806|lyfalmen|V0275|4788|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10395||10395|15806||1|0|E|0|||0
117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|20109|26793|lyfalmen|V0273|5008|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||18378||18378|26793||1|0|G|0|||0
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1373|3388|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||1373||1373|3388||2|0|G|0|||0
117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|G|0|ASZ|0|0|0|100|SEK|28861|39777|lyfalmen|V0272|8917|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||28861||28861|39777||1|0|G|0|||0
117676|L01DB0107|Caelyx pegylated liposomal|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|0|0|JCI|0|1|0|100|SEK|53300|70687|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||53300||53300|70687||1|H|L|0|||0
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|NOK|5092|9831|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5092||5092|9831||2|0||0|||0
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|KEL|0|0|0|100|XEU|13142|25104|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||13142||13142|25104||2|0||0|||0
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1694|3830|lyfalmen|V0278|3726|2|28|0|7,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1694||1694|3830||1|0|G|0|||0
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2549|3792|lyfalmen|V0279|3663|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1667||1667|3792||1|0|G|0|||0
118046|N07BC0102|Buvidal|stl|96|mg|0,27|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|55856|73920|lyfsjukr|||1|0,27|0|45,7143|Vistor hf|Camurus AB|Búprenorfín||55856||55856|73920||1|H|L|1|30|dagar|0
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7648|7507|lyfalmen|V0282|6725|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4366||4366|7507||1|0|G|0|||0
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1621|3729|lyfalmen|V0283|3729|2|28|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||1621||1621|3729||1|0|G|0|||0
118153|L02BB0401|Xtandi|filmhtfl|40|mg|112|stk|1|þpakki||L02BB04|01.10.2019||R|1|0|0|0|0|APE|0|1|0|100|XEU|402234|506778|lyfsjukr|||1|112|0|28,0000|Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||402234||402234|506778||1|0|L|0|||0
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|AGA|0|0|0|100|XEU|14980|22116|lyfalmen|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||14980||14980|22116||5|H|0|0|||0
118421|C02AC0201|Intuniv|forðatfl|3|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|11148|16842|lyfalmen|||1|28|0|28,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||11148||11148|16842||1|0|E|0|||0
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|G|0|ATE|0|0|0|100|XEU|7815|8118|lyfalmen|V0280|6725|2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||4810||4810|8118||1|0|G|0|||0
118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|4997|9651|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4997||4997|9651||2|0||0|||0
118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|G|0|FER|0|0|0|100|DKK|19411|28215|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19411||19411|28215||1|0|G|0|||0
118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1185|3129|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1185||1185|3129||2|H|0|0|||0
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|G|0|AEP|0|0|0|100|DKK|453|2121|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||453||453|2121||2|0|G|0|||0
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|1336|3337|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1336||1336|3337||2|0|G|0|||0
119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2326|4457|lyfalmen|V0824|3968|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2150||2150|4457||2|0|G|0|||0
119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|GAN|0|0|0|100|XEU|2880|5462|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||2880||2880|5462||2|0|E|0|||0
119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|5500|9068|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5500||5500|9068||2|0|E|0|||0
119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|1297|3283|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1297||1297|3283||2|0||2|60|mg|0
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|314014|397057|lyfsjukr|||1|30|0|20,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||314014||314014|397057||1|0|L|0|||0
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|1|0|0|RGP|0|1|0|100|DKK|291527|369089|lyfsjukr|||1|30|0|40,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Ambrisentanum||291527||291527|369089||1|0|L|0|||0
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|G|0|CLA|0|0|0|100|XEU|1678|3808|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Cýklópentólat||1678||1678|3808||1|0|G|0|||0
120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|0|0|NED|0|1|0|100|XEU|36208|49069|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||36208||36208|49069||2|H|L|0|||0
120278|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|51231|68071|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||51231||51231|68071||1|H|L|0|||0
120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|KRK|0|0|0|100|IKR|7679|7898|lyfalmen|V0118|7812|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4650||4650|7898||2|0|E|0|||0
121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|392095|494168|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||392095||392095|494168||2|H|L|0|||0
121133|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7410|8242|lyfalmen|V0118|7812|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4900||4900|8242||2|0|E|0|||0
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|skpokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|GRH|0|0|1|100|DKK|3638|6505|lyfalmen|||1|28|0|9,3300|Vistor hf|Grünenthal GmbH|Esómeprazól||3638||3638|6505||1|0|E|0|||0
121274|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2355|4739|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer Aps|Hýdrókortisón||2355||2355|4739||1|0|G|0|||0
121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|786|2580|lyfalmen|V1051|2580|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||786||786|2580||1|0|0|1|30|dagar|0
121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2995|5620|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2995||2995|5620||2|0|G|0|||0
122129|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|áfspr|27Gx13mm áföst nál með hlíf|B06AC05|01.04.2021||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1824289|2275416|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1824289||1824289|2275416||1|0|L|0|||0
122231|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2190|4512|lyfalmen|V0214|4512|2|98|0|49,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2190||2190|4512||2|0|E|0|||0
122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2|0||0|||0
122326|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|2500|2861|lyfalmen|V0010|2193|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||990||990|2861||2|0|G|0|||0
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|BIV|0|0|0|100|DKK|8838|15233|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||8838||8838|15233||1|0||0|||0
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|30512|52590|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||30512||30512|52590||2|0||0|||0
123487|L01BC0603|Ecansya|filmhtfl|500|mg|120|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|18000|26273|lyfalmen|||2|120|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||18000||18000|26273||2|0|0|0|||0
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|612|2340|lyfalmen|||2|100|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||612||612|2340||1|0|G|0|||0
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|1|G|0|SMA|0|0|0|100|XEU|30218|41493|lyfalmen|V0579|29113|1|56|0|28,0000|Vistor hf|Sanofi Mature IP|Rílúzól||30218||30218|41493||1|0|G|0|||0
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|CHP|0|0|0|100|XEU|1688|3318|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||1688|3318||2|0||0|||0
124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|1|0|0|OUS|0|0|0|100|XEU|33905|46157|lyfalmen|||1|60|0|15,0000|Recordati AB|Orphan Europe SARL|Tocofersolanum||33905||33905|46157||3|0|E|0|||0
124225|B01AF0102|Rivaroxaban WH|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8480|13170|lyfalmen|V1035|13170|2|28|0|21,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8480||8480|13170||2|0|G|0|||0
124347|R03AC0206|Ventoline|innönddu|200|mcg/sk|60|skammtar|1|stk||R03AC02|01.03.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|677|2430|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||677||677|2430||1|0|G|0|||0
124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7690|12082|lyfalmen|V0995|5283|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||7690||7690|12082||1|0|G|0|||0
124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|G|0|GAB|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||4529||1|0|G|0|||0
125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|3254|5977|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||3254||3254|5977||2|0|G|0|||0
125246|N03AX1214|Gabapentin Alvogen|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|12590|18827|lyfalmen|V0256|18827|2|100|0|44,4400|Alvogen|Alvogen|Gabapentín||12590||12590|18827||2|0|G|0|||0
125376|B03BA0105|Optovite B12|stl|1000|mcg|2|ml|5|lykjur||B03BA01|01.05.2020||R|0|0|0|G|0|LNA|0|0|1|100|XEU|5706|9352|lyfalmen|||2|10|0|250,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Cyanocobalamin||5706||5706|9352||2|0|G|0|||0
125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|5524|3356|lyfalmen|V0285|3261|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1350||1350|3356||2|0|G|0|||0
125613|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|1569143|1958086|lyfsjukr|||1|20|0|23,2600|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||1569143||1569143|1958086||2|H|L|0|||0
125713|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|8791|13598|lyfalmen|V0347|13596|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8791||8791|13598||1|0|G|0|||0
126390|A10BK0101|Forxiga|filmhtfl|5|mg|28|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|6473|10407|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||6473||6473|10407||1|0|G|0|||0
126496|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2163|2577|lyfalmen|V0057|2207|2|100|0|200,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||784||784|2577||1|0|G|0|||0
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|43982|58902|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||43982||43982|58902||2|H|L|0|||0
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|87963|114529|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||87963||87963|114529||2|H|L|0|||0
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|CSB|0|1|0|100|SEK|175926|225314|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||175926||175926|225314||2|H|L|0|||0
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|0|0|FIN|0|1|0|100|DKK|118546|153949|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||118546||118546|153949||2|H|L|0|||0
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29903|41095|lyfalmen|V0976|41095|1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||29903|41095||2|0|G|0|||0
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|G|0|NEL|0|0|1|100|DKK|3282|6015|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||3282|6015||1|0|G|0|||0
126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|G|0|ABC|0|0|1|100|SEK|7080|11243|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7080||7080|11243||2|0|G|0|||0
127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|XEU|3091|4796|lyfalmen|V0011|4796|2|100|0|66,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||2396||2396|4796||1|0|G|0|||0
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||2|0||0|||0
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|NED|0|0|0|100|XEU|5827|9518|lyfalmen|V0279|3663|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5827||5827|9518||2|0|E|0|||0
128348|C03AB0102|Centyl mite med kaliumklorid|filmhtfl|||100|stk|1|glas|1,5 mg / 573 mg|C03AB01|01.05.1999||R|1|0|0|G|0|KPA|0|0|0|100|DKK|1447|3490|lyfalmen|||1|100|0|50,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||1447||1447|3490||2|0|G|0|||0
128750|L04AA2901|Xeljanz|filmhtfl|10|mg|56|stk|1|þpakki||L04AA29|01.01.2019||R|0|1|1|0|0|PEU|0|1|0|100|DKK|226002|287594|lyfsjukr|||1|56|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||226002||226002|287594||1|0|L|0|||0
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|G|0|NED|0|0|0|100|XEU|22393|31596|lyfalmen|V0282|6725|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22393||22393|31596||2|0|G|0|||0
129152|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|1 innöndunartæki og 1 rörlykja|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4159|7222|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4159||4159|7222||1|0|G|0|||0
129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|17493|14915|lyfalmen|V0680|14915|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||9748||9748|14915||2|0||0|||0
129289|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|V0997|9291|2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169||2|0|E|1|30|dagar|0
129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3386||2|0||0|||0
129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|G|0|BOI|0|0|0|100|DKK|3487|6297|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3487||3487|6297||1|0|G|0|||0
129860|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|29469|40546|lyfalmen|V0977|40273|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||29469||29469|40546||2|0|G|0|||0
129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0812|3197|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15164|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15164||2|0|E|1|30|dagar|0
130001|N06AB0608|Sertralin WH|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|3423|4251|lyfalmen|V0323|4251|2|100|0|200,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||2000||2000|4251||2|0|G|0|||0
130242|L04AA4001|Mavenclad|töflur|10|mg|1|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|304844|385652|lyfsjukr|||1|1|0|29,4118|Icepharma hf|Merck Europe B.V.|Cladribine||304844||304844|385652||2|0|L|0|||0
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|DKK|5149|4876|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2454||2454|4876||2|0||0|||0
130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|0|0|PFM|0|1|0|100|DKK|351147|443240|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||351147||351147|443240||1|H|L|0|||0
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|19115|36435|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||19115||19115|36435||1|0||0|||0
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|MYL|0|0|1|100|SEK|1469|3520|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1469||1469|3520||2|0||0|||0
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9551|14644|lyfalmen|V1049|14644|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9551|14644||1|0||0|||0
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|PHA|0|0|0|100|NOK|40172|64757|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||40172|64757||1|0||0|||0
131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|RPG|1|0|0|100|XEU|6554|12605|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||6554||6554|12605||2|0||0|||0
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|MYL|0|0|0|100|SEK|4595|7277|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||4199||4199|7277||2|0||0|||0
131620|C08CA0107|Amlodipine Vitabalans|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|2461|lyfalmen|V0057|2207|2|100|0|200,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
132106|H05BX0107|Cinacalcet STADA|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|15128|8380|lyfalmen|V0720|8288|2|28|0|14,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||5000||5000|8380||2|0||0|||0
132322|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|0|0|VAL|0|0|1|100|XEU|1112|2160|lyfalmen|V0003|2160|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||481||481|2160||2|0||0|||0
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|5076|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||3100||3100|5765|||0|G|0|||0
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|G|0|ATE|0|0|0|100|IKR|3156|5159|lyfalmen|V0580|5159|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||2660||2660|5159|||0|G|0|||0
132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|0|0|TPA|0|1|0|100|DKK|387278|488177|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||387278||387278|488177||1|H|L|0|||0
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|G|0|AGC|0|0|0|100|XEU|8606|13343|lyfalmen|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||8606||8606|13343||1|0|G|0|||0
132554|L04AD0205|Advagraf (Lyfjaver)|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|14725|21765|lyfalmen|V1044|21765|3|50|0|10,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||14725||14725|21765||3|0|G|0|||0
132633|D11AH0501|Dupixent|stl|300|mg|2|áf.spr|1|pakki|með nálarhlíf|D11AH05|01.08.2019||R|0|0|1|0|0|SGB|0|1|0|100|XEU|174471|223504|lyfsjukr|||1|2|0|28,0374|Vistor hf|Sanofi-aventis groupe|Dupilumab||174471||174471|223504||1|0|L|0|||0
132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2364|3631|lyfalmen|V0089|3631|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1550||1550|3631||2|0|G|0|||0
132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|0|0|0|JAS|0|0|0|100|SEK|4706|7975|lyfalmen|V0681|7321|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4706||4706|7975||1|0|E|1|30|dagar|0
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|6112|11766|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||||6112|11766||2|0||0|||0
132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|4382|3947|lyfalmen|V0335|2568|2|100|0|150,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1779||1779|3947||1|0|G|0|||0
132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|MUP|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Mundipharma A/S|Joð/pólývídón|||||||2|0||0|||0
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|418|2073|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Proxýmetakaín||418||418|2073||1|0||0|||0
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1|0||0|||0
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|22473|31697|lyfalmen|||1|0,5|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||22473||22473|31697||1|H|0|0|||0
133101|M01AH0108|Celecoxib Medical|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|1323|3319|lyfalmen|V0037|3319|2|20|0|20,0000|LYFIS ehf|Medical ehf|Celekoxíb||1323||1323|3319||2|0|G|0|||0
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|29882|41068|lyfalmen|||1|1|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||29882||29882|41068||1|H|0|0|||0
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009|30.06.2021|R|0|0|0|0|0|SLP|0|0|0|100|SEK|40632|54665|lyfalmen|||1|2|0||Vistor hf|Sloan Pharma S.a.r.l.|Clostridium botulinum toxín-A||||40632|54665||1|H|0|0|||0
133227|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2019|31.05.2021|R|0|0|0|G|0|GLZ|0|0|0|100|DKK|5176|7495|lyfalmen|||2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||4757||4357|7495||2|0|G|0|||0
133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|0|0|GAA|0|0|0|100|SEK|5405|8937|lyfalmen|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||5405||5405|8937||2|H|0|0|||0
133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|BLS|0|0|0|100|XEU|1284|3265|lyfalmen|V0333|3204|2|30|0|11,2500|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1284||1284|3265||1|0|E|0|||0
134067|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2019||R|0|0|1|G|0|AZA|0|0|0|100|SEK|47709|62258|lyfalmen|V0451|52775|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||46635||46635|62258||1|0|G|0|||0
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2764|5302|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2764||2764|5302||2|0|G|0|||0
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7025|11167|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7025||7025|11167||2|0|G|0|||0
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|1|0|0|BRS|0|1|0|100|DKK|55622|73624|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||55622||55622|73624||1|0|L|0|||0
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|1|0|0|GAD|0|1|0|100|DKK|101590|132861|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Sciences Ireland UC|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||101590||101590|132861||2|0|L|0|||0
135062|C09CA0306|Valsartan Krka|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3912|3838|lyfalmen|V0678|3563|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan||1700||1700|3838||2|0|G|0|||0
135084|C09CA0306|Valsartan Krka|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5538|4251|lyfalmen|V0679|3904|2|98|0|196,0000|LYFIS ehf|Krka Sverige AB|Valsartan||2000||2000|4251||2|0|G|0|||0
135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|9428|14475|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9428||9428|14475||1|0|G|0|||0
135253|A10BB0906|Gliclazíð Krka|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3500|5008|lyfalmen|V0020|3502|2|90|0|45,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||2550||2550|5008||2|0|G|0|||0
135264|A10BB0906|Gliclazíð Krka|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2019||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4800|7004|lyfalmen|V0020|7004|2|180|0|90,0000|LYFIS ehf|Krka Sverige AB|Glíklazíð||4000||4000|7004||2|0|G|0|||0
135384|R03BA0501|Flixotide|innönddu|500|mcg/sk|60|skammtar|1|sk-ílá|Fjölskammtaílát|R03BA05|01.09.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4172|7240|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4172||4172|7240||1|0|G|0|||0
135434|R03BA0501|Flixotide|innönddu|100|mcg/sk|60|skammtar|1|pakki|fjölskammtaílát|R03BA05|01.07.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1184|3128|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1184||1184|3128||1|0|G|0|||0
135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|G|0|VAL|0|0|0|100|DKK|2190|2771|lyfalmen|V0909|2771|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||925||925|2771||2|0|G|0|||0
135533|R03AC1201|Serevent|innönddu|50|mcg/sk|60|skammtar|1|innö.t||R03AC12|01.10.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|2708|5225|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2708||2708|5225||1|0|G|0|||0
136121|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|2 hgl m 5 ml leysi + 2 millist|B06AC01|01.03.2019||R|0|1|1|0|0|SSE|0|1|0|100|DKK|193103|246677|lyfsjukr|||1|2|0|0,7143|Shire Services BVBA|Shire Services BVBA|C1 hemill||193103||193103|246677||1|0|L|0|||0
136180|M05BA0306|Pamidronatdinatrium Pfizer|irþ|3|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5816|9503|lyfalmen|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5816||5816|9503||1|H|0|0|||0
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|1|G|0|PEU|0|0|0|100|DKK|34763|47242|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||34763||34763|47242||1|0|G|0|||0
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|MEA|0|0|0|100|DKK|8397|13056|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||8397||8397|13056||2|0||0|||0
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|57907|76514|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||57907||57907|76514||1|0|L|0|||0
136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|2714|5233|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2714||2714|5233||1|0||0|||0
136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|1|100|IKR|804|2605|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||804||804|2605||2|0||2|60|mg|0
136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metrónídazól|||||||1|0||0|||0
137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|16195|14574|lyfalmen|V0261|11408|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||9500||9500|14574||2|0|G|0|||0
137665|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|30|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|1612|3400|lyfalmen|V1002|3400|2|30|0|2,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||1382||1382|3400||2|0|E|1|30|dagar|0
137690|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|619|2350|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck AB|Levótýroxínnatríum||619||619|2350||2|0|G|0|||0
137721|L04AA4001|Mavenclad|töflur|10|mg|6|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1829067|2281358|lyfsjukr|||1|6|0|176,4706|Icepharma hf|Merck Europe B.V.|Cladribine||1829067||1829067|2281358||2|0|L|0|||0
137883|N05AH0415|Quetiapin Krka|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6500|7004|lyfalmen|V0273|5008|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Quetíapín||4000||4000|7004||2|0|G|0|||0
138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4824|5613|lyfalmen|V0689|3390|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2990||2990|5613||2|0|E|0|||0
138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2612|5093|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2612||2612|5093||2|0|G|0|||0
138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|1|0|0|GSE|0|1|0|100|DKK|2294267|2859937|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|sofosbuvir,velpatasvir,voxilaprevir||||2294267|2859937||2|0|L|0|||0
138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2500|2806|lyfalmen|V0114|2736|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||950||950|2806||2|0|G|0|||0
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|15890|23369|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||15890||15890|23369||1|0||0|||0
138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3365|6130|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3365||3365|6130||2|0|G|0|||0
138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|4764|5582|lyfalmen|V0691|5572|2|30|0|18,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||2967||2967|5582||1|0|E|1|30|dagar|0
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|G|0|ATE|0|0|0|100|XEU|2571|4803|lyfalmen|V0373|4803|2|15|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tímólól í blöndum||2401||2401|4803||1|0|G|0|||0
139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|101102|132254|lyfsjukr|||1|56|0|28,0000|Vistor hf|Amgen Europe B.V.|Apremilast||101102||101102|132254||1|0|L|0|||0
139959|N06DA0304|Nimvastid|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|510|2200|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||510||510|2200||1|0|G|0|||0
140132|C08CA0107|Amlodipine Vitabalans|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.08.2020||R|1|0|0|G|0|VIB|0|0|0|100|IKR|1267|2461|lyfalmen|V0056|2207|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Amlódipín||700||700|2461||2|0|G|0|||0
140191|R06AX2708|Dasergin|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.04.2020||L|1|0|0|0|0|KAN|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Deslóratadín|||||||2|0||0|||0
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|966|2828|lyfalmen|V0266|2503|1|30|0|1,5000|Vistor hf|Boehringer Ingelheim International |Pramipexól||966||966|2828||1|0|G|0|||0
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|LBK|0|0|0|100|DKK|8937|13799|lyfalmen|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8937||8937|13799||1|0|0|0|||0
140563|A07DA0201|Dropizol|dropar|10|mg/ml|10|ml|1|dropaí||A07DA02|01.06.2018||R|0|0|0|0|0|ARO|0|0|0|100|DKK|6618|10607|lyfalmen|||2|10|0|1,0000|Pharmanovia A/S|Pharmanovia A/S|opium||6618||6618|10607||2|0|E|1|30|dagar|0
140611|N06BA0408|Methylphenidate Teva|hylki|10|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|3050|5696|lyfalmen|V0958|5696|2|30|0|10,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3050||3050|5696||1|0|E|1|30|dagar|0
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|SRR|0|0|0|100|NOK|70842|134572|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||70842||70842|134572||1|0||0|||0
140792|L04AD0205|Advagraf (Lyfjaver)|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|43857|58744|lyfalmen|V1045|58744|3|50|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||43857||43857|58744||3|0|G|0|||0
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|1|0|0|JAS|0|1|0|100|SEK|61938|81613|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||61938||61938|81613||1|0|L|0|||0
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|G|0|PLS|0|0|1|100|DKK|1122|3042|lyfalmen|V0413|2812|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1122||1122|3042||1|0|G|0|||0
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|G|0|NEL|0|0|1|100|DKK|2941|5546|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||2941||2941|5546||1|0|G|0|||0
141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1|0||0|||0
141238|N05CH0104|Melatonin Vitabalans|töflur|3|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|4000|4113|lyfalmen|||2|50|0|75,0000|LYFIS ehf|LYFIS ehf|Melatonin||1900||1900|4113||2|0|0|0|||0
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|3340|6095|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3340||3340|6095||1|0|0|0|||0
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|13974|20732|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||13974|20732||2|0|G|0|||0
141783|R02AX0103|Strefen Körsbär & Mint|munnhúði|16,2|mg/ml|15|ml|1|glas||R02AX01|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
141847|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|100|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|33715|45916|lyfalmen|V1007|45916|2|100|0|53,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||33715||33715|45916||2|0|E|1|30|dagar|0
141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2532||1|0||0|||0
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|G|0|BII|0|0|0|100|DKK|5854|9555|lyfalmen|V0267|4277|1|100|0|10,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5854||5854|9555||1|0|G|0|||0
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1584|3678|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1584||1584|3678||2|0|G|0|||0
142123|R07AX0101|INOmax|lyfjagas|800|ppm|2|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|21472|30431|lyfalmen|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21472|30431||5|H|0|0|||0
142177|QP54AA5401|BROADLINE|bl.lausn|||0,3|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2496|4302|vetorma|||0|0,9|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||2496||2496|4302||1|0||0|||0
142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|3932|4622|lyfalmen|V0384|3252|2|10|0|5,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2270||2270|4622||1|0|G|0|||0
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|G|0|SNP|0|0|0|100|XEU|859|2680|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||859||859|2680||1|0|G|0|||0
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|YLA|0|0|1|100|DKK|3091|5752|lyfalmen|||1|100|0|50,0000|Icepharma hf|Mylan ApS|Metenamín||3091||3091|5752||2|0|E|0|||0
142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|421131|530280|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||421131||421131|530280||1|0|L|0|||0
142606|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|979|2845|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||979||979|2845||2|0|G|1|30|dagar|0
142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|2599|lyfalmen|V0946|2599|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||800||800|2599||2|0|G|0|||0
142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2043|2984|lyfalmen|V0049|2910|2|100|0|66,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1080||1080|2984||2|0|G|0|||0
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16820||1|0||0|||0
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2093|4379|lyfalmen|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2093||2093|4379||1|H|0|0|||0
143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|ATE|0|0|0|100|XEU|8119|4704|lyfalmen|V0687|4664|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||2329||2329|4704||1|0|E|0|||0
143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4510|7705|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4510||4510|7705||1|0||0|||0
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|CLA|0|0|0|100|XEU|1013|2892|lyfalmen|||1|15|0||Vistor hf|Alcon Nordic A/S|Trópíkamíð||1013||1013|2892||1|0||0|||0
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1262|3235|lyfalmen|V0173|2676|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1262||1262|3235||1|0|E|0|||0
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4667|7922|lyfalmen|V0387|6927|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4667||4667|7922||1|0|G|0|||0
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|G|0|MBV|0|0|0|100|DKK|4573|7792|lyfalmen|V0386|6748|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Metforminum og sitagliptinum||4573||4573|7792||1|0|G|0|||0
143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|G|0|ATE|0|0|0|100|DKK|2708|5225|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Litíum||2708||2708|5225||1|0|G|0|||0
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1593|3691|lyfalmen|V0174|2599|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1593||1593|3691||1|0|E|0|||0
144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|G|0|AZD|0|0|1|100|SEK|3825|6763|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3825||3825|6763||1|0|G|0|||0
144490|N07XX0801|Vyndaqel|hylki|61|mg|30|stk|1|stsk.þ||N07XX08|01.10.2020||R|0|1|1|0|0|PEU|0|1|0|100|DKK|1351975|1687990|lyfsjukr|||1|30|0|91,5000|Icepharma hf|Pfizer Europe MA EEIG|Tafamidis||1351975||1351975|1687990||1|0|L|0|||0
144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8919|13484|lyfalmen|V0587|13484|2|98|0|52,2700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||8708||8708|13484||1|0|G|1|30|dagar|0
144940|C07AB0706|Bisoprolol Medical Valley|filmhtfl|5|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1240|3205|lyfalmen|V1038|3205|2|105|0|52,5000|Acare ehf|Medical Valley Invest AB|bisoprolol||1240||1240|3205||2|0|G|0|||0
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|tfílát||N05BA02|01.04.2020||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1340|3342|lyfalmen|||2|24|0|8,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1340||1340|3342||1|0||2|50|töflur|0
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|tfílát||N05BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1110|3026|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1110||1110|3026||1|0||2|25|töflur|0
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|0|0|0|0|JAN|0|1|0|100|DKK|74959|98082|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||74959||74959|98082||1|H|L|0|||0
145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4411|7569|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4411|7569||1|0|G|0|||0
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|4356|8435|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4356||4356|8435||1|0||0|||0
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|5889|11343|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5889||5889|11343||1|0||0|||0
145479|L04AX0402|Lenalidomid Alvogen|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|638030|786567|lyfsjukr|||2|21|0|31,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||627196||627196|786567||2|0|L|0|||0
145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|472|2148|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||472||472|2148||1|0|G|0|||0
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2|0||0|||0
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|7163|13760|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||7163||7163|13760||1|0||0|||0
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|VIR|0|0|0|100|XEU|8574|16437|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||8574||8574|16437||1|0||0|||0
145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6661|10666|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6661||6661|10666||2|0|0|0|||0
145691|L03AA1302|Pelgraz|stl|6|mg/spr|0,6|ml|1|spr|áföst nál með nálavörn|L03AA13|01.03.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|106041|138397|lyfsjukr|||2|0,6|0|20,0000|Artasan ehf|Accord Healthcare S.L.U.|Pegfilgrastím||106041||106041|138397||1|0|L|0|||0
145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|G|0|VIF|0|0|1|100|CHF|24272|33973|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||24272||24272|33973||1|0|G|0|||0
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|23722|33277|lyfsjukr|||1|1|0|4,8000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||23722||23722|33277||1|H|L|0|||0
146428|L04AD0205|Advagraf (Lyfjaver)|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.06.2021||R|0|0|1|G|0|LVR|0|0|0|100|XEU|68559|89987|lyfalmen|V1046|89987|3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Tacrolimus||68559||68559|89987||3|0|G|0|||0
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|DAN|0|0|0|100|XEU|16464|24159|lyfalmen|V0817|3325|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16464||16464|24159||2|0|E|0|||0
146494|G04BD0806|Solifenacin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|13744|11163|lyfalmen|V0441|11163|2|90|0|180,0000|Icepharma hf|Mylan AB|Sólífenacín||7022||7022|11163||2|0|G|0|||0
146529|B06AC0201|Firazyr|stl|30|mg|3|ml|1|áfspr|+ ein nál|B06AC02|01.05.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|238590|303250|lyfsjukr|||1|3|0|1,0000|Vistor hf|Shire Pharmaceuticals Ireland Limited|Icatibant ||238590||238590|303250||1|0|L|0|||0
146751|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0815|3197|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
146812|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.08.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|14970|13097|lyfalmen|||2|56|0|42,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||8427||8427|13097||1|0|G|0|||0
146827|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2873|lyfalmen|V0114|2873|2|105|0|210,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||999||999|2873||2|0|G|0|||0
147365|G04BD1202|Betmiga (Lyfjaver)|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|15204|22425|lyfalmen|V1031|22425|3|90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||15204||15204|22425||3|0|G|0|||0
147481|N06AB0608|Sertralin WH|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2019||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1825|2916|lyfalmen|V0322|2916|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Sertralín||1030||1030|2916||2|0|G|0|||0
147578|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3370||1|0||0|||0
147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|1624|3733|lyfalmen|||2|30|0|3,7500|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1624||1624|3733||1|0|E|0|||0
147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|6431|5311|lyfalmen|V0687|4664|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2770||2770|5311||2|0|E|0|||0
147902|L01EX0801|Lenvima|hylki|10|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|228659|290899|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||228659||228659|290899||1|0|L|0|||0
147931|D11AX1802|Solaraze 3%|hlaup|3|% w/w|100|g|1|túpa||D11AX18|01.01.2020||R|0|0|0|0|0|ALM|0|0|0|100|XEU|15114|22301|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15114||15114|22301||1|0|E|0|||0
148087|J01DD0402|Ceftriaxona Normon|irs|2000|mg|50|stk|1|hgl|lausn|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|147618|190107|lyfalmen|||2|50|0|50,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||||147618|190107||2|0|0|0|||0
148170|J05AE1003|Darunavir Medical Valley|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|47360|61559|lyfsjukr|||2|60|0|30,0000|Acare ehf|Medical Valley Invest AB|Darunavír||46083||46083|61559||2|0|L|0|||0
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|1|0|0|ROA|0|0|0|100|DKK|92417|120163|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||92417||92417|120163||2|0||0|||0
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1116|2763|lyfalmen|V0577|2763|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||919||919|2763||1|0|E|0|||0
148266|QI01AN0101|Evalon|innúðal|||5000|skammtar|1|hgl|+250ml af HipramuneT(leysir)|QI01AN01|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|IKR|104840|180702|vetorma|||0|5000|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Coccidia||104840||104840|180702||2|0|0|0|||0
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|1660|3783|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1660||1660|3783||1|0|E|0|||0
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|COR|0|0|1|100|DKK|5707|8976|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||5433||5433|8976||1|0|E|0|||0
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|57183|75599|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||57183||57183|75599||1|0|E|0|||0
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|1|0|0|STG|0|0|0|100|DKK|57183|75599|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Alítretínóín||57183||57183|75599||1|0|E|0|||0
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|SEK|527|2088|lyfalmen|V0601|2088|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fúrósemíð||429||429|2088||1|0|G|0|||0
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|G|0|LFS|0|0|0|100|DKK|919|2763|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||919||919|2763||1|0|G|0|||0
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|AGA|0|0|0|100|XEU|90243|117413|lyfalmen|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||90243||90243|117413||5|H|0|0|||0
148780|J01DH0205|Meropenem WH|sts/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|13148|15156|lyfalmen|||2|10|0|1,6667|Williams & Halls efh|Williams & Halls ehf|Meropenem||9923||9923|15156||2|0|0|0|||0
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|BAN|1|0|0|100|DKK|3360|6545|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|Xylazinum||3360||3360|6545||2|0||0|||0
149203|R03AC0206|Ventoline|innúðal|0,1|mg/sk|200|skammtar|1|úðaílá|dreifa|R03AC02|01.04.2019||R|0|0|0|G|0|GPH|0|0|1|100|DKK|434|2095|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||434||434|2095||1|0|G|0|||0
149240|A02BX1301|Gaviscon|mixtúra|||400|ml|1|glas||A02BX13|01.06.2019||L|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4121||1|0||0|||0
149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|262437|332909|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||262437||262437|332909||1|H|L|0|||0
149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015|31.07.2021|R|0|0|0|0|0|FKA|0|0|1|100|DKK|2282|4639|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2282||2282|4639||1|0|0|0|||0
149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|WEH|0|0|0|100|XEU|14164|20993|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14164||14164|20993||2|H|0|0|||0
150005|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|12945|13737|lyfalmen|||2|56|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||8892||8892|13737||1|0|G|0|||0
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||L|0|0|0|G|0|TEA|0|0|0|100|SEK|||lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen|||||7335||1|0|G|0|||0
150281|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4613|6591|lyfalmen|V0253|4878|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||3700||3700|6591||2|0|G|0|||0
150448|L01XG0201|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XG02|01.10.2016||R|0|0|0|0|0|AEB|0|1|0|100|DKK|156418|201051|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomib||156418||156418|201051||1|H|L|0|||0
150498|B01AC2202|Prasugrel Krka|filmhtfl|5|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|V0805|10445|2|30|0|15,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445||2|0|G|0|||0
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|38720|52247|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||38720|52247||1|0|L|0|||0
151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4300|5627|lyfalmen|V0607|3019|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0
151060|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í bláæð|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|42396|53799|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||39947||39947|53799||2|0|0|0|||0
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|G|0|LBK|0|0|0|100|DKK|5600|9206|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5600||5600|9206||1|0|G|0|||0
151207|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|200|skammtar|1|glas|1 x 200 úðaskammtar|N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|200|0|6,6667|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|G|0|SNP|0|0|0|100|XEU|1419|3451|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1419||1419|3451||1|0|G|0|||0
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|G|0|LUN|0|0|0|100|DKK|28311|39081|lyfalmen|V0607|3019|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||28311||28311|39081||1|0|G|0|||0
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|392|2037|lyfalmen|V0633|2017|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||392||392|2037||1|0|G|0|||0
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|4038|7056|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Europe B.V.|Chóríógónadótrópín alfa||||4038|7056||2|0|G|0|||0
151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|4855|3375|lyfalmen|V0682|3375|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|LTH|0|0|1|100|SEK|1058|2954|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1058||1058|2954||1|0||0|||0
151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1195|2349|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1195|2349||2|0||0|||0
151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|G|0|BFP|0|0|0|100|XEU|1770|2731|lyfalmen|V0234|1694|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||896||896|2731||1|0|G|0|||0
151905|L03AX1302|Remurel|stl|40|mg/ml|12|áf.spr|1|pakki||L03AX13|01.07.2018||R|0|0|1|G|0|ZET|0|0|0|100|XEU|108296|93910|lyfalmen|||2|12|0|24,0000|Alvogen|Zentiva, k.s.|Glatíramer acetat||71661||71661|93910||2|0|G|0|||0
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|HES|0|0|0|100|DKK|1637|3751|lyfalmen|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1637||1637|3751||1|H|0|0|||0
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|PLS|0|0|1|100|DKK|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1|0||0|||0
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|G|0|AZD|0|0|0|100|SEK|2619|5103|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2619||2619|5103||1|0|G|0|||0
152408|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|30|stk|1|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|4851|8175|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||4851||4851|8175||1|0|G|0|||0
152410|N05AH0416|Quetiapin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|7800|8917|lyfalmen|V0272|8917|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||5390||5390|8917||2|0|0|0|||0
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|AZD|0|0|0|100|SEK|4203|7283|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4203||4203|7283||1|0|G|0|||0
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|G|0|ASZ|0|0|0|100|SEK|7685|12076|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||7685||7685|12076||1|0|G|0|||0
152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6017|5123|lyfalmen|V0182|4189|2|42|0|7,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2634||2634|5123||1|0|G|0|||0
152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6200|9654|lyfalmen|||2|90|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||5926||5926|9654||1|0|G|0|||0
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1432|3469|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1432||1432|3469||2|0||0|||0
153145|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|15790|23231|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15790||15790|23231||1|0|G|0|||0
153179|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2019|31.05.2021|R|0|0|0|G|0|GLZ|0|0|0|100|DKK|3478|5529|lyfalmen|||2|60|0|30,0000|Icepharma hf|Glenmark Arzneimittel GmbH|Salmeteról og fluticason||2929||2929|5529||2|0|G|0|||0
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||||1|0||0|||0
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|29161|40156|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||29161|40156||1|0|L|0|||0
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|V0575|1677|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cetirizín|||||5019||1|0|G|0|||0
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|GSE|0|1|0|100|DKK|166285|213323|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Sciences Ireland|Amfóterícín||166285||166285|213323||2|H|L|0|||0
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|800|2599|lyfalmen|||2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Própranólól||800||800|2599||1|0|G|0|||0
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|36349|49248|lyfalmen|V0452|49248|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Exemestan||36349||36349|49248||1|0|G|0|||0
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|3461|6262|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3461||3461|6262||1|0|E|0|||0
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012|30.06.2021|R|1|0|0|0|0|ATE|0|0|1|100|XEU|1181|3123|lyfalmen|||2|24|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1181||1181|3123||1|0||2|25|töflur|0
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|IKR|726|2131|lyfalmen|V0908|2048|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||460||460|2131||2|0|G|0|||0
154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|20695|19271|lyfalmen|V0183|19271|2|1|0|27,9070|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||12913||12913|19271||2|0|G|0|||0
154116|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|6978|5352|lyfalmen|V0995|5283|2|7,5|0|75,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||2800||2800|5352||2|0|G|0|||0
154147|R03AL0801|Trelegy Ellipta|innönddu|||30|skammtar|1|innö.t|92 mcg/55 mcg/22 mcg|R03AL08|01.06.2019||R|0|0|0|G|0|GSD|0|0|0|100|DKK|8161|12731|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Vilanterol, umeclidinium bromide, fluticasone furoate||8161||8161|12731||1|0|G|0|||0
154377|G03CA0325|Estrofem 1 mg|filmhtfl|1|mg|84|stk|1|skífup||G03CA03|01.05.2020||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2112|4405|lyfalmen|V0129|2205|1|84|0|42,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2112||2112|4405||1|0|G|0|||0
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||12398||1|0|G|0|||0
154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20031|28609|lyfalmen|||1|28|0|42,0000|Eisai AB|Eisai GmbH|Perampanel||20031||20031|28609||1|0|G|0|||0
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|16510|24222|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||16510||16510|24222||1|0|0|0|||0
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|18865|27464|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||18865||18865|27464||1|0|0|0|||0
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|23599|33122|lyfalmen|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||23599||23599|33122||1|0|0|0|||0
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21530|30505|lyfalmen|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||21530||21530|30505||1|0|0|0|||0
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|21589|30579|lyfalmen|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||21589||21589|30579||1|0|0|0|||0
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|26165|36367|lyfalmen|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||26165||26165|36367||1|0|0|0|||0
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|14076|20872|lyfalmen|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||14076||14076|20872||1|0|0|0|||0
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|G|0|PLS|0|0|1|100|DKK|2819|5378|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2819||2819|5378||1|0|G|0|||0
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|20801|29583|lyfalmen|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||20801||20801|29583||1|0|0|0|||0
154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|G|0|ATE|0|0|0|100|XEU|5684|2734|lyfalmen|V0335|2517|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Venlafaxín||898||898|2734||1|0|G|0|||0
155121|L04AA4001|Mavenclad|töflur|10|mg|4|stk|1|þpakki||L04AA40|01.11.2018||R|0|1|1|0|0|MRP|0|1|0|100|SEK|1219378|1523076|lyfsjukr|||1|4|0|117,6471|Icepharma hf|Merck Europe B.V.|Cladribine||1219378||1219378|1523076||2|0|L|0|||0
155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1544|3623|lyfalmen|V0247|3623|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||1544||1544|3623||2|0|G|0|||0
155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|2886|5019|lyfalmen|V0248|5017|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||2558||2558|5019||2|0|G|0|||0
155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5456|4248|lyfalmen|V0249|4248|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1998||1998|4248||2|0|G|0|||0
155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16402|24074|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16402||16402|24074||1|0||0|||0
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1438|3477|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1438||1438|3477||1|0|G|0|||0
155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|5334|6552|lyfalmen|V0253|4878|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3672||3672|6552||1|0|G|0|||0
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|G|0|LBK|0|0|0|100|DKK|620|2351|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||620||620|2351||1|0|G|0|||0
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|ATE|0|0|0|100|XEU|1306|2950|lyfalm11|V0590|2916|2|84|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Desógestrel||1306||1306|2950||1|0||0|||1
155485|L01XK0101|Lynparza|filmhtfl|150|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|356719|450170|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||356719||356719|450170||1|0|L|0|||0
155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|RHG|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
155579|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|35437|48094|lyfalmen|||1|50|0|8,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||35437||35437|48094||1|0|E|0|||0
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|JAS|0|0|1|100|SEK|5582|9181|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5582||5582|9181||1|0|E|0|||0
156066|J05AR0603|Efavirenz/Emtricitabine/Tenofovir Krka|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|59860|78985|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||59860||59860|78985||2|0|L|0|||0
156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|18950|27581|lyfalmen|V0383|18962|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||18950||18950|27581||1|0|G|0|||0
156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|4589|2737|lyfalmen|V0552|2737|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||900||900|2737||2|0|E|0|||0
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|4815|8125|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4815||4815|8125||2|0|G|0|||0
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|G|0|NED|0|0|0|100|XEU|5589|9191|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5589||5589|9191||2|0|G|0|||0
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|MEA|0|0|1|100|DKK|364|1999|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||364||364|1999||2|0|0|0|||0
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|CNI|0|0|0|100|SEK|603|2328|lyfalmen|||1|6|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||603||603|2328||1|0||0|||0
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|0|0|0|RPG|1|0|0|100|DKK|7281|13421|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6984||6984|13421||2|0|0|1|30|dagar|0
157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13451|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13451||2|0|E|1|30|dagar|0
157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||2|0||0|||0
157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2|0||2|||0
157673|D05AX5205|Calcipotriol/Betamethasone Teva|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2021||R|0|0|0|G|0|TVI|0|0|0|100|XEU|10988|16089|lyfalmen|V1030|16089|2|120|0||Teva Pharma Iceland ehf|Teva B.V|Kalcípótríól í blöndum||10601||10601|16089||1|0|G|0|||0
157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|61451|80997|lyfalmen|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||61451||61451|80997||2|H|0|0|||0
157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|36559|44887|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||32901||32901|44887||1|0|L|0|||0
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|G|0|HES|0|0|0|100|DKK|1362|3373|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1362||1362|3373||1|0|G|0|||0
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|ALM|0|0|0|100|DKK|5987|9738|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5987||5987|9738||1|0||0|||0
157995|J06BA0210|Octagam 10%|irl|100|mg/ml|20|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|22515|31751|lyfsjukr|||1|20|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||22515||22515|31751||1|H|L|0|||0
158007|J06BA0210|Octagam 10%|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|56288|74467|lyfsjukr|||1|50|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||56288||56288|74467||1|H|L|0|||0
158018|J06BA0210|Octagam 10%|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|112576|146524|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||112576||112576|146524||1|H|L|0|||0
158040|J06BA0210|Octagam 10%|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.07.2021||R|0|0|0|0|1|OCT|0|1|0|100|DKK|225152|286537|lyfsjukr|||1|200|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, gefin í æð||225152||225152|286537||1|H|L|0|||0
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|SNP|0|0|0|100|XEU|947|2801|lyfalmen|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||947||947|2801||1|H|0|0|||0
158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|ASA|0|0|0|100|SEK|18706|27245|lyfalmen|V0910|7540|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||18706|27245||1|0||0|||0
158608|J02AX0501|Mycamine|irþstofn|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|42135|56566|lyfalmen|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||42135|56566||1|H|0|0|||0
158619|J02AX0501|Mycamine|irþstofn|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|0|0|APG|0|0|0|100|XEU|64624|85010|lyfalmen|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||64624||64624|85010||1|H|0|0|||0
158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|GPA|0|0|0|100|XEU|3722|3525|lyfalmen|V0143|3378|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1473||1473|3525||1|0|E|0|||0
158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|235091|298899|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||235091||235091|298899||2|0|L|0|||0
158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13466|3374|lyfalmen|V0817|3325|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1363||1363|3374||2|0|E|0|||0
158860|J01FA0904|Clarithromycin Krka|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|1724|3871|lyfalmen|||2|14|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1724||1724|3871||2|0||0|||0
158992|A04AA0501|Aloxi|hylki|500|mcg|5|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|53285|70668|lyfalmen|||1|5|0|5,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||53285||53285|70668||3|0|E|0|||0
159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|1873|4076|lyfalmen|V0219|4076|2|5|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||1873||1873|4076||1|0|G|1|30|dagar|0
159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|3328|5967|lyfalmen|V0220|5967|2|5|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||3247||3247|5967||1|0|G|1|30|dagar|0
159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4805|8112|lyfalmen|||2|5|0|22,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4805||4805|8112||1|0|G|1|30|dagar|0
159138|A02AA0403|Magnesia medic|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3180||2|0||0|||0
159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4757|8045|lyfalmen|V0223|8045|2|5|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fentanýl||4757||4757|8045||1|0|G|1|30|dagar|0
159207|G04CB0204|Dutasteride Sumar Pharma|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.04.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|2127|2771|lyfalmen|V0909|2771|2|30|0|30,0000|Alvogen|Alvogen|Dútasteríð||925||925|2771||2|0|G|0|||0
159387|N06BA0905|Atomoxetin STADA|hylki|25|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4800|3425|lyfalmen|V0814|3425|2|30|0|9,3750|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
159405|A10BD2401|Steglujan|filmhtfl|115|mg|28|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|9930|14956|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||9778||9778|14956||1|0|G|0|||0
159454|L01XG0102|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.12.2015||R|0|0|0|0|0|IPC|0|1|0|100|SEK|122285|144726|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomib||111130||111130|144726||2|H|L|0|||0
159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|ESS|0|0|0|100|DKK|41190|55371|lyfalmen|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||41190||41190|55371||2|H|0|0|||0
159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|647|2388|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||647||647|2388||2|0|G|0|||0
159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|G|0|MYL|0|0|1|100|SEK|1589|3685|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1589||1589|3685||2|0|G|0|||0
159711|R03AK0605|Salmex|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|4960|7772|lyfalmen|V0981|6227|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||4558||4558|7772||2|0|G|0|||0
159762|N06DA0304|Nimvastid|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|27510|38068|lyfalmen|||2|112|0|74,6700|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||27510||27510|38068||2|0|G|0|||0
159765|N05AX1212|Abilify Maintena (Lyfjaver)|sts|400|mg|1|hgl|1|pakki||N05AX12|01.05.2019||R|0|0|0|0|0|LVR|0|0|0|100|DKK|40692|54741|lyfalmen|V0980|54741|3|1|0|30,0800|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||40692||40692|54741||3|0|E|0|||0
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|GRP|0|0|0|100|DKK|127125|164619|lyfalmen|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||127125||127125|164619||1|H|0|0|||0
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|NIL|1|0|0|100|XEU|3893|7556|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Flunixinum||3893||3893|7556||2|0||0|||0
160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|58045|76689|lyfsjukr|||2|4|0|14,2900|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||58045||58045|76689||2|0|L|0|||0
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|G|0|ATE|0|0|1|100|XEU|5304|2962|lyfalmen|V0010|2193|2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1064||1064|2962||1|0|E|0|||0
160487|N06BA0409|Methylphenidate STADA|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|5600|7898|lyfalmen|V0996|6950|2|30|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||4650||4650|7898||2|0|E|1|30|dagar|0
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981|30.06.2021|R|1|0|0|G|0|SNP|0|0|0|100|XEU|780|2572|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||780||780|2572||1|0|G|0|||0
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|PLS|0|0|0|100|DKK|855|2675|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||855||855|2675||1|H|0|0|||0
161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1365|3377|lyfalmen|V0169|2530|1|14|0|8,1667|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1365||1365|3377||1|0|E|0|||0
161117|H02AB0901|Solu-Cortef|sts|100|mg|5|hgl|1|pakki|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2355|4739|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2355||2355|4739||1|0|G|0|||0
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|563|2273|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||563||563|2273||1|0|G|0|||0
161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1567|2427|lyfalmen|V0143|1126|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||675||675|2427||1|0|E|0|||0
161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10000|7692|lyfalmen|V0145|7115|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||4500||4500|7692||2|0|E|0|||0
161488|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|9551|14644|lyfalmen|V1049|14644|1|53|0|23,7500|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||9551|14644||1|0||0|||0
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|G|0|PLS|0|0|0|100|DKK|53181|70537|lyfalmen|V0452|49248|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||53181||53181|70537||1|0|G|0|||0
161592|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|NAV|0|0|1|100|DKK|6037|9807|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||||6037|9807||2|0|0|0|||0
161596|R03BA0501|Flixotide|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.08.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2493|4929|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2493||2493|4929||1|0|G|0|||0
161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|G|0|AGC|0|0|0|100|XEU|26032|36199|lyfalmen|||1|90|0|90,0000|Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ltd.|Linaclotídum||26032||26032|36199||1|0|G|0|||0
162055|QN02BG9102|Librela|stl|10|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|10509|20108|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||10509||10509|20108||2|0||2|||0
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|506542|636508|lyfalmen|||1|60|0|30,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||506542||506542|636508||1|0|E|0|||0
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|G|0|PLS|0|0|0|100|DKK|1806|3984|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1806||1806|3984||1|0|G|0|||0
162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|13997|20763|lyfalmen|V0145|10673|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||13997||13997|20763||2|0|E|0|||0
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|LEV|1|0|0|100|XEU|5242|10116|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|Detomidinum||5242||5242|10116||2|0||0|||0
162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|G|0|MYL|0|0|0|100|SEK|2324|3780|lyfalmen|V0041|3780|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1658||1658|3780||2|0|G|0|||0
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|458|2048|lyfalmen|V0500|2048|2|100|0|25,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||400||400|2048||1|0|G|0|||0
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|663|2410|lyfalmen|||2|100|0|42,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||663||663|2410||1|0|G|0|||0
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|G|0|BLS|0|0|0|100|XEU|414|2068|lyfalmen|V0502|2068|2|60|0|30,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Metformín||414||414|2068||1|0|G|0|||0
162872|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.10.2019||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24061|33706|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24061||24061|33706||1|0|L|0|||0
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1108|3023|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1108||1108|3023||1|0|G|0|||0
163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|9076|13990|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai GmbH|Rúfínamíð||9076||9076|13990||1|0|G|0|||0
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|0|0|0|HES|0|0|0|100|DKK|1139|3066|lyfalmen|V0671|2701|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1139||1139|3066||1|0|E|1|30|dagar|0
163164|QH01CA9002|Busol|stl|0,004|mg/ml|10|ml|5|hgl|lausn|QH01CA90|01.11.2018||R|0|0|0|0|0|TPW|1|0|0|100|IKR|14280|27263|vetalmen|||0|50|0||Dýraheilsa ehf|T.P. Whelehan Son & Co. Ltd.|Buserelin||14280||14280|27263||2|0||0|||0
163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|3795|6721|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3795||3795|6721||2|0|G|0|||0
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|SNP|0|0|1|100|XEU|1052|2946|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1052||1052|2946||1|0||0|||0
163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3291|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5863|9568|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5863||5863|9568||1|0||0|||0
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10262|15623|lyfalmen|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10262||10262|15623||2|H|0|0|||0
163445|A04AA0109|Ondansetron STADA|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|6200|9481|lyfalmen|V0383|9481|2|50|0|12,5000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||5800||5800|9481||2|0|G|0|||0
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|G|0|GPH|0|0|0|100|DKK|2255|4602|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2255||2255|4602||1|0|G|0|||0
163494|L01EX0201|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01EX02|01.06.2013||R|0|0|1|0|0|FIN|0|1|0|100|DKK|403035|507774|lyfsjukr|||1|112|0||Icepharma hf|Bayer AG|Sorafenib||403035||403035|507774||2|0|L|0|||0
163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1643|3759|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1643||1643|3759||1|0|G|0|||0
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RHG|0|0|1|100|XEU|565|2276|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm GmbH|Íbúprófen||565||565|2276||2|0|G|0|||0
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|G|0|RTH|0|0|1|100|XEU|1694|3830|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm GmbH|Íbúprófen||1694||1694|3830||2|0|G|0|||0
163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||500||500|2186||2|0|G|0|||0
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3427|6215|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3427||3427|6215||1|0|0|0|||0
164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|1|0|0|NRO|0|0|0|100|DKK|36679|49665|lyfalmen|||1|100|0||Pharmanovia A/S|Nova Laboratories Ireland Limited|Merkaptópúrín||36679||36679|49665||2|0|0|0|||0
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|10289|19691|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||10289||10289|19691||1|0||0|||0
164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|357901|451640|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||357901||357901|451640||1|0|L|0|||0
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|948|2803|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||948||948|2803||2|0|G|0|||0
164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|4917|8266|lyfalmen|||1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4917||4917|8266||2|0|G|0|||0
164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||2|0||0|||0
165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1|0||0|||0
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|ATE|0|0|0|100|GBP|3907|6876|lyfalmen|||2|100|0|33,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klórdíazepoxíð||3907||3907|6876||1|0||2|50|töflur|0
165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20031|28609|lyfalmen|||1|28|0|35,0000|Eisai AB|Eisai GmbH|Perampanel||20031||20031|28609||1|0|G|0|||0
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|LAS|1|0|0|100|XEU|6414|12339|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6414||6414|12339||2|0||0|||0
165507|L01CE0201|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.04.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|7952|12443|lyfalmen|||2|25|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Irinotecan||7952||7952|12443||1|H|0|0|||0
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|155975|200500|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||155975||155975|200500||2|0|L|0|||0
165689|N06AB0406|Citalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2600|5077|lyfalmen|V0318|5077|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||2600||2600|5077||2|0|G|0|||0
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972|31.05.2021|L|1|0|0|0|0|CAM|0|0|1|100|DKK|||lyflausa|||0|10|0|5,0000|CampusPharma AB|CampusPharma AB|Meklózín||||||||0|0|0|||0
165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|182928|234022|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||182928||182928|234022||1|0|L|0|||0
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3887|6848|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3887||3887|6848||1|0|0|0|||0
165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|RPG|1|0|0|100|XEU|5549|10698|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|butylscopolamine and analgesics||||5549|10698||2|0||0|||0
166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8916|6728|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6728||2|0|E|0|||0
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1419|3451|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1419||1419|3451||1|0|G|0|||0
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|1|G|0|PLS|0|0|0|100|DKK|13382|19917|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13382||13382|19917||1|0|G|0|||0
166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2665|2806|lyfalmen|V0113|2735|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|1795|3969|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1795||1795|3969||2|0|G|0|||0
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|G|0|MYL|0|0|1|100|SEK|3398|6175|lyfalmen|V0428|6175|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3398||3398|6175||2|0|G|0|||0
166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|1|0|0|ABD|0|1|0|100|DKK|114122|148447|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Deutschland GmbH & Co. KG|Adalimumab||114122||114122|148447||1|0|L|0|||0
167366|C01CA1702|Midodrin Evolan|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|8346|11312|lyfalmen|V0968|10556|2|50|0|4,1666|LYFIS ehf|Evolan Pharma AB|midodrine||7130||7130|11312||2|0|G|0|||0
167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|40529|54535|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||40529||40529|54535||2|0|L|0|||0
167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|||2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907|31.7.2021|2|0|G|0|||0
167887|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|1220|2668|lyfalmen|V0189|2668|2|100|0|50,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||850||850|2668||2|0|G|0|||0
167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1664|2922|lyfalmen|V0005|2874|2|28|0|37,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||1035||1035|2922||1|0|E|0|||0
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|1|0|0|GEI|0|1|0|100|DKK|129272|167289|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||129272||129272|167289||2|0|L|0|||0
168079|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.02.2021||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1929|3545|lyfalmen|V0123|3545|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1487||1487|3545||2|0|E|0|||0
168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|16638|lyfalmen|V0420|16638|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11000||11000|16638||2|0|G|0|||0
168119|B06AC0102|Berinert|sts/irs|500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|95919|124592|lyfsjukr|||1|1|0|0,3571|Icepharma hf|CSL Behring GmbH|C1 hemill||95919||95919|124592||2|0|L|0|||0
168222|B05BA1024|SmofKabiven extra Nitrogen|irl|||1518|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|39702|53489|lyfalmen|||1|6072|0||Vistor hf|Fresenius Kabi AB|Blöndur||39702||39702|53489||1|0|0|0|||0
168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5208|5737|lyfalmen|V0007|4939|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Lansóprazól||3080||3080|5737||1|0|E|0|||0
168388|L04AC1301|Taltz|stl|80|mg|1|ml|1|áfpen||L04AC13|01.06.2020||R|0|0|1|0|0|NED|0|1|0|100|XEU|139552|180075|lyfsjukr|||1|1|0|27,5862|Icepharma hf|Eli Lilly Nederland B.V.|Ixekizumab||139552||139552|180075||2|0|L|0|||0
168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2353|4737|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2353||2353|4737||2|0|G|0|||0
168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2801|5353|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2801||2801|5353||2|0|G|0|||0
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|3098|5762|lyfalmen|V0240|5286|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3098||3098|5762||1|0|G|0|||0
168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|G|0|HES|0|0|0|100|DKK|5648|9272|lyfalmen|||1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5648||5648|9272||1|0|G|0|||0
169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|8106|12655|lyfalmen|V0688|12655|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||8106||8106|12655||2|0|E|0|||0
169293|L01XX2702|Arsenic Trioxide Accord|irþ|1|mg/ml|10|ml|10|hgl||L01XX27|01.05.2020||R|0|0|0|0|0|CLU|0|1|0|100|XEU|492010|618434|lyfsjukr|||2|100|0||Artasan ehf|Accord Healthcare S.L.U.|Arsenic trioxide||492010||492010|618434||1|H|L|0|||0
169402|S01ED5121|Travoprost/Timolol STADA|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|2815|2461|lyfalmen|V0994|2448|2|2,5|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Tímólól í blöndum||700||700|2461||2|0|G|0|||0
169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|1508|3199|lyfalmen|V0411|3199|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1236||1236|3199||2|0|E|0|||0
169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|997|2442|lyfalmen|V0177|2442|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||686||686|2442||2|0|E|0|||0
169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|GOV|0|0|1|100|XEU|984|2431|lyfalmen|V0418|2430|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||678||678|2431||2|0|E|0|||0
169872|QG03XA9101|Improvac|stl|||100|ml|1|glas||QG03XA91|01.04.2019||R|0|0|0|0|0|ZBE|0|0|0|100|IKR|9550|18289|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||9550||9550|18289||2|0|0|0|||0
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3075|5730|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3075||3075|5730||2|0||0|||0
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3788|6712|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||3788||3788|6712||2|0||0|||0
169944|L01ED0501|Lorviqua|filmhtfl|100|mg|30|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|706423|885104|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||706423||706423|885104||1|0|L|0|||0
169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|EVE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Elara Pharmaservices Europe Limited|Nafazólín|||||||2|0||0|||0
170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|19592|28464|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||19592||19592|28464||2|H|L|0|||0
170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|48722|64897|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||48722||48722|64897||2|H|L|0|||0
170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|GBI|0|0|0|100|DKK|4906|8251|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4906||4906|8251||1|0||0|||0
170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|0|0|RRG|0|1|0|100|DKK|97573|126684|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||97573||97573|126684||2|H|L|0|||0
170237|L04AA2701|Gilenya|hylki|0,25|mg|28|stk|1|þpakki||L04AA27|01.07.2019||R|0|1|1|0|0|NEL|0|1|0|100|DKK|246883|313565|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||246883||246883|313565||1|0|L|0|||0
170309|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.07.2018||R|1|0|0|G|0|BLS|0|0|0|100|XEU|880|2194|lyfalmen|V0108|2194|2|100|0|33,3400|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||506||506|2194||1|0|G|0|||0
170335|N02AX0213|Tramadol Krka|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|1|100|IKR|550|2248|lyfalmen|V0226|2247|2|20|0|6,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||545||545|2248||2|0|G|1|30|dagar|0
170486|C10AX1401|Praluent|stl|75|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|178075|227987|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||178075||178075|227987||1|0|E|0|||0
170534|L01ED0401|Alunbrig|filmhtfl|180|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|659014|826140|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||659014||659014|826140||1|0|L|0|||0
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2257|4604|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||2257||2257|4604||2|0||0|||0
170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|1|0|0|SAR|0|1|0|100|DKK|28874|36141|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||25986||25986|36141||1|0|L|0|||0
170758|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|888|2720|lyfalmen|||1|120|0|15,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||888||888|2720||1|0|G|0|||0
170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|Meloxícam||1158||1158|2276||2|0||0|||0
170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|0|0|CPV|0|1|0|100|DKK|48629|64780|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe B.V.|Azasitidín||48629||48629|64780||2|H|L|0|||0
171292|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|12809|13886|lyfalmen|V0441|12403|2|100|0|200,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||9000||9000|13886||2|0|G|0|||0
171340|R01AX0302|Lomuspray|nefúði|21|mcg/sk|15|ml|1|úðaílá|180 sk, lausn|R01AX03|01.04.2020||L|0|0|0|G|0|SNP|0|0|1|100|XEU|||lyfalmen|||1|15|0|15,7500|Vistor hf|Sanofi-aventis Norge AS|Ípratrópínbrómíð|||||2920||1|0|G|0|||0
171486|L04AB0202|Remsima|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|0|0|0|0|HUN|0|1|0|100|DKK|44093|59042|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||44093||44093|59042||1|H|L|0|||0
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3116|5787|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||||3116|5787||2|0||0|||0
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3536|6365|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||3536||3536|6365||2|0||0|||0
171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|G|0|MYL|0|0|0|100|DKK|1177|3118|lyfalmen|||1|30|0|20,0000|Icepharma hf|Mylan AB|Mebeverín||1177||1177|3118||2|0|G|0|||0
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2814|5371|lyfalmen|V0247|3623|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2814||2814|5371||1|0|G|0|||0
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|4878|8212|lyfalmen|V0248|5017|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4878||4878|8212||1|0|G|0|||0
172269|N03AX1408|Levetiracetam STADA|filmhtfl|500|mg|200|stk|1|þpakki||N03AX14|01.12.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|13449|9756|lyfalmen|V0253|9756|2|200|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||6000||6000|9756||2|0|G|0|||0
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|9024|13919|lyfalmen|V0249|4248|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9024||9024|13919||1|0|G|0|||0
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|G|0|JAS|0|0|0|100|SEK|16353|24006|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||16353||16353|24006||1|0|G|0|||0
172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|15115|22302|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||15115||15115|22302||1|0||0|||0
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|G|0|RDT|0|0|0|100|DKK|8545|13259|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||8545||8545|13259||1|0|G|0|||0
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2525|2369|lyfalmen|V0284|2324|2|100|0|6,2500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||633||633|2369||1|0|G|0|||0
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|7074|7743|lyfalmen|V0118|7656|2|98|0|196,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||4537||4537|7743||1|0|E|0|||0
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3925||1|0|E|0|||0
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|11627|17501|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11627||11627|17501||1|0|L|0|||0
174063|C03EA0115|Amiloride/HCT Alvogen|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.03.2020||R|1|0|0|G|0|POF|0|0|0|100|IKR|2015|4271|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Hýdróklórtíazíð og kalíumsparandi lyf||2015||2015|4271||2|0|G|0|||0
174267|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|ílát|150+37,5+200 mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|11062|16724|lyfalmen|V0900|16724|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11062||11062|16724||3|0|G|0|||0
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989|31.07.2021|R|0|0|0|0|0|MEA|0|0|1|100|DKK|541|2243|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||541||541|2243||2|0|E|0|||0
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|1332|3331|lyfalmen|||1|5|0|25,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1332||1332|3331||1|0|G|0|||0
174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5489|lyfalmen|||2|30|0|4,5000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5489||2|0|G|0|||0
174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|9807|14996|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9807||9807|14996||1|0|G|0|||0
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|G|0|LPT|0|0|0|100|XEU|3484|6293|lyfalmen|V0368|4468|1|15|0|75,0000|Teva Pharma Iceland ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3484||3484|6293||1|0|G|0|||0
174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|1|0|0|ALO|0|1|0|100|XEU|49737|44692|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||32747||32747|44692||2|0|L|0|||0
174825|N02CX0001|Glitinum|hylki|100|mg|30|stk|1|þpakki||N02CX|01.12.2018||L|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|30|0||Florealis ehf|Florealis ehf|Tanacetum parthenium|||||||2|0||0|||0
174903|N06BA1201|Elvanse Adult|hylki|70|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|15274|22521|lyfalmen|||1|30|0|70,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||15274||15274|22521||1|0|E|1|30|dagar|0
175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|22059|31174|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||22059|31174||3|0|L|0|||0
175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|6663|8681|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||5219||5219|8681||1|0|G|0|||0
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|0|0|0|100|XEU|4958|9577|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||4958||4958|9577||2|0||0|||0
175351|L01XC0203|Truxima|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|172221|220706|lyfsjukr|||2|50|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||172221||172221|220706||1|H|L|0|||0
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|NED|0|0|0|100|XEU|4331|7459|lyfalmen|V0278|3726|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4331||4331|7459||2|0|E|0|||0
176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|G|0|KPA|0|0|1|100|DKK|1280|3260|lyfalmen|||1|100|0||Alvogen|Karo Pharma AB|Hýdrókortisón||1280||1280|3260||2|0|G|0|||0
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2463|4404|lyfalmen|V0429|4073|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2111||2111|4404||2|0|G|0|||0
176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|RNE|0|0|1|100|DKK|2558|5019|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||2558||2558|5019||1|0|0|0|||0
176773|R02AA0308|Strepsils Ingefær|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2018||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3105|5772|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||3105||3105|5772||2|0|G|0|||0
176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6131|10567|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6131||6131|10567||2|0||0|||0
177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|0|0|AEB|0|1|0|100|DKK|400356|504442|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||400356||400356|504442||1|H|L|0|||0
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7335|11594|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7335||7335|11594||2|0|0|0|||0
177199|L01EF0101|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|303981|384578|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||303981||303981|384578||1|0|L|0|||0
177320|A04AA0501|Aloxi|hylki|500|mcg|1|stk|1|þpakki||A04AA05|01.02.2021||R|0|0|0|0|0|HBL|0|0|1|100|DKK|10900|16501|lyfalmen|||1|1|0|1,0000|Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||10900||10900|16501||3|0|E|0|||0
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|ATE|0|0|1|100|XEU|942|2794|lyfalmen|V0231|2555|2|300|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól||||942|2794||1|0|0|0|||0
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|DOR|1|0|0|100|XEU|4256|8245|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4256||4256|8245||2|0||0|||0
177723|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.11.2020||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3442|3378|lyfalmen|V0143|3378|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1366||1366|3378||2|0|E|0|||0
177754|N06AX1203|Wellbutrin Retard (Lyfjaver)|töflur|150|mg|30|stk|1|askja|m/br. losunarhraða|N06AX12|01.10.2020||R|0|0|0|0|0|LVR|0|0|0|100|DKK|2454|4876|lyfalmen|V1028|4876|3|30|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Bupropionum||2454||2454|4876||3|0|E|0|||0
177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|337073|425736|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration GmbH|Pírfenidon||||337073|425736||2|0|E|0|||0
177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|G|0|ATE|0|0|0|100|XEU|8738|11719|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kolkisín||7426||7426|11719|31.7.2021|1|0|G|0|||0
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|31597|43237|lyfalmen|V0975|42530|1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||31597||31597|43237||2|0|G|0|||0
178273|L01EE0101|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|767857|961510|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||767857||767857|961510||1|0|L|0|||0
178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|88239|114878|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||88239|114878||3|0|L|0|||0
178752|L04AD0204|Dailiport|forðahlk|1|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|9423|14468|lyfalmen|||2|50|0|10,0000|Artasan ehf|Sandoz A/S|Tacrolimus||9423||9423|14468||1|0|G|0|||0
178991|N05AH0416|Quetiapin Medical Valley|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|3000|4788|lyfalmen|V0275|4788|2|100|0|12,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||2390||2390|4788||2|0|0|0|||0
179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|128464|150306|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||115617||115617|150306||1|0|L|0|||0
179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8487|13179|lyfalmen|V1035|13170|1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8487|13179||2|0|G|0|||0
179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16630|24387|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16630||16630|24387||1|0||0|||0
179733|N02AA0507|OxyContin Depot|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|1289|3272|lyfalmen|V0597|2708|1|28|0|3,7300|Icepharma hf|Mundipharma A/S|Oxýcódon||1289||1289|3272||2|0|G|1|30|dagar|0
179790|N06BA0903|Atomoxetin Medical Valley|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2020||R|1|1|0|0|0|VAL|0|0|0|100|XEU|7357|11624|lyfalmen|V0818|11624|2|28|0|35,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7357||7357|11624||2|0|E|0|||0
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|1|0|0|WIL|0|1|0|100|XEU|108492|141445|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||108492||108492|141445||2|0|L|0|||0
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|G|0|MED|0|0|0|100|IKR|5799|4939|lyfalmen|V0148|4708|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2500||2500|4939||2|0|G|0|||0
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|G|0|PLS|0|0|1|100|DKK|662|2409|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||662||662|2409||1|0|G|0|||0
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
181502|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|60|pokar|lausn|B05BA03|01.07.2021||R|0|0|0|0|0|BAM|0|0|0|100|SEK|9044|13946|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9044||9044|13946||2|0|0|0|||0
181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|0|0|PLS|0|0|0|100|DKK|9094|14015|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9094||9094|14015||1|H|0|0|||0
181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1|0||0|||1
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5692|9332|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||5692||5692|9332||1|0||0|||0
182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||6355||2|0|G|0|||0
182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|POF|0|0|1|100|IKR|2031|2186|lyfalmen|V0556|2186|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||500||500|2186||2|0|E|0|||0
182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|8994|13877|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||8994||8994|13877||1|0|G|0|||0
182416|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|glas|47,5 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|1297|3283|lyfalmen|V0048|2993|2|100|0|33,3333|Artasan ehf|Hexal A/S|Metóprólól||1297||1297|3283||1|0|G|0|||0
182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|14130|20946|lyfalmen|||2|50|0|8,3333|Icepharma hf|Abcur AB|Noradrenalín||14130||14130|20946||2|H|0|0|||0
182561|L01EB0201|Erlotinib WH|filmhtfl|150|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|295804|283144|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||222424||222424|283144||2|0|L|0|||0
182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|7692|3374|lyfalmen|V0817|3325|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1363||1363|3374||1|0|E|0|||0
182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|16178|30863|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||16178||16178|30863||1|0||0|||0
182805|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.03.2021||R|1|0|0|G|0|NEL|0|0|0|100|DKK|6408|10318|lyfalmen|V0024|10318|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6408||6408|10318||1|0|G|0|||0
182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|0|0|0|RPG|1|0|0|100|XEU|19179|36557|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19179|36557||2|0||1|30|dagar|0
183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|0|0|PIP|0|0|1|100|DKK|165356|212168|lyfalmen|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||165356||165356|212168||1|0|0|0|||0
183175|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|11175|16879|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||11175||11175|16879||1|0|G|0|||0
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|IBV|1|0|0|100|DKK|5015|9685|vetalmen|||0|50|0||Vistor hf|Intervet International BV|Flunixinum||5015||5015|9685||1|0||0|||0
183366|L04AD0204|Dailiport|forðahlk|0,5|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|5641|9262|lyfalmen|||2|50|0|5,0000|Artasan ehf|Sandoz A/S|Tacrolimus||5641||5641|9262||1|0|G|0|||0
183455|C10AX0903|Ezetimib Krka|töflur|10|mg|30|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3187|5885|lyfalmen|V0612|5885|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||3187||3187|5885||2|0|E|0|||0
183485|L01EF0201|Kisqali|filmhtfl|200|mg|21|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|140595|181372|lyfsjukr|||1|21|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||140595||140595|181372||1|0|L|0|||0
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5384|8908|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5384|8908||1|0|G|0|||0
183794|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|27324|37833|lyfalmen|V0652|37833|3|168|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||27324||27324|37833||3|0|G|0|||0
183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|BAN|0|0|0|100|DKK|6476|11162|vetorma|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6476||6476|11162||2|0||0|||0
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|G|0|MDK|0|0|0|100|SEK|1705|3845|lyfalmen|||1|100|0|100,0000|Icepharma hf|Mylan Denmark ApS|Flúdrókortisón||1705||1705|3845||2|0|G|0|||0
183924|N06BA0905|Atomoxetin STADA|hylki|40|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3425|lyfalmen|V0815|3425|2|30|0|15,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|332281|419776|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||332281||332281|419776||1|H|L|0|||0
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|G|0|TIL|0|0|0|100|DKK|2950|5558|lyfalmen|V0017|5558|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||2950||2950|5558||2|0|G|0|||0
184247|V08CA0901|Gadovist|stl|1|mmol/ml|10|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|40934|55047|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadóbútról||||40934|55047||2|H|0|0|||0
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|G|0|HES|0|0|0|100|DKK|43641|58471|lyfalmen|V0185|21514|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||43641||43641|58471||1|0|G|0|||0
184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|PHM|0|0|0|100|XEU|11886|22721|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||11886||11886|22721||2|0||0|||0
184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|3362|6125|lyfalmen|V0690|6125|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||3362||3362|6125||2|0|E|0|||0
185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2|0||0|||0
185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2554|lyfalm11|V0545|1867|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||985||985|2554||2|0||0|||1
185822|A02BC0512|Nexium (Lyfjaver)|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.10.2020||R|1|0|0|0|0|LVR|0|0|1|100|DKK|9061|6123|lyfalmen|V0011|4796|3|100|0|66,6667|Lyfjaver ehf|Lyfjaver ehf|Esómeprazól||3360||3360|6123||3|0|E|0|||0
185859|C02AC0201|Intuniv|forðatfl|4|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|12521|18732|lyfalmen|||1|28|0|37,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||12521||12521|18732||1|0|E|0|||0
186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|264716|335744|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||264716|335744||3|0|L|0|||0
186236|N06BA0409|Methylphenidate STADA|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|4000|6040|lyfalmen|V0960|5368|2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||3300||3300|6040||2|0|E|1|30|dagar|0
186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|ATE|0|0|1|100|XEU|16538|10548|lyfalmen|V0419|10548|2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||6575||6575|10548||1|0|E|0|||0
186615|R03AK0706|DuoResp Spiromax|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|15102|18465|lyfalmen|||2|360|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12327||12327|18465||2|0|G|0|||0
186638|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.10.2019||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1|0||0|||0
186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|927|2708|lyfalmen|V0597|2708|2|28|0|3,7300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||879||879|2708||1|0|G|1|30|dagar|0
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|10028|3081|lyfalmen|V0607|3081|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||1150||1150|3081||2|0|G|0|||0
186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5795|9474|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5795||5795|9474||1|0||0|||0
187067|L04AB0205|Flixabi|st/irþ|100|mg|1|hgl|1|pakki||L04AB02|01.12.2018||R|0|1|0|0|0|SUG|0|1|0|100|XEU|39149|52789|lyfsjukr|||2|1|0|26,6700|Icepharma hf|Samsung Bioepis NL B.V.|Infliximab||39149||39149|52789||2|H|L|0|||0
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2459|4882|lyfalmen|V0462|4882|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4882||2|0|G|0|||0
187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|5423|9347|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5423||5423|9347||2|0||0|||0
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|G|0|MEA|0|0|1|100|DKK|3611|6468|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3611||3611|6468||2|0|G|0|||0
187612|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.05.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|846|2662|lyfalmen|V0066|2662|2|100|0|100,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||846||846|2662||1|0|G|0|||0
188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3117||2|0|G|0|||0
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|PEU|0|0|0|100|DKK|65820|86523|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Europe MA EEIG|Tigecýklín||65820||65820|86523||1|H|0|0|||0
188405|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|G|0|POF|0|0|0|100|XEU|1983|3726|lyfalmen|V0621|2911|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||1619||1619|3726||2|0|G|0|||0
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|G|0|DEA|0|0|0|100|XEU|5022|8410|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5022||5022|8410||1|0|G|0|||0
188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|G|0|LTH|0|0|0|100|SEK|5233|8701|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5233||5233|8701||1|0|G|0|||0
188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1400|3012|lyfalmen|V0458|2979|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|3012||2|0|G|0|||0
188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|2931|3631|lyfalmen|V0422|3287|2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||1550||1550|3631||2|0|G|0|||0
189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|PSA|0|0|0|100|DKK|8978|13162|lyfalmen|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8474||8474|13162||2|H|0|0|||0
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|1|0|0|JCI|0|1|0|100|SEK|39042|52654|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||39042||39042|52654||1|0|L|0|||0
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|HES|0|0|0|100|DKK|6334|10216|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6334||6334|10216||1|H|0|0|||0
189312|N02CD0101|Aimovig|stl|140|mg|1|ml|1|áfpen||N02CD01|01.12.2019||R|0|0|1|0|0|NEL|0|0|0|100|DKK|71819|94110|lyfalmen|||1|1|0|56,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||71819||71819|94110||1|0|E|0|||0
189430|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|5069|8475|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5069||5069|8475||2|0|G|1|30|dagar|0
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|2499|4938|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2499||2499|4938||1|0|G|0|||0
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|955|2812|lyfalmen|V0413|2812|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||955||955|2812||1|0|G|0|||0
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|G|0|PLS|0|0|1|100|DKK|462|2134|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||462||462|2134||1|0|G|0|||0
189567|D01BA0203|Terbinafin Actavis|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.2021||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5752|8753|lyfalmen|V0737|8720|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín||5271||5271|8753||1|0|E|0|||0
190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1588|3684|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1588||1588|3684||2|0|G|0|||0
190696|N03AX1610|Pregabalin Medical Valley|hylki|25|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1038|2737|lyfalmen|V0685|2661|2|70|0|5,8333|Acare ehf|Medical Valley Invest AB|Pregabalín||900||900|2737||2|0|E|0|||0
190715|M04AA0106|Allopurinol Alvogen|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|Alvogen|Allópúrinol||2615||2615|5097||2|0|G|0|||0
191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3980||1|0|G|0|||0
191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3299|6039|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3299||3299|6039||1|0|0|0|||0
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5042|4900|lyfalmen|V0117|4773|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rósuvastatín||2472||2472|4900||1|0|E|0|||0
191242|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|þpakki||C07AA07|01.08.2020||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1132|3056|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||1132||1132|3056||2|0|G|0|||0
191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3385|6157|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3385||3385|6157||1|0|0|0|||0
191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|2149|3108|lyfalmen|V0088|3108|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||1170||1170|3108||2|0|G|0|||0
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3583|6430|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3583||3583|6430||1|0|0|0|||0
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
191724|S01ED5119|Cosopt sine|augndr|25|mg/ml|10|ml|1|glas|20mg/ml+5mg/ml|S01ED51|01.05.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3333|6085|lyfalmen|||1|10|0|50,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3333||3333|6085||2|0|G|0|||0
191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.12.2018||R|1|0|0|0|0|ATE|0|0|0|100|XEU|17361|8409|lyfalmen|V0689|6053|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Pregabalín||5021||5021|8409||1|0|E|0|||0
192030|QD06AA0203|Cyclospray|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|ERO|0|0|0|100|XEU|1062|2087|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||1062||1062|2087||1|0||0|||0
192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|G|0|POF|0|0|1|100|IKR|||lyfalmen|V0033|2657|2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||2657||2|0|G|0|||0
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|G|0|ATE|0|0|0|100|XEU|4879|7832|lyfalmen|||2|96|0|48,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mirtazapín||4602||4602|7832||1|0|G|0|||0
192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|2833|4073|lyfalmen|V0429|4073|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||1871||1871|4073||1|0|G|0|||0
192617|C03AB0101|Centyl med kaliumklorid|filmhtfl|||100|stk|1|glas|2,5 mg / 573 mg|C03AB01|01.12.1972||R|1|0|0|G|0|KPA|0|0|0|100|DKK|2370|4760|lyfalmen|||1|100|0|100,0000|Alvogen|Karo Pharma AB|Bendróflúmetíazíð og kalíum||2370||2370|4760||2|0|G|0|||0
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|6174|9996|lyfalmen|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6174||6174|9996||2|0|0|0|||0
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|0|0|TIC|0|1|0|100|XEU|138221|178419|lyfsjukr|||2|1|0||Actavis Pharmaceuticals Iceland ehf.|Allergan Pharmaceuticals Ireland|Dexametasón||138221||138221|178419||1|H|L|0|||0
193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|G|0|BFP|0|0|0|100|XEU|2528|2730|lyfalmen|V0233|2195|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||895||895|2730||1|0|G|0|||0
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|G|0|MCS|0|0|0|100|SEK|802|2602|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||802||802|2602||1|0|G|0|||0
193285|N06DX0109|Marbodin|filmhtfl|10|mg|98|stk|1|stsk.þ||N06DX01|01.11.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|4000|5627|lyfalmen|V0605|2817|2|98|0|49,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||3000||3000|5627||2|0|G|0|||0
193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015|31.05.2021|R|1|0|0|G|0|EIG|0|0|0|100|SEK|20546|29260|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai GmbH|Perampanel||20546||20546|29260||1|0|G|0|||0
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|20,0000|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2760||1|0|E|0|||0
193975|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfspr||R03DX10|01.12.2018||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|330745|417865|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||330745||330745|417865||1|0|L|0|||0
194245|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.04.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3442|3378|lyfalmen|V0143|3378|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1366||1366|3378||2|0|E|0|||0
194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|2327|2266|lyfalmen|V0556|2186|2|4|0|3,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||558||558|2266||1|0|E|0|||0
194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5079|9806|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||5079||5079|9806||2|0||0|||0
194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|G|0|ATE|0|0|1|100|IKR|5841|5765|lyfalmen|V0012|5765|2|100|0|133,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól||3100||3100|5765||1|0|G|0|||0
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|2740|5158|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||2659||2659|5158||2|0|G|0|||0
195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
195449|A02BC0403|Rabeprazol Krka|sh-tfl|10|mg|14|stk|1|þpakki||A02BC04|01.01.2019||L|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|7,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0||0|||0
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|BAM|0|0|1|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13320||2|0||0|||0
195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|G|0|MED|0|0|0|100|IKR|23000|28570|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28570||2|0|G|0|||0
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|51992|69033|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||51992||51992|69033||2|0|L|0|||0
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|1|0|0|JAN|0|1|0|100|DKK|141425|182404|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||141425||141425|182404||1|0|L|0|||0
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|887|2719|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||887||887|2719||1|0|G|0|||0
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KRO|0|0|1|100|SEK|628|2362|lyfalmen|||1|15|0||Vistor hf|Karo Pharma AB|Blöndur||628||628|2362||1|0|E|0|||0
195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|G|0|WEH|0|0|0|100|IKR|3842|3893|lyfalmen|V0205|3838|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1740||1740|3893||2|0|G|0|||0
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|G|0|MYL|0|0|0|100|SEK|3059|5158|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2659||2659|5158||2|0|G|0|||0
196218|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1567|3521|lyfalmen|V0584|3517|2|28|0|7,4700|Alvogen|Alvogen ehf|Oxýcódon||1470||1470|3521||2|0|G|1|30|dagar|0
196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|2615|5097|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||2615||2615|5097||2|0|G|0|||0
196518|L01CE0101|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01CE01|01.04.2019||R|0|0|0|0|0|NEL|0|0|0|100|DKK|52090|69157|lyfalmen|||1|1|0||Vistor hf|Novartis Europharm Ltd|Topotecan||52090||52090|69157||1|H|0|0|||0
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||2141||1|0|E|0|||0
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|G|0|AEP|0|0|0|100|DKK|5743|9403|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5743||5743|9403||2|0|G|0|||0
196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|G|0|CPM|0|0|1|100|DKK|574|2288|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||574||574|2288||1|0|G|0|||0
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|19456|28277|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19456|28277||1|0|L|0|||0
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014|31.07.2021|R|1|0|0|G|0|RTH|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||842||842|2657||2|0|G|0|||0
197320|L04AB0204|Inflectra|st/irþ|100|mg|100|mg|1|hgl||L04AB02|01.06.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|39404|53112|lyfsjukr|||2|100|0|26,6700|Icepharma hf|Pfizer Europe MA EEIG|Infliximab||39404||39404|53112||1|H|L|0|||0
197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3625|6487|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||3625||3625|6487||2|0||0|||0
197927|L01EX0901|Ofev|hylki|100|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|238090|302629|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||238090||238090|302629||1|0|E|0|||0
198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
198361|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|2872|3563|lyfalmen|||2|14|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||1500||1500|3563|31.7.2021|2|0||0|||0
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|G|0|RTH|0|0|0|100|IKR|3429|2943|lyfalmen|V0069|2943|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||1050||1050|2943||2|0|G|0|||0
198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3738|6643|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3738||3738|6643||1|0|G|0|||0
199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|G|0|DSA|0|0|0|100|XEU|7757|12175|lyfalmen|V0805|9749|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||7757|12175||2|0|G|0|||0
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|PLS|0|0|1|100|DKK|585|2303|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||585||585|2303||1|0||2|30|töflur|0
199637|A02AA0403|Magnesia medic|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.07.2020||L|1|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2299||2|0||0|||0
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|69699|91429|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||69699|91429||1|0|L|0|||0
199903|A10BK0401|Steglatro|filmhtfl|15|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5516|9090|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Ertugliflozin||5516||5516|9090||1|0|G|0|||0
199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|2105750|2625475|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2105750||2105750|2625475||1|H|L|0|||0
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|VIR|1|0|0|100|XEU|36226|68898|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||36226||36226|68898||1|0||0|||0
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1773|3938|lyfalmen|||2|20|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1773||1773|3938||2|0|E|0|||0
370901|L01EB0202|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.07.2017||R|1|1|1|0|0|ALO|0|1|0|100|XEU|236919|279581|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlotinib||219559||219559|279581||2|0|L|0|||0
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1|0||0|||0
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9810||1|0|E|0|||0
371826|L01ED0301|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01ED03|01.06.2017||R|0|0|1|0|0|RRG|0|1|0|100|DKK|718588|900234|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration GmbH|Alectinib||718588||718588|900234||2|0|L|0|||0
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|3440|6233|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3440||3440|6233||1|0|G|0|||0
372074|L01XX3502|Anagrelide AOP|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.05.2020||R|0|0|1|G|0|AOP|0|0|0|100|XEU|30094|41336|lyfalmen|V1034|33468|1|100|0||AOP Orphan Pharmaceuticals AG|AOP Orphan Pharmaceuticals AG|Anagrelidum||||30094|41336||2|0|G|0|||0
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|3030|5668|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||3030||3030|5668||2|0|G|0|||0
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|6594|10574|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||6594||6594|10574||2|H|L|0|||0
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
372531|N06BA0408|Methylphenidate Teva|hylki|40|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|7722|6950|lyfalmen|V0996|6950|2|30|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||3961||3961|6950||1|0|E|1|30|dagar|0
372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2833||2|0|G|0|||0
372780|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.07.2021||L|0|0|0|0|0|KRK|0|0|1|100|IKR|||lyflausa|||2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól|||||||2|0|0|0|||0
373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3105|5772|lyfalmen|V0934|5772|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3105||3105|5772||2|0||0|||0
373205|V04CX0005|Hexvix|duft|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.05.2018||R|0|0|0|0|0|CUR|0|0|0|100|XEU|76740|100334|lyfalmen|||1|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||76740|100334||3|H|0|0|||0
373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2770|5311|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5311||2|0|G|0|||0
373239|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|5051|7444|lyfalmen|||2|60|0|30,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||4320||4320|7444||2|0|G|0|||0
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|G|0|SNP|0|0|0|100|XEU|11728|17640|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||11728||11728|17640||1|0|G|0|||0
373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|79324|103603|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||79324||79324|103603||2|0|G|0|||0
373324|R03AK0601|Seretide|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3533|6361|lyfalmen|V0436|5489|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3533||3533|6361||1|0|G|0|||0
373340|R03AK0601|Seretide|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|4314|7436|lyfalmen|V0437|5268|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4314||4314|7436||1|0|G|0|||0
373365|R03AK0601|Seretide|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2000||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5465|9020|lyfalmen|V0981|6227|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5465||5465|9020||1|0|G|0|||0
373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|MBV|0|0|0|100|DKK|3922|6896|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3922||3922|6896||1|0||0|||0
373887|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|386151|486775|lyfsjukr|||1|30|0|15,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||386151||386151|486775||2|0|L|0|||0
374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|7830|12275|lyfalmen|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7830||7830|12275||3|H|0|0|||0
374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
374143|L01EX0401|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|335036|413725|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||327416||327416|413725||1|0|L|0|||0
374194|L01EE0101|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01EE01|01.01.2016||R|0|0|1|0|0|NEL|0|1|0|100|DKK|220549|280812|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||220549||220549|280812||1|0|L|0|||0
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|G|0|MCK|0|0|0|100|SEK|456|2126|lyfalmen|V0500|2048|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||456||456|2126||2|0|G|0|||0
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|5088|8501|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5088||5088|8501||1|0|0|0|||0
374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|G|0|ASP|0|0|0|100|XEU|3539|6369|lyfalmen|V0926|4386|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3539||3539|6369||1|0|G|0|||0
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|G|0|GPH|0|0|1|100|DKK|10018|15287|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10018||10018|15287||1|0|G|0|||0
374450|L01EF0101|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|303981|384578|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||303981||303981|384578||1|0|L|0|||0
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|TAE|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|1 hgl og1 áf spr+ 2 aðsk nálar|J07CA06|01.04.2020||R|0|0|0|0|0|SSS|0|0|0|100|XEU|5019|8406|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5019||5019|8406|31.7.2021|1|0||0|||0
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|7537|11872|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7537||7537|11872||1|0|G|0|||0
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|9988|15245|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9988||9988|15245||1|0|G|0|||0
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|G|0|SNP|0|0|1|100|XEU|11855|17815|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11855||11855|17815||1|0|G|0|||0
374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6026|9792|lyfalmen|V0383|9481|2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6026||6026|9792||1|0|G|0|||0
374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|3774|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||1920||1920|3774||2|0|0|0|||0
375005|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|3027983|3772474|lyfsjukr|||1|20|0|46,5100|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||3027983||3027983|3772474||2|H|L|0|||0
375153|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3448|5352|lyfalmen|V0580|5159|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||2800||2800|5352||2|0|G|0|||0
375275|J02AC0304|Voriconazole Accord|filmhtfl|50|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|10531|15993|lyfalmen|V1033|15993|2|30|0|3,7500|Artasan ehf|Accord Healthcare Limited|Voricónazól||||10531|15993||1|0|G|0|||0
375508|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|1|glas||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|2393|4792|lyfalmen|||1|3|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2393||2393|4792||2|0|G|0|||0
376235|A04AA5501|Akynzeo|hylki|||1|stk|1|þpakki|300 mg/0,5 mg|A04AA55|01.02.2021||R|1|0|0|0|0|HBI|0|0|1|100|DKK|10240|15592|lyfalmen|||1|1|0||Swedish Orphan Biovitrum A/S|Helsinn Birex Pharmaceuticals Ltd.|Palonosetron,combinations||10240||10240|15592||3|0|E|0|||0
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|30153|41411|lyfalmen|V0459|40233|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||30153||30153|41411||1|0|G|0|||0
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|5388|8914|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||5388||5388|8914||1|0|G|0|||0
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|15664|23058|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||15664||15664|23058||1|0|G|0|||0
376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2|0||0|||0
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|82018|107010|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||82018||82018|107010||1|0|G|0|||0
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|BRO|1|0|0|100|IKR|13110|22596|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Ivermectinum||13110||13110|22596||2|0||0|||0
377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|199053|254077|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||199053||199053|254077||1|0|E|0|||0
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|G|0|GPH|0|0|1|100|DKK|8482|7575|lyfalmen|V0182|4189|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4415||4415|7575||1|0|G|0|||0
377504|G04CB0203|Dutasteride ratiopharm|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.06.2018|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|2135|2777|lyfalmen|||2|30|0|30,0000|Alvogen|Teva B.V.|Dútasteríð||929||929|2777||2|0|G|0|||0
377577|G03DA0408|Cyclogest|sk-stíll|400|mg|15|stk|1|pakki||G03DA04|01.05.2020||R|0|0|1|G|0|GRI|0|0|0|100|SEK|4815|8125|lyfalmen|||1|15|0||Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Prógesterón||4815||4815|8125||3|0|G|0|||0
377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|25693|32522|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||23125||23125|32522||1|0|L|0|||0
377966|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|550|mcg/sk|60|skammtar|1|innö.t|50/500 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|4960|6227|lyfalmen|V0981|6227|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||3436||3436|6227||3|0|G|0|||0
378432|L01EM0101|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|526958|661899|lyfsjukr|||1|60|0|20,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||526958||526958|661899||2|0|L|0|||0
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2029|4291|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2029||2029|4291||1|0|G|0|||0
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012|30.06.2021|R|0|0|0|0|0|ALM|0|0|0|100|XEU|15505|22839|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15505||15505|22839||1|0|E|0|||0
378801|A10BH0102|Januvia (Lyfjaver)|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.06.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|14493|21446|lyfalmen|V0982|21446|3|98|0|49,0000|Lyfjaver ehf|Lyfjaver ehf|Sítagliptín||14493||14493|21446||3|0|G|0|||0
378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|1777|3944|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1777||1777|3944||1|0|G|0|||0
379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1286|3268|lyfalmen|V0677|2753|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1286||1286|3268||1|0|G|0|||0
379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5289|7004|lyfalmen|V0830|7004|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4000||4000|7004||2|0|G|0|||0
379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|176477|225999|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||176477|225999||3|0|L|0|||0
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|114954|149482|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||114954||114954|149482||1|0|L|0|||0
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|108212|90439|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||68916||68916|90439||1|0|L|0|||0
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|118446|99154|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||75807||75807|99154||1|0|L|0|||0
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|HES|0|1|0|100|DKK|151120|125601|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||96717||96717|125601||1|0|L|0|||0
379796|N04BC0408|Ropinirole Alvogen|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|G|0|POF|0|0|0|100|XEU|5387|6717|lyfalmen|V0532|6717|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3792||3792|6717||2|0|G|0|||0
379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2935|5538|lyfalmen|||2|12,5|0|2,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2935||2935|5538||1|0||2|50|túpur|0
379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2874|5454|lyfalmen|||2|12,5|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||2874||2874|5454||1|0||2|25|túpur|0
379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2153|3128|lyfalmen|V0322|2916|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Sertralín||1184||1184|3128||1|0|G|0|||0
380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2|0||2|||0
380308|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3563|lyfalmen|V0687|2612|2|56|0|28,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|27275|37771|lyfalmen|V0653|37771|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||27275|37771||1|0|G|0|||0
380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|556|2263|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||556||556|2263||1|0|G|0|||0
380658|G04CA5204|Duta Tamsaxiro|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.06.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|8194|8869|lyfalmen|V1010|8869|2|90|0|90,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð og tamsúlósínhýdroklóríð||5355||5355|8869||2|0|G|0|||0
380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|10426|10169|lyfalmen|V0195|10169|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6300||6300|10169||2|0|E|0|||0
380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|533|2232|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||533||533|2232||1|0|G|0|||0
380973|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.05.2021||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21296|30209|lyfalmen|V1042|30209|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21296||21296|30209||1|H|0|0|||0
381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2929|5048|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2929||2929|5048||2|0||0|||0
381510|A10BK0101|Forxiga|filmhtfl|5|mg|98|stk|1|þpakki||A10BK01|01.04.2019||R|1|1|0|G|0|AZE|0|0|0|100|SEK|21390|30328|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||21390||21390|30328||1|0|G|0|||0
381578|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|100|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0
381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|292119|369825|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||292119||292119|369825||1|0||0|||0
382162|N04BC0408|Ropinirole Alvogen|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.06.2021||R|1|0|0|G|0|POF|0|0|0|100|XEU|5902|9317|lyfalmen|V0533|9317|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5681||5681|9317||2|0|G|0|||0
382318|S01XA2103|Cystadrops|augndr|3,8|mg/ml|5|ml|1|glas||S01XA21|01.01.2019||R|0|0|1|0|0|OUS|0|0|0|100|XEU|179008|229147|lyfalmen|||1|5|0||Recordati AB|Orphan Europe SARL|mercaptamine ||179008||179008|229147||3|0||0|||0
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5|0||0|||0
382474|V03AN0502|Airapy|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|132358|171128|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||132358|171128||3|0|L|0|||0
382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4665|7919|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4665||4665|7919||1|0|G|0|||0
383037|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfspr||N02CD03|01.11.2019||R|0|0|1|0|0|TGH|0|0|0|100|XEU|69219|90822|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||69219||69219|90822||1|0|E|0|||0
383105|J06BA0104|Cutaquig|stl|165|mg/ml|6|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|11288|17035|lyfsjukr|||1|6|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||11288||11288|17035||1|0|L|0|||0
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1189|2018|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Prazikvantelum í blöndum||1171||1171|2018||2|0||0|||0
383238|N02AA0508|Oxycodone Alvogen|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|5340|7622|lyfalmen|V0585|7595|2|98|0|26,1300|Alvogen|Alvogen ehf|Oxýcódon||4449||4449|7622||2|0|G|1|30|dagar|0
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|60|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|120|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ketókónazól|||||||1|0||0|||0
383672|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.02.2019||R|1|0|0|G|0|ZRB|0|0|0|100|DKK|1590|3686|lyfalmen|||1|100|0|25,0000|zr pharma& GmbH|zr pharma& GmbH|Klómípramín||1590||1590|3686|31.7.2021|0|0|G|0|||0
383719|L01BA0402|Pemetrexed W&H|irþ|25|mg/hgl|20|ml|1|hgl||L01BA04|01.05.2020||R|0|0|0|0|0|WEH|0|1|0|100|XEU|152964|196756|lyfsjukr|||2|20|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||152964||152964|196756||2|H|L|0|||0
384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|6625|10617|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6625||6625|10617||1|0|G|0|||0
384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|15|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Terbínafín|||||||1|0||0|||0
384837|N07BC0102|Buvidal|stl|32|mg|0,64|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13061|19475|lyfsjukr|||1|0,64|0|15,2381|Vistor hf|Camurus AB|Búprenorfín||13061||13061|19475||1|H|L|1|30|dagar|0
384858|L01EA0103|Imatinib ratiopharm|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|156408|102798|lyfsjukr|||2|30|0||Alvogen|ratiopharm GmbH|Imatinib||78688||78688|102798||2|0|L|0|||0
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7018|11157|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7018||7018|11157||1|0||0|||0
385343|G04CB0107|Finasteride Medical Valley|filmhtfl|5|mg|100|stk|1|þpakki||G04CB01|01.05.2021||R|1|0|0|G|0|VAL|0|0|0|100|IKR|3900|2943|lyfalmen|V0445|2943|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Fínasteríð||1050||1050|2943||2|0|G|0|||0
386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|ROD|0|1|0|100|DKK|345790|436577|lyfsjukr|||1|1|0|50,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||345790||345790|436577||1|0|L|0|||0
386950|L04AB0404|IDACIO|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.08.2020||R|0|1|1|0|0|FKA|0|1|0|100|DKK|33574|45738|lyfsjukr|||2|1,6|0|27,5862|Vistor hf|Fresenius Kabi AB|Adalimumab||33574||33574|45738||1|0|L|0|||0
386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|13329|6701|lyfalmen|V0111|6315|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||3780||3780|6701||2|0|E|0|||0
387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|7196|11402|lyfalmen|||1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||7196||7196|11402||1|0|G|0|||0
387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|0|0|WEH|0|1|0|100|XEU|137476|177493|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||137476||137476|177493||2|H|L|0|||0
387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|857|2677|lyfalmen|V0308|2677|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||857||857|2677||2|0||2|60|mg|0
387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|5325|10273|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||5325||5325|10273||2|0||0|||0
387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|DIC|0|0|0|100|IKR|6709|10732|lyfalmen|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10732||2|H|0|0|||0
387918|QD11AH9102|Cytopoint|stl|30|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|21732|41400|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||21732||21732|41400||2|0||0|||0
388032|A02BC0513|Esomeprazole Jubilant|sþ-tfl|20|mg|30|stk|1|þpakki||A02BC05|01.09.2019||L|1|0|0|0|0|JUB|0|0|0|100|IKR|||lyflausa|||2|30|0|20,0000|Acare ehf|Jubilant Pharmaceuticals nv|Esómeprazól|||||||2|0||0|||0
388180|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.2020||L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
388256|N01BB2001|Emla|krem|50|mg/g|5|g|5|túpa|25mg/g+25mg/g|N01BB20|01.01.1987||R|0|0|0|0|0|MAR|0|0|1|100|DKK|2425|4836|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2425||2425|4836||2|0||0|||0
388264|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.01.1987|31.05.2021|R|0|0|0|0|0|MAR|0|0|1|100|DKK|3616|6475|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3616||3616|6475||2|0||0|||0
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2|0||0|||0
388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|62397|44854|lyfalmen|V0722|43747|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||32875||32875|44854||2|0||0|||0
388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|8441|13116|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8441||8441|13116||2|0|G|0|||0
389095|A04AA0108|Cinveron|stl|2|mg/ml|4|ml|5|lykjur|lausn|A04AA01|01.07.2018||R|0|0|0|G|0|WEH|0|0|0|100|XEU|6323|10201|lyfalmen|||2|20|0|2,5000|Williams & Halls efh|Williams & Halls ehf|Ondansetrón||6323||6323|10201||2|H|G|0|||0
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|G|0|MEA|0|0|0|100|DKK|2370|4237|lyfalmen|V0410|4237|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||1990||1990|4237||2|0|G|0|||0
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|743|2521|lyfalmen|V0128|2521|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||743||743|2521||2|0|G|0|||0
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|G|0|MEA|0|0|0|100|DKK|514|2205|lyfalmen|V0129|2205|1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||514||514|2205||2|0|G|0|||0
389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|304104|384731|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||304104|384731||2|0|L|0|||0
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|G|0|HEA|0|0|1|100|SEK|744|2522|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Díklófenak||744||744|2522||1|0|G|0|||0
389404|N06DA0405|Galantamin STADA|forðahlk|24|mg|84|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|11830|17781|lyfalmen|||2|84|0|126,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||11830||11830|17781||2|0|G|0|||0
389424|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|100|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|7500|11821|lyfalmen|||2|100|0|300,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||7500||7500|11821||2|0|0|0|||0
389603|R06AX2709|Desloratadine Alvogen|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.11.2020||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2|0||0|||0
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|1|G|0|MRP|0|0|0|100|SEK|40211|54132|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Europe B.V.|Follitrópín alfa||||40211|54132||2|0|G|0|||0
389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|14727|21768|lyfalmen|V1044|21765|1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14727||14727|21768||1|0|G|0|||0
390439|R01AD0905|Mometason Apofri|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.10.2018||L|0|0|0|G|0|APO|0|0|1|100|IKR|||lyfalmen|V0677|2753|2|140|0|35,0000|LYFIS ehf|Apofri AB|Mómetasón|||||2753||2|0|G|0|||0
390541|R03DX0801|Cinqaero|irþ|10|mg/ml|10|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|66166|86960|lyfsjukr|||1|10|0|14,0845|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||66166||66166|86960||1|H|L|0|||0
390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|0|0|COR|0|0|0|100|DKK|72750|95288|lyfalmen|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||72750||72750|95288||1|H|0|0|||0
390835|A04AA0101|Zofran|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.07.2019||R|1|0|0|G|0|NAA|0|0|1|100|DKK|3178|5872|lyfalmen|V0381|4526|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3178||3178|5872||1|0|G|0|||0
390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18190|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18190||2|0|E|1|30|dagar|0
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|5470|9027|lyfalmen|V0429|4073|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Celekoxíb||5470||5470|9027||1|0|G|0|||0
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|2566|5030|lyfalmen|V0037|3319|1|20|0|20,0000|Icepharma hf|Upjohn EESV|Celekoxíb||2566||2566|5030||1|0|G|0|||0
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|G|0|UPJ|0|0|1|100|DKK|9386|14417|lyfalmen|V0196|5948|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Celekoxíb||9386||9386|14417||1|0|G|0|||0
391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|0|1|0|0|NEL|0|1|0|100|DKK|255828|324690|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||255828||255828|324690||1|0|L|0|||0
392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|ATE|0|0|0|100|XEU|904|1985|lyfalm11|V0545|1867|2|63|0|84,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||523||523|1985||1|0||0|||1
392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|1|G|0|ASR|0|0|0|100|IKR|45000|31099|lyfalmen|V0984|31099|2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||22000||22000|31099||2|0|G|0|||0
392196|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.07.2019||R|0|0|0|G|0|BAB|0|0|0|100|DKK|946|2800|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||946||946|2800||2|0|G|0|||0
392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|1|0|0|SAO|0|0|0|100|XEU|12281|18401|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12281||12281|18401||2|0|E|0|||0
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|8708|10114|lyfalmen|||2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||6260||6260|10114||1|0|G|0|||0
392438|L04AX0701|Tecfidera|hylki|120|mg|14|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|22373|31571|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||22373||22373|31571||2|0|L|0|||0
393642|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3474||1|0||0|||0
393939|S01EE0404|Travoprost Alvogen|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|DKK|2119|3893|lyfalmen|V0669|3893|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1740||1740|3893||2|0|G|0|||0
394026|C10AA0704|Rosuvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.04.2021||R|0|0|0|0|0|VAL|0|0|0|100|XEU|4761|7656|lyfalmen|V0118|7656|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||4474||4474|7656||2|0|E|0|||0
394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|VAL|0|0|0|100|XEU|1929|3545|lyfalmen|V0123|3545|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1487||1487|3545||2|0|E|0|||0
394364|J01DB0402|Cefazolina Normon|sts|1|g|100|stk|1|hgl|í vöðva|J01DB04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|48760|64945|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Cefazólín||48760||48760|64945||2|0|0|0|||0
394768|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4847|7321|lyfalmen|V0681|7321|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4231||4231|7321||1|0|E|1|30|dagar|0
395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|1|0|0|NEL|0|0|0|100|DKK|79009|103204|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||79009||79009|103204||1|0||0|||0
395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|NAS|0|0|0|100|DKK|33208|45275|lyfalmen|||1|15|0|60,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||33208||33208|45275||1|0|E|0|||0
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|1|0|0|RAG|0|1|0|100|DKK|133455|172492|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||133455||133455|172492||1|0|L|0|||0
395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|5938|9671|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||5938||5938|9671||1|0||0|||0
395781|A04AA0109|Ondansetron STADA|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.06.2021||R|1|0|0|G|0|ASR|0|0|1|100|IKR|10000|15262|lyfalmen|V0388|15262|2|50|0|25,0000|LYFIS ehf|STADA Arzneimittel AG|Ondansetrón||10000||10000|15262||2|0|G|0|||0
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|17001|24898|lyfalmen|V0356|24898|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||17001||17001|24898||3|0|G|0|||0
396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|4596|7824|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4596||4596|7824||1|0|G|0|||0
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|G|0|APS|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||5177||1|0|G|0|||0
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|RPG|1|0|0|100|DKK|19775|37688|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||19775||19775|37688||2|0||0|||0
396463|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|dreifa,dreifa|J07CA06|01.04.2019||R|0|0|0|0|0|SSS|0|0|0|100|XEU|49985|66495|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||49985||49985|66495||1|0|0|0|||0
396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2300|2048|lyfalmen|V0006|1224|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|2048||2|0|G|0|||0
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|5223|10080|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5223||5223|10080||1|0||0|||0
396873|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|50|stk|1|þpakki||J01CF01|01.07.2019||R|0|0|0|0|0|BLS|0|0|1|100|XEU|3105|5772|lyfalmen|||2|50|0|12,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||3105||3105|5772||1|0|0|0|||0
397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|KNM|0|0|0|100|IKR|4186|3838|lyfalmen|V0686|3437|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|G|0|SHS|0|0|0|100|DKK|2142|2788|lyfalmen|V0250|2453|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||937||937|2788||1|0|G|0|||0
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|0|0|MRP|0|1|0|100|SEK|30780|42204|lyfsjukr|||1|20|0||Icepharma hf|Merck Europe B.V.|Cetúxímab||30780||30780|42204||2|H|L|0|||0
397659|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|10|lykjur|innr.lyf, fleyti|N01AX10|01.05.2020||R|0|0|0|0|0|FKA|0|0|0|100|DKK|3198|5900|lyfalmen|||2|200|0||Vistor hf|Fresenius Kabi AB|Própófól||3198||3198|5900||1|H|0|0|||0
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5828||1|0|E|0|||0
397933|L04AA0607|Mycofenolsýra Accord|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.01.2020||R|0|1|1|G|0|AEE|0|0|0|100|XEU|29168|32786|lyfalmen|V1008|31676|2|120|0|21,6000|Artasan ehf|Accord Healthcare B.V.|Mýcófenólsýra||23334||23334|32786||1|0|G|0|||0
397981|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.08.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0
398181|N05CD0804|Midazolam Accord|stl/irl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1362|3373|lyfalmen|||2|50|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1362||1362|3373||1|H|0|2|450|mg|0
398265|R03AL1201|Enerzair Breezhaler|innönddu|||90|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|23594|33115|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||23594||23594|33115||1|0|G|0|||0
398565|N06AA0907|Amitriptylin Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|624|2357|lyfalmen|||2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||624||624|2357||2|0|G|0|||0
398659|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.08.2019||R|0|0|0|0|0|ATE|0|0|0|100|XEU|21582|30571|lyfalmen|||2|2|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúdarabín||21582||21582|30571||1|H|0|0|||0
399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|1|0|0|GSD|0|1|0|100|DKK|163462|209812|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||163462||163462|209812||1|0|L|0|||0
399210|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.07.2019||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
399390|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.06.2021||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|V0003|1080|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0
399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|0|0|OCT|0|1|0|100|DKK|74585|97609|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||74585||74585|97609||1|H|L|0|||0
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|0|100|DKK|464|2137|lyfalmen|||1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||464||464|2137||1|0|G|1|30|dagar|0
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|G|0|GPH|0|0|0|100|DKK|2508|3008|lyfalmen|V0244|3008|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1097||1097|3008||1|0|G|0|||0
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/sprautu|B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|8378|13029|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8378||8378|13029||1|0|G|0|||0
399825|L01EF0101|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01EF01|01.02.2017||R|1|0|1|0|0|PEU|0|1|0|100|DKK|303981|384578|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||303981||303981|384578||1|0|L|0|||0
399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2326|4251|lyfalmen|V0824|3968|2|28|0|14,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0
399997|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2872|lyfalmen|V0113|2872|2|105|0|105,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||998||998|2872||2|0|G|0|||0
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|G|0|SNP|0|0|1|100|XEU|1140|3067|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1140||1140|3067||1|0|G|0|||0
400134|J05AR2201|Symtuza|filmhtfl|||30|stk|1|glas|800+150+200+10 mg|J05AR22|01.03.2018||R|0|0|1|0|0|JCI|0|1|0|100|SEK|118054|153337|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||118054||118054|153337||1|0|L|0|||0
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|PLS|0|0|0|100|DKK|2416|4823|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2416||2416|4823||1|0|E|0|||0
400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|G|0|VIF|0|0|1|100|CHF|55382|73321|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||55382||55382|73321||1|0|G|0|||0
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|462|2134|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||462||462|2134||1|0||2|50|töflur|0
400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|510|2200|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||510||510|2200||1|0|G|0|||0
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|1464|3513|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||1464||1464|3513||1|0||2|100|töflur|0
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|409|2061|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||409||409|2061||1|0||2|100|töflur|0
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|5006|8388|lyfalmen|V0612|5493|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||5006||5006|8388||1|0|E|0|||0
400574|L04AX0701|Tecfidera|hylki|240|mg|56|stk|1|þpakki||L04AX07|01.12.2014||R|0|0|1|0|0|BNB|0|1|0|100|XEU|142832|184154|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Netherlands B.V.|Dimethyl fumarate||142832||142832|184154||2|0|L|0|||0
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|2164|3375|lyfalmen|V0037|3319|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1364||1364|3375||2|0|G|0|||0
401139|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.04.2020||R|1|1|0|G|0|PEU|0|0|1|100|DKK|20125|28728|lyfalmen|V1033|15993|1|30|0|3,7500|Icepharma hf|Pfizer Europe MA EEIG|Voricónazól||20125||20125|28728||1|0|G|0|||0
401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|856|2676|lyfalmen|V0173|2676|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||856||856|2676||2|0|E|0|||0
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|G|0|AZA|0|0|0|100|SEK|8655|13411|lyfalmen|V0459|13411|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||8655||8655|13411||1|0|G|0|||0
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|766|2552|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||766||766|2552||1|0|G|0|||0
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1123|3044|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1123||1123|3044||1|0|G|0|||0
402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|0|WEH|0|0|0|100|IKR|1032|2918|lyfalmen|||2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1032||1032|2918||2|0|G|0|||0
402141|J05AE1003|Darunavir Medical Valley|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.06.2020||R|1|0|1|0|0|VAL|0|1|0|100|XEU|33123|43717|lyfsjukr|||2|30|0|20,0000|Acare ehf|Medical Valley Invest AB|Darunavír||31976||31976|43717||2|0|L|0|||0
402203|D07AC1302|Ovixan|húðlausn|1|mg/g|100|ml|1|glas||D07AC13|01.08.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1267|3242|lyfalmen|V0952|3242|2|100|0||Vistor hf|Galenica AB|Mómetasón||1267||1267|3242||1|0|G|0|||0
402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|1|0|0|SPD|0|1|0|100|DKK|715907|896899|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||715907||715907|896899||1|0|L|0|||0
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|BID|0|0|0|100|DKK|1959|3850|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Penicillín í blöndum með öðrum sýklalyfjum||1959||1959|3850||1|0||0|||0
402801|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfspr||L04AC16|01.01.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|332708|420307|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||332708||332708|420307||1|0|L|0|||0
402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|7967|12210|lyfalmen|V0349|12210|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7783||7783|12210||3|0|G|0|||0
402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|4799|2931|lyfalmen|V0552|2737|2|30|0|7,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||1041||1041|2931||1|0|E|0|||0
403163|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|936|2786|lyfalmen|V0597|2708|2|28|0|3,7300|Alvogen|Alvogen ehf|Oxýcódon||936||936|2786||2|0|G|1|30|dagar|0
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|IBV|1|0|0|100|DKK|6076|11698|vetalmen|||0|20|0||Vistor hf|Intervet International BV|Cloprostenolum||6076||6076|11698||1|0||0|||0
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|dropaí||S01GX01|01.09.2018||R|0|0|0|G|0|SNP|0|0|0|100|XEU|981|2848|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||||981|2848||1|0|G|0|||0
403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|G|0|MYR|0|0|0|100|DKK|17215|25193|lyfalmen|||1|6|0|30,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||17215||17215|25193||2|0|G|0|||0
404136|J01XD0102|Flagyl|irl|5|mg/ml|100|ml|40|pokar||J01XD01|01.04.2020||R|0|0|0|0|0|SNP|0|0|1|100|XEU|20109|28707|lyfalmen|||1|4000|0|13,3333|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||20109||20109|28707||1|0|0|0|||0
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2690||2|0|G|0|||0
404491|B01AD0201|Actilyse|sts/irs|20|mg|1|hgl|1|pakki||B01AD02|01.12.2019||R|0|0|0|0|0|BOI|0|0|0|100|DKK|36659|49640|lyfalmen|||1|1|0|0,2000|Vistor hf|Boehringer Ingelheim|Alteplasi||36659||36659|49640||1|H|0|0|||0
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.03.2020||R|0|0|0|0|0|BOI|0|0|0|100|DKK|61304|80811|lyfalmen|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||61304||61304|80811||1|H|0|0|||0
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|G|0|MEV|0|0|0|100|DKK|954|2811|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||954||954|2811||1|0|G|0|||0
404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|DKK|2937|5062|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2937||2937|5062||2|0||0|||0
405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|FKA|0|0|1|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3567||1|0||0|||0
405200|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|glas||A05AA04|01.12.2018||R|1|0|0|0|0|ILT|0|1|0|100|XEU|386151|486775|lyfsjukr|||1|30|0|30,0000|Intercept|Intercept Pharma International Ltd|Obeticholic acid||386151||386151|486775||2|0|L|0|||0
405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|G|0|KRK|0|0|1|100|IKR|2436|4851|lyfalmen|V0467|4851|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2436||2436|4851||2|0|G|0|||0
405491|V08CA0901|Gadovist|stl|1|mmol/ml|7,5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|30701|42104|lyfalmen|||1|37,5|0||Icepharma hf|Bayer AB|Gadóbútról||||30701|42104||2|H|0|0|||0
405677|J01DD0401|Rocephalin|irs|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|ROA|0|0|1|100|DKK|4915|8263|lyfalmen|||1|1|0|1,0000|Icepharma hf|Roche A.S.|Ceftríaxón||4915||4915|8263||2|0|0|0|||0
405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|17041|24953|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||17041||17041|24953||1|0||0|||0
405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|416|2071|lyfalmen|||2|60|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||416||416|2071|31.7.2021|1|0|G|0|||0
406106|C10AX1401|Praluent|stl|150|mg/ml|6|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|178075|227987|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||178075||178075|227987||1|0|E|0|||0
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|17064|24985|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17064||17064|24985||1|0|E|0|||0
406356|L01XK0101|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XK01|01.07.2016||R|0|0|1|0|0|AZA|0|1|0|100|SEK|703857|881912|lyfsjukr|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||703857||703857|881912||1|0|L|0|||0
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|51480|68386|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||51480||51480|68386||1|0|E|0|||0
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|LBK|0|0|0|100|DKK|61488|81044|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||61488||61488|81044|30.6.2021|1|0|E|0|||0
406435|L01ED0501|Lorviqua|filmhtfl|25|mg|90|stk|1|þpakki||L01ED05|01.04.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|706423|885104|lyfsjukr|||1|90|0||Icepharma hf|Pfizer Europe MA EEIG|Lorlatinib||706423||706423|885104||1|0|L|0|||0
407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Cyanocobalamin|||||4432||1|0|G|0|||0
407101|N02AA0507|OxyContin Depot|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|7424|11716|lyfalmen|V0585|7595|1|98|0|26,1300|Icepharma hf|Mundipharma A/S|Oxýcódon||7424||7424|11716||2|0|G|1|30|dagar|0
407393|L04AA3701|OLUMIANT|filmhtfl|2|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|116149|150968|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||116149||116149|150968||2|0|L|0|||0
407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17159|32725|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Penetamathýdrójoðíð||||17159|32725||2|0||0|||0
407586|N06BA0905|Atomoxetin STADA|hylki|80|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|7000|3563|lyfalmen|V0817|3563|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Atomoxetín||1500||1500|3563||2|0|E|0|||0
407933|QP54AA5401|BROADLINE|bl.lausn|||0,9|ml|3|sk-ílá||QP54AA54|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|DKK|4143|7141|vetorma|||0|2,7|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Praziquantelum ,Fipronil, s-Methoprene ,Eprinomectinum||4143||4143|7141||1|0||0|||0
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|1|100|DKK|341|1967|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||341||341|1967||1|0||2|150|töflur|0
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|PLS|0|0|0|100|DKK|613|2342|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||613||613|2342||1|0||2|150|töflur|0
408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|29053|40020|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||29053||29053|40020||1|0|G|0|||0
408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|15801|23246|lyfalmen|V0974|19553|1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||15801||15801|23246||2|0|G|0|||0
408166|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|3|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|13535|17812|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||11853||11853|17812||1|0|G|0|||0
408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|KRK|0|0|0|100|XEU|1812|3992|lyfalmen|V0310|2752|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1812||1812|3992||2|0||2|60|mg|0
408561|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|GAN|0|0|0|100|XEU|4284|7394|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4284||4284|7394||2|0||0|||0
408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0813|3197|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
408927|N03AX1408|Levetiracetam STADA|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2688|5198|lyfalmen|V0515|5198|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||2688||2688|5198||2|0|G|0|||0
409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|3042|5243|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3042||3042|5243||2|0||0|||0
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|PLS|0|0|1|100|DKK|3575|6419|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3575||3575|6419||1|0|E|0|||0
409115|QJ51CE0902|Procapen vet.|spenalyf|3|g|10|ml|24|dælur|dreifa|QJ51CE09|01.04.2020||R|0|0|0|0|0|ANI|0|0|0|100|IKR|5258|10146|vetalmen|||0|240|0||Dýraheilsa ehf|aniMedica GmbH|Benzylpenicillínprokaín||5258||5258|10146||2|0||0|||0
409210|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|60|mg|30|stk|1|þpakki|40+20 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|10403|15817|lyfalmen|||2|30|0|16,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||10403||10403|15817||2|0|E|1|30|dagar|0
409594|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|105|stk|1|glas||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|1330|3329|lyfalmen|V0414|3113|2|105|0|52,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||1330||1330|3329||2|0|G|0|||0
409673|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|2|mg|28|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|2630|5118|lyfalmen|||3|28|0|9,3333|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||2630||2630|5118||3|0|G|0|||0
409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|0|0|G|0|GRP|0|0|0|100|XEU|14694|21723|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||14694||14694|21723||1|0|G|0|||0
409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|56088|74214|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||56088||56088|74214||1|0|E|0|||0
409748|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.12.2019||R|1|0|0|G|0|TOG|0|0|0|100|SEK|1967|4205|lyfalmen|V1001|4205|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||1967||1967|4205||1|0|G|0|||0
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|BII|0|0|0|100|DKK|6380|10279|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6380||6380|10279||1|0|E|0|||0
409850|J07BA0104|TicoVac Junior|stl|1,2|mcg/sk|0,25|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3190|5889|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3190||3190|5889||1|0||0|||0
409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|14870|21965|lyfalmen|V0651|21962|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||14870||14870|21965||1|0|G|0|||0
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|3599|6452|lyfalmen|V0196|5948|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3599||3599|6452||2|0|G|0|||0
410223|L01EL0101|IMBRUVICA|filmhtfl|280|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|463220|582627|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||463220||463220|582627||1|0|L|0|||0
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|3440|5576|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2963||2963|5576||1|0|G|0|||0
410465|N03AX1214|Gabapentin Alvogen|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|1974|2806|lyfalmen|V0250|2453|2|100|0|16,6667|Alvogen|Alvogen|Gabapentín||950||950|2806||2|0|G|0|||0
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|G|0|MYL|0|0|1|100|SEK|658|2404|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||658||658|2404||2|0|G|0|||0
411034|N06AA0907|Amitriptylin Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|828|2638|lyfalmen|||2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||828||828|2638||2|0|G|0|||0
411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|G|0|MEV|0|0|0|100|DKK|1924|4146|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1924||1924|4146||1|0|G|0|||0
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|RTH|0|0|1|100|XEU|405|2024|lyfalmen|V0230|2024|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||382||382|2024||2|0|E|0|||0
411409|N03AX1602|Lyrica (Lyfjaver)|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|10842|16421|lyfalmen|V0689|3390|3|56|0|56,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||10842||10842|16421||3|0|E|0|||0
411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|G|0|WEH|0|0|0|100|IKR|8924|13781|lyfalmen|||2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13781|31.5.2021|2|0|G|0|||0
411723|N06BA0703|Aspendos|töflur|100|mg|90|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|12650|18909|lyfalmen|||2|90|0|30,0000|LYFIS ehf|Medochemie Limited|Modafinil||12650||12650|18909||2|0|E|2|||0
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|1|0|0|VIC|0|1|0|100|DKK|22096|31221|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Lamívúdín||22096||22096|31221||1|0|L|0|||0
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól|||||2292||1|0|E|0|||0
411913|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|2695|2448|lyfalmen|V0994|2448|2|2,5|0|25,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||690||690|2448||2|0|G|0|||0
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|SNP|0|0|0|100|XEU|2860|5434|lyfalmen|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2860||2860|5434||1|H|0|0|||0
412395|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|CES|1|0|0|100|DKK|4120|7987|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4120||4120|7987||2|0||0|||0
412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|VEB|1|0|0|100|XEU|4571|8843|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||4571||4571|8843||2|0||0|||0
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|1|G|0|BNB|0|0|0|100|XEU|83627|109045|lyfalmen|||1|2|0|27,9100|Icepharma hf|Biogen Netherlands B.V.|Interferón beta-1a||83627||83627|109045||2|0|G|0|||0
412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|G|0|TEE|0|0|0|100|NOK|45364|60650|lyfalmen|V0711|29328|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||45364||45364|60650||1|0|G|0|||0
412566|N03AX1213|Gabapentin Teva|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.08.2019||R|1|0|0|G|0|TVA|0|0|0|100|DKK|7263|11495|lyfalmen|V0254|11495|2|100|0|33,3300|Alvogen|Teva B.V.|Gabapentín||7263||7263|11495||2|0|G|0|||0
412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|44574|59651|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||44574||44574|59651||1|0|E|0|||0
412662|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|5864|7004|lyfalmen|V0581|5765|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4000||4000|7004||2|0|G|0|||0
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|G|0|MYL|0|0|0|100|SEK|3163|5851|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3163||3163|5851||2|0|G|0|||0
413053|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|4060|7086|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4060||4060|7086||2|0|G|1|30|dagar|0
413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|OVE|0|0|0|100|DKK|31265|42818|lyfalmen|||1|50|0||Pharmanovia A/S|Provepharm S.A.S.|Metýltíónín||31265||31265|42818||2|H|0|0|||0
413289|L01BA0403|Pemetrexed Accord|irþ|500|mg|500|mg|1|hgl|stofn f. innr.þykkni lausn|L01BA04|01.04.2021||R|0|0|0|0|0|CLU|0|1|0|100|XEU|137475|177492|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare S.L.U.|Pemetrexed||137475||137475|177492||1|H|L|0|||0
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Paracetamól|||||||1|0||0|||0
414424|N06AA0907|Amitriptylin Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|G|0|ABC|0|0|0|100|SEK|1178|3119|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1178||1178|3119||2|0|G|0|||0
414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|1|G|0|TGM|0|0|0|100|NOK|88230|114867|lyfalmen|||1|12|0|24,0000|Teva Pharma Iceland ehf|TEVA GmbH|Glatíramer acetat||88230||88230|114867||1|0|G|0|||0
414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|38624|52125|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||38624||38624|52125||2|H|0|0|||0
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|G|0|LLS|0|0|0|100|DKK|1213|3167|lyfalmen|||1|90|0|54,0000|Icepharma hf|Les Laboratoires Servier|Indapamíð||1213||1213|3167||2|0|G|0|||0
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|G|0|HES|0|0|0|100|DKK|1145|3074|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1145||1145|3074||1|0|G|0|||0
414921|L04AA4201|Mayzent|filmhtfl|2|mg|28|stk|1|þpakki||L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|221574|282087|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Limited|Siponimod||221574||221574|282087||1|0|L|0|||0
414991|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.12.2020||R|1|0|0|G|0|BLS|0|0|0|100|IKR|3122|4030|lyfalmen|V0203|4026|2|12|0|84,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1840||1840|4030||1|0|G|0|||0
415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|182928|234022|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||182928||182928|234022||1|0|L|0|||0
415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|150233|193359|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||150233||150233|193359||1|0|G|0|||0
415724|G04CA5202|Dutaprostam|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.10.2019||R|0|0|0|G|0|ALO|0|0|0|100|DKK|2948|4357|lyfalmen|V1010|2956|2|30|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||2077||2077|4357||2|0|G|0|||0
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|G|0|PSA|0|0|0|100|XEU|5334|6454|lyfalmen|V0253|4878|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3601||3601|6454||2|0|G|0|||0
416072|L01AX0304|Temozolomide Accord|hylki|140|mg|5|stk|1|skpoki||L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|24061|33706|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||24061||24061|33706||1|0|L|0|||0
416121|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|150|g|1|túpa||M02AA15|01.05.2021||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
416330|A10BD2401|Steglujan|filmhtfl|115|mg|98|stk|1|þpakki|15/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|34530|46750|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||34374||34374|46750||1|0|G|0|||0
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|G|0|MSD|0|0|0|100|DKK|8588|9500|lyfalmen|V0088|3108|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5814||5814|9500||1|0|G|0|||0
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|G|0|GOG|0|0|1|100|XEU|2679|5185|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2679||2679|5185||2|0|G|0|||0
417562|N03AX1214|Gabapentin Alvogen|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.07.2021||R|1|0|0|G|0|POF|0|0|0|100|DKK|7263|11495|lyfalmen|V0254|11495|2|100|0|33,3300|Alvogen|Alvogen|Gabapentín||7263||7263|11495||2|0|G|0|||0
417633|A10BJ0601|Ozempic|stl|0,5|mg|1,5|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18238|26601|lyfalmen|||1|1,5|0|18,1818|Vistor hf|Novo-Nordisk|Semaglutide||18238||18238|26601||1|0|E|0|||0
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|1|0|0|VIC|0|1|0|100|DKK|36167|49018|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Abacavír||36167||36167|49018||1|0|L|0|||0
417880|B02BD0401|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD04|01.07.2012||R|0|0|1|0|0|PEU|0|1|0|100|DKK|92252|119954|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||92252||92252|119954||1|0|L|0|||0
417898|C01CA1703|Hypotron|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|17695|25853|lyfalmen|V0969|20079|2|100|0|16,6666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||17695||17695|25853||1|0|G|0|||0
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|26343|36592|lyfalmen|V0460|36592|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||26343|36592||1|0|G|0|||0
418642|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.02.2019||R|0|1|1|G|0|BIO|0|0|0|100|DKK|27603|37685|lyfalmen|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||27207||27207|37685||3|0|G|0|||0
418667|L01XC0203|Truxima|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.08.2019||R|0|1|0|0|0|CTH|0|1|0|100|DKK|68888|90403|lyfsjukr|||2|20|0||Vistor hf|Celltrion Healthcare Hungary Kft.|Rítúxímab||68888||68888|90403||1|H|L|0|||0
418714|C10BA0202|Ezetimib/Simvastatin Krka|töflur|50|mg|100|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|18000|26273|lyfalmen|V0615|26273|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||18000||18000|26273||2|0||0|||0
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|2321|4693|lyfalmen|||1|100|0|25,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||2321||2321|4693||1|0|G|0|||0
419294|J01DD0403|Rocephalin IV|sts|1|g|1|stk|1|hgl|+ leysir, lausn|J01DD04|01.09.2018||R|0|0|0|0|0|ROA|0|0|1|100|DKK|2757|5293|lyfalmen|||1|1|0|0,5000|Icepharma hf|Roche A.S.|Ceftríaxón||2757||2757|5293||2|0|0|0|||0
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|G|0|CHE|0|0|0|100|DKK|8448|13126|lyfalmen|||1|100|0|100,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Alfakalsídól||8448||8448|13126||1|0|G|0|||0
419311|N03AX1408|Levetiracetam STADA|mixtúra|100|mg/ml|300|ml|1|glas|+ 10 ml munngj.spr.|N03AX14|01.12.2019||R|0|0|0|G|0|ASR|0|0|0|100|IKR|11000|16638|lyfalmen|V1000|16638|2|300|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||11000||11000|16638||2|0|G|0|||0
419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5426|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5426||2|0|E|1|30|dagar|0
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|1|0|0|OUS|0|0|0|100|XEU|36982|50048|lyfalmen|||1|100|0|7,5000|Recordati AB|Orphan Europe SARL|Mercaptamín||36982||36982|50048||3|0|E|0|||0
419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|1|0|0|OUS|0|0|0|100|XEU|12714|18997|lyfalmen|||1|100|0|2,5000|Recordati AB|Orphan Europe SARL|Mercaptamín||12714||12714|18997||3|0|E|0|||0
419952|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AD01|01.10.2018||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1695|3831|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||1695||1695|3831||1|0|G|0|||0
419969|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2020||R|0|0|0|G|0|AGE|0|0|1|100|XEU|2087|4370|lyfalmen|||1|4,5|0||Agepha Pharma s.r.o.|Agepha Pharma s.r.o.|Acíklóvír||2087||2087|4370||2|0|G|0|||0
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|G|0|PLS|0|0|1|100|DKK|11194|16905|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11194||11194|16905||1|0|G|0|||0
420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|1|0|0|GEI|0|1|0|100|DKK|131006|169446|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||131006||131006|169446||2|0|L|0|||0
420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|G|0|RTH|0|0|1|100|IKR|4816|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||500||500|2186||2|0|G|0|||0
420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|áf.spr|2.500 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|3475|6281|lyfalmen|||1|2|0|10,0000|Icepharma hf|Pfizer Aps|Dalteparín||3475||3475|6281||1|0|G|0|||0
420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|áf.spr|5.000 a.e. anti-Xa/sprautu|B01AB04|01.05.2018||R|0|0|0|G|0|PLS|0|0|1|100|DKK|4953|8315|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer Aps|Dalteparín||4953||4953|8315||1|0|G|0|||0
420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|RTH|0|0|1|100|DKK|1441|2936|lyfalmen|V0479|2936|2|60|0|4,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1045||1045|2936||2|0|E|0|||0
420639|L01EL0101|IMBRUVICA|filmhtfl|140|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|231282|294161|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||231282||231282|294161||1|0|L|0|||0
420696|M02AA1504|Diklofenak Apofri|hlaup|11,6|mg/g|60|g|1|túpa||M02AA15|01.01.2019||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|Apofri AB|Díklófenak|||||||2|0||0|||0
420952|J01CF0204|Cloxacillin Navamedic Nordic|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.08.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|2555|5015|lyfalmen|V1053|5015|1|10|0|5,0000|Icepharma hf|Navamedic ASA|Kloxacillín||2555||2555|5015||2|0|0|0|||0
421120|C10AA0704|Rosuvastatin Xiromed|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2280|4636|lyfalmen|V0214|4604|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|G|0|SNP|0|0|0|100|XEU|1195|3143|lyfalmen|||1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1195||1195|3143||1|0|G|0|||0
421434|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|98|stk|1|þpakki||C10AA05|01.07.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2000|2779|lyfalmen|V0114|2681|2|98|0|196,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
421673|M04AA0303|Febuxostat Medical Valley|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.10.2019||R|1|0|0|0|0|VAL|0|0|0|100|XEU|8555|9586|lyfalmen|V1011|9586|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|febuxostat||5876||5876|9586||2|0|E|0|||0
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|36161|68775|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||36161||36161|68775||1|0||0|||0
421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|G|0|TVA|0|0|1|100|XEU|1642|3268|lyfalmen|V0458|2979|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1286||1286|3268||2|0|G|0|||0
421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|ERC|0|0|0|100|IKR|||lyfalmen|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||1925||1|0||0|||0
422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|618|2349|lyfalmen|V0596|2349|2|28|0|1,8600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||618||618|2349||1|0|G|1|30|dagar|0
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|2614|5096|lyfalmen|V0049|2852|1|98|0|62,0667|Vistor hf|Recordati Ireland Limited|Metóprólól||2614||2614|5096||1|0|G|0|||0
422323|L01DB1101|Pixuvri|st/irþ|29|mg|1|hgl|1|pakki||L01DB11|01.02.2020||R|0|0|0|0|0|LLS|0|0|0|100|DKK|91128|118532|lyfalmen|||1|1|0||Icepharma hf|Les Laboratoires Servier|Pixantron||91128||91128|118532||2|H|0|0|||0
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|G|0|RDT|0|0|0|100|DKK|6660|10665|lyfalmen|V0054|4840|1|98|0|124,1333|Vistor hf|Recordati Ireland Limited|Metóprólól||6660||6660|10665||1|0|G|0|||0
422340|C02AC0201|Intuniv|forðatfl|1|mg|28|stk|1|þpakki||C02AC02|01.10.2020||R|1|1|1|0|0|HPI|0|0|0|100|DKK|9254|14235|lyfalmen|||1|28|0|9,3333|Vistor hf|Shire Pharmaceuticals Ireland Limited|Guanfacine||9254||9254|14235||1|0|E|0|||0
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|0|0|CSB|0|1|0|100|SEK|69911|91697|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||69911||69911|91697||2|H|L|0|||0
422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|1|0|0|SAB|0|1|0|100|DKK|44119|59075|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||44119|59075||3|0|L|0|||0
422591|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.10.2020||R|1|0|0|0|0|ASA|0|0|0|100|SEK|18677|27205|lyfalmen|V0195|9966|1|98|0|392,0000|Vistor hf|Astra Zeneca A/S|Rósuvastatín||18677||18677|27205||1|0|E|0|||0
422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|2778|5322|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2778||2778|5322||3|0|G|0|||0
422860|N03AF0401|Zebinix|töflur|200|mg|60|stk|1|þpakki||N03AF04|01.12.2018||R|1|0|0|G|0|BPC|0|0|0|100|SEK|10551|16020|lyfalmen|||1|60|0|15,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||10551||10551|16020||1|0|G|0|||0
422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8870|13707|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||8870||8870|13707||2|0|G|0|||0
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|BAB|0|0|0|100|DKK|2848|4850|lyfalm11|V0993|4383|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2848|4850||2|0||0|||1
423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|LEM|0|0|1|100|XEU|18108|26422|lyfalmen|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||18108||18108|26422||2|0|0|0|||0
423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|5435|8979|lyfalmen|V0373|4803|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5435||5435|8979||2|0|G|0|||0
424199|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.03.2020||R|1|0|0|0|0|SSE|0|0|1|100|DKK|66377|87227|lyfalmen|||1|50|0|33,3300|Shire Services BVBA|Shire Services BVBA|Hýdrókortisón||66377||66377|87227||1|0|E|0|||0
424477|N06BA1201|Elvanse Adult|hylki|30|mg|30|stk|1|glas|hart|N06BA12|01.06.2018||R|1|1|0|0|0|SHE|0|0|0|100|DKK|10860|16446|lyfalmen|||1|30|0|30,0000|Shire Pharmaceuticals Ireland Limited|Shire Pharmaceuticals Ireland Limited|lisdexamfetamine||10860||10860|16446||1|0|E|1|30|dagar|0
424761|A07AA0204|Nystatin Orifarm|mixtúra|100000|ae/ml|100|ml|1|glas|dreifa|A07AA02|01.03.2020||R|0|0|0|0|0|IRO|0|0|1|100|XEU|5232|8699|lyfalmen|||2|100|0|6,6667|Artasan ehf|Orifarm Generics A/S|Nýstatín||5232||5232|8699||1|0|0|0|||0
424829|N06AX2108|Aritavi|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.08.2019||R|1|0|0|G|0|ATE|0|0|0|100|XEU|9548|3940|lyfalmen|V0694|3940|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Duloxetín||1774||1774|3940||1|0|G|0|||0
424973|R03BB0404|Braltus|innönddu|10|mcg|30|stk|3|glas|hart hylki|R03BB04|01.09.2018||R|0|0|0|G|0|TVA|0|0|0|100|DKK|12409|17057|lyfalmen|||2|90|0|90,0000|Alvogen|Teva B.V.|Tíótrópíumbrómíð||11304||11304|17057||2|0|G|0|||0
424981|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|20|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.05.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0
425016|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|1|G|0|AZA|0|0|0|100|SEK|21186|24792|lyfalmen|V0183|19271|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||16924||16924|24792||1|0|G|0|||0
425282|L01EA0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|18188|26532|lyfsjukr|||2|60|0||Artasan ehf|Accord Healthcare Limited|Imatinib||18188||18188|26532||1|0|L|0|||0
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|G|0|GPA|0|0|0|100|XEU|1528|3458|lyfalmen|V0213|3291|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1424||1424|3458||1|0|G|0|||0
425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|G|0|TTT|0|0|0|100|DKK|13345|19866|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||13345||13345|19866||2|0|G|0|||0
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|939|2790|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||939||939|2790||2|0|E|0|||0
427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018|30.06.2021|R|1|0|1|0|0|SHS|0|1|0|100|DKK|104227|121917|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||93804||93804|121917||1|0|L|0|||0
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2|0||0|||0
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|7891|12359|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||7891||7891|12359||1|0||0|||0
427289|B01AC0603|Hjartamagnýl|sþ-tfl|75|mg|100|stk|1|þpakki||B01AC06|01.04.2019||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1|0|0|0|||0
427324|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|IKR|||lyfalmen|V1048|4668|3|250|0|62,5000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||4873||3|0|G|0|||0
427556|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|30|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|2976|4862|lyfalmen|V1004|4862|2|30|0|4,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||2444||2444|4862||2|0|E|1|30|dagar|0
427754|B01AF0102|Rivaroxaban WH|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.02.2021||R|1|1|0|G|0|WEH|0|0|0|100|XEU|8480|13170|lyfalmen|V1036|13170|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Rivaoxaban||8480||8480|13170||2|0|G|0|||0
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3268||1|0|E|0|||0
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2405||1|0|G|0|||0
428489|L02BB0501|Erleada|filmhtfl|60|mg|112|stk|1|þpakki||L02BB05|01.02.2021||R|0|0|0|0|0|JCI|0|1|0|100|SEK|409365|515647|lyfsjukr|||1|112|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Apalutamide||409365||409365|515647||1|0|L|0|||0
428515|N02AA0508|Oxycodone Alvogen|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3136|5246|lyfalmen|V0598|5246|2|98|0|13,0700|Alvogen|Alvogen ehf|Oxýcódon||2723||2723|5246||2|0|G|1|30|dagar|0
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|3182|5878|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3182||3182|5878||2|0|0|0|||0
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|1|0|0|MLD|0|1|0|100|DKK|75834|99188|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||75834||75834|99188||1|0|L|0|||0
429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6411|3240|lyfalmen|V0812|3197|2|28|0|3,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1266||1266|3240||1|0|E|0|||0
429759|S01EE0501|Taflotan|augndr|15|mcg/ml|3|ml|3|glös||S01EE05|01.03.2019||R|0|0|0|G|0|SAO|0|0|0|100|XEU|7169|11365|lyfalmen|||1|9|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7169||7169|11365||2|0|G|0|||0
429787|D07AA0210|Hydrokortison Evolan|krem|10|mg/g|50|g|1|túpa||D07AA02|01.08.2021||L|0|0|0|0|0|EVO|0|0|1|100|IKR|||lyflausa|||0|50|0||LYFIS ehf|Evolan Pharma AB|Hýdrókortisón|||||||2|0||0|||0
429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|tfílát|30+500 mg|N02AJ06|01.02.2018||R|2|0|0|0|0|ATE|0|0|1|100|XEU|4256|7356|lyfalmen|||2|200|0|66,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||4256||4256|7356||1|0|E|1|||0
429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|9178|14131|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9178||9178|14131||3|0|G|0|||0
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|IBV|0|0|0|100|DKK|5303|10231|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Sulfadiazinum og trimethoprimum||5303||5303|10231||1|0||0|||0
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|G|0|WEH|0|0|0|100|XEU|17201|13083|lyfalmen|V0184|12537|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||8417||8417|13083||2|0|G|0|||0
430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|5488|7875|lyfalmen|V0831|7403|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4633||4633|7875||2|0|G|0|||0
430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|G|0|TTT|0|0|0|100|DKK|5410|8944|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5410||5410|8944||2|0|G|0|||0
430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
431017|B06AC0501|Takhzyro|stl|300|mg|2|ml|1|hgl|+ein spr og tvær nálar|B06AC05|01.09.2020||R|0|0|1|0|0|HPI|0|1|0|100|DKK|1824290|2275415|lyfsjukr|||1|2|0|14,0187|Vistor hf|Shire Pharmaceuticals Ireland Limited|Lanadelumab||1824288||1824288|2275415||1|0|L|0|||0
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1057|2953|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1057||1057|2953||1|0||0|||0
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|1312|3304|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1312||1312|3304||1|0|G|0|||0
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|G|0|PLS|0|0|1|100|DKK|3408|6189|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3408||3408|6189||1|0|G|0|||0
431922|S01ED5120|Travoprost/Timolol Medical Valley|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.11.2019||R|0|0|0|G|0|VAL|0|0|0|100|IKR|7042|5283|lyfalmen|V0995|5283|2|7,5|0|75,0000|Acare ehf|Medical Valley Invest AB|Tímólól í blöndum||2750||2750|5283||2|0|G|0|||0
431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17596|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17596||2|0|E|1|30|dagar|0
431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|0|0|TPA|0|1|0|100|DKK|293005|370927|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||293005||293005|370927||1|H|L|0|||0
431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|2185|4505|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2185||2185|4505||1|0|G|0|||0
432189|L01EM0301|Piqray|filmhtfl|200|mg|28|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|484186|608703|lyfsjukr|||1|28|0|18,6667|Vistor hf|Novartis Europharm Limited|Alpelisib||484186||484186|608703||1|0|L|0|||0
432220|QM01AC0603|Rheumocam|stl|20|mg/ml|100|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.06.2018||R|0|0|0|0|0|CHP|1|0|0|100|IKR|6850|13166|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||||6850|13166||2|0||0|||0
432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|3245|3700|lyfalmen|V0693|3700|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1600||1600|3700||2|0|E|0|||0
432723|A10BJ0602|Rybelsus|töflur|7|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20650|29392|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20650||20650|29392||1|0|E|0|||0
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|BRO|0|0|0|100|XEU|2686|4053|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||2062||2062|4053||2|0|0|0|||0
433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||2176||1|0|E|0|||0
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|G|0|COR|0|0|0|100|DKK|10345|15737|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10345||10345|15737||1|0|G|0|||0
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2330|4705|lyfalmen|||1|28|0|8,4000|Icepharma hf|Mundipharma A/S|Morfín||2330||2330|4705||2|0|G|1|30|dagar|0
433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|0|G|0|MDI|0|0|0|100|DKK|5120|8545|lyfalmen|||1|28|0|25,2000|Icepharma hf|Mundipharma A/S|Morfín||5120||5120|8545||2|0|G|1|30|dagar|0
433345|QI08AA0101|Eravac|stl|||0,5|ml|10|hgl|fleyti|QI08AA01|01.05.2020||R|0|0|0|0|0|LHS|0|0|0|100|IKR|14085|24277|vetbolu|||0|5|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Rabbit haemorrhagic disease virus||14085||14085|24277||2|0||0|||0
433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|1|0|0|MLD|0|1|0|100|DKK|382504|482239|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||382504||382504|482239||1|0|L|0|||0
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|146789|189076|lyfalmen|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||146789||146789|189076||2|H|0|0|||0
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|NOK|66064|101106|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||62721||62721|101106||1|0||0|||0
434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Vedaprofenum||15098||15098|28814||2|0||0|||0
434366|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|áfpen|+ 3 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|13736|20404|lyfalmen|||1|0,36|0|1,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||13736||13736|20404||1|0|G|0|||0
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|7569|11916|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai GmbH|Zonisamíð||7569||7569|11916||1|0|G|0|||0
434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3272|3838|lyfalmen|V0010|3838|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
434601|N07BC0102|Buvidal|stl|128|mg|0,36|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|55856|73920|lyfsjukr|||1|0,36|0|60,9524|Vistor hf|Camurus AB|Búprenorfín||55856||55856|73920||1|H|L|1|30|dagar|0
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|MCS|0|0|1|100|SEK|736|2511|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||736||736|2511||1|0|E|0|||0
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6486|10425|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||6486||6486|10425||2|0|G|0|||0
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|1|0|G|0|MEA|0|0|1|100|IKR|6471|10405|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||6471||6471|10405||2|0|G|0|||0
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|9523|14605|lyfalmen|V0315|6716|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9523||9523|14605||2|0|E|0|||0
434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|1|0|0|AMC|0|1|0|100|XEU|2324351|2897353|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeutics Europe Limited|Migalastat||2324351||2324351|2897353||1|0|L|0|||0
435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|1|0|0|SDG|0|1|0|100|DKK|12847|19181|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||12847||12847|19181||1|0|L|0|||0
435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2979|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3847||1|0|G|0|||0
435882|N05CD0806|Buccolam|munnh.l|5|mg|1|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12389|18550|lyfalmen|||2|4|0|2,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12389||12389|18550||3|0|E|2|450|mg|0
436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|202213|258008|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||202213||202213|258008||2|H|L|0|||0
436044|N02AJ0601|Parkodin|filmhtfl|510|mg|10|stk|1|þpakki|10+500 mg|N02AJ06|01.07.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|279|1882|lyfalmen|||2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||279||279|1882||1|0|E|3|||0
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0
436308|J05AR2001|Biktarvy|filmhtfl|275|mg|30|stk|1|glas|50+200+25 mg|J05AR20|01.10.2018||R|0|0|1|0|0|GSE|0|1|0|100|DKK|127624|165240|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Emtricitabine, Tenofovir alafenamide og Bictegravir||127624||127624|165240||2|0|L|0|||0
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|LEP|0|0|1|100|DKK|1018|2899|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1018||1018|2899||1|0||0|||0
436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|68180|89508|lyfsjukr|||1|60|0|0,7500|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||68180||68180|89508||3|0|L|0|||0
436810|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk|Stök áfyllingarpakkning|R03AC19|01.08.2019||R|0|0|0|G|0|BII|0|0|1|100|DKK|3961|6950|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3961||3961|6950||1|0|G|0|||0
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|G|0|JAS|0|0|0|100|SEK|677|2430|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||677||677|2430||1|0|G|0|||0
437007|N06BA0905|Atomoxetin STADA|hylki|18|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4200|3425|lyfalmen|V0813|3425|2|30|0|6,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
437221|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7646|9548|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||5849||5849|9548||1|0|G|0|||0
437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|0|0|FIN|0|1|0|100|DKK|596217|748038|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||596217||596217|748038||2|H|L|0|||0
437581|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|10484|15928|lyfalmen|V0253|4878|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||10484||10484|15928||3|0|G|0|||0
437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|20345|29006|lyfalmen|V0712|29006|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||20345||20345|29006||1|0|G|0|||0
437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|G|0|DEA|0|0|0|100|XEU|1097|3008|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1097||1097|3008||1|0|G|0|||0
437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|0|0|AST|0|1|0|100|DKK|53310|70700|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||53310||53310|70700||2|H|L|0|||0
438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|DEH|1|0|0|100|XEU|22016|41939|vetalmen|||0|1|0||Vistor hf|Dechra Regulatory B.V.|Clodronic acid||22016||22016|41939||1|0|0|0|||0
438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|FKA|0|0|1|100|DKK|1931|4156|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1931||1931|4156||1|0|0|0|||0
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002|31.07.2021|R|0|0|0|G|0|HES|0|0|1|100|DKK|2049|4318|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2049||2049|4318||1|0|G|0|||0
438514|R06AE0708|Cetirizine Alvogen|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.06.2021||L|1|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|Alvogen|Cetirizín|||||||2|0||0|||0
438571|A07EC0204|Asacol|töflur|1600|mg|60|stk|1|þpakki|með breyttan.losunarhraða|A07EC02|01.02.2019||R|1|0|0|G|0|TIL|0|0|0|100|DKK|9885|15104|lyfalmen|||1|60|0|64,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||9885||9885|15104||2|0|G|0|||0
438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|1587|3682|lyfalmen|||1|100|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||1587||1587|3682||1|0|G|0|||0
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5646|6341|lyfalmen|V0605|2817|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3519||3519|6341||2|0|G|0|||0
438759|L01EC0101|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01EC01|01.08.2012||R|0|0|1|0|0|RRG|0|1|0|100|DKK|224493|285718|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration GmbH|Vemurafenib||224493||224493|285718||2|0|L|0|||0
438775|R03AK1401|Atectura Breezhaler|innönddu|187,5|mcg/sk|30|stk|1|stsk.þ|125 mcg/62,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|3728|6629|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||3728||3728|6629||1|0|G|0|||0
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|150842|194116|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||150842||150842|194116||1|0|L|0|||0
438974|D01AE1501|Lamisil|krem|1|%|15|g|1|túpa||D01AE15|01.10.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Xýlómetazólín|||||||1|0||0|||0
439419|B06AC0102|Berinert|sts/irs|2000|ae|1|hgl|1|pakki||B06AC01|01.07.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|448549|564381|lyfsjukr|||1|1|0|1,4286|Icepharma hf|CSL Behring GmbH|C1 hemill||448549||448549|564381||2|0|L|0|||0
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|G|0|RDT|0|0|0|100|DKK|4793|8095|lyfalmen|||1|98|0|98,0000|Vistor hf|Recordati Ireland Limited|Metóprólól og Felodipin||4793||4793|8095||1|0|G|0|||0
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|19852|28822|lyfalmen|V0615|25748|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb og simvastatín||19852||19852|28822||1|0||0|||0
439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|15138|11624|lyfalmen|V0818|11624|2|28|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||7357||7357|11624||1|0|E|0|||0
439822|R03DC0306|Montelukast ratiopharm|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10619|16114|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||10619||10619|16114||2|0|G|0|||0
439954|H02AB0901|Solu-Cortef|sts|250|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|0|0|PLS|0|0|0|100|DKK|855|2675|lyfalmen|||1|1|0|8,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||855||855|2675||1|H|0|0|||0
440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|169434|217240|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||169434||169434|217240||1|0|G|0|||0
440431|N02AX0213|Tramadol Krka|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4500|6591|lyfalmen|V0224|6591|2|100|0|66,6700|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||3700||3700|6591||2|0|G|1|30|dagar|0
440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|G|0|KRK|0|0|0|100|IKR|3115|5785|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5785||2|0|G|0|||0
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|1308|3298|lyfalmen|||2|10|0|1,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||1308||1308|3298||1|0|0|0|||0
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|2063|4337|lyfalmen|||2|10|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||2063||2063|4337||1|0|0|0|||0
441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|KRO|0|0|1|100|SEK|1063|2961|lyfalmen|||1|30|0||Vistor hf|Karo Pharma AB|Blöndur||1063||1063|2961||1|0|E|0|||0
441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|1064|2962|lyfalmen|V0046|2402|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1064||1064|2962||1|0|G|0|||0
441432|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|786|2580|lyfalmen|V1051|2580|1|10|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||786||786|2580||1|0|0|1|30|dagar|0
441451|N02CC0101|Imigran|nefúði|20|mg/sk|0,1|ml|6|úðaílá||N02CC01|01.04.2020||R|0|0|0|G|0|GPH|0|0|0|100|DKK|5761|9427|lyfalmen|||1|0,6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5761||5761|9427||1|0|G|0|||0
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|1|0|0|GEI|0|1|0|100|DKK|100137|131054|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Sciences Ireland|Emtrícítabín, rilpívírin og tenófóvír||100137||100137|131054||2|0|L|0|||0
442258|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|2.000 PFU bóluefni|J07BK01|01.01.2020||R|0|0|0|0|0|GPH|0|0|0|100|DKK|5517|9092|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||5517||5517|9092||1|0|0|0|||0
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|G|0|KNM|0|0|0|100|XEU|2470|4898|lyfalmen|V0283|3729|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2470||2470|4898||2|0|G|0|||0
442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|69424|91081|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||69424||69424|91081||3|0|L|0|||0
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|G|0|BII|0|0|0|100|DKK|10358|15755|lyfalmen|V0460|12197|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10358|15755||1|0|G|0|||0
443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1571|3660|lyfalmen|V0560|3304|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1571||1571|3660||2|0||0|||0
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|G|0|NAS|0|0|1|100|DKK|3115|5785|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3115||3115|5785||1|0|G|0|||0
443255|N02BE0127|Dolorin Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.04.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|G|0|NAS|0|0|1|100|DKK|24721|34541|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||24721||24721|34541||1|0|G|0|||0
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|22818|32134|lyfalmen|||1|90|0|180,0000|Icepharma hf|Mundipharma A/S|Morfín||22818||22818|32134||2|0|G|1|30|dagar|0
443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|EUS|0|0|0|100|XEU|23491|32985|lyfalmen|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||23491||23491|32985||3|H|0|0|||0
443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1761|2998|lyfalmen|V0039|2998|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1090||1090|2998||2|0|G|0|||0
444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2512|4955|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2512||2512|4955||2|0|G|0|||0
444260|L04AC0801|Ilaris|stl|150|mg/ml|1|ml|1|hgl|lausn|L04AC08|01.04.2018||R|0|1|1|0|0|NEP|0|1|0|100|DKK|1565671|1953768|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Limited|Canakinumab||1565671||1565671|1953768||1|0|L|0|||0
444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|BLS|0|0|1|100|XEU|1997|3948|lyfalmen|V0337|3948|2|30|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1780||1780|3948||1|0|E|0|||0
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|DAN|0|0|0|100|XEU|2898|5487|lyfalmen|||1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2898||2898|5487||2|0|E|0|||0
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|20356|29020|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||20356||20356|29020||2|H|0|0|||0
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|G|0|ROA|0|0|0|100|DKK|2086|4369|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2086||2086|4369||2|0|G|0|||0
444511|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.04.2021||R|0|1|0|G|0|NEL|0|0|0|100|DKK|8230|12826|lyfalmen|V0349|12210|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||8230||8230|12826||1|0|G|0|||0
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|3537|6366|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||3537||3537|6366||2|0|G|0|||0
444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|G|0|IRO|0|0|0|100|XEU|4888|8226|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4888||4888|8226||1|0|G|0|||0
444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|158229|203304|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||158229||158229|203304||2|0|L|0|||0
445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|G|0|BOE|0|0|0|100|DKK|18048|26339|lyfalmen|||1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||18048||18048|26339||1|0|G|0|||0
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4559|7773|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og flútícason||4559||4559|7773||1|0|G|0|||0
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|G|0|LEO|0|0|1|100|DKK|1855|4051|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1855||1855|4051||1|0|G|0|||0
445169|L01CE0202|Irinotecan Accord|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01CE02|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|39625|53391|lyfalmen|||2|25|0||Artasan ehf|Accord Healthcare B.V.|Irinotecan||39625||39625|53391||1|H|0|0|||0
445240|N05CH0104|Melatonin Vitabalans|töflur|5|mg|50|stk|1|þpakki||N05CH01|01.03.2019||R|0|0|0|0|0|LYF|0|0|1|100|IKR|7000|5902|lyfalmen|||2|50|0|125,0000|LYFIS ehf|LYFIS ehf|Melatonin||3200||3200|5902||2|0|0|0|||0
445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6662|3375|lyfalmen|V0684|3375|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
445576|L04AC1001|Cosentyx|stl|300|mg|2|ml|1|áfpen||L04AC10|01.08.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|157048|201835|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||157048||157048|201835||1|0|L|0|||0
445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|G|0|SDH|0|0|0|100|XEU|5505|9075|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5505||5505|9075||1|0|G|0|||0
445892|QD11AH9102|Cytopoint|stl|40|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|27583|52501|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||27583||27583|52501||2|0||0|||0
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|1|G|0|EIG|0|0|0|100|SEK|15612|22986|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai GmbH|Rúfínamíð||15612||15612|22986||1|0|G|0|||0
446639|C10BA0202|Ezetimib/Simvastatin Krka|töflur|30|mg|100|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.10.2019||R|1|0|0|0|0|KNM|0|0|0|100|IKR|17377|22144|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb og simvastatín||15000||15000|22144||2|0||0|||0
447013|L04AB0402|Imraldi|stl|40|mg/spr|0,8|ml|2|áf.spr|áfylltar sprautur|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|56525|74766|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||56525||56525|74766||2|0|L|0|||0
447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|G|0|KNM|0|0|0|100|IKR|7968|5214|lyfalmen|V0694|3940|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2700||2700|5214||2|0|G|0|||0
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|10747|16290|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10747||10747|16290||1|0|G|0|||0
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|6016|9778|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6016||6016|9778||1|0|G|0|||0
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|7563|11908|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7563||7563|11908||1|0|G|0|||0
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/sprautu|B01AB04|01.04.2008||R|0|0|0|G|0|PLS|0|0|1|100|DKK|7825|12268|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7825||7825|12268||1|0|G|0|||0
447357|A10AE0407|Toujeo [DoubleStar]|stl|300|ein/ml|3|ml|3|áfpen|áfylltir lyfjapennar|A10AE04|01.09.2019||R|0|1|0|G|0|SDH|0|0|0|100|XEU|11010|16652|lyfalmen|||1|9|0|67,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||11010||11010|16652||1|0|G|0|||0
447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2999|3631|lyfalmen|V0948|3631|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||1550||1550|3631||2|0|G|0|||0
447608|J06BA0104|Cutaquig|stl|165|mg/ml|12|ml|1|hgl||J06BA01|01.04.2020||R|0|0|1|0|0|OCT|0|1|0|100|DKK|22575|31826|lyfsjukr|||1|12|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||22575||22575|31826||1|0|L|0|||0
447939|G04BE0806|Tadalafil Krka|filmhtfl|5|mg|84|stk|1|þpakki||G04BE08|01.07.2020||R|1|0|0|0|0|KNM|0|0|0|100|IKR|28000|38688|lyfalmen|||2|84|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||28000||28000|38688||2|0|E|0|||0
448253|A10AB0505|Fiasp|stl|100|ein/ml|10|ml|1|hgl||A10AB05|01.02.2019||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2780|5324|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2780||2780|5324||1|0|G|0|||0
448379|G03AD0103|Levonorgestrel Apofri|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.12.2019||L|0|0|0|0|0|APO|0|0|0|100|IKR|||lyflau11|||0|1|0|1,0000|LYFIS ehf|Apofri AB|Levonorgestrel|||||||2|0||0|||1
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|G|0|HES|0|0|1|100|DKK|1932|4157|lyfalmen|V0202|4157|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1932||1932|4157||1|0|G|0|||0
448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|KRK|0|0|0|100|IKR|4087|4636|lyfalmen|V0214|4604|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2280||2280|4636||2|0|E|0|||0
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|RAU|0|0|0|100|XEU|1062|2960|lyfalmen|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1062||1062|2960||2|H|0|0|||0
449480|B02BC3002|TISSEEL|vefjalím|||4|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|32432|44294|lyfalmen|||1|4|0||Icepharma hf|Baxter Medical AB|Blöndur||32432||32432|44294||2|H|0|0|||0
449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2271|3474|lyfalmen|V0686|1925|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1436||1436|3474||2|0|E|0|||0
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1796|3141|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1194||1194|3141||2|0|G|0|||0
449697|R03DX1001|Fasenra|stl|30|mg|1|ml|1|áfpen||R03DX10|01.05.2020||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|330745|417865|lyfsjukr|||1|1|0|55,5556|Vistor hf|AstraZeneca AB|Benralizumab||330745||330745|417865||1|0|L|0|||0
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|ATE|0|0|1|100|DKK|4891|8230|lyfalmen|||2|10|0|8,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Benzýlpenicillín||4891||4891|8230||1|0|0|0|||0
449842|L01XX2401|Oncaspar|stl/irs|750|ein/ml|5|ml|1|hgl||L01XX24|01.04.2019||R|0|0|0|0|0|LLS|0|1|0|100|DKK|232887|296157|lyfsjukr|||1|5|0||Icepharma hf|Les Laboratoires Servier|Pegaspargase||||232887|296157||2|H|L|0|||0
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|3211|5918|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||3211||3211|5918||2|0|G|0|||0
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|0|0|0|LEV|1|0|0|100|XEU|4499|8706|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4499||4499|8706||2|0||1|30|dagar|0
450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|G|0|AEP|0|0|0|100|DKK|1142|3070|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1142||1142|3070||2|0|G|0|||0
450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|0|0|MBV|0|0|0|100|DKK|117612|152788|lyfalmen|||1|20|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||117612||117612|152788||1|H|0|0|||0
450216|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0814|3197|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|BOE|0|0|0|100|DKK|342830|432896|lyfalmen|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||342830||342830|432896||1|H|0|0|||0
450537|N05CD0806|Buccolam|munnh.l|10|mg|2|ml|4|spr|munngjaf.spr|N05CD08|01.11.2019||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12389|18550|lyfalmen|||2|8|0|4,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12389||12389|18550||3|0|E|2|450|mg|0
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992|30.06.2021|R|1|0|0|0|0|SNP|0|0|0|100|XEU|2388|3955|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1785||1785|3955||1|0||2|30|töflur|0
450846|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|4000|ml|1|glas|HDPE plastílát|QN01AX94|01.03.2019||R|0|0|0|0|0|SAS|0|0|0|100|NOK|246125|396754|veteldis|||0|4000|0||Vistor hf|Scan Aqua AS|Isoeugenol||246125||246125|396754||1|0||0|||0
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|9072|15636|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||9072||9072|15636||2|0||0|||0
450993|R07AX0101|INOmax|lyfjagas|800|ppm|10|l|1|gashyl|undir þrýstingi|R07AX01|01.09.2014||R|0|1|0|0|0|LIN|0|0|0|100|XEU|19813|28769|lyfalmen|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||19813|28769||5|H|0|0|||0
451009|L01ED0401|Alunbrig|filmhtfl|30|mg|28|stk|1|þpakki||L01ED04|01.02.2021||R|1|1|1|0|0|ASS|0|1|0|100|DKK|164754|211419|lyfsjukr|||1|28|0||Vistor hf|Takeda AS|Brigatinib||164754||164754|211419||1|0|L|0|||0
451135|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|3158|5845|lyfalmen|||3|84|0|7,0000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||3158||3158|5845||3|0|G|0|||0
451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|OTS|0|0|0|100|DKK|40693|54742|lyfalmen|V0980|54741|1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||40693||40693|54742||1|0|E|0|||0
451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|G|0|ATE|0|0|1|100|XEU|625|2358|lyfalmen|||2|25|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prednisólón||625||625|2358||1|0|G|0|||0
451428|B06AC0102|Berinert|sts/irs|1500|ae|1|hgl|1|pakki||B06AC01|01.05.2020||R|0|0|1|0|0|CSB|0|1|0|100|SEK|293600|371667|lyfsjukr|||1|1|0|1,0714|Icepharma hf|CSL Behring GmbH|C1 hemill||293600||293600|371667||2|0|L|0|||0
451655|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.09.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Terbínafín|||||||1|0||0|||0
451670|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2594|3563|lyfalmen|V0687|3265|2|70|0|35,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1500||1500|3563||2|0|E|0|||0
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|1|G|0|AEP|0|0|0|100|IKR|16132|23702|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||16132||16132|23702||2|0|G|0|||0
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|120|0||Alvogen|Trimb Healthcare AB|Ketókónazól|||||||2|0||0|||0
452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1|0||0|||0
452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|7535|11869|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||7535||7535|11869||2|0|G|0|||0
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5813||2|0||0|||0
452499|A10BJ0602|Rybelsus|töflur|3|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20650|29392|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20650||20650|29392||1|0|E|0|||0
452500|L01EE0201|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01EE02|01.02.2016||R|1|0|1|0|0|RRG|0|1|0|100|DKK|772620|967434|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration GmbH|Cobimetinib||||772620|967434||2|0|L|0|||0
452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|G|0|KRK|0|0|1|100|IKR|3500|2874|lyfalmen|V0010|2193|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2874||2|0|G|0|||0
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|MEA|0|0|1|100|DKK|8086|12627|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||8086||8086|12627||2|0|E|0|||0
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|11812|17756|lyfalmen|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|albumin||11812||11812|17756||2|H|0|0|||0
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|BOA|0|0|0|100|XEU|1366|2354|vetorma|||0|6,4|0||Vistor hf|Boehringer Ingelheim Animal Health SCS|Ivermectinum||1366||1366|2354||1|0||0|||0
453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|97667|126803|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration GmbH|Pírfenidon||||97667|126803||2|0|E|0|||0
453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|6315|lyfalmen|||2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||3500||3500|6315||2|0|G|0|||0
454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|Bel|1|0|0|100|DKK|4929|9522|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4929||4929|9522||2|0||0|||0
454650|D05AX5204|Enstilar|húðfroða|||60|g|1|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|8206|12793|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8206||8206|12793||1|0|G|0|||0
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|G|0|PLS|0|0|0|100|DKK|33072|41527|lyfalmen|V0342|10597|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30245||30245|41527||1|0|G|0|||0
454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0||0|||0
454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|1|0|0|BIM|0|0|0|100|SEK|376162|474351|lyfalmen|||1|120|0||Icepharma hf|BioMarin International Limited|Saprópterín||376162||376162|474351||2|0||0|||0
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|BID|0|0|0|100|DKK|1066|2095|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín (BAN)||1066||1066|2095||1|0||0|||0
454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|ASR|0|0|1|100|IKR|1100|2599|lyfalmen|V0174|2599|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||800||800|2599||2|0|E|0|||0
455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|7222|11438|lyfalmen|V0713|9763|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||7222||7222|11438||1|0|G|0|||0
455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1028346|1285486|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1028346||1028346|1285486||2|0|L|0|||0
455398|B01AF0202|Eliquis (Lyfjaver)|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.03.2020||R|1|1|0|G|0|LVR|0|0|0|100|DKK|27275|37771|lyfalmen|V0653|37771|3|168|0|42,0000|Lyfjaver ehf|Lyfjaver ehf|Apixaban 	||27275||27275|37771||3|0|G|0|||0
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|755|2537|lyfalmen|||2|10|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||755||755|2537||1|0|E|0|||0
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|ATE|0|0|1|100|XEU|852|2671|lyfalmen|||2|15|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||852||852|2671||1|0|E|0|||0
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1595|3693|lyfalmen|||2|30|0|30,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Doxýcýklín||1595||1595|3693||1|0|E|0|||0
456724|L01EA0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01EA01|01.05.2021||R|0|0|1|0|0|NEL|0|1|0|100|DKK|93397|121402|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatinib||93397||93397|121402||1|0|L|0|||0
456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|4262|7364|lyfalmen|V1040|4077|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||4262||4262|7364||2|0|G|0|||0
456795|L01EB0401|Tagrisso|filmhtfl|80|mg|30|stk|1|stsk.þ||L01EB04|01.06.2019||R|0|0|1|0|0|ZEN|0|1|0|100|SEK|878104|1098627|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Osimertinib||878104||878104|1098627||1|0|L|0|||0
456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|G|0|MED|0|0|0|100|IKR|4926|6315|lyfalmen|V0277|6189|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3500||3500|6315||2|0|G|0|||0
457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6411|3374|lyfalmen|V0816|3325|2|28|0|21,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1363||1363|3374||1|0|E|0|||0
457185|H05BX0107|Cinacalcet STADA|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|28190|11821|lyfalmen|V0721|11682|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||7500||7500|11821||2|0||0|||0
457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|1|G|0|ALE|0|0|0|100|SEK|48210|52775|lyfalmen|V0451|52775|2|1|0|83,7200|Alvogen|Alvogen Pharma Trading Europe EOOD|Góserelín||39138||39138|52775||2|0|G|0|||0
457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.04.2019||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3382|6153|lyfalmen|V0326|5245|2|98|0|147,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||3382||3382|6153||1|0|0|0|||0
457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|MYE|0|0|1|100|DKK|1466|3516|lyfalmen|V0561|3516|2|100|0||Icepharma hf|Mylan Ireland Limited|Lídókaín||1466||1466|3516||2|0||0|||0
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|PEU|0|0|0|100|DKK|5947|9683|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Europe MA EEIG|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||5947||5947|9683||1|0||0|||0
457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|2817|5375|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2817||2817|5375||2|0|G|0|||0
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|ATE|0|0|1|100|XEU|2522|2160|lyfalmen|V0003|2160|2|28|0|28,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||481||481|2160||1|0|E|0|||0
457755|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|rörlyk|lausn|R03BB04|01.08.2019||R|0|0|0|G|0|BII|0|0|0|100|DKK|4078|7111|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4078||4078|7111||1|0|G|0|||0
457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|LHS|0|0|0|100|XEU|10344|17829|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10344||10344|17829||2|0||0|||0
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|CHE|0|0|1|100|DKK|1063|2961|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1063||1063|2961||1|0|E|2|150|hylki|0
458149|L01EX0501|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01EX05|01.06.2014||R|0|0|1|0|0|FIN|0|1|0|100|DKK|366521|462361|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||366521||366521|462361||2|0|L|0|||0
458266|L04AB0402|Imraldi|stl|40|mg/penna|0,8|ml|2|áfpen|áfylltur penni|L04AB04|01.03.2019||R|0|1|1|0|0|SUG|0|1|0|100|XEU|56525|74766|lyfsjukr|||2|1,6|0|27,5900|Icepharma hf|Samsung Bioepis NL B.V.|Adalimumab||56525||56525|74766||2|0|L|0|||0
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|KPA|0|0|1|100|DKK|1224|3183|lyfalmen|V0577|2763|1|20|0|6,6667|Alvogen|Karo Pharma AB|Pívmecillínam||1224||1224|3183||2|0|E|0|||0
458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|106209|138605|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||106209||106209|138605||3|0|L|0|||0
458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|9377|13742|lyfalmen|V0653|13490|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||8896||8896|13742||1|0|G|0|||0
458838|M09AX0701|Spinraza|stl|12|mg|5|ml|1|hgl|lausn|M09AX07|01.11.2018||R|0|0|0|0|0|BNB|0|1|0|100|XEU|11149043|13872793|lyfsjukr|||1|5|0|120,0000|Icepharma hf|Biogen Netherlands B.V.|Nusinersen||11149038||11149038|13872793||2|H|L|0|||0
459037|L01EC0201|Tafinlar|hylki|75|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|814115|1019042|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||814115||814115|1019042||1|0|L|0|||0
459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|79324|103603|lyfalmen|||1|2|0|17,6400|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||79324||79324|103603||2|0|G|0|||0
459324|V08CA0901|Gadovist|stl|1|mmol/ml|5|ml|5|áfspr|lausn|V08CA09|01.04.2018||R|0|0|0|0|0|BAB|0|0|0|100|DKK|20467|29160|lyfalmen|||1|25|0||Icepharma hf|Bayer AB|Gadóbútról||||20467|29160||2|H|0|0|||0
459342|N05AX1304|Paliperidon Krka|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|G|0|KNM|0|0|0|100|IKR|11123|16808|lyfalmen|V0964|16808|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||11123||11123|16808||2|0|G|0|||0
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|795|2592|lyfalmen|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||795||795|2592||1|0|0|0|||0
459405|L01EL0101|IMBRUVICA|filmhtfl|560|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|934657|1168963|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||934657||934657|1168963||1|0|L|0|||0
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|PLS|0|0|1|100|DKK|1457|3503|lyfalmen|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1457||1457|3503||1|0|0|0|||0
459423|N07BC0102|Buvidal|stl|16|mg|0,32|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|13061|19475|lyfsjukr|||1|0,32|0|7,6190|Vistor hf|Camurus AB|Búprenorfín||13061||13061|19475||1|H|L|1|30|dagar|0
459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|19700|37545|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|Cefovecinum||19700||19700|37545||2|0||0|||0
459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|2514|2393|lyfalmen|V0284|2324|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||650||650|2393||2|0|G|0|||0
459838|N05AH0416|Quetiapin Medical Valley|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|10500|11408|lyfalmen|V0261|11408|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Quetíapín||7200||7200|11408||2|0|0|0|||0
459845|A10BD2301|Segluromet|filmhtfl|1007,5|mg|56|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|5727|9381|lyfalmen|||1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||5727||5727|9381||1|0|G|0|||0
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1903|4117|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1903||1903|4117||2|0|G|0|||0
459926|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.04.2019||L|1|0|0|G|0|ATE|0|0|1|100|IKR|||lyfalmen|V0033|2657|2|10|0|1,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Valacíklóvír|||||2657||1|0|G|0|||0
460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|0|0|AEE|0|1|0|100|XEU|132023|170711|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare B.V.|Bendamústín||132023||132023|170711||1|H|L|0|||0
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|G|0|HSS|0|0|0|100|DKK|8791|13598|lyfalmen|||1|100|0|25,0000|Artasan ehf|Sandoz GmbH|Rífampicín||8791||8791|13598||1|0|G|0|||0
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|235162|298987|lyfsjukr|||1|5|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||235162||235162|298987||2|H|L|0|||0
460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|6986|4084|lyfalmen|V0144|3885|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1879||1879|4084||1|0|E|0|||0
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|4770|8581|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||4433||4433|8581||2|0|0|0|||0
460889|N02AE0105|Buprenorphine Alvogen|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.10.2020||R|0|0|0|G|0|POF|0|0|0|100|DKK|1734|3885|lyfalmen|V0943|3885|2|4|0|2,8000|Alvogen|Alvogen|Búprenorfín||1734||1734|3885||2|0|G|1|30|dagar|0
461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4556|7622|lyfalmen|V0585|7595|2|98|0|26,1300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||4449||4449|7622||1|0|G|1|30|dagar|0
461113|L01EJ0101|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|424361|534298|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||424361||424361|534298||1|0|L|0|||0
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1916||2|0|E|0|||0
461405|N02AA0508|Oxycodone Alvogen|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3853|6801|lyfalmen|||2|28|0|14,9300|Alvogen|Alvogen ehf|Oxýcódon||3853||3853|6801||2|0|G|1|30|dagar|0
461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1060146|1325036|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1060146||1060146|1325036||2|0|L|0|||0
461563|V03AB1506|Nyxoid|nefúði|1,8|mg|0,1|ml|2|stsk.í||V03AB15|01.03.2020||R|0|1|0|0|0|MIP|0|0|1|100|DKK|6033|9802|lyfalmen|||1|0,2|0||Icepharma hf|Mundipharma Corporation (Ireland) Ltd|Naloxón||6033||6033|9802||2|0|E|0|||0
461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|294029|372201|lyfalmen|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Sugammadex||294029||294029|372201||1|H|0|0|||0
461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|17828|26036|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||17828||17828|26036||1|0|G|0|||0
462130|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3374|lyfalmen|V0816|3325|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1363||1363|3374||2|0|E|0|||0
462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|3802|6731|lyfsjukr|||1|28|0|7,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||3802||3802|6731||1|0|L|1|30|dagar|0
462429|L01EM0301|Piqray|filmhtfl|150|mg|56|stk|1|þpakki||L01EM03|01.05.2021||R|1|1|1|0|0|NEP|0|1|0|100|DKK|484186|608703|lyfsjukr|||1|56|0|28,0000|Vistor hf|Novartis Europharm Limited|Alpelisib||484186||484186|608703||1|0|L|0|||0
462849|C09DA0311|Valsartan/ Hydrochlorothiazide Krka|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.08.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|4245|7341|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Valsartan og þvagræsilyf||4245||4245|7341||2|0|G|0|||0
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|G|0|RTH|0|0|0|100|IKR|5821|2874|lyfalmen|V0605|2874|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1000||1000|2874||2|0|G|0|||0
463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.04.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|2538|4991|lyfalmen|V0325|4435|2|98|0|98,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Escítalópram||2538||2538|4991||1|0|0|0|||0
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|1|0|0|JCI|0|1|0|100|SEK|48961|65199|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||48961|65199||1|0|L|0|||0
463744|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|tfílát||G02CB03|01.07.1993||R|1|0|0|G|0|PLS|0|0|0|100|DKK|4315|7437|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer Aps|Kabególín||||4315|7437||1|0|G|0|||0
463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.11.2020||R|0|0|0|G|0|MBV|0|0|1|100|DKK|1843|4035|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1843||1843|4035||1|0|G|0|||0
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2|0||0|||0
463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Flurbiprofen|||||||1|0||0|||0
464078|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|150 mg/30 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|3253|5607|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||3253||3253|5607||1|0||0|||0
464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
464170|N02BA5104|Treo Citrus|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.08.2019||L|0|0|0|0|0|MEA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
464201|J07BX0304|COVID-19 Vaccine Janssen|stl|||2,5|ml|10|hgl|hvert hgl.inniheldur 5x0,5ml|J07BX03|01.04.2021||R|0|0|0|0|0|JCI|0|0|0|100|IKR|||lyfalmen|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Covid-19 vaccines|||||||1|0||0|||0
464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|G|0|RTH|0|0|0|100|IKR|2130|3356|lyfalmen|V0947|3356|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||1350||1350|3356||2|0|G|0|||0
464327|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|10|hgl||B01AB01|01.07.2019||R|0|0|0|0|0|LEP|0|0|0|100|DKK|7271|11506|lyfalmen|||1|50|0|25,0000|Vistor hf|LEO Pharma A/S|Heparín||7271||7271|11506||1|H|0|0|||0
464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|1|G|0|WIL|0|0|0|100|XEU|6153|9967|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6153||6153|9967||2|0|G|0|||0
464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016|31.07.2021|L|0|0|0|G|0|ATE|0|0|1|100|XEU|||lyfalmen|||2|140|0|35,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mómetasón|||||2991||1|0|G|0|||0
464827|M01AB0521|Voltafenak Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|505|2193|lyfalmen|V0188|2193|2|30|0|15,0000|LYFIS ehf|Evolan Pharma AB|Díklófenak||505||505|2193||2|0|G|0|||0
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|G|0|ATE|0|0|0|100|DKK|2524|4972|lyfalmen|V0376|4972|2|7,5|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Latanóprost||2524||2524|4972||1|0|G|0|||0
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|IBV|0|0|0|100|DKK|1327|2608|vetalmen|||0|100|0||Vistor hf|Intervet International BV|Penicillín í blöndum með öðrum sýklalyfjum||1327||1327|2608||1|0||0|||0
465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|G|0|MDK|0|0|0|100|DKK|1901|4114|lyfalmen|||1|98|0|49,0000|Icepharma hf|Mylan Denmark ApS|Verapamíl||1901||1901|4114||2|0|G|0|||0
465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|G|0|WIL|0|0|0|100|SEK|3122|5795|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3122||3122|5795||2|0|G|0|||0
465772|L01XC0302|Kanjinti|st/irþ|150|mg|1|hgl|1|pakki||L01XC03|01.12.2018||R|0|0|0|0|0|AEB|0|1|0|100|DKK|72916|95498|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||72916||72916|95498||1|H|L|0|||0
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|581|2298|lyfalmen|||1|25|0|2,5000|Icepharma hf|Mundipharma A/S|Morfín||581||581|2298||2|0|G|1|30|dagar|0
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1811|3991|lyfalmen|||1|100|0|10,0000|Icepharma hf|Mundipharma A/S|Morfín||1811||1811|3991||2|0|G|1|30|dagar|0
466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|BAB|0|0|0|100|DKK|1200|2819|lyfalm11|V0545|1867|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1200|2819||2|0||0|||1
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1373|3388|lyfalmen|||1|25|0|7,5000|Icepharma hf|Mundipharma A/S|Morfín||1373||1373|3388||2|0|G|1|30|dagar|0
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4756|8044|lyfalmen|||1|100|0|30,0000|Icepharma hf|Mundipharma A/S|Morfín||4756||4756|8044||2|0|G|1|30|dagar|0
466276|J01XD0103|Metronidazol Normon|irl|5|mg/ml|100|ml|50|pokar||J01XD01|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|28086|34295|lyfalmen|||2|5000|0|16,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Metrónídazól||24527||24527|34295||2|0|0|0|||0
466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|245438|311767|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab emtansine||245438||245438|311767||2|H|L|0|||0
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|G|0|EIG|0|0|0|100|SEK|17751|25930|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai GmbH|Zonisamíð||17751||17751|25930||1|0|G|0|||0
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|0|G|0|MDI|0|0|0|100|DKK|2552|5010|lyfalmen|||1|25|0|15,0000|Icepharma hf|Mundipharma A/S|Morfín||2552||2552|5010||2|0|G|1|30|dagar|0
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|6605|10589|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6605||6605|10589||1|0|G|0|||0
466571|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|ílát|100+25+200mg|N04BA03|01.05.2021||R|1|0|0|G|0|LVR|0|0|0|100|DKK|9665|14801|lyfalmen|V0829|14801|3|100|0|22,2200|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9665||9665|14801||3|0|G|0|||0
466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1|0||0|||0
466658|V08CA1001|Primovist|stl|0,25|mmol/ml|10|ml|5|áfspr|lausn|V08CA10|01.02.2021||R|0|0|0|0|0|BAB|0|0|0|100|DKK|99079|128589|lyfalmen|||1|50|0||Icepharma hf|Bayer AB|Gadoxetic acid||99079||99079|128589||1|H|0|0|||0
466667|L01AA0501|LEDAGA|hlaup|160|mcg/g|60|g|1|túpa||L01AA05|01.03.2020||R|0|1|0|0|0|HEL|0|1|0|100|XEU|350820|442833|lyfsjukr|||1|60|0||Recordati AB|Helsinn Birex Pharmaceuticals Ltd.|Chlormethine||350820||350820|442833||3|0|L|0|||0
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|0|G|0|MDI|0|0|0|100|DKK|4198|7276|lyfalmen|||1|25|0|25,0000|Icepharma hf|Mundipharma A/S|Morfín||4198||4198|7276||2|0|G|1|30|dagar|0
466723|V03AN0502|Airapy|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5|0||0|||0
466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|19722|28643|lyfalmen|V0728|26036|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||19722||19722|28643||1|0|E|0|||0
466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|WEH|0|0|1|100|IKR|361|1995|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||361||361|1995||2|0|E|0|||0
467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6542|6142|lyfalmen|V0622|6132|2|30|0|54,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||3374||3374|6142||1|0|E|1|30|dagar|0
467437|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|250|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|5568|9597|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||5568||5568|9597||2|0||0|||0
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|5812|9498|lyfalmen|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5812||5812|9498||2|0|0|0|||0
467473|H02AB0912|Alkindi|kyrnhylk|2|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|28891|39815|lyfalmen|||1|50|0|3,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||28891||28891|39815||2|0|G|0|||0
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|11221|16943|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11221||11221|16943||1|0|G|0|||0
467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|BAB|0|0|0|100|DKK|5769|9438|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||5769||5769|9438||2|0||0|||0
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|21058|29908|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21058||21058|29908||1|0|G|0|||0
467756|A10BJ0301|Lyxumia|stl|20|mcg/sk|3|ml|2|áfpen||A10BJ03|01.10.2013||R|0|0|0|0|0|SGB|0|0|0|100|XEU|10724|16258|lyfalmen|||1|6|0|28,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||10724||10724|16258||1|0|E|0|||0
467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|PIP|0|0|1|100|DKK|74905|98013|lyfalmen|||1|10|0|5,0000|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftarólin||74905||74905|98013||1|0|0|0|||0
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|JAS|0|0|0|100|SEK|387|2031|lyfalmen|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||387||387|2031||1|0|0|0|||0
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|5665|6796|lyfalmen|V0317|3700|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3849||3849|6796||1|0|G|0|||0
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|G|0|LBK|0|0|0|100|DKK|6979|6770|lyfalmen|V0318|5077|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3830||3830|6770||1|0|G|0|||0
468374|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|120|skammtar|1|stauk||R03AC03|01.02.2019||R|0|0|0|G|0|AZD|0|0|1|100|SEK|928|2775|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||928||928|2775||1|0|G|0|||0
468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|ZBE|1|0|0|100|XEU|2178|3754|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2178||2178|3754||2|0||0|||0
468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|3200|5022|lyfalmen|V0467|4950|2|100|0|50,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||2560||2560|5022||1|0|G|0|||0
469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|G|0|BOE|0|0|0|100|DKK|6920|11023|lyfalmen|V0712|9669|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6920||6920|11023||1|0|G|0|||0
469152|N06BA0408|Methylphenidate Teva|hylki|30|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|5973|5368|lyfalmen|V0960|5368|2|30|0|30,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||2812||2812|5368||1|0|E|1|30|dagar|0
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3020|5655|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3020||3020|5655||1|0|E|0|||0
469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|AEP|0|0|0|100|DKK|3279|5381|lyfalm11|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||3279||3279|5381||2|0||0|||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6454|10381|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6454||6454|10381||1|0|0|0|||0
469899|C01CA1703|Hypotron|töflur|2,5|mg|100|stk|1|þpakki||C01CA17|01.10.2018||R|1|0|0|G|0|RET|0|0|0|100|IKR|14250|21112|lyfalmen|V0968|21112|2|100|0|8,3333|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||14250||14250|21112||1|0|G|0|||0
469912|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|þpakki||C01AA05|01.08.2020||R|1|0|0|G|0|AEP|0|0|0|100|DKK|363|1998|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||363||363|1998||2|0|G|0|||0
469990|L04AB0403|Amgevita|stl|40|mg/penna|0,8|ml|2|áfpen|SureClick penni|L04AB04|01.06.2020||R|0|1|1|0|0|AEB|0|1|0|100|DKK|58108|76769|lyfsjukr|||1|1,6|0|27,5860|Vistor hf|Amgen Europe B.V.|Adalimumab||58108||58108|76769||1|0|L|0|||0
470202|R03AK0706|DuoResp Spiromax|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.05.2018||R|0|0|0|G|0|TAB|0|0|0|100|XEU|14581|18465|lyfalmen|||2|180|0|90,0000|Alvogen|Teva Pharma B.V.|Formóteról og budesonide||12327||12327|18465||2|0|G|0|||0
470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|1|0|0|IPC|0|1|0|100|DKK|45623|55254|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||41098||41098|55254||2|0|L|0|||0
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|G|0|GPH|0|0|0|100|DKK|3836|6778|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3836||3836|6778||1|0|G|0|||0
470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|G|0|MYR|0|0|0|100|DKK|5762|9429|lyfalmen|||1|5|0|10,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||5762||5762|9429||2|0|G|0|||0
470817|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|59167|78108|lyfalmen|V0728|78108|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||59167||59167|78108||1|0|E|0|||0
471066|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2020||R|1|0|0|G|0|MEC|0|0|0|100|SEK|478|2156|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck AB|Levótýroxínnatríum||478||478|2156||2|0|G|0|||0
471122|M01AE5102|Parapró|filmhtfl|700|mg|20|stk|1|þpakki|200/500mg|M01AE51|01.03.2021||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||2|20|0||Acare ehf|Acare ehf|Íbúprófen í blöndum|||||||2|0||0|||0
471632|QA05AX9001|Menbutil|stl|100|mg/ml|100|ml|1|hgl|lausn|QA05AX90|01.06.2021||R|0|0|0|0|0|ANI|1|0|0|100|IKR|2753|5393|vetalmen|||0|100|0||Dýraheilsa ehf|aniMedica GmbH|Menbutone||2753||2753|5393||2|0||0|||0
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|COR|1|0|0|100|DKK|5489|10584|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||5489||5489|10584||1|0||0|||0
471970|N05CH0105|Slenyto|forðatfl|5|mg|30|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|15921|19116|lyfalmen|||2|30|0|75,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||12800||12800|19116||2|0|0|0|||0
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|G|0|RDT|0|0|0|100|DKK|1611|3715|lyfalmen|V0048|2933|1|98|0|31,0333|Vistor hf|Recordati Ireland Limited|Metóprólól||1611||1611|3715||1|0|G|0|||0
472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3562|6401|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3562||3562|6401||1|0||0|||0
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|0|0|TEA|0|0|0|100|SEK|8071|12607|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||8071||8071|12607||1|H|0|0|||0
472590|B05BA1024|SmofKabiven extra Nitrogen|irl|||2025|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|50563|67226|lyfalmen|||1|8100|0||Vistor hf|Fresenius Kabi AB|Blöndur||50563||50563|67226||1|0|0|0|||0
472610|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|98|stk|1|þpakki||N06AX21|01.12.2018||R|1|0|0|G|0|WEH|0|0|0|100|XEU|4906|5185|lyfalmen|V0811|5157|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2679||2679|5185||2|0|G|0|||0
472741|N03AX1402|Keppra (Lyfjaver)|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.03.2019||R|1|0|0|G|0|LVR|0|0|0|100|DKK|20348|29010|lyfalmen|V0516|12509|3|100|0|66,6700|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||20348||20348|29010||3|0|G|0|||0
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.12.2019||R|1|0|0|G|0|NVO|0|0|1|100|DKK|2978|5597|lyfalmen|V0458|2979|1|100|0|100,0000|Vistor hf|N.V. Organon|Deslóratadín||2978||2978|5597||1|0|G|0|||0
472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2443|4860|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2443||2443|4860||1|0|G|0|||0
473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|G|0|ATR|0|0|1|100|DKK|1346|3351|lyfalmen|||1|5|0|5,0000|Atnahs Pharma Nordics A/S|Atnahs Pharma Netherlands B.V.|Ketórólak||1346||1346|3351||2|0|G|0|||0
473879|B01AF0101|Xarelto|filmhtfl|2,5|mg|196|stk|1|þpakki||B01AF01|01.05.2020||R|1|1|0|G|0|FIN|0|0|0|100|DKK|27712|38324|lyfalmen|V0974|38324|1|196|0|24,5000|Icepharma hf|Bayer AG|Rivaoxaban||27712||27712|38324||2|0|G|0|||0
473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|82115|107133|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||82115||82115|107133||2|0|L|0|||0
473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|G|0|OEL|0|0|1|100|DKK|4275|7382|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4275||4275|7382||1|0|G|0|||0
474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|PHM|0|0|0|100|DKK|28230|53728|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||28230||28230|53728||2|0||0|||0
475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|2904|5495|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2904||2904|5495||2|0|E|0|||0
475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||2|0||2|||0
475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2|0||0|||0
476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Amoxicillinum||5695||5695|10975||2|0||0|||0
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|57642|76179|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||57642|76179||1|0|L|0|||0
476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4197|7275|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4197|7275||2|0|0|0|||0
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|MBV|0|0|0|100|DKK|14696|21725|lyfalmen|V0954|5964|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme B.V.|Ezetimíb||14696||14696|21725||1|0|E|0|||0
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|GPH|0|0|0|100|DKK|4230|7320|lyfalmen|V0934|5772|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4230||4230|7320||1|0||0|||0
477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|1|0|0|AEB|0|1|0|100|XEU|54881|72687|lyfsjukr|||1|27|0|11,5000|Vistor hf|Amgen Europe B.V.|Apremilast||54881||54881|72687||1|0|L|0|||0
477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|1|0|0|SUG|0|1|0|100|XEU|82115|107133|lyfsjukr|||2|4|0|28,5800|Icepharma hf|Samsung Bioepis NL B.V.|Etanercept||82115||82115|107133||2|0|L|0|||0
477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|10359|9481|lyfalmen|V0272|8917|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5800||5800|9481||2|0|G|0|||0
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||2|0||0|||0
477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|5+2 mg/ml|H02AB01|01.04.2021||R|0|0|0|G|0|MBV|0|0|1|100|DKK|953|2810|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||953||953|2810||1|0|G|0|||0
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|FKA|0|0|1|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3400||1|0||0|||0
477864|L01EF0101|Ibrance|filmhtfl|100|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|303981|384578|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||303981||303981|384578||1|0|L|0|||0
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|496|2050|lyfalmen|V0500|2048|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metformín||401||401|2050||1|0|G|0|||0
478163|D05AX5204|Enstilar|húðfroða|||60|g|2|ílát|50 mcg/g+0,5 mg/g|D05AX52|01.06.2018||R|0|0|0|G|0|LEP|0|0|0|100|DKK|16412|24087|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||16412||16412|24087||1|0|G|0|||0
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|CHP|1|0|0|100|XEU|7035|13517|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Meloxícam||7035||7035|13517||2|0||0|||0
478386|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.10.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3499|5196|lyfalm11|V0983|5196|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3129||3129|5196||2|0||0|||1
478808|R03DX0901|Nucala|stl|100|mg|1|pennar|1|pakki||R03DX09|01.07.2020||R|0|0|1|0|0|GSD|0|1|0|100|DKK|163462|209812|lyfsjukr|||1|1|0|27,7778|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||163462||163462|209812||1|0|L|0|||0
478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2221|3287|lyfalmen|V0825|2811|2|28|0|28,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1300||1300|3287||2|0|G|0|||0
479127|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|0|0|MVX|0|0|0|100|IKR|4900|7829|lyfalmen|V0115|7808|2|98|0|392,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||4600||4600|7829||2|0|E|0|||0
479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3187|5885|lyfalmen|V1052|5885|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3187||3187|5885||1|0|0|1|30|dagar|0
479904|L01EA0401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|113627|147831|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||113627||113627|147831||1|0|L|0|||0
479954|L01XC1701|OPDIVO|irþ|10|mg/ml|24|ml|1|hgl||L01XC17|01.10.2019||R|0|1|0|0|0|BMS|0|1|0|100|DKK|383778|483824|lyfsjukr|||1|24|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||383778||383778|483824||1|H|L|0|||0
479991|L01XG0301|Ninlaro|hylki|4|mg|1|stk|3|þpakki|Hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|784553|982275|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||784553||784553|982275||1|0|L|0|||0
480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|OCO|0|0|0|100|DKK|3060|5976|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|Dexmedetomidinum||3060||3060|5976||2|0||0|||0
480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|4088|6074|lyfalmen|V0080|6074|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3325||3325|6074||2|0|G|0|||0
480750|B01AF0101|Xarelto|filmhtfl|10|mg|98|stk|1|þpakki||B01AF01|01.12.2018||R|1|1|0|G|0|FIN|0|0|0|100|DKK|30390|41711|lyfalmen|V0975|41679|1|98|0|49,0000|Icepharma hf|Bayer AG|Rivaoxaban||30390||30390|41711||2|0|G|0|||0
481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|GPH|0|0|0|100|DKK|12174|18254|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||12174||12174|18254||1|0||0|||0
481208|D07AC1302|Ovixan|krem|1|mg/g|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|669|2419|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||669||669|2419||1|0|G|0|||0
481345|N06DA0304|Nimvastid|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2018||R|1|0|0|G|0|KNM|0|0|0|100|IKR|25104|35025|lyfalmen|||2|112|0|37,3300|LYFIS ehf|Krka d.d. Novo mesto|Rívastigmín||25104||25104|35025||2|0|G|0|||0
481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|0|0|0|ATE|0|0|0|100|XEU|5556|7331|lyfalmen|V0681|7321|2|30|0|27,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Metýlfenídat||4238||4238|7331||1|0|E|1|30|dagar|0
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|0|G|0|GLP|0|0|1|100|DKK|242|1831|lyfalmen|V0055|1830|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||242||242|1831||1|0|G|1|30|dagar|0
482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|G|0|BAB|0|0|0|100|DKK|14597|21589|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||14597||14597|21589||2|0|G|0|||0
482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|MDK|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|BVL|0|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||2|0||0|||0
483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|0|0|0|0|AEB|0|1|0|100|DKK|55469|73431|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||55469||55469|73431||1|H|L|0|||0
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29494|40578|lyfalmen|V0977|40273|1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||29494|40578||2|0|G|0|||0
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|9959|15205|lyfalmen|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|albumin||9959||9959|15205||2|H|0|0|||0
483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|46087|61564|lyfalmen|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||46087||46087|61564||2|H|0|0|||0
483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|G|0|DAN|0|0|0|100|XEU|4729|8007|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4729||4729|8007||2|0|G|0|||0
483556|S01EA0502|Brimonidin Bluefish|augndr|2|mg/ml|5|ml|3|glös|lausn|S01EA05|01.04.2018||R|0|0|0|G|0|BLS|0|0|0|100|XEU|2158|4468|lyfalmen|V0368|4468|2|15|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Brímónidín||2158||2158|4468||1|0|G|0|||0
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|G|0|SHS|0|0|1|100|DKK|6307|10179|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6307||6307|10179||1|0|G|0|||0
483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2486|4920|lyfalmen|||2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4920||2|0|G|0|||0
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|G|0|MEV|0|0|0|100|DKK|1076|2979|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1076||1076|2979||1|0|G|0|||0
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|0|G|0|ATE|0|0|1|100|XEU|270|1830|lyfalmen|V0055|1830|2|20|0|3,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Tramadól||241||241|1830||1|0|G|1|30|dagar|0
484271|L01EX0901|Ofev|hylki|150|mg|60|stk|1|þpakki||L01EX09|01.07.2016||R|0|0|1|0|0|BOE|0|0|0|100|DKK|327107|413341|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||327107||327107|413341||1|0|E|0|||0
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|1|0|0|AEB|0|1|0|100|DKK|117262|152352|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||117262||117262|152352||1|0|L|0|||0
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|G|0|FIN|0|0|0|100|DKK|9633|14757|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||9633||9633|14757||2|0|G|0|||0
484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|43858|58745|lyfalmen|V1045|58744|1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||43858||43858|58745||1|0|G|0|||0
484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|G|0|NAS|0|0|0|100|DKK|8173|12747|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8173||8173|12747||1|0|G|0|||0
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|G|0|ANS|0|0|1|100|XEU|1311|3302|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1311||1311|3302||2|0|G|0|||0
485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|G|0|ATN|0|0|0|100|DKK|16553|24281|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||||16553|24281|30.6.2021|2|0|G|0|||0
485303|D01AE1604|Amorolfin Alvogen|lakk|5|%|5|ml|1|glas||D01AE16|01.05.2021||L|0|0|0|0|0|POF|0|0|1|100|IKR|||lyfalmen|||2|5|0||Alvogen|Alvogen|Amorolfín|||||5077||2|0|E|0|||0
485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|365854|461531|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||365854||365854|461531||1|0|L|0|||0
485348|J07BX0302|COVID-19 Vaccine Moderna|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.02.2021||R|0|0|0|0|0|MOD|0|0|0|100|IKR|||lyfalmen|||1|50|0||MODERNA BIOTECH SPAIN, S.L|MODERNA BIOTECH SPAIN, S.L|Covid-19 vaccines|||||||1|0||0|||0
485398|C02DD0102|Nipruss|irs|60|mg|5|lykjur|1|pakki||C02DD01|01.03.2021||R|0|0|0|0|0|ORE|0|0|0|100|NOK|72641|95150|lyfalmen|||2|5|0|6,0000|Oresund Pharma ApS|Oresund Pharma ApS|Nitroprusside||72641||72641|95150||2|H|0|0|||0
485462|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|30|mg|30|stk|1|þpakki|20+10 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5862|8474|lyfalmen|V1006|8474|2|30|0|8,0000|Alvogen|Alvogen ehf|Oxycodonum í blöndum||5068||5068|8474||2|0|E|1|30|dagar|0
485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|13544|20140|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13544||13544|20140||1|0|G|0|||0
485553|L04AX0402|Lenalidomid Alvogen|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|606136|747578|lyfsjukr|||2|21|0|21,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||595847||595847|747578||2|0|L|0|||0
485592|QL04AD0101|Sporimune vet.|mixtúra|50|mg/ml|25|ml|1|glas||QL04AD01|01.06.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|6260|12047|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ciclosporin||6260||6260|12047||2|0||0|||0
485593|J01FA0904|Clarithromycin Krka|filmhtfl|500|mg|21|stk|1|þpakki||J01FA09|01.09.2018||R|1|0|0|0|0|KNM|0|0|1|100|IKR|4800|4939|lyfalmen|V0116|4939|2|21|0|21,0000|LYFIS ehf|Krka d.d. Novo mesto|Klaritrómýcín||2500||2500|4939||2|0||0|||0
485764|J05AJ0301|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AJ03|01.04.2014||R|1|0|1|0|0|VIC|0|1|0|100|DKK|68018|89303|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravír||68018||68018|89303||1|0|L|0|||0
485799|A10BK0401|Steglatro|filmhtfl|5|mg|28|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|5516|9090|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Ertugliflozin||5516||5516|9090||1|0|G|0|||0
485911|L04AX0402|Lenalidomid Alvogen|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.04.2019||R|1|1|1|0|0|ALO|0|1|0|100|XEU|660368|813880|lyfsjukr|||2|21|0|10,5000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Lenalídómíd||649156||649156|813880||2|0|L|0|||0
486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|15|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2|0||0|||0
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|G|0|HES|0|0|1|100|DKK|327|1948|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||327||327|1948||1|0|G|0|||0
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|G|0|HES|0|0|1|100|DKK|514|2205|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||514||514|2205||1|0|G|0|||0
487105|L01ED0201|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01ED02|01.05.2017||R|1|0|1|0|0|NEL|0|1|0|100|DKK|776760|972583|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||776760||776760|972583||1|0|L|0|||0
487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|G|0|ARN|0|0|1|100|DKK|1726|3874|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1726||1726|3874||1|0|G|0|||0
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|1|0|0|PEU|0|1|0|100|DKK|23815|33395|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||23815||23815|33395||1|0|L|0|||0
487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|G|0|RTH|0|0|1|100|IKR|2489|4924|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||2489||2489|4924||2|0|G|0|||0
487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|8987|17221|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||8987||8987|17221||1|0||0|||0
488024|J07BX0301|Comirnaty|stþ|||1|stk|195|hgl|hvert hgl.6x0,3ml sk.e.þynning|J07BX03|01.01.2021||R|0|0|0|0|0|BNT|0|0|0|100|IKR|||lyfalmen|||1|195|0||Icepharma hf|BioNTech Manufacturing GmbH|Covid-19 vaccines|||||||1|0||0|||0
488468|L01EJ0101|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|215051|273974|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||215051||215051|273974||1|0|L|0|||0
488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|2626|5112|lyfalmen|||1|50|0|14,2857|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||2626||2626|5112||1|0|G|0|||0
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|1|G|0|ATE|0|0|0|100|DKK|7284|11524|lyfalmen|||1|50|0|35,7143|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Acitretín||7284||7284|11524||1|0|G|0|||0
488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
489128|A10BD2301|Segluromet|filmhtfl|1007,5|mg|196|stk|1|þpakki|7,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|19875|28854|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||19875||19875|28854||1|0|G|0|||0
489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|5992|9745|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||5992||5992|9745||3|0|G|0|||0
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|76834|100453|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||76834|100453||1|0|L|0|||0
489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Karo Pharma AB|Hýdrókortisón|||||||2|0||0|||0
489274|R03AK0707|Symbicort (Lyfjaver)|innúðal|164,5|mcg/sk|120|skammtar|1|sk-ílá|160+4,5 mcg/sk|R03AK07|01.02.2021||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5594|9198|lyfalmen|||3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5594||5594|9198||3|0|G|0|||0
489349|N03AX0901|Lamictal|dreifit.|5|mg|60|stk|1|glas||N03AX09|01.10.2019||R|0|0|0|G|0|GPH|0|0|0|100|DKK|1515|3583|lyfalmen|||1|60|0|1,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1515||1515|3583||1|0|G|0|||0
489662|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 33 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|19286|28043|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||19286||19286|28043||1|0|E|0|||0
490174|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0
490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|G|0|IRO|0|0|0|100|XEU|4032|7048|lyfalmen|||2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4032||4032|7048|31.5.2021|1|0|G|0|||0
490525|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.2020||R|0|0|0|G|0|RDT|0|0|0|100|DKK|2271|4624|lyfalmen|||1|25|0|0,1667|Vistor hf|Recordati Ireland Limited|Metóprólól||2271||2271|4624||1|0|G|0|||0
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|10052|10468|lyfalmen|V0112|2733|1|100|0|50,0000|Icepharma hf|Upjohn EESV|Atorvastatín||6517||6517|10468||1|0|E|0|||0
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|12271|13982|lyfalmen|V0113|2735|1|100|0|100,0000|Icepharma hf|Upjohn EESV|Atorvastatín||9070||9070|13982||1|0|E|0|||0
490823|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Stök áfyllingarpakkn|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19143|24919|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17016||17016|24919||1|0|G|0|||0
490827|J01CF0503|Flucloxacillin WH|sts/irs|1000|mg|10|hgl|1|pakki||J01CF05|01.08.2020||R|0|0|0|0|0|WEH|0|0|1|100|XEU|14284|21158|lyfalmen|||2|10|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Flúkloxacillín||14284||14284|21158||2|0|0|0|||0
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14409|17256|lyfalmen|V0114|2736|1|100|0|200,0000|Icepharma hf|Upjohn EESV|Atorvastatín||11449||11449|17256||1|0|E|0|||0
491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20031|28609|lyfalmen|||1|28|0|21,0000|Eisai AB|Eisai GmbH|Perampanel||20031||20031|28609||1|0|G|0|||0
491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|1327874|1658015|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvír og Velpatasvír||1327874||1327874|1658015||2|0|L|0|||0
491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|JCI|0|1|0|100|SEK|347160|438281|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||347160||347160|438281||1|0|L|0|||0
491257|A10BK0401|Steglatro|filmhtfl|5|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19284|28040|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Ertugliflozin||19284||19284|28040||1|0|G|0|||0
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|1|0|0|PEU|0|1|0|100|DKK|114954|149482|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Europe MA EEIG|Etanercept||114954||114954|149482||1|0|L|0|||0
491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|0|0|AEB|0|0|0|100|DKK|42292|56765|lyfalmen|||1|1,7|0|363,6364|Vistor hf|Amgen Europe B.V.|Denosúmab||42292||42292|56765||1|H|0|0|||0
491660|N05CD0806|Buccolam|munnh.l|7,5|mg|1,5|ml|4|spr|munngjaf.spr|N05CD08|01.08.2020||R|0|0|0|0|0|LOS|0|0|1|100|DKK|12389|18550|lyfalmen|||2|6|0|3,0000|Laboratorios Lesvi, S.L.|Laboratorios Lesvi, S.L.|Mídazólam||12389||12389|18550||3|0|E|2|450|mg|0
491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015|31.07.2021|R|0|0|0|0|0|ASD|0|0|0|100|SEK|2216|3525|lyfalmen|||2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Duloxetín||1473||1473|3525||2|0|E|0|||0
491758|H01CB0203|Octreoanne|sts|10|mg|10|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|108643|86093|lyfsjukr|||2|10|0|14,2900|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||65480||65480|86093||1|0|L|0|||0
492377|L01EA0401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01EA04|01.09.2014||R|1|0|1|0|0|PEU|0|1|0|100|DKK|511320|642450|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|bosutinib||511320||511320|642450||1|0|L|0|||0
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2568|5033|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2568||2568|5033||2|0|G|0|||0
492507|S01BA0201|Softacort|augndr|3,35|mg/ml|0,4|ml|30|sk-ílá|lausn í staksk.íláti|S01BA02|01.05.2018||R|0|0|0|G|0|TEA|0|0|1|100|SEK|1496|3557|lyfalmen|||1|12|0||Vistor hf|Laboratories THEA|Hydrocortisone||1496||1496|3557||1|0|G|0|||0
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009|31.05.2021|L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999|31.05.2021|R|1|0|0|0|0|AZD|0|0|1|100|SEK|6421|10336|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6421||6421|10336||1|0|E|0|||0
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009|31.05.2021|L|1|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1|0||0|||0
492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|MBV|0|0|0|100|DKK|16199|23794|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme B.V.|Atorvastin og ezetimibe||16199||16199|23794||1|0||0|||0
492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2|0||0|||0
493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
493143|QN02AE0102|Bupredine vet|stl|0,3|mg/ml|10|ml|1|hgl||QN02AE01|01.06.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|3725|7238|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Buprenorphinhýdróklóríð||||3725|7238||2|0||1|30|dagar|0
493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6411|3240|lyfalmen|V0813|3197|2|28|0|6,3000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1266||1266|3240||1|0|E|0|||0
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|G|0|PAC|0|0|1|100|DKK|22201|31353|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22201||22201|31353||1|0|G|0|||0
493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|105800|138097|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||105800||105800|138097||1|0|G|0|||0
493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|JCI|0|1|0|100|SEK|65726|86404|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||65726||65726|86404||1|H|L|0|||0
493782|L04AD0204|Dailiport|forðahlk|3|mg|50|stk|1|stsk.þ||L04AD02|01.09.2020||R|0|0|1|G|0|SHS|0|0|0|100|DKK|27843|38489|lyfalmen|||2|50|0|30,0000|Artasan ehf|Sandoz A/S|Tacrolimus||27843||27843|38489||1|0|G|0|||0
493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1455|3501|lyfalmen|V0213|3225|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1455||1455|3501||2|0|G|0|||0
493896|C10AA0509|Atorvastatin Xiromed|filmhtfl|20|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0113|2681|2|98|0|98,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995|30.06.2021|R|1|0|0|G|0|SNP|0|0|0|100|XEU|1109|3024|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1109||1109|3024||1|0|G|0|||0
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|G|0|HES|0|0|0|100|DKK|3198|5900|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||3198||3198|5900||1|0|G|0|||0
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|72940|95528|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||72940||72940|95528||2|H|L|0|||0
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|0|0|RRG|0|1|0|100|DKK|182458|233438|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||182458||182458|233438||2|H|L|0|||0
494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|MBP|0|0|0|100|DKK|7103|7115|lyfalmen|V0145|7115|2|8|0|16,0000|BGP Products ApS|Mylan S.A.S|Tadalafíl||4081||4081|7115||2|0|E|0|||0
494534|N01BB2001|Emla|krem|50|mg/g|30|g|1|túpa|25mg/g+25mg/g|N01BB20|01.03.2021||R|0|0|0|0|0|MAR|0|0|1|100|DKK|3521|6344|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||3521||3521|6344||2|0||0|||0
494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|PLS|0|0|0|100|DKK|1922|4143|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1922||1922|4143||1|0||0|||0
494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0||0|||0
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2097|4384|lyfalmen|V0128|2521|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2097||2097|4384||1|0|G|0|||0
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3048|5693|lyfalmen|V0410|4237|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3048||3048|5693||1|0|G|0|||0
494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014|31.05.2021|R|0|0|0|0|0|OCO|0|0|0|100|IKR|3363|6551|vetalmen|||0|100|0||Icepharma hf|Orion Corporation (I)|Magnesíum súlfat||3363||3363|6551||2|0||0|||0
494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|1|0|0|CFS|0|1|0|100|XEU|852250|1066472|lyfsjukr|||1|250|0|9,3700|Chiesi Pharma AB|Chiesi Farmaceutici S.p.A|Mercaptamín||852250||852250|1066472||3|0|L|0|||0
495203|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|402797|507478|lyfsjukr|||1|20|0|4,6500|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||402797||402797|507478||2|H|L|0|||0
495256|A02BC0404|Rabeprazol Medical Valley|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.09.2018||R|0|0|0|G|0|VAL|0|0|1|100|IKR|3000|3838|lyfalmen|V0010|3838|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rabeprazól||1700||1700|3838||2|0|G|0|||0
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|G|0|NAA|0|0|1|100|DKK|20399|7755|lyfalmen|V0384|4878|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||4546||4546|7755||1|0|G|0|||0
495637|J02AC0304|Voriconazole Accord|filmhtfl|200|mg|30|stk|1|þpakki||J02AC03|01.04.2018||R|1|1|0|G|0|ACC|0|0|1|100|XEU|69864|91638|lyfalmen|||2|30|0|15,0000|Artasan ehf|Accord Healthcare Limited|Voricónazól||69864||69864|91638||1|0|G|0|||0
495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|5075|8483|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||5075||5075|8483||1|0||0|||0
496076|N06BA0408|Methylphenidate Teva|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2019||R|1|1|0|0|0|TVI|0|0|0|100|XEU|9087|9291|lyfalmen|V0997|9291|2|30|0|60,0000|Teva Pharma Iceland ehf|Teva B.V|Metýlfenídat||5662||5662|9291||1|0|E|1|30|dagar|0
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4249|8232|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4249||4249|8232||2|0||0|||0
496614|B03BB0108|Folsyra Evolan|töflur|5|mg|105|stk|1|þpakki||B03BB01|01.11.2019||R|1|0|0|G|0|EVO|0|0|1|100|IKR|2100|4388|lyfalmen|||2|105|0|1312,5000|LYFIS ehf|Evolan Pharma AB|Fólínsýra||2100||2100|4388||2|0|G|0|||0
496912|N02AA0507|OxyContin Depot|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|866|2690|lyfalmen|V0596|2349|1|28|0|1,8600|Icepharma hf|Mundipharma A/S|Oxýcódon||866||866|2690||2|0|G|1|30|dagar|0
496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Klemastín|||||5300||1|0||0|||0
496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|435|2097|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||435||435|2097||1|0|G|1|30|dagar|0
496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|786|2580|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||786||786|2580||1|0|G|1|30|dagar|0
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|TPM|0|1|1|100|XEU|209759|267393|lyfsjukr|||1|20|0|10,0000|Vistor hf|Tillotts Pharma GmbH|Fidaxomicin||209759||209759|267393||1|0|L|0|||0
497083|H02AB0912|Alkindi|kyrnhylk|1|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|14445|21380|lyfalmen|||1|50|0|1,6667|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||14445||14445|21380||2|0|G|0|||0
497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|0|G|0|PLS|0|0|0|100|DKK|2996|5622|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2996||2996|5622||1|0|G|1|30|dagar|0
497730|H03BB0212|Thiamazole Uni-Pharma|töflur|5|mg|100|stk|1|þpakki||H03BB02|01.12.2018||R|0|0|0|G|0|UNI|0|0|0|100|XEU|3939|6920|lyfalmen|||2|100|0|50,0000|Artasan ehf|Uni-Pharma Kleon Tsetis|thiamazole||3939||3939|6920||1|0|G|0|||0
497905|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|glas|23,75 mg metoprololsuccinat|C07AB02|01.01.2020||R|1|0|0|G|0|SSA|0|0|0|100|DKK|827|2636|lyfalmen|V0050|2485|2|100|0|16,6667|Artasan ehf|Hexal A/S|Metóprólól||827||827|2636||1|0|G|0|||0
497995|S01EC0304|Dorzolamide Alvogen|augndr|20|mg/ml|5|ml|1|ílát||S01EC03|01.01.2019||R|0|0|0|G|0|POF|0|0|0|100|XEU|1817|3999|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1817||1817|3999||2|0|G|0|||0
498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2300|4664|lyfalmen|V0472|4664|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4664||2|0|G|0|||0
498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6140|3375|lyfalmen|V0683|3375|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|SAS|0|0|0|100|NOK|64573|104092|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||64573||64573|104092||1|0||0|||0
498656|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2019||R|1|0|0|G|0|BFP|0|0|0|100|XEU|6692|5082|lyfalmen|V0234|5082|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2604||2604|5082||1|0|G|0|||0
498877|N06BA0905|Atomoxetin STADA|hylki|10|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4000|3425|lyfalmen|V0812|3425|2|30|0|3,7500|LYFIS ehf|LYFIS ehf|Atomoxetín||1400||1400|3425||2|0|E|0|||0
498978|G03AC0904|Desirett|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.03.2020||R|0|0|0|0|0|EXH|0|0|0|100|XEU|1432|2916|lyfalm11|V0590|2916|2|84|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Desógestrel||1278||1278|2916||2|0||0|||1
499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.02.2020||R|1|0|0|G|0|SIE|0|0|0|100|SEK|20031|28609|lyfalmen|||1|28|0|14,0000|Eisai AB|Eisai GmbH|Perampanel||20031||20031|28609||1|0|G|0|||0
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|8487|13179|lyfalmen|V1036|13170|1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||8487|13179||2|0|G|0|||0
499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|G|0|MUP|0|0|0|100|DKK|5823|9513|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||5823||5823|9513||2|0|G|0|||0
499865|J01FA0905|Clarithromycin Alvogen|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.10.2020||R|1|0|0|0|0|POF|0|0|1|100|IKR|2475|3425|lyfalmen|V0116|3293|2|14|0|14,0000|Alvogen|Alvogen|Klaritrómýcín||1400||1400|3425||2|0|E|0|||0
499902|N02BE0127|Dolorin Junior|mixtúra|24|mg/ml|200|ml|1|glas||N02BE01|01.07.2021||L|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|200|0|0,1600|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2|0||0|||0
499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|LUN|0|0|0|100|DKK|9548|14640|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||9548||9548|14640||1|0||0|||0
500188|S02CA0303|Ciflox|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.05.2021||R|0|0|0|G|0|HES|0|0|1|100|DKK|2041|4307|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||2041||2041|4307||1|0|G|0|||0
500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|G|0|KNM|0|0|0|100|IKR|900|2640|lyfalmen|V0050|2485|2|100|0|16,6667|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||830||830|2640||2|0|G|0|||0
500476|L01EX1001|Rydapt|hylki|25|mg|112|stk|1|þpakki|4 x 28|L01EX10|01.04.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|1911795|2384249|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||1911795||1911795|2384249||1|0|L|0|||0
500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|60022|79189|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||60022||60022|79189||2|0|L|0|||0
501204|R03DX0801|Cinqaero|irþ|10|mg/ml|2,5|ml|1|hgl||R03DX08|01.12.2018||R|0|0|0|0|0|TVB|0|1|0|100|NOK|16617|24370|lyfsjukr|||1|2,5|0|3,5211|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Reslizumab||16617||16617|24370||1|H|L|0|||0
501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|5488|9052|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5488||5488|9052||1|0|G|0|||0
501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.11.2015||R|1|1|0|0|0|HES|0|0|0|100|DKK|13537|14232|lyfalmen|V0997|9291|1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||9252||9252|14232||1|0|E|1|30|dagar|0
501382|C01CA1702|Midodrin Evolan|töflur|5|mg|100|stk|1|þpakki||C01CA17|01.07.2021||R|1|0|0|G|0|EVO|0|0|0|100|IKR|13500|20079|lyfalmen|V0969|20079|2|100|0|16,6666|LYFIS ehf|Evolan Pharma AB|midodrine||13500||13500|20079||2|0|G|0|||0
501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|G|0|FIN|0|0|0|100|DKK|26204|36416|lyfalmen|V0974|32849|1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||26204||26204|36416||2|0|G|0|||0
501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
501880|QA12AX0003|Calmafusion|irl|||500|ml|12|glös|380mg/60mg/50 mg/ml|QA12AX|01.03.2021||R|0|0|0|0|0|INC|1|0|0|100|IKR|10644|20364|vetalmen|||0|6000|0||Dýraheilsa ehf|Interchemie Werken De Adelaar Eesti AS|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||10644||10644|20364||2|0||0|||0
501950|R03DC0306|Montelukast ratiopharm|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|9642|14769|lyfalmen|V0490|14769|2|98|0|98,0000|Alvogen|Teva Sweden AB|Montelúkast||9642||9642|14769||2|0|G|0|||0
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|G|0|ROA|0|0|0|100|DKK|2252|4598|lyfalmen|V0434|4598|1|100|0|16,6667|Icepharma hf|Roche A.S.|Levódópa og dópadekarboxýl­asa­hemill||2252||2252|4598||2|0|G|0|||0
502157|L01XC2801|Imfinzi|irþ|50|mg/ml|2,4|ml|1|hgl|120 mg/2,4 ml|L01XC28|01.06.2019||R|0|0|0|0|0|AZE|0|1|0|100|SEK|103964|135813|lyfsjukr|||1|2,4|0||Vistor hf|AstraZeneca AB|Durvalumab||||103964|135813||1|H|L|0|||0
502299|M02AA1506|Diclofenac Teva|hlaup|23,2|mg/g|50|g|1|túpa||M02AA15|01.07.2021||L|0|0|0|0|0|TVI|0|0|1|100|IKR|||lyflausa|||0|50|0||Teva Pharma Iceland ehf|Teva B.V|Díklófenak|||||||1|0||0|||0
502341|QP52AF0203|Nematel Vet.|pasta|439|mg/g|30,33|g|1|spr||QP52AF02|01.12.2020||R|0|0|0|0|0|VEB|0|0|0|100|SEK|1284|2213|vetorma|||0|30,33|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Pyrantelum||||1284|2213||2|0||0|||0
502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|VAL|0|0|0|100|XEU|3442|3795|lyfalmen|V0143|3378|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1669||1669|3795||2|0|E|0|||0
502486|S01LA0501|Eylea|stl|40|mg/ml|1|áf.spr|1|pakki||S01LA05|01.08.2020||R|0|1|0|0|0|FIN|0|1|0|100|DKK|112706|146686|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||112706||112706|146686||2|H|L|0|||0
502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|2098|4386|lyfalmen|V0926|4386|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||2098||2098|4386||2|0|G|0|||0
502761|QP51AA0101|Metrobactin vet|töflur|250|mg|100|stk|1|þpakki||QP51AA01|01.04.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|3335|5748|vetorma|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metronidazolum||3335||3335|5748||2|0||0|||0
502790|A10BD2401|Steglujan|filmhtfl|105|mg|28|stk|1|þpakki|5/100 mg|A10BD24|01.03.2019||R|1|0|0|G|0|MBV|0|0|0|100|DKK|9930|14956|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme B.V.|sitagliptin og ertugliflozin||9778||9778|14956||1|0|G|0|||0
502843|L04AC1601|Tremfya|stl|100|mg|1|stk|1|áfpen|m. áfastri nál og nálarhlíf|L04AC16|01.03.2019||R|0|0|1|0|0|JCI|0|1|0|100|SEK|332708|420307|lyfsjukr|||1|1|0|55,8659|Vistor hf|Janssen-Cilag International N.V.|Guselkumab||332708||332708|420307||1|0|L|0|||0
502851|N06AB0314|Fluoxetine Vitabalans|filmhtfl|20|mg|100|stk|1|þpakki||N06AB03|01.08.2021||R|1|0|0|G|0|VIB|0|0|0|100|IKR|2050|3150|lyfalmen|V0039|2998|2|100|0|100,0000|LYFIS ehf|Vitabalans Oy|Flúoxetín||1200||1200|3150||2|0|G|0|||0
502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|G|0|AZE|0|0|0|100|SEK|5517|9092|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca AB|Dapagliflozin||5517||5517|9092||1|0|G|0|||0
503078|N02BE0115|Paracet|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.04.2019||L|0|0|0|0|0|KPA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Alvogen|Karo Pharma AB|Paracetamól|||||||2|0|0|0|||0
503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015|31.05.2021|R|1|0|0|G|0|EIG|0|0|0|100|SEK|20546|29260|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai GmbH|Perampanel||20546||20546|29260||1|0|G|0|||0
503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|G|0|ZEN|0|0|0|100|SEK|4727|8004|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4727||4727|8004||1|0|G|0|||0
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|SPP|0|0|0|100|XEU|6225|10066|lyfalmen|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|albumin||6225||6225|10066||2|H|0|0|||0
504026|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.10.2019||L|1|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2|0||0|||0
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1419|2841|lyfalmen|V0494|2706|2|90|0|180,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Glímepíríð||976||976|2841||1|0|G|0|||0
504120|R03AL0302|Anoro Ellipta|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|G|0|RGP|0|0|0|100|DKK|6064|9844|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline (Ireland) Limited|Vilanterol og umeclidinium bromide||6064||6064|9844||1|0|G|0|||0
504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|1|G|0|UPJ|0|0|0|100|DKK|35225|47826|lyfalmen|||1|112|0|22,4000|Icepharma hf|Upjohn EESV|Síldenafíl||35225||35225|47826||1|0|G|0|||0
504231|N02AB0310|Fentanyl Alvogen|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|1923|4076|lyfalmen|V0219|4076|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1873||1873|4076||2|0|G|1|30|dagar|0
504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|G|0|CPM|0|0|1|100|DKK|531|2229|lyfalmen|||1|30|0||Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Hýdrókortisón bútýrat||531||531|2229||1|0|G|0|||0
504763|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.09.2020||R|0|1|0|0|0|GRP|0|0|0|100|XEU|10600|5474|lyfalmen|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||2889||2889|5474||1|H|0|0|||0
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|BIV|0|0|0|100|DKK|17047|32512|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||17047||17047|32512||1|0||0|||0
505003|S01ED5122|Fixopost|augndr|||0,2|ml|30|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|2421|4830|lyfalmen|||2|6|0|30,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||2421||2421|4830||1|0|G|0|||0
505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3018|2839|lyfalmen|V0335|2568|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||974||974|2839||2|0|G|0|||0
505571|J01MA0207|Ciprofloxacin Navamedic|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|8394|13051|lyfalmen|||2|2000|0|5,0000|Icepharma hf|Navamedic ASA|Cíprófloxacín||8394||8394|13051||2|0|0|0|||0
505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
505803|N06BA0703|Aspendos|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.05.2019||R|1|0|1|0|0|MOL|0|0|0|100|IKR|5200|8655|lyfalmen|V0657|8655|2|30|0|10,0000|LYFIS ehf|Medochemie Limited|Modafinil||5200||5200|8655||2|0|E|2|||0
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|2955|5565|lyfalmen|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2955||2955|5565||1|H|0|0|||0
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|0|0|PLS|0|0|0|100|DKK|7388|11667|lyfalmen|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7388||7388|11667||1|H|0|0|||0
506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015|31.05.2021|R|1|0|0|G|0|EIG|0|0|0|100|SEK|20546|29260|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai GmbH|Perampanel||20546||20546|29260||1|0|G|0|||0
506553|C01CA1703|Hypotron|töflur|2,5|mg|50|stk|1|þpakki||C01CA17|01.10.2018|30.06.2021|R|1|0|0|G|0|RET|0|0|0|100|IKR|7114|11290|lyfalmen|||2|50|0|4,1666|CampusPharma AB|Brancaster Pharma Ireland Ltd|midodrine||7114||7114|11290||1|0|G|0|||0
506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|5601|7554|lyfalmen|V0831|7554|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4400||4400|7554||2|0|G|0|||0
506788|R03AK1401|Atectura Breezhaler|innönddu|252,5|mcg/sk|90|stk|3|stsk.þ|125 mcg/127,5mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|13149|19596|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||13149||13149|19596||1|0|G|0|||0
506938|N02AA0507|OxyContin Depot|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|13846|20556|lyfalmen|V0587|13484|1|98|0|52,2700|Icepharma hf|Mundipharma A/S|Oxýcódon||13846||13846|20556||2|0|G|1|30|dagar|0
507822|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0812|3197|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|G|0|RHA|0|0|0|100|IKR|4233|7324|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||4233||4233|7324||2|0|G|0|||0
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1811|3991|lyfalmen|V0092|3991|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1811||1811|3991||1|0|G|0|||0
507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|G|0|AML|0|0|1|100|SEK|842|2657|lyfalmen|||1|5|0||Amdipharm Limited|Amdipharm Limited|Fúsidínsýra||842||842|2657||2|0|G|0|||0
508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|KNM|0|0|0|100|IKR|3276|3838|lyfalmen|V0687|2612|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3838||2|0|E|0|||0
508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|ATE|0|0|1|100|XEU|688|2221|lyfalmen|||2|2|0|1,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||525||525|2221||1|0|E|0|||0
508634|J07BM0301|Gardasil 9|stl|||0,5|ml|1|áf.spr|dreifa + 2 nálar|J07BM03|01.04.2018||R|0|0|0|0|0|MVA|0|0|0|100|DKK|19025|27684|lyfalmen|||1|0,5|0||Vistor hf|MSD VACCINS|Papillomavírus (mannagerð 6, 11, 16, 18, 31, 33, 45, 52, 58)||19025||19025|27684||1|0||0|||0
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4743|9169|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4743|9169||2|0||0|||0
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|4273|8277|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4273||4273|8277||2|0||0|||0
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|BAN|0|0|0|100|DKK|12660|24189|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12660||12660|24189||2|0||0|||0
508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|0|0|SGB|0|1|0|100|XEU|601175|754205|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||601175||601175|754205||1|H|L|0|||0
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|G|0|LBK|0|0|0|100|DKK|8308|12933|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8308||8308|12933||1|0|G|0|||0
509050|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.06.2020||R|0|1|1|G|0|ATE|0|0|0|100|XEU|6406|7400|lyfalmen|||2|50|0|12,5000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Mýcófenólsýra||4288||4288|7400|31.7.2021|1|0|G|0|||0
509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||5425||5425|10463||2|0||0|||0
509259|J07BB0209|VaxigripTetra|stl|15|mcg|0,5|ml|1|áfspr|dreifa í áf. sprautu|J07BB02|01.06.2020||R|0|0|0|0|0|SPU|0|0|0|100|XEU|1347|3352|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur|Inflúensa, hreinsaðir  mótefnavakar||1347||1347|3352||2|0||0|||0
509296|QA11JA0001|Vitamin AD3E pro injectione|stl|||100|ml|1|hgl|176,47 / 50 / 100 mg/ml|QA11JA|01.01.2021||R|0|0|0|0|0|Bel|0|0|0|100|XEU|1579|3103|vetalmen|||0|100|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Vítamínblöndur||1579||1579|3103||2|0||0|||0
509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2|0||0|||0
509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|BAB|0|0|0|100|DKK|2042|3857|lyfalm11|V0134|3269|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||2042||2042|3857||2|0||0|||0
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|1|0|0|VIC|0|1|0|100|DKK|41974|56362|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare BV|Zídóvúdín og lamívúdín||41974||41974|56362||1|0|L|0|||0
509806|L01XC2401|Darzalex|stl|1800|mg|15|ml|1|hgl|120mg/ml|L01XC24|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|787312|985707|lyfsjukr|||1|15|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||787312||787312|985707||1|H|L|0|||0
509895|QD11AH9102|Cytopoint|stl|20|mg|1|ml|2|hgl||QD11AH91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|15542|29657|vetalmen|||1|2|0||Icepharma hf|Zoetis Belgium S.A.|lokivetmab||15542||15542|29657||2|0||0|||0
510462|J01DH0205|Meropenem WH|sts/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.06.2019||R|0|0|0|0|0|WEH|0|0|1|100|XEU|23125|23936|lyfalmen|||2|10|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Meropenem||16302||16302|23936||2|0|0|0|||0
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|G|0|TPA|0|0|0|100|DKK|447|2113|lyfalmen|V0601|2088|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||447||447|2113||1|0|G|0|||0
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|139525|180041|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||139525|180041||1|0|L|0|||0
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3862|3554|lyfalmen|V0445|2884|2|98|0|98,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Fínasteríð||1494||1494|3554||1|0|G|0|||0
510983|N03AX1610|Pregabalin Medical Valley|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|4149|4664|lyfalmen|V0687|4664|2|100|0|50,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||2300||2300|4664||2|0|E|0|||0
511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|þpakki|30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|ATE|0|0|1|100|XEU|754|2536|lyfalmen|||2|30|0|10,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||754||754|2536||1|0|E|3|||0
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2499|4938|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2499||2499|4938||1|0|G|0|||0
511418|A10BD2301|Segluromet|filmhtfl|1002,5|mg|196|stk|1|þpakki|2,5mg/1000mg|A10BD23|01.04.2019||R|1|0|0|G|0|DSM|0|0|0|100|DKK|19875|28854|lyfalmen|||1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme|Ertugliflozin og metformin||19875||19875|28854||1|0|G|0|||0
511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|0|0|WIL|0|0|0|100|XEU|2450|4870|lyfalmen|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2450|4870||2|H|0|0|||0
511560|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|áfpen|+ 6 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|41210|55396|lyfalmen|||1|1,08|0|3,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||41210||41210|55396||1|0|G|0|||0
511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
511900|B02BC3002|TISSEEL|vefjalím|||2|ml|1|áf.spr|4 nálar og 2 millistykki|B02BC30|01.06.2020||R|0|0|0|0|0|BAM|0|0|0|100|SEK|16216|23818|lyfalmen|||1|2|0||Icepharma hf|Baxter Medical AB|Blöndur||16216||16216|23818||2|H|0|0|||0
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|BAB|0|0|0|100|DKK|15069|19907|lyfalm11|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||15069||15069|19907||2|0|E|0|||1
511988|B05BA1024|SmofKabiven extra Nitrogen|irl|||1012|ml|4|pokar|fleyti|B05BA10|01.05.2021||R|0|0|0|0|0|FKA|0|0|0|100|DKK|34004|46282|lyfalmen|||1|4048|0||Vistor hf|Fresenius Kabi AB|Blöndur||34004||34004|46282||1|0|0|0|||0
512465|J05AR0304|Emtricitabine/Tenofovir disoproxil Mylan|filmhtfl|445|mg|30|stk|1|þpakki|200+245 mg|J05AR03|01.06.2020||R|1|1|1|0|0|ASD|0|1|0|100|DKK|49386|65737|lyfsjukr|||2|30|0|30,0000|Icepharma hf|Mylan S.A.S.|Tenófóvír dísóproxíl og emtrícítabín||49386||49386|65737||2|0|L|0|||0
512477|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.01.2020||R|1|0|0|G|0|SHS|0|0|1|100|DKK|2597|2287|lyfalmen|V0006|2186|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||573||573|2287||1|0|G|0|||0
512532|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|2|úðapum|2 x 150 úðaskammar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|FKA|0|0|0|100|DKK|6221|10061|lyfalmen|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||6221||6221|10061||1|0|0|0|||0
512646|G04BD1202|Betmiga (Lyfjaver)|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.01.2021||R|1|0|0|G|0|LVR|0|0|0|100|XEU|14868|21962|lyfalmen|V0651|21962|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Mírabegrón||14868||14868|21962||3|0|G|0|||0
512821|H02AB0912|Alkindi|kyrnhylk|0,5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|7223|11367|lyfalmen|||1|50|0|0,8333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||7170||7170|11367||2|0|G|0|||0
512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|1971|3563|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1500||1500|3563||2|0|G|0|||0
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|G|0|BLS|0|0|0|100|XEU|990|2349|lyfalmen|V0109|2334|2|100|0|66,6700|Artasan ehf|Bluefish Pharmaceuticals AB|Simvastatín||618||618|2349||1|0|G|0|||0
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2|0||0|||0
513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|3901|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||1985||1985|3901||2|0|0|0|||0
513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|2498|4910|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2498||2498|4910||2|0||0|||0
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|BRO|0|0|0|100|XEU|1964|3555|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Ltd|Amoxicillín og beta-laktamasa hemill||1809||1809|3555||2|0|0|0|||0
513993|N02BG0901|Penthrox|innö.guf|99,9|%|3|ml|1|glas||N02BG09|01.10.2019||R|0|0|0|0|0|MCL|0|0|0|100|DKK|4768|8061|lyfalmen|||1|3|0||Icepharma hf|Medical Developments NED B.V.|Methoxyflurane||4768||4768|8061||1|H|0|0|||0
514029|C03DA0407|Eplerenon Krka|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.12.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|9764|6315|lyfalmen|V0111|6315|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Eplerenón||3500||3500|6315||2|0||0|||0
514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|G|0|KRK|0|0|0|100|IKR|2000|4251|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4251||2|0|G|0|||0
514105|N05AH0415|Quetiapin Krka|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.04.2018||R|0|1|0|G|0|KRK|0|0|0|100|IKR|6000|7554|lyfalmen|V0910|7540|2|100|0|37,5000|LYFIS ehf|Krka Sverige AB|Quetíapín||4400||4400|7554||2|0|G|0|||0
514280|J07BB0210|Influvactetra|stl|||0,5|ml|10|áf.spr|með nál|J07BB02|01.10.2019||R|0|0|0|0|0|MDK|0|0|0|100|DKK|15046|22207|lyfalmen|||1|5|0||Icepharma hf|Mylan Denmark ApS|Inflúensa, hreinsaðir  mótefnavakar||15046||15046|22207||2|0||0|||0
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|DAN|0|0|0|100|XEU|16931|24802|lyfalmen|V0818|11624|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||16931|24802||2|0|E|0|||0
514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|KNM|0|0|0|100|IKR|2131|2530|lyfalmen|V0692|2402|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2530||2|0|G|0|||0
514949|M04AA0106|Allopurinol Alvogen|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.03.2021||R|1|0|0|G|0|POF|0|0|0|100|IKR|842|2657|lyfalmen|||2|100|0|25,0000|Alvogen|Alvogen|Allópúrinol||842||842|2657||2|0|G|0|||0
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|0|PLS|0|0|0|100|DKK|3911|5137|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2644||2644|5137||1|0|G|0|||0
515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||2|0||0|||0
515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|12059|18096|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||12059||12059|18096||3|0|G|0|||0
515699|C08CA0106|Amlodipin Medical Valley|töflur|5|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|1489|2472|lyfalmen|V0056|2472|2|112|0|112,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||708||708|2472||2|0|G|0|||0
516033|M01AB0523|Dimax Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.07.2021||R|1|0|0|G|0|POF|0|0|1|100|XEU|618|2349|lyfalmen|V0188|2193|2|30|0|15,0000|Alvogen|Alvogen|Díklófenak||618||618|2349||2|0|G|0|||0
516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|1|0|0|LLS|0|1|0|100|DKK|116574|151497|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||116574|151497||2|0|L|0|||0
516532|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|3187|5885|lyfalmen|V1052|5885|1|50|0||Williams & Halls efh|Piramal Critical Care B.V.|Fentanýl||3187||3187|5885||1|0|0|1|30|dagar|0
516694|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.08.2019||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1800|2909|lyfalmen|V0069|2884|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1025||1025|2909||2|0|G|0|||0
516803|L01EA0103|Imatinib ratiopharm|filmhtfl|100|mg|120|stk|1|þpakki||L01EA01|01.01.2019||R|1|0|1|0|0|RTH|0|1|0|100|XEU|96912|64840|lyfsjukr|||2|120|0||Alvogen|ratiopharm GmbH|Imatinib||48677||48677|64840||2|0|L|0|||0
516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|6622|10612|lyfalmen|V0384|9756|2|30|0|15,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||6622||6622|10612||1|0|G|0|||0
517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|G|0|TAB|0|0|0|100|IKR|9000|5077|lyfalmen|V0273|5008|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||2600||2600|5077||2|0|G|0|||0
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2825|5386|lyfalmen|V0462|3661|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2825||2825|5386||1|0|G|0|||0
517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|1|G|0|EIG|0|0|0|100|SEK|29538|40633|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai GmbH|Rúfínamíð||29538||29538|40633||1|0|G|0|||0
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3005|5634|lyfalmen|V0471|3723|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3005||3005|5634||1|0|G|0|||0
517803|H02AB0208|Dexavit|stl/irl|4|mg/ml|1|ml|3|lykjur||H02AB02|01.03.2019||R|0|0|0|0|0|VIT|0|0|1|100|DKK|3440|6233|lyfalmen|||2|3|0|8,0000|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||3440||3440|6233||1|0|0|0|||0
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|3233|5948|lyfalmen|V0472|3498|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3233||3233|5948||1|0|G|0|||0
517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|28260|39017|lyfalmen|||2|100|0|16,6667|Icepharma hf|Abcur AB|Noradrenalín||28260||28260|39017||2|H|0|0|||0
517914|QI09AL0801|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL08|01.01.2017||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|9550|16460|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||9550||9550|16460||2|0||0|||0
518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|29328|lyfalmen|V0711|29328|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||20600||20600|29328||2|0|G|0|||0
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|1037|2925|lyfalmen|||1|20|0|15,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||1037||1037|2925||1|0|G|0|||0
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|G|0|ATE|0|0|1|100|DKK|4283|7393|lyfalmen|||1|100|0|75,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díklófenak||4283||4283|7393||1|0|G|0|||0
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|MBV|0|0|0|100|DKK|1935|3725|lyfalm11|V0590|2916|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1935||1935|3725||1|0||0|||1
518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
518534|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|rörlyk||A10AE06|01.08.2021||R|0|1|0|G|0|NAS|0|0|0|100|DKK|7775|12199|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7775||7775|12199||1|0|G|0|||0
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|G|0|BII|0|0|0|100|DKK|15175|22385|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||15175||15175|22385||1|0|G|0|||0
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|MEA|0|0|1|100|DKK|932|2781|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||932||932|2781||2|0|E|0|||0
519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|792|2310|lyfalmen|V0564|2265|2|100|0|50,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||590||590|2310||2|0|G|0|||0
519096|N06AB1008|Escitalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|2200|4526|lyfalmen|V0325|4526|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||2200||2200|4526||2|0|0|0|||0
519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|Sulfadiazinum og trimethoprimum||||2463|4841||2|0||0|||0
519162|H02AB0208|Dexavit|stl/irl|4|mg/ml|5|ml|5|lykjur||H02AB02|01.04.2021||R|0|0|0|0|0|VIT|0|0|1|100|DKK|45766|61158|lyfalmen|||2|25|0|66,6670|Vital Pharma Nordic ApS|Vital Pharma Nordic ApS|Dexametasón||45766||45766|61158||1|0|0|0|||0
519172|L01EB0201|Erlotinib WH|filmhtfl|100|mg|30|stk|1|þpakki||L01EB02|01.06.2020||R|0|1|1|0|0|WEH|0|1|0|100|XEU|252006|267913|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Erlotinib||210177||210177|267913||2|0|L|0|||0
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|AEP|0|0|1|100|DKK|1015|2895|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1015||1015|2895||2|0|E|0|||0
519655|A12BA0103|Kaliumklorid Orifarm (Lyfjaver)|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.06.2021||L|1|0|0|G|0|LVR|0|0|0|100|IKR|||lyfalmen|V1047|2697|3|100|0|25,0000|Lyfjaver ehf|Lyfjaver ehf|Kalíumklóríð|||||2774||3|0|G|0|||0
519722|N07BC0102|Buvidal|stl|64|mg|0,18|ml|1|áfspr||N07BC01|01.10.2019||R|0|0|0|0|0|CMS|0|1|0|100|DKK|55856|73920|lyfsjukr|||1|0,18|0|30,4762|Vistor hf|Camurus AB|Búprenorfín||55856||55856|73920||1|H|L|1|30|dagar|0
519755|L01EX1001|Rydapt|hylki|25|mg|56|stk|1|þpakki|2x28|L01EX10|01.03.2020||R|0|0|1|0|0|NEL|0|1|0|100|DKK|924250|1156019|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Midostaurin||924250||924250|1156019||1|0|L|0|||0
520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|2915|5510|lyfalmen|V0515|5198|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2915||2915|5510||1|0|G|0|||0
520082|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|112|stk|1|þpakki||C09CA01|01.07.2020||R|1|0|0|G|0|VAL|0|0|0|100|IKR|1629|3686|lyfalmen|V0213|3686|2|112|0|28,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1590||1590|3686||2|0|G|0|||0
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|22499|31730|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||22499||22499|31730||1|0|G|0|||0
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|16629|24386|lyfalmen|V0143|3378|1|12|0|12,0000|Icepharma hf|Upjohn EESV|Síldenafíl||16629||16629|24386||1|0|E|0|||0
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|5411|8946|lyfalmen|V0144|1295|1|4|0|8,0000|Icepharma hf|Upjohn EESV|Síldenafíl||5411||5411|8946||1|0|E|0|||0
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|UPJ|0|0|0|100|DKK|14971|22104|lyfalmen|V0144|3885|1|12|0|24,0000|Icepharma hf|Upjohn EESV|Síldenafíl||14971||14971|22104||1|0|E|0|||0
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1359|2660|lyfalmen|V0056|2207|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||844||844|2660||1|0|G|0|||0
520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|0|0|IND|0|1|0|100|DKK|11340|17106|lyfsjukr|||1|28|0|28,0000|Vistor hf|Indivior Europe Limited|Búprenorfín í blöndum||11340||11340|17106||1|0|L|1|30|dagar|0
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2199|2660|lyfalmen|V0057|2207|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Amlódipín||844||844|2660||1|0|G|0|||0
520633|N06AB0607|Sertralin Krka|filmhtfl|100|mg|250|stk|1|ílát||N06AB06|01.11.2018||R|1|0|0|G|0|KRK|0|0|0|100|IKR|9918|8380|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Sertralín||5000||5000|8380||2|0|G|0|||0
520659|G04BD0806|Solifenacin Mylan|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.07.2019||R|1|0|0|G|0|MYL|0|0|0|100|DKK|11316|8889|lyfalmen|V0440|8889|2|90|0|90,0000|Icepharma hf|Mylan AB|Sólífenacín||5370||5370|8889||2|0|G|0|||0
520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|621|2353|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||621||621|2353||2|0|G|0|||0
520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016|30.06.2021|L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
520936|L01AX0304|Temozolomide Accord|hylki|100|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|8097|12643|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||8097||8097|12643||1|0|L|0|||0
521273|B01AA0303|Warfarin Teva|töflur|3|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1547|3627|lyfalmen|||2|100|0|40,0000|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1547||1547|3627||1|0|G|0|||0
521428|N07BA0154|Nicorette Quickmist Cool Berry|munnhúði|1|mg/sk|150|skammtar|1|úðapum|1 x 150 úðaskammtar|N07BA01|01.09.2020||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
522158|L01XC0302|Kanjinti|st/irþ|420|mg|1|hgl|1|pakki||L01XC03|01.07.2020||R|0|0|0|0|0|AEB|0|1|0|100|DKK|195852|250096|lyfsjukr|||2|1|0||Vistor hf|Amgen Europe B.V.|Trastuzumab||195852||195852|250096||1|H|L|0|||0
522175|N02BE0124|Paracaff|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE01|01.04.2019||L|1|0|0|0|0|ACE|0|0|1|100|IKR|||lyflausa|||0|20|0|3,7666|Acare ehf|Acare ehf|Paracetamól|||||||2|0|0|0|||0
522290|C01BD0702|Dronedarone STADA|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2020||R|1|1|1|0|0|ASR|0|0|0|100|IKR|12900|17877|lyfalmen|V1027|17117|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Dronedarón||11900||11900|17877||2|0|E|0|||0
522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|83627|109045|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||83627||83627|109045||2|0|G|0|||0
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|0|0|NEL|0|1|0|100|DKK|142187|183352|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||142187||142187|183352||1|H|L|0|||0
522985|D01AE1603|Amorolfin Apofri|lakk|5|%|3|ml|1|glas||D01AE16|01.05.2018||L|0|0|0|0|0|APO|0|0|1|100|IKR|||lyflausa|||2|3|0||LYFIS ehf|Apofri AB|Amorolfín|||||||2|0||0|||0
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|4668|3261|lyfalmen|V0285|3261|2|100|0|25,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Quetíapín||1281||1281|3261||1|0|G|0|||0
523273|H02AB0901|Solu-Cortef|sts|100|mg|1|hgl|1|pakki|Act-O-Vial|H02AB09|01.02.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|563|2273|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer Aps|Hýdrókortisón||563||563|2273||1|0|G|0|||0
523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1916||1|0|G|0|||0
523284|L01EF0101|Ibrance|filmhtfl|75|mg|21|stk|1|þpakki||L01EF01|01.03.2021||R|1|0|1|0|0|PEU|0|1|0|100|DKK|303981|384578|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Europe MA EEIG|Palbociclib||303981||303981|384578||1|0|L|0|||0
523346|L01XC0304|Ontruzant|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.05.2020||R|0|0|0|0|0|SUN|0|1|0|100|DKK|78929|103103|lyfsjukr|||1|150|0||Vistor hf|Samsung Bioepis NL B.V.|Trastuzumab||78929||78929|103103||1|H|L|0|||0
523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|164054|210548|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||164054||164054|210548||1|H|L|0|||0
523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|GPA|0|0|0|100|XEU|1582|2573|lyfalmen|V0144|1295|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||781||781|2573||1|0|E|0|||0
523758|L01EA0301|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01EA03|01.03.2013||R|0|1|1|0|0|NEL|0|1|0|100|DKK|335498|423777|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotinib||335498||335498|423777||1|0|L|0|||0
523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2|0||0|||0
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|G|0|SNP|0|0|1|100|XEU|918|2761|lyfalmen|V0903|2508|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||918||918|2761||1|0|G|0|||0
523937|C10AX0903|Ezetimib Krka|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.05.2018||R|1|0|0|0|0|KNM|0|0|0|100|IKR|10278|7004|lyfalmen|V0954|6086|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Ezetimíb||4000||4000|7004||2|0|E|0|||0
523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1467|3517|lyfalmen|V0584|3517|2|28|0|7,4700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxýcódon||1467||1467|3517||1|0|G|1|30|dagar|0
524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|G|0|TOG|0|0|0|100|SEK|1967|4205|lyfalmen|V1001|4205|1|98|0|73,5000|Navamedic AB|TopRidge Pharma (Ireland) Limited|Ísósorbíð mónónítrat||1967||1967|4205||1|0|G|0|||0
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|EIS|0|0|1|100|IKR|7518|6501|lyfalmen|V0010|3838|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6501||1|0|E|0|||0
524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|3042|lyfalmen|V0039|2938|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|3042||2|0|G|0|||0
524630|N03AX1610|Pregabalin Medical Valley|hylki|300|mg|70|stk|1|þpakki||N03AX16|01.04.2020||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2900|4237|lyfalmen|V0689|4237|2|70|0|70,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1990||1990|4237||2|0|E|0|||0
524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|GAL|0|0|0|100|XEU|6626|10618|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6626||6626|10618||2|0|E|0|||0
525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|G|0|MEA|0|0|1|100|DKK|1241|3206|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||1241||1241|3206||2|0|G|0|||0
525122|R03AK0605|Salmex|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2019||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3822|6346|lyfalmen|V0437|5268|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||3522||3522|6346||2|0|G|0|||0
525418|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||500|ml|20|pokar|lausn|B05BB01|01.07.2018||R|0|0|0|0|0|BAM|0|0|1|100|SEK|4446|7617|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4446||4446|7617||2|0|0|0|||0
525689|N02CD0301|AJOVY|stl|225|mg|1,5|ml|1|áfpen||N02CD03|01.07.2020||R|0|0|1|0|0|TGH|0|0|0|100|XEU|74336|90822|lyfalmen|||1|1,5|0|30,0000|Actavis Pharmaceuticals Iceland ehf.|TEVA GmbH|Fremanezumab||69219||69219|90822||1|0|E|0|||0
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29903|41095|lyfalmen|V0977|41095|1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||29903|41095||2|0|G|0|||0
525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|5410|8944|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||5410||5410|8944||2|H|0|0|||0
525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|RAU|0|0|0|100|XEU|4948|8308|lyfalmen|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||4948||4948|8308||2|H|0|0|||0
525913|C07AB0706|Bisoprolol Medical Valley|filmhtfl|10|mg|105|stk|1|glas||C07AB07|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2022|4281|lyfalmen|V1040|4281|2|105|0|105,0000|Acare ehf|Medical Valley Invest AB|bisoprolol||2022||2022|4281||2|0|G|0|||0
525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|VIN|0|0|1|100|DKK|2394|4793|lyfalmen|||2|1000|0|2,5000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2394|4793||2|0|0|0|||0
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4863||2|0||0|||0
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|RAU|0|0|1|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4925||2|0||0|||0
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|7211|11423|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||7211||7211|11423||1|0|G|0|||0
526396|N03AX1408|Levetiracetam STADA|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.08.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|9168|12509|lyfalmen|V0516|12509|2|100|0|66,6700|LYFIS ehf|STADA Arzneimittel AG|Levetíracetam||8000||8000|12509||2|0|G|0|||0
526496|H02AB0207|Dexamethasone Krka|töflur|4|mg|100|stk|1|þpakki|stakskammtaþynna|H02AB02|01.04.2018||R|0|0|0|G|0|KNM|0|0|1|100|IKR|15000|13060|lyfalmen|V0423|13060|2|100|0|266,6666|LYFIS ehf|Krka d.d. Novo mesto|Dexametasón||8400||8400|13060||2|0|G|0|||0
526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|WEH|0|0|0|100|XEU|14194|6409|lyfalmen|V0111|6315|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||3568||3568|6409||2|0|E|0|||0
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|G|0|DEA|0|0|0|100|XEU|4018|7028|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4018||4018|7028||1|0|G|0|||0
527132|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|18|stk|1|þpakki||N02CC04|01.06.2019||R|0|0|0|G|0|MSD|0|0|0|100|DKK|6187|10014|lyfalmen|V0621|8734|1|18|0|18,0000|Vistor hf|M.S.D.|Rizatriptan||6187||6187|10014||1|0|G|0|||0
527355|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.01.2021||R|0|0|0|0|0|PBV|0|0|0|100|XEU|18605|25592|lyfalmen|||1|250|0||Williams & Halls efh|Piramal Critical Care B.V.|Sevóflúran||17505||17505|25592||2|H|0|0|||0
527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|G|0|GRP|0|0|0|100|XEU|10254|12773|lyfalmen|V0516|12509|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8192||8192|12773||1|0|G|0|||0
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1481|3536|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1481||1481|3536||1|0|G|0|||0
527632|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|áfpen|FlexTouch|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|5018|8405|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5018||5018|8405||1|0|G|0|||0
527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2273|3150|lyfalmen|V0825|2811|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1200||1200|3150||2|0|G|0|||0
527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|G|0|JCI|0|0|0|100|SEK|247179|313933|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||247179||247179|313933||1|0|G|0|||0
527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|RPG|0|0|0|100|XEU|1690|3322|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|Prednisolonum og sýkingalyf||1690||1690|3322||2|0||0|||0
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|930|2402|lyfalmen|V0046|2402|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||657||657|2402||1|0|G|0|||0
528076|D11AX1002|Finasterid STADA|filmhtfl|1|mg|30|stk|1|þpakki||D11AX10|01.07.2018||R|1|0|0|0|0|ASR|0|0|0|100|IKR|3884|6844|lyfalmen|||2|30|0|30,0000|LYFIS ehf|STADA Arzneimittel AG|Fínasteríð||3884||3884|6844||2|0||0|||0
528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13632|lyfalmen|||2|100|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13632||2|0|G|0|||0
528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Skópólamín|||||3081||1|0||0|||0
528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|GRH|0|0|1|100|DKK|9064|6125|lyfalmen|V0011|4796|1|100|0|66,6700|Vistor hf|Grünenthal GmbH|Esómeprazól||3362||3362|6125||1|0|G|0|||0
528303|N02AA0507|OxyContin Depot|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.11.2020||R|1|0|0|G|0|MUP|0|0|0|100|DKK|2463|4888|lyfalmen|V0584|3517|1|28|0|7,4700|Icepharma hf|Mundipharma A/S|Oxýcódon||2463||2463|4888||2|0|G|1|30|dagar|0
528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|G|0|PIL|0|0|1|100|IKR|668|2417|lyfalmen|V0562|2402|2|100|0|33,3300|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen||668||668|2417||2|0|G|0|||0
528418|D07AC1302|Ovixan|krem|1|mg/g|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|G|0|GAB|0|0|1|100|SEK|1923|4145|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1923||1923|4145||1|0|G|0|||0
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|G|0|LVR|0|0|0|100|SEK|5666|9297|lyfalmen|V0971|9297|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5666||5666|9297||3|0|G|0|||0
528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|G|0|FEL|0|0|0|100|DKK|6125|9928|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6125||6125|9928||1|0|G|0|||0
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|G|0|RTH|0|0|0|100|XEU|6011|8734|lyfalmen|V0621|8734|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||5257||5257|8734||2|0|G|0|||0
528948|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2020||R|1|0|0|G|0|ATE|0|0|0|100|XEU|20375|22978|lyfalmen|||2|56|0|56,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ziprasidon||15606||15606|22978||1|0|G|0|||0
529142|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|7,5|mg|100|stk|1|þpakki|5+2,5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|5145|8330|lyfalmen|V1003|8330|2|100|0|6,6667|Alvogen|Alvogen ehf|Oxycodonum í blöndum||4964||4964|8330||2|0|E|1|30|dagar|0
529352|N05AX1304|Paliperidon Krka|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.08.2018||R|0|0|0|0|0|KNM|0|0|0|100|IKR|9787|14969|lyfalmen|V0963|14969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Paliperídón||9787||9787|14969||2|0|E|0|||0
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|PLS|0|0|0|100|DKK|60253|79482|lyfalmen|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||60253||60253|79482||1|H|0|0|||0
529955|J05AE0803|Atazanavir Krka|hylki|300|mg|30|stk|1|glas||J05AE08|01.06.2020||R|0|0|1|0|0|KAN|0|1|0|100|IKR|39565|53315|lyfsjukr|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Atazanavír||39565||39565|53315||2|0|L|0|||0
530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1|0||0|||0
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6966||1|0|E|0|||0
530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2488|4251|lyfalmen|V0824|4251|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||2000||2000|4251||2|0|G|0|||0
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|1510|2968|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|Xylazinum||1510||1510|2968||2|0||0|||0
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|G|0|NAS|0|0|0|100|DKK|2648|5143|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2648||2648|5143||1|0|G|0|||0
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|FKA|0|0|0|100|DKK|5897|9615|lyfalmen|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5897||5897|9615||1|0|0|0|||0
531360|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|6514|6132|lyfalmen|V0622|6132|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3367||3367|6132||1|0|E|1|30|dagar|0
531382|A10BK0401|Steglatro|filmhtfl|15|mg|98|stk|1|þpakki||A10BK04|01.01.2019||R|1|0|0|G|0|MSD|0|0|0|100|DKK|19305|28069|lyfalmen|||1|98|0|147,0000|Vistor hf|M.S.D.|Ertugliflozin||19305||19305|28069||1|0|G|0|||0
531501|N05CH0105|Slenyto|forðatfl|1|mg|60|stk|1|þpakki||N05CH01|01.12.2019||R|1|0|0|0|0|RNU|0|0|1|100|XEU|6486|10282|lyfalmen|||2|60|0|30,0000|Williams & Halls efh|RAD Neurim Pharmaceuticals EEC SARL|Melatonin||6382||6382|10282||2|0|0|0|||0
531894|J01DD0103|Cefotaxim Navamedic|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.05.2021||R|0|0|0|0|0|NAV|0|0|1|100|XEU|6310|10183|lyfalmen|||2|100|0|2,5000|Icepharma hf|Navamedic ASA|Cefotaximum||6310||6310|10183||2|0|0|0|||0
532257|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2020||R|0|0|0|0|0|VAL|0|0|0|100|XEU|2522|4781|lyfalmen|V0117|4773|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2385||2385|4781||2|0|E|0|||0
532351|C09BA0204|Enalapril HCTZ Medical Valley|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.02.2021||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2145|2556|lyfalmen|V0098|2556|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Enalapríl og þvagræsilyf||769||769|2556||2|0|G|0|||0
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|CNI|0|0|0|100|SEK|798|2596|lyfalmen|||1|30|0|3,0000|Vistor hf|McNeil Sweden AB|Mebendazól||798||798|2596||1|0||0|||0
532526|L04AA4201|Mayzent|filmhtfl|0,25|mg|12|stk|1|þpakki|Skammtastillingarpakkning|L04AA42|01.11.2020||R|1|1|1|0|0|NEP|0|1|0|100|DKK|23740|33300|lyfsjukr|||1|12|0||Vistor hf|Novartis Europharm Limited|Siponimod||23740||23740|33300||1|0|L|0|||0
532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|G|0|WEH|0|0|0|100|XEU|42925|29666|lyfalmen|V0711|26186|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||20867||20867|29666||2|0|G|0|||0
532726|N06AB1008|Escitalopram STADA|filmhtfl|20|mg|100|stk|1|þpakki||N06AB10|01.08.2021||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3500|6315|lyfalmen|V0327|6315|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Escítalópram||3500||3500|6315||2|0|0|0|||0
532821|L01XG0101|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XG01|01.02.2016||R|0|1|0|0|0|WEH|0|1|0|100|XEU|109082|142179|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomib||109082||109082|142179||2|H|L|0|||0
532869|QP51AJ0103|Baycoxine vet|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.08.2018||R|0|0|0|0|0|BAN|0|0|0|100|DKK|24669|42519|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|Toltrazuril||24669||24669|42519||2|0||0|||0
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|1860|4058|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1860||1860|4058||2|0|0|0|||0
532984|N02AJ0601|Parkodin|filmhtfl|510|mg|100|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1253|3223|lyfalmen|||2|100|0|16,6667|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1253||1253|3223||1|0|E|3|||0
533001|A10BA0205|Metformin EQL|filmhtfl|500|mg|105|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|500|2186|lyfalmen|V0500|2150|2|105|0|26,2500|LYFIS ehf|EQL Pharma AB|Metformín||500||500|2186||2|0|G|0|||0
533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|1|0|0|CSB|0|1|0|100|SEK|237344|301701|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||237344||237344|301701||2|0|L|0|||0
533363|L04AA3601|Ocrevus|irþ|300|mg|10|ml|1|hgl|lausn|L04AA36|01.04.2018||R|0|0|0|0|0|RRG|0|1|0|100|DKK|750619|940071|lyfsjukr|||1|10|0|91,1854|Icepharma hf|Roche Registration GmbH|Ocrelizumab||||750619|940071||2|H|L|0|||0
533563|R03AK0605|Salmex|innönddu|150|mcg/sk|60|skammtar|1|innö.t|50/100 mcg/sk|R03AK06|01.01.2021||R|0|0|0|G|0|GPN|0|0|0|100|DKK|3333|5489|lyfalmen|V0436|5489|2|60|0|30,0000|Icepharma hf|Glenmark Pharmaceuticals Nordic AB|Salmeteról og fluticason||2900||2900|5489||2|0|G|0|||0
533979|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|án rotvarnar/án laktósa|H02AB04|01.01.2021||R|0|0|0|G|0|PLS|0|0|1|100|DKK|456|2126|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer Aps|Metýlprednisólón||456||456|2126||1|0|G|0|||0
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|20980|29809|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||20980||20980|29809||1|0|G|0|||0
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|1|G|0|PEU|0|0|0|100|DKK|54441|72131|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Europe MA EEIG|Sirolimus||54441||54441|72131||1|0|G|0|||0
534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|CES|0|0|0|100|XEU|2781|5447|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Amoxicillinum||2781||2781|5447||2|0||0|||0
534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|KRK|0|0|0|100|IKR|5481|4870|lyfalmen|V0117|4870|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2450||2450|4870||2|0|E|0|||0
534712|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|2300|4664|lyfalmen|||1|100|0|20,0000|Icepharma hf|Abcur AB|Metadón||2300||2300|4664||2|0|G|1|30|dagar|0
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|4987|8362|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||4987||4987|8362||2|H|0|0|||0
534942|R01AD5801|Dymista|nefúði|187|mcg/sk|120|skammtar|1|glas|137+50mcg|R01AD58|01.10.2019||R|0|0|0|G|0|MEA|0|0|1|100|DKK|2924|5523|lyfalmen|||1|120|0|30,0000|Icepharma hf|Meda AB|Fluticasone í samsetningum||2924||2924|5523||2|0|G|0|||0
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|G|0|TPA|0|0|0|100|DKK|2083|4365|lyfalmen|V0092|3991|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2083||2083|4365||1|0|G|0|||0
535453|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|19 mg/4 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2323|4004|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2323||2323|4004||1|0||0|||0
535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|2378|3907|lyfalmen|V0826|3647|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2|0||0|||0
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|347|1976|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||347||347|1976||1|0|G|0|||0
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|G|0|HES|0|0|0|100|DKK|361|1995|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||361||361|1995||1|0|G|0|||0
536179|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|10|ml|10|lykjur||N05CD08|01.07.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|5782|9456|lyfalmen|||2|100|0|33,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||5782||5782|9456||1|H|0|2|450|mg|0
536385|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|98|stk|1|þpakki||C10AA05|01.04.2018||R|1|0|0|G|0|MVX|0|0|0|100|IKR|1960|2779|lyfalmen|V0112|2679|2|98|0|49,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||931||931|2779||2|0|G|0|||0
536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|JCI|0|0|0|100|SEK|83661|109088|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||83661||83661|109088||1|0|E|0|||0
536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|POF|0|0|1|100|IKR|14133|10995|lyfalmen|V0419|9845|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||6900||6900|10995||2|0|E|0|||0
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|2494|4931|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2494||2494|4931||2|H|0|0|||0
536958|N02CC0406|Rizatriptan Alvogen|munndr.t|10|mg|2|stk|1|þpakki||N02CC04|01.08.2020||L|0|0|0|0|0|POF|0|0|0|100|XEU|||lyflausa|||2|2|0|2,0000|Alvogen|Alvogen|Rizatriptan|||||||2|0|0|0|||0
537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|1|0|0|GSE|0|1|0|100|DKK|60022|79189|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|emtricitabine og tenofovir alafenamide||60022||60022|79189||2|0|L|0|||0
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|FKA|0|0|1|100|DKK|5114|8537|lyfalmen|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5114||5114|8537||1|0|0|0|||0
537580|R03DC0306|Montelukast ratiopharm|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.07.2019||R|1|0|0|G|0|TSA|0|0|0|100|XEU|10467|15905|lyfalmen|V0492|15905|2|98|0|39,2000|Alvogen|Teva Sweden AB|Montelúkast||10467||10467|15905||2|0|G|0|||0
537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1500|3563|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3563||2|0|G|0|||0
537772|N02AE0105|Buprenorphine Alvogen|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2021||R|0|0|0|G|0|POF|0|0|0|100|IKR|3504|6321|lyfalmen|V0945|4174|2|4|0|11,2000|Alvogen|Alvogen|Búprenorfín||3504||3504|6321||2|0|G|1|30|dagar|0
537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|G|0|MED|0|0|0|100|IKR|14000|13473|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13473||2|0|G|0|||0
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2390||1|0|G|0|||0
537873|N05CM0901|Sefitude|húðuðtfl|445|mg|60|stk|1|þpakki||N05CM09|01.06.2018||L|1|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||1|60|0||Florealis ehf|Florealis ehf|Valerianae radix|||||||2|0||0|||0
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2|0||0|||0
538272|N04BC0409|Adartrel (Lyfjaver)|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.11.2020||R|1|0|0|G|0|LVR|0|0|0|100|XEU|1052|2946|lyfalmen|||3|12|0|0,5000|Lyfjaver ehf|Lyfjaver ehf|Rópíníról||1052||1052|2946||3|0|G|0|||0
538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2762|5300|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2762||2762|5300||2|0|G|0|||0
538713|R03BB0702|Incruse Ellipta|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|G|0|RGP|0|0|0|100|DKK|4308|7427|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Umeclidiniumbrómið||4308||4308|7427||1|0|G|0|||0
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|1|G|0|SNP|0|0|0|100|XEU|7939|12425|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7939||7939|12425||1|0|G|0|||0
539310|A10AB0505|Fiasp|stl|100|ein/ml|3|ml|5|rörlyk|Penfill|A10AB05|01.07.2018||R|0|0|0|G|0|NAS|0|0|0|100|DKK|4757|8045|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4757||4757|8045||1|0|G|0|||0
539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|63212|83224|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||63212||63212|83224||1|H|L|0|||0
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|1|100|DKK|729|2501|lyfalmen|||2|25|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||729||729|2501||1|0||2|130|töflur|0
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|ATE|0|0|0|100|DKK|1105|3019|lyfalmen|||2|100|0|20,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Díazepam||1105||1105|3019||1|0||2|130|töflur|0
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1|0||0|||0
539793|L01EF0201|Kisqali|filmhtfl|200|mg|63|stk|1|þpakki||L01EF02|01.11.2018||R|0|0|1|0|0|NEL|0|1|0|100|DKK|478671|601844|lyfsjukr|||1|63|0||Vistor hf|Novartis Europharm Ltd|Ribociclib||478671||478671|601844||1|0|L|0|||0
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|1665|3790|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1665||1665|3790||1|0|G|0|||0
539990|C10AX0905|Ezetimibe ratiopharm|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.12.2018||R|1|0|0|0|0|RTH|0|0|0|100|DKK|9088|6476|lyfalmen|V0954|5964|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Ezetimíb||3617||3617|6476||2|0||0|||0
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|FKA|0|0|0|100|DKK|17856|26075|lyfalmen|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||17856||17856|26075||1|0|0|0|||0
540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|40501|11682|lyfalmen|V0721|11682|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7399||7399|11682||2|0||0|||0
540141|N03AX1213|Gabapentin Teva|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.10.2019|31.07.2021|R|1|0|0|G|0|TVA|0|0|0|100|DKK|12641|18897|lyfalmen|||2|100|0|44,4400|Alvogen|Teva B.V.|Gabapentín||12641||12641|18897||2|0|G|0|||0
540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|0|0|TEA|0|0|0|100|SEK|21296|30209|lyfalmen|V1042|30209|1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||21296||21296|30209||1|H|0|0|||0
540503|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|60|pokar|lausn|B05BB01|01.03.2020||R|0|0|0|0|0|BAM|0|0|1|100|DKK|7179|11379|lyfalmen|||1|6000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7179||7179|11379||2|0|0|0|||0
540752|H01CB0203|Octreoanne|sts|30|mg|30|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|173559|119500|lyfsjukr|||2|30|0|42,8600|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||91893||91893|119500||1|0|L|0|||0
540854|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|100|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|2075|3561|lyfalmen|||2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Pregabalín||1499||1499|3561|31.5.2021|2|0|E|0|||0
540857|L01XC3201|Tecentriq|irþ|840|mg|14|ml|1|hgl|lausn|L01XC32|01.02.2020||R|0|1|0|0|0|RRG|0|1|0|100|DKK|469409|590325|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Atezolizumab||469409||469409|590325||2|H|L|0|||0
540859|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.12.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0813|3197|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|1|0|0|BSQ|0|1|0|100|DKK|623129|781509|lyfsjukr|||1|21|0|5,2500|Bristol-Myers Squibb Pharma EEIG|Bristol-Myers Squibb Pharma EEIG|Lenalídómíd||623129||623129|781509||2|0|L|0|||0
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|EKI|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Díklórbenzýlalkóhól|||||||1|0||0|||0
541493|N03AX1602|Lyrica (Lyfjaver)|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|2211|4541|lyfalmen|V0685|2129|3|56|0|4,6667|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||2211||2211|4541||3|0|E|0|||0
541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|182928|234022|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||182928||182928|234022||1|0|L|0|||0
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|5018|8405|lyfalmen|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||5018||5018|8405||2|0|0|0|||0
542291|L01BC0603|Ecansya|filmhtfl|150|mg|60|stk|1|þpakki||L01BC06|01.06.2020||R|0|0|1|0|0|KAN|0|0|0|100|IKR|4301|7418|lyfalmen|||2|60|0||Krka Sverige AB|Krka d.d. Novo mesto|Capecitabín||4301||4301|7418||2|0|0|0|||0
542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|5132|3375|lyfalmen|V0682|3375|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1364||1364|3375||2|0|G|0|||0
542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|mælipumpa|G03CA03|01.07.2019||R|0|0|0|G|0|BES|0|0|0|100|DKK|1286|3268|lyfalmen|||2|64|0||Vistor hf|Besins Healthcare Ireland Limited|Estradíól||1286||1286|3268||1|0|G|0|||0
542694|G04CA5202|Dutaprostam|hylki|0,9|mg|90|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.02.2021||R|0|0|0|G|0|ALO|0|0|0|100|DKK|9113|8869|lyfalmen|V1010|8869|2|90|0|90,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Dútasteríð og tamsúlósínhýdroklóríð||5355||5355|8869||2|0|G|0|||0
542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|3856|6805|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||3856||3856|6805||2|0|0|0|||0
542893|H05BX0106|Cinacalcet ratiopharm|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.07.2018||R|1|0|0|0|0|RTH|0|0|0|100|XEU|17053|8296|lyfalmen|V0720|8288|2|28|0|14,0000|Alvogen|ratiopharm GmbH|Cinacalcet||4939||4939|8296||2|0||0|||0
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|16953|24832|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||16953||16953|24832||1|0|G|0|||0
543374|S01ED5118|Dorzolamide/Timolol Alvogen|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011|31.07.2021|R|0|0|0|G|0|POF|0|0|0|100|XEU|1535|3611|lyfalmen|||2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1535||1535|3611||2|0|G|0|||0
543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|BAM|0|0|0|100|SEK|87446|113875|lyfalmen|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||87446||87446|113875||2|H|0|0|||0
543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1|0||0|||0
544374|L01EM0101|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01EM01|01.07.2016||R|1|0|1|0|0|GSE|0|1|0|100|DKK|526958|661899|lyfsjukr|||1|60|0|30,0000|Gilead Sience Sweden AB|Gilead Sciences Ireland|Idelalisib||526958||526958|661899||2|0|L|0|||0
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|CSB|0|1|0|100|SEK|351851|444115|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||351851||351851|444115||2|H|L|0|||0
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|1|G|0|ASP|0|0|0|100|XEU|11232|16958|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11232||11232|16958||1|0|G|0|||0
545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37583|lyfalmen|||2|100|0|120,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37583||2|0|G|0|||0
545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|0|0|RRG|0|1|0|100|DKK|257259|326469|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration GmbH|Rítúxímab||257259||257259|326469||2|H|L|0|||0
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|RTH|0|0|0|100|XEU|1565|3269|lyfalm11|V0134|3269|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1565||1565|3269||2|0||0|||0
545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
545639|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3533|4664|lyfalmen|V0438|4580|2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||2300||2300|4664||2|0|G|0|||0
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|855|2675|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||855||855|2675||1|0||0|||0
545705|N02AB0310|Fentanyl Alvogen|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.11.2020||R|0|0|0|G|0|RTH|0|0|0|100|XEU|5318|8045|lyfalmen|V0223|8045|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4757||4757|8045||2|0|G|1|30|dagar|0
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|812|2616|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||812||812|2616||1|0|G|0|||0
545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|0|0|G|0|ATE|0|0|1|100|XEU|1147|2508|lyfalmen|V0903|2508|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Prómetazín||734||734|2508||1|0|G|0|||0
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|G|0|LBK|0|0|0|100|DKK|1866|4066|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1866||1866|4066||1|0|G|0|||0
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|66118|86900|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||66118||66118|86900||1|0|G|0|||0
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|49378|65727|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||49378||49378|65727||1|0|G|0|||0
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|57657|76198|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||57657||57657|76198||1|0|G|0|||0
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|1|G|0|ALK|0|0|0|100|DKK|47755|63674|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||47755||47755|63674||1|0|G|0|||0
546660|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.04.2020||R|1|0|0|G|0|ABC|0|0|0|100|SEK|529|2226|lyfalmen|||1|20|0|4,0000|Icepharma hf|Abcur AB|Metadón||529||529|2226||2|0|G|1|30|dagar|0
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|G|0|ATE|0|0|1|100|XEU|4014|4059|lyfalmen|V0010|3916|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Rabeprazól||1861||1861|4059||1|0|G|0|||0
547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|G|0|FER|0|0|0|100|DKK|14788|21852|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14788||14788|21852||1|0|G|0|||0
547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|2939|5543|lyfalmen|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||2939||2939|5543||2|0|0|0|||0
547200|C09DA0312|Valsartan/Hydroklortiazid Jubilant|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|IKR|4100|5765|lyfalmen|V0581|5765|2|98|0|98,0000|Acare ehf|Jubilant Pharmaceuticals nv|Valsartan og þvagræsilyf||3100||3100|5765||2|0|G|0|||0
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|ORC|0|0|1|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5334||1|0||0|||0
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|8963|13835|lyfalmen|||1|100|0|0,3800|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||8963||8963|13835||1|H|0|0|||0
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|0|0|RGP|0|0|0|100|DKK|2882|5465|lyfalmen|||1|10|0|0,1000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Eptifibatíð||2882||2882|5465||1|H|0|0|||0
547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|BAM|0|0|0|100|SEK|6311|10184|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6311|10184||2|0|0|0|||0
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|1|G|0|FIN|0|0|0|100|DKK|99009|128500|lyfalmen|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||99009||99009|128500||2|0|G|0|||0
548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|G|0|WEH|0|0|0|100|XEU|2070|4347|lyfalmen|V1038|3052|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2070||2070|4347||2|0|G|0|||0
548162|M04AA0304|Aburic|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.03.2020||R|1|0|0|0|0|WEH|0|0|0|100|XEU|8555|11394|lyfalmen|V1011|9586|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|febuxostat||7190||7190|11394||2|0|E|0|||0
548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|G|0|MBV|0|0|1|100|DKK|520|2214|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||520||520|2214||1|0|G|0|||0
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2145||1|0|G|0|||0
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|142890|184226|lyfalmen|||1|20|0||Icepharma hf|Baxter Medical AB|Blöndur||142890||142890|184226||2|H|0|0|||0
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|G|0|JAS|0|0|0|100|SEK|6614|10601|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6614||6614|10601||1|0|G|0|||0
549442|C10AA0704|Rosuvastatin Xiromed|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.04.2018||R|0|0|0|0|0|VAL|0|0|0|100|IKR|4950|5283|lyfalmen|V0117|4870|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Rósuvastatín||2750||2750|5283||2|0|E|0|||0
549476|N06BA0409|Methylphenidate STADA|hylki|60|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|7500|10169|lyfalmen|||2|30|0|60,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||6300||6300|10169|30.6.2021|2|0|E|1|30|dagar|0
549545|QM01AE0301|Romefen vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.2020||R|0|0|0|0|0|CES|1|0|0|100|DKK|4120|7987|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|Ketóprófen||4120||4120|7987||2|0||0|||0
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|G|0|FIN|0|0|0|100|DKK|29494|40578|lyfalmen|V0976|40273|1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||29494|40578||2|0|G|0|||0
550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|G|0|SAO|0|0|1|100|XEU|874|2701|lyfalmen|||2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||874||874|2701||2|0|G|0|||0
550147|QN01BB0201|Lidor vet.|stl|20|mg/ml|50|ml|1|hgl|lausn|QN01BB02|01.05.2019||R|0|0|0|0|0|RPG|1|0|0|100|XEU|1238|2433|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Lidocaine||1238||1238|2433||2|0||0|||0
550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|ATE|0|0|1|100|XEU|1443|2095|lyfalmen|V0551|2095|2|7|0|1,7500|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Flúkónazól||434||434|2095||1|0|E|0|||0
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.05.2019||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|G|0|KNM|0|0|0|100|IKR|2518|4964|lyfalmen|V0471|4964|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4964||2|0|G|0|||0
551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|G|0|GGM|0|0|0|100|NOK|2808|5363|lyfalmen|||1|100|0|25,0000|Glenwood GmbH P. Erzeugnisse|Glenwood GmbH P. Erzeugnisse|Dípýrídamól||2808||2808|5363||2|0|G|0|||0
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1|0||0|||0
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|BAM|0|0|0|100|SEK|7318|11570|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7318||7318|11570||2|H|0|0|||0
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|G|0|MEA|0|0|1|100|DKK|4680|7939|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||4680||4680|7939||2|0|G|0|||0
551683|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.06.2021||R|0|0|0|0|0|PEU|0|0|1|100|DKK|19051|27720|lyfalmen|V1050|27720|1|112|0|56,0000|Icepharma hf|Pfizer Europe MA EEIG|Vareniclin||||19051|27720||1|0||0|||0
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|1812|2276|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2691|3966|lyfalmen|V0467|2772|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001|30.06.2021|R|0|0|0|0|0|EIS|0|0|1|100|IKR|1160|1527|lyfalmen|||1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1527||1|0|E|0|||0
551904|L01XC0204|Rixathon|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|51231|68071|lyfsjukr|||2|20|0||Artasan ehf|Sandoz GmbH|Rítúxímab||51231||51231|68071||1|H|L|0|||0
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|2821|2276|lyfalmen|V0003|2160|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2276||1|0|E|0|||0
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|EIS|0|0|1|100|IKR|5587|3966|lyfalmen|V0010|2193|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3966||1|0|E|0|||0
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1569|3657|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1569||1569|3657||2|0|0|0|||0
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|ATE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Íbúprófen|||||||1|0||0|||0
552481|R06AE0501|Postafen|töflur|25|mg|20|stk|1|þpakki||R06AE05|01.05.2018|31.05.2021|L|1|0|0|0|0|CAM|0|0|1|100|DKK|||lyflausa|||1|20|0|10,0000|CampusPharma AB|CampusPharma AB|Meklózín|||||||1|0|0|0|||0
552648|C07AB0215|Metoprolol Alvogen|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.01.2021||R|1|0|0|G|0|GOV|0|0|0|100|XEU|1026|2485|lyfalmen|V0050|2485|2|100|0|15,8333|Alvogen|Alvogen ehf|Metóprólól||717||717|2485||2|0|G|0|||0
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|QAS|0|0|0|100|GBP|15813|25491|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ AS|Tricaine Methane Sulfónat||15813||15813|25491||1|0||0|||0
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|2984|5605|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2984||2984|5605||1|0|G|0|||0
552913|QJ01GB0301|Genta-Equine|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01GB03|01.01.2019||R|0|0|0|0|0|FRA|1|0|0|100|IKR|3657|7109|vetalmen|||0|100|0||Dýraheilsa ehf|Franklin Pharmaceuticals Ltd.|Gentamicin||3657||3657|7109||2|0||0|||0
553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|164181|210706|lyfalmen|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||164181||164181|210706||2|H|0|0|||0
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|5962|9704|lyfalmen|V0237|9704|1|18|0|18,0000|Icepharma hf|Upjohn EESV|Eletriptan||||5962|9704||1|0|G|0|||0
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|2251|4596|lyfalmen|V0237|3235|1|6|0|6,0000|Icepharma hf|Upjohn EESV|Eletriptan||2251||2251|4596||1|0|G|0|||0
553382|R06AD0102|Alimemazin Evolan|hylki|20|mg|100|stk|1|glas|hart|R06AD01|01.09.2018||R|1|0|0|G|0|EVO|0|0|1|100|IKR|5684|9321|lyfalmen|||2|100|0|66,6667|LYFIS ehf|Evolan Pharma AB|Alímemazín||5684||5684|9321||2|0|G|0|||0
553387|J01CR0205|Spectracillin|filmhtfl|1000|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.12.2018||R|0|0|0|0|0|WEH|0|0|1|100|IKR|1430|2530|lyfalmen|V0169|2530|2|14|0|8,1667|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill||750||750|2530||2|0||0|||0
553555|J07BX0303|COVID-19 Vaccine AstraZeneca|stl|||5|ml|10|hgl|hvert hgl.10x0,5ml sk.|J07BX03|01.03.2021||R|0|0|0|0|0|AZE|0|0|0|100|IKR|||lyfalmen|||1|50|0||Vistor hf|AstraZeneca AB|Covid-19 vaccines|||||||1|0||0|||0
553580|QN01BB0202|BelOcain vet.|stl|20|mg/ml|100|ml|12|hgl|lausn|QN01BB02|01.06.2019||R|0|0|0|0|0|Bel|1|0|0|100|IKR|15300|24075|vetalmen|||0|1200|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Lidocaine||12600||12600|24075||2|0||0|||0
553720|L01EJ0101|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01EJ01|01.02.2014||R|1|0|1|0|0|NEL|0|1|0|100|DKK|424361|534298|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||424361||424361|534298||1|0|L|0|||0
554131|L01XC0303|Trazimera|st/irþ|150|mg|150|mg|1|hgl||L01XC03|01.04.2020||R|0|0|0|0|0|PEU|0|1|0|100|DKK|81778|106706|lyfsjukr|||1|150|0||Icepharma hf|Pfizer Europe MA EEIG|Trastuzumab||81778||81778|106706||1|H|L|0|||0
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|BID|1|0|0|100|DKK|9210|17644|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||9210||9210|17644||1|0||0|||0
554441|N02AA0508|Oxycodone Alvogen|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.12.2020||R|1|0|0|G|0|GOV|0|0|0|100|XEU|18833|25058|lyfalmen|V0588|25058|2|98|0|104,5300|Alvogen|Alvogen ehf|Oxýcódon||17117||17117|25058||2|0|G|1|30|dagar|0
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|G|0|ATE|0|0|0|100|XEU|6153|5655|lyfalmen|V0029|5655|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Klópídógrel||3020||3020|5655||1|0|G|0|||0
554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1200876|1500065|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1200876||1200876|1500065||2|0|L|0|||0
555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|1|0|0|NEL|0|1|0|100|DKK|159881|205358|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||159881||159881|205358||1|0|L|0|||0
555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1547|3627|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1547||1547|3627||1|0|G|0|||0
555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|2152|4460|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2152||2152|4460||1|0|G|0|||0
555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|G|0|COR|0|0|0|100|DKK|1100|3012|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1100||1100|3012||1|0|G|0|||0
556146|J01FF0104|Clindamycin EQL Pharma|hylki|300|mg|21|stk|1|þpakki||J01FF01|01.05.2019||R|1|0|0|0|0|EQL|0|0|1|100|IKR|2011|3563|lyfalmen|V0461|3563|2|21|0|5,2500|LYFIS ehf|EQL Pharma AB|Klindamýcín||1500||1500|3563||2|0|E|0|||0
556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2|0||0|||0
556578|N02BE5106|Panodil Extra|filmhtfl|565|mg|20|stk|1|þpakki|500+65 mg|N02BE51|01.12.2019||L|1|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)|||||||1|0|0|0|||0
556694|C10AX1401|Praluent|stl|150|mg/ml|2|áf-penni|1|pakki|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|SGB|0|0|0|100|XEU|67990|89267|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||67990||67990|89267||1|0|E|0|||0
556903|C10AX0904|Ezetimib Medical Valley|töflur|10|mg|100|stk|1|þpakki||C10AX09|01.07.2018||R|0|0|0|0|0|VAL|0|0|0|100|DKK|10982|6443|lyfalmen|V0954|6086|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ezetimíb||3593||3593|6443||2|0|E|0|||0
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|18375|26789|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||18375||18375|26789||2|0|L|0|||0
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|4523|7723|lyfalmen|V0972|6787|1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4523||4523|7723||1|0|G|0|||0
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|G|0|HES|0|0|0|100|DKK|9460|14519|lyfalmen|V0973|11806|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9460||9460|14519||1|0|G|0|||0
557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|VAL|0|0|0|100|XEU|9891|3240|lyfalmen|V0814|3197|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||1266||1266|3240||2|0|E|0|||0
557239|R03AK0606|Salmeterol/Fluticasone Neutec|innönddu|300|mcg/sk|60|skammtar|1|innö.t|50/250 mcg/sk|R03AK06|01.05.2021||R|0|0|0|G|0|NET|0|0|0|100|DKK|3822|5268|lyfalmen|V0437|5268|2|60|0|30,0000|Lyfjaver ehf|Neutec Inhaler Ireland Limited|Salmeteról og fluticason||2739||2739|5268||3|0|G|0|||0
557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Paracetamól|||||||1|0||0|||0
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|G|0|WEH|0|0|1|100|XEU|1327|3324|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1327||1327|3324||2|0|G|0|||0
558386|N01BB2001|Emla|plástur|||20|stk|1|pakki|25mg+25mg/plástur|N01BB20|01.07.2020||L|0|0|0|0|0|MAR|0|0|0|100|DKK|||lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur|||||8665||2|0||0|||0
558417|L01EA0401|Bosulif|filmhtfl|400|mg|28|stk|1|þpakki||L01EA04|01.03.2019||R|1|0|1|0|0|PEU|0|1|0|100|DKK|481264|605069|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Europe MA EEIG|Bosutinib||481264||481264|605069||1|0|L|0|||0
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|1|0|0|NEL|0|1|0|100|DKK|214604|273419|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||214604|273419||1|0|L|0|||0
558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1|0||0|||0
559165|M02AA1505|Voltaren Forte|hlaup|23,2|mg/g|100|g|1|túpa||M02AA15|01.06.2020||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2|0||0|||0
559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|G|0|PLS|0|0|0|100|DKK|4332|7460|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4332||4332|7460||1|0|G|0|||0
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1911||1|0|G|0|||0
560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|0|0|BMS|0|1|0|100|DKK|38411|51856|lyfsjukr|||1|100|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Paklítaxel||38411||38411|51856||2|H|L|0|||0
560293|L01XK0101|Lynparza|filmhtfl|100|mg|56|stk|1|þpakki||L01XK01|01.03.2020||R|0|0|1|0|0|AZA|0|1|0|100|SEK|356719|450170|lyfsjukr|||1|56|0||Vistor hf|AstraZeneca AB|Olaparib||356719||356719|450170||1|0|L|0|||0
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Acíklóvír|||||||1|0||0|||0
560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017|30.06.2021|L|1|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2|0||0|||0
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|0|0|COR|0|0|0|100|DKK|102401|133869|lyfalmen|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||102401||102401|133869||1|H|0|0|||0
560682|L01EA0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01EA01|01.09.2017||R|0|0|1|0|0|ACC|0|1|0|100|XEU|159025|113860|lyfsjukr|||2|30|0||Artasan ehf|Accord Healthcare Limited|Imatinib||87434||87434|113860||1|0|L|0|||0
560982|M04AA0305|Febuxostat Krka|filmhtfl|80|mg|28|stk|1|þpakki||M04AA03|01.07.2021||R|1|0|0|0|0|KAN|0|0|0|100|IKR|6000|9756|lyfalmen|V1011|9586|2|28|0|28,0000|Krka Sverige AB|Krka d.d. Novo mesto|febuxostat||6000||6000|9756||2|0|E|0|||0
561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
561239|L01EL0101|IMBRUVICA|filmhtfl|420|mg|28|stk|1|þpakki||L01EL01|01.04.2020||R|1|0|1|0|0|JCI|0|1|0|100|SEK|695157|871092|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||695157||695157|871092||1|0|L|0|||0
561745|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|innöndunartæki og 1 áfylling|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|5971|9716|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||5971||5971|9716||1|0|G|0|||0
561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|1|0|0|BRE|0|1|0|100|DKK|182928|234022|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||182928||182928|234022||1|0|L|0|||0
562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|G|0|ATE|0|0|0|100|XEU|1540|2978|lyfalmen|V0098|2556|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1075||1075|2978||1|0|G|0|||0
562176|B02BD0401|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD04|01.02.2013||R|0|0|1|0|0|PEU|0|1|0|100|DKK|46193|61699|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Faktor IX||46193||46193|61699||1|0|L|0|||0
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|G|0|TEA|0|0|0|100|SEK|4012|7020|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4012||4012|7020||1|0|G|0|||0
562419|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.01.2019||R|0|1|0|0|0|FEC|0|1|0|100|XEU|883370|1105176|lyfsjukr|||1|20|0|11,6300|Ferrer Internacional S.A.|Ferrer Internacional S.A.|Treprostiníl natríum||883370||883370|1105176||2|H|L|0|||0
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|0|0|RGP|0|1|0|100|DKK|78714|102831|lyfsjukr|||1|1|0|16,0000|Vistor hf|GlaxoSmithKline (Ireland) Limited|Belimumab||78714||78714|102831||1|H|L|0|||0
562774|H01CB0203|Octreoanne|sts|20|mg|20|mg|1|hgl|+ leysir|H01CB02|01.05.2020|30.06.2021|R|0|0|0|0|0|TVI|0|1|0|100|NOK|136094|94372|lyfsjukr|||2|20|0|28,5700|Teva Pharma Iceland ehf|Teva B.V|Oktreótíð||72026||72026|94372||1|0|L|0|||0
563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|32836|44805|lyfalmen|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||32836||32836|44805||2|H|0|0|||0
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|0|G|0|MDI|0|0|0|100|DKK|1281|3261|lyfalmen|||1|100|0|5,0000|Icepharma hf|Mundipharma A/S|Morfín||1281||1281|3261||2|0|G|1|30|dagar|0
563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|WEH|0|0|0|100|XEU|22130|8288|lyfalmen|V0720|8288|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||4933||4933|8288||2|0||0|||0
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3466|6269|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||||3466|6269||2|0|G|0|||0
563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|DIV|0|0|0|100|IKR|1398|2748|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|Penetamathýdrójoðíð||||1398|2748||2|0||0|||0
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|ROD|0|0|0|100|DKK|426629|537118|lyfalmen|||1|60|0|15,0000|Recordati AB|Recordati Rare Diseases|PAsireótið disapartate||426629||426629|537118||1|0|E|0|||0
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|NIL|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories (Ireland) Limited|Ivermectinum||10463||10463|18034||2|0||0|||0
563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||2|0||0|||0
564048|J07BA0103|TicoVac|stl|2,4|mcg/sk|0,5|ml|1|áfspr|bóluefni|J07BA01|01.06.2019||R|0|0|0|0|0|PLS|0|0|0|100|DKK|3437|6229|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Aps|Heilabólguveira óvirk, borin með blóðmaur||3437||3437|6229||1|0||0|||0
564124|N06DA0405|Galantamin STADA|forðahlk|8|mg|30|stk|1|þpakki|Hart forðahylki|N06DA04|01.04.2018||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3200|5902|lyfalmen|||2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Galantamín||3200||3200|5902||2|0|G|0|||0
564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|1|0|0|TMA|0|1|0|100|DKK|18685|27216|lyfsjukr|||1|1|0||Lyfjaver ehf|Takeda Manufacturing Austria AG|Storkuþáttur VIII||18685||18685|27216||3|0|L|0|||0
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|G|0|NVO|0|0|1|100|DKK|825|2633|lyfalmen|||1|120|0|12,0000|Vistor hf|N.V. Organon|Deslóratadín||825||825|2633||1|0|G|0|||0
564448|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.05.2020||R|1|0|0|G|0|BLS|0|0|0|100|XEU|1366|2578|lyfalmen|V0056|2207|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Amlódipín||785||785|2578||1|0|G|0|||0
564607|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.12.2019||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|||2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870|30.6.2021|2|0|E|1|30|dagar|0
564827|QP54AB5101|Nexgard Spectra|tuggutfl|||3|stk|1|þpakki|9 mg/2 mg|QP54AB51|01.04.2018||R|0|0|0|0|0|BIV|0|0|0|100|XEU|2216|3819|vetorma|||0|3|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Milbemycin oxime í blöndum||2216||2216|3819||1|0||0|||0
565251|A10BJ0602|Rybelsus|töflur|14|mg|30|stk|1|þpakki||A10BJ06|01.12.2020||R|0|0|0|0|0|NAS|0|0|0|100|DKK|20650|29392|lyfalmen|||1|30|0||Vistor hf|Novo-Nordisk A/S|Semaglutide||20650||20650|29392||1|0|E|0|||0
565303|C01CA0303|Noradrenalina Normon|irþ|1|mg/ml|10|ml|100|lykjur|lausn|C01CA03|01.04.2019||R|0|0|0|0|0|LNA|0|0|0|100|XEU|258076|327486|lyfalmen|||2|1000|0|166,6667|Williams & Halls efh|Laboratorios Normon, S.A.|Noradrenalín||258076||258076|327486||2|H|0|0|||0
565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|G|0|TSA|0|0|0|100|IKR|8782|6109|lyfalmen|V0286|5611|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3350||3350|6109||2|0|G|0|||0
565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|8030|15405|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|maropitant||||8030|15405||2|0||0|||0
565921|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|glas|95 mg metoprololsuccinat|C07AB02|01.12.2019||R|1|0|0|G|0|SSA|0|0|0|100|DKK|2117|4102|lyfalmen|V0049|2910|2|100|0|66,6667|Artasan ehf|Hexal A/S|Metóprólól||1892||1892|4102||1|0|G|0|||0
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|FEL|0|0|0|100|DKK|22191|31341|lyfalmen|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||22191||22191|31341||1|H|0|0|||0
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|G|0|NEL|0|0|0|100|DKK|1420|3452|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1420||1420|3452||1|0|G|0|||0
566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|G|0|COR|0|0|0|100|DKK|13737|20406|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13737||13737|20406||1|0|G|0|||0
567028|L01EH0101|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01EH01|01.02.2012||R|1|0|1|0|0|NEL|0|1|0|100|DKK|174191|223156|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Lapatinib||174191||174191|223156||1|0|L|0|||0
567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|G|0|ASR|0|0|0|100|IKR|3587|2806|lyfalmen|V0114|2736|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||950||950|2806||2|0|G|0|||0
567371|M05BA0306|Pamidronatdinatrium Pfizer|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5742|9401|lyfalmen|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5742||5742|9401||1|H|0|0|||0
567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||3217||2|0|G|0|||0
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|G|0|ALK|0|0|1|100|DKK|5384|8908|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5384|8908||1|0|G|0|||0
567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|G|0|GPH|0|0|1|100|DKK|1923|4145|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1923||1923|4145||1|0|G|0|||0
567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|G|0|JAS|0|0|0|100|SEK|2516|4961|lyfalmen|V0291|2273|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2516||2516|4961||1|0|G|0|||0
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|G|0|AEP|0|0|0|100|DKK|3294|6032|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||3294||3294|6032||2|0|G|0|||0
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1|0||0|||0
567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|1|0|0|RRG|0|0|0|100|DKK|329013|415711|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration GmbH|Pírfenidon||||329013|415711||2|0|E|0|||0
567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|PIL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Brillpharma (Ireland) Limited|Íbúprófen|||||||2|0||0|||0
567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
568054|N02CD0101|Aimovig|stl|70|mg|1|ml|1|áfpen||N02CD01|01.12.2018||R|0|0|1|0|0|NEL|0|0|0|100|DKK|64262|84552|lyfalmen|||1|1|0|28,0000|Vistor hf|Novartis Europharm Ltd|Erenumab||64262||64262|84552||1|0|E|0|||0
568324|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.04.2019||R|0|0|0|0|0|LHS|0|0|0|100|XEU|6001|10343|vetbolu|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Escherichia bóluefni + Clostridium bóluefni||6001||6001|10343||2|0|0|0|||0
568413|QN01AX0305|Ketabel vet.|stl|100|mg/ml|10|ml|1|hgl|lausn|QN01AX03|01.04.2021||R|0|0|0|0|0|Bel|1|0|0|100|XEU|1545|3037|vetalmen|||0|10|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Ketaminum||1545||1545|3037||2|0|0|1|30|dagar|0
568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|ZET|0|0|1|100|IKR|2446|4044|lyfalmen|V0826|3647|2|28|0|42,0000|Alvogen|Zentiva, k.s.|Etoríkoxíb||1850||1850|4044||2|0|G|0|||0
568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|G|0|VAL|0|0|0|100|XEU|2726|2839|lyfalmen|V0334|2568|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||974||974|2839||2|0|G|0|||0
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|GPH|0|0|1|100|DKK|955|2812|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||955||955|2812||1|0||0|||0
568745|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.02.2020||L|1|0|0|0|0|ATE|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6700|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Esómeprazól|||||||1|0|0|0|||0
568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2389|2679|lyfalmen|V0058|2679|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||858||858|2679||1|0|G|0|||0
568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|G|0|ATE|0|0|0|100|XEU|3624|3286|lyfalmen|V0059|3090|2|100|0|200,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Felódipín||1299||1299|3286||1|0|G|0|||0
569171|H02AB0609|Prednisolon EQL Pharma|töflur|5|mg|25|stk|1|þpakki||H02AB06|01.02.2019||R|1|0|0|G|0|EQL|0|0|1|100|IKR|759|2543|lyfalmen|||2|25|0|12,5000|LYFIS ehf|EQL Pharma AB|Prednisólón||759||759|2543||2|0|G|0|||0
569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|G|0|WEH|0|0|1|100|IKR|776|2186|lyfalmen|V0827|2186|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||500||500|2186||2|0|G|0|||0
569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|0|1|0|0|VIC|0|1|0|100|DKK|121173|157217|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare BV|Abacavír, dolutegravír og lamivudín||121173||121173|157217||1|0|L|0|||0
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|0|0|BAM|0|0|0|100|SEK|10005|15269|lyfalmen|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10005||10005|15269||2|H|0|0|||0
569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|4800|2874|lyfalmen|V0001|2874|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2874||2|0|G|0|||0
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|12525|18737|lyfalmen|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12525||12525|18737||1|0|0|0|||0
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|1|0|0|HES|0|0|0|100|DKK|14403|21322|lyfalmen|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14403||14403|21322||1|0|0|0|||0
569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|5971|lyfalmen|V0811|5262|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3250||3250|5971||2|0|G|0|||0
570106|N02AA5502|Oxycodone/Naloxone Alvogen|forðatfl|15|mg|100|stk|1|þpakki|10+5 mg|N02AA55|01.11.2019||R|1|0|0|0|0|GOV|0|0|0|100|DKK|9779|13382|lyfalmen|V1005|13382|2|100|0|13,3333|Alvogen|Alvogen ehf|Oxycodonum í blöndum||8634||8634|13382||2|0|E|1|30|dagar|0
570227|QN02BG9102|Librela|stl|15|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|11622|22220|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||11622||11622|22220||2|0||2|||0
570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|G|0|GOV|0|0|0|100|XEU|3549|2576|lyfalmen|V0110|2576|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||783||783|2576||2|0|G|0|||0
570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|G|0|WIL|0|0|0|100|XEU|2363|4750|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2363||2363|4750||2|0|G|0|||0
570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|G|0|MSD|0|0|0|100|DKK|2230|4567|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2230||2230|4567||1|0|G|0|||0
570775|M01AH0108|Celecoxib Medical|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2018||R|1|0|0|G|0|DIC|0|0|1|100|IKR|3584|6431|lyfalmen|V0196|5948|2|100|0|100,0000|LYFIS ehf|Medical ehf|Celekoxíb||3584||3584|6431||2|0|G|0|||0
571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|EST|0|0|0|100|DKK|3146|6139|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3146||3146|6139||1|0||0|||0
571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|650|2048|lyfalmen|V0908|2048|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||400||400|2048||2|0|G|0|||0
571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|G|0|BLS|0|0|1|100|XEU|3281|6014|lyfalmen|V0384|4878|2|15|0|7,5000|Artasan ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3281||3281|6014||1|0|G|0|||0
571181|R07AA0201|Curosurf|innönddr|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|0|0|CHI|0|0|0|100|XEU|67335|88439|lyfalmen|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||67335||67335|88439||1|H|0|0|||0
571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|0|0|RRG|0|1|0|100|DKK|506284|636187|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Obinutuzumab||506284||506284|636187||2|H|L|0|||0
571647|QN02BG9102|Librela|stl|20|mg|1|ml|2|hgl||QN02BG91|01.08.2021||R|0|0|0|0|0|ZBE|0|0|0|100|DKK|13373|25542|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Bedinvetmab||13373||13373|25542||2|0||2|||0
571667|N03AX1602|Lyrica (Lyfjaver)|hylki|150|mg|100|stk|1|þpakki||N03AX16|01.12.2019||R|1|0|0|0|0|LVR|0|0|0|100|DKK|15369|22652|lyfalmen|V0687|4664|3|100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Pregabalín||15369||15369|22652||3|0|E|0|||0
571872|J01CR0206|Amoxicillin/Clavulanic Acid Normon|sts/irs|1200|mg|100|hgl|1|pakki|1000+200 mg|J01CR02|01.09.2019||R|0|0|0|0|0|LNA|0|0|1|100|XEU|53002|70311|lyfalmen|||2|100|0|33,3333|Williams & Halls efh|Laboratorios Normon, S.A.|Amoxicillín og beta-laktamasa hemill||53002||53002|70311||2|0|0|0|||0
571902|N05AH0416|Quetiapin Medical Valley|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2019||R|1|1|0|G|0|VAL|0|0|0|100|IKR|5400|7540|lyfalmen|V0910|7540|2|100|0|37,5000|Acare ehf|Medical Valley Invest AB|Quetíapín||4390||4390|7540||2|0|0|0|||0
572062|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.04.2018||R|0|0|1|0|0|CLU|0|1|0|100|XEU|35624|48331|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||35624||35624|48331||1|0|L|0|||0
572119|J01DD0206|Ceftazidima Normon|sts|1|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|83136|108424|lyfalmen|||2|50|0|12,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||83136||83136|108424||2|0|0|0|||0
572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|1|G|0|APE|0|0|0|100|XEU|68561|89990|lyfalmen|V1046|89987|1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||68561||68561|89990||1|0|G|0|||0
572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|1677|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2695||2|0|G|0|||0
572777|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|6490|3375|lyfalmen|V0684|3375|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2958|5569|lyfalmen|V0994|2448|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2958||2958|5569||1|0|G|0|||0
573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|1|0|0|GSE|0|1|0|100|DKK|1991827|2483786|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Sciences Ireland|Sofosbuvir og ledipasvir||||1991827|2483786||2|0|L|0|||0
573477|L01XC0301|Herceptin|st/irþ|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|0|0|RRG|0|1|0|100|DKK|82356|107437|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration GmbH|Trastuzumab||82356||82356|107437||2|H|L|0|||0
573579|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2020||R|1|1|0|G|0|VAL|0|0|0|100|XEU|5982|3375|lyfalmen|V0683|3375|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||1364||1364|3375||2|0|G|0|||0
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|13767|14685|lyfalmen|||1|10|0|1,6667|Icepharma hf|Pfizer ApS|Meropenem||9581||9581|14685||1|0|0|0|||0
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|PLS|0|0|1|100|DKK|22413|23162|lyfalmen|||1|10|0|3,3333|Icepharma hf|Pfizer ApS|Meropenem||15740||15740|23162||1|0|0|0|||0
573863|V03AB3403|FOMEPIZOLE SERB|irþ|5|mg/ml|20|ml|5|lykjur||V03AB34|01.06.2020||R|0|0|0|0|0|SER|0|0|0|100|XEU|89535|116517|lyfalmen|||1|100|0||SERB SA|SERB SA|Fómepízól||89535||89535|116517||3|H|0|0|||0
574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2|0||0|||0
574395|N05CD0804|Midazolam Accord|stl/irl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.06.2020||R|0|0|0|0|0|AEE|0|0|0|100|XEU|1362|3373|lyfalmen|||2|10|0|3,3333|Artasan ehf|Accord Healthcare B.V.|Mídazólam||1362||1362|3373||1|H|0|2|450|mg|0
574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|0|0|RRG|0|1|0|100|DKK|394409|497046|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration GmbH|Pertuzumab||394409||394409|497046||2|H|L|0|||0
574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|G|0|NAA|0|0|1|100|DKK|8495|13190|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8495||8495|13190||1|0|G|0|||0
574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|7149|7056|lyfalmen|V0322|2858|1|98|0|98,0000|Icepharma hf|Upjohn EESV|Sertralín||4038||4038|7056||1|0|G|0|||0
575356|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.11.2019||R|1|1|0|0|0|VAL|0|0|0|100|XEU|13466|3374|lyfalmen|V0817|3325|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||1363||1363|3374||2|0|E|0|||0
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|G|0|UPJ|0|0|0|100|DKK|12189|7056|lyfalmen|V0323|4166|1|98|0|196,0000|Icepharma hf|Upjohn EESV|Sertralín||4038||4038|7056||1|0|G|0|||0
575458|A10AE5401|Suliqua|stl|||3|ml|5|áfpen|100 ein/ml + 50 mcg/ml|A10AE54|01.05.2018||R|0|1|0|0|0|SGB|0|0|0|100|XEU|23152|32556|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi-aventis groupe|Insulin glargine og  lixisenatide||23152||23152|32556||1|0|E|0|||0
575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|0|0|WIL|0|1|0|100|XEU|37013|50088|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||37013||37013|50088||2|H|L|0|||0
575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|0|0|0|0|NAS|0|1|0|100|DKK|717557|898951|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||717557||717557|898951||1|H|L|0|||0
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1279|2306|lyfalmen|V0159|2306|2|20|0|6,6667|Alvogen|ratiopharm GmbH|Amoxicillín||587||587|2306||2|0|E|0|||0
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1567|2748|lyfalmen|V0160|2748|2|30|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||908||908|2748||2|0|E|0|||0
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|RTH|0|0|1|100|SEK|1425|2983|lyfalmen|V0158|2983|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1079||1079|2983||2|0|E|0|||0
575715|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|áfpen|+ 9 inndælingarnálar|G03GA10|01.08.2018||R|0|0|1|G|0|FEP|0|0|0|100|DKK|82421|107520|lyfalmen|||1|2,16|0|6,0000|Vistor hf|Ferring Pharmaceuticals A/S|Follitrópín delta||82421||82421|107520||1|0|G|0|||0
576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|1|0|0|CPV|0|1|0|100|DKK|1164306|1454582|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe B.V.|Pomalidómide||1164306||1164306|1454582||2|0|L|0|||0
576253|B01AC2202|Prasugrel Krka|filmhtfl|10|mg|30|stk|1|þpakki||B01AC22|01.04.2019||R|0|1|0|G|0|KAN|0|0|0|100|IKR|6577|10445|lyfalmen|||2|30|0|30,0000|Krka Sverige AB|Krka d.d. Novo mesto|Prasugrel||6500||6500|10445|31.7.2021|2|0|G|0|||0
576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Dexmedetomidinum||5680||5680|10947||2|0||0|||0
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|G|0|AEP|0|0|0|100|IKR|6315|10190|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||6315||6315|10190||2|0|G|0|||0
576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|ASR|0|0|0|100|IKR|13500|15262|lyfalmen|V0680|14915|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||10000||10000|15262||2|0||0|||0
576846|L01AX0304|Temozolomide Accord|hylki|250|mg|5|stk|1|skpoki|hart|L01AX03|01.06.2021||R|0|0|1|0|0|CLU|0|1|0|100|XEU|35624|48331|lyfsjukr|||2|5|0||Artasan ehf|Accord Healthcare S.L.U.|Temozolomid||35624||35624|48331||1|0|L|0|||0
577021|N02AJ0601|Parkodin|filmhtfl|510|mg|30|stk|1|þpakki|10+500 mg|N02AJ06|01.06.2018||R|1|0|0|0|0|ATE|0|0|1|100|XEU|441|2105|lyfalmen|||2|30|0|5,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||441||441|2105||1|0|E|3|||0
577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|NEL|0|0|0|100|DKK|19722|28643|lyfalmen|V0727|26036|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||19722||19722|28643||1|0|E|0|||0
577505|L04AC0701|RoActemra|stl|162|mg|4|áf-penni|1|pakki||L04AC07|01.03.2019||R|0|1|1|0|0|RRG|0|1|0|100|DKK|135979|175631|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration GmbH|Tocilizúmabi||135979||135979|175631||2|0|L|0|||0
577616|N06BA0905|Atomoxetin STADA|hylki|60|mg|30|stk|1|þpakki|hart hylki|N06BA09|01.08.2020||R|1|1|0|0|0|LYF|0|0|0|100|IKR|4500|3563|lyfalmen|V0816|3563|2|30|0|22,5000|LYFIS ehf|LYFIS ehf|Atomoxetín||1500||1500|3563||2|0|E|0|||0
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10775|16329|lyfalmen|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10775||10775|16329||2|H|0|0|||0
578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|PLS|0|0|0|100|DKK|4288|7400|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4288||4288|7400||1|0||0|||0
578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|GEH|0|0|0|100|NOK|328362|414902|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||328362||328362|414902||2|H|0|0|||0
578537|J05AR2501|DOVATO|filmhtfl|350|mg|30|stk|1|glas|50 mg/300 mg|J05AR25|01.09.2020||R|1|0|1|0|0|VIC|0|1|0|100|DKK|98479|127830|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare BV|Dolutegravir og lamivudin||98479||98479|127830||1|0|L|0|||0
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|CHP|0|0|0|100|XEU|6492|11190|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|Prazikvantelum í blöndum||6492||6492|11190||2|0||0|||0
578991|R03AK1401|Atectura Breezhaler|innönddu|385|mcg/sk|90|stk|3|stsk.þ|125 mcg/260mcg|R03AK14|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|14523|21487|lyfalmen|||1|270|0||Vistor hf|Novartis Europharm Limited|Indacaterol og mometasone||14523||14523|21487||1|0|G|0|||0
579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|G|0|ABC|0|0|1|100|IKR|14658|14436|lyfalmen|V0423|13060|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||9400||9400|14436||2|0|G|0|||0
579184|L01CD0205|Docetaxel Accord|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.06.2020||R|0|0|0|0|0|CLU|0|0|0|100|XEU|32875|44854|lyfalmen|||2|8|0||Artasan ehf|Accord Healthcare S.L.U.|Docetaxel||32875||32875|44854||1|H|0|0|||0
579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|0|0|BMS|0|1|0|100|DKK|157953|202961|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||157953||157953|202961||1|H|L|0|||0
579322|L01BC0503|Gemcitabine W&H|irs|1000|mg|1000|mg|1|hgl|innrennslistofn|L01BC05|01.02.2019||R|0|0|0|0|0|WEH|0|0|0|100|XEU|8727|13510|lyfalmen|||2|1000|0||Williams & Halls efh|Williams & Halls ehf|Gemcitabín||8727||8727|13510||2|H|0|0|||0
579491|R03AL0601|Spiolto Respimat|innöndl|5|mcg|3|rörlyk|1|pakki|Innöndunartæki og 3 áfyllingar|R03AL06|01.08.2019||R|0|0|0|G|0|BOE|0|0|0|100|DKK|19260|25661|lyfalmen|||1|3|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||17555||17555|25661||1|0|G|0|||0
579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|þpakki|30+500 mg|N02AJ06|01.02.2018||R|1|0|0|0|0|ATE|0|0|1|100|IKR|1810|3989|lyfalmen|||2|100|0|33,3333|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Kódein og Paracetamól||1810||1810|3989||1|0|E|1|||0
579910|L04AA3701|OLUMIANT|filmhtfl|4|mg|28|stk|1|þpakki||L04AA37|01.04.2020||R|0|1|1|0|0|NED|0|1|0|100|XEU|116149|150968|lyfsjukr|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Baricitinib||116149||116149|150968||2|0|L|0|||0
579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|G|0|OPE|0|0|0|100|DKK|9545|14636|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||9545||9545|14636||1|0|G|0|||0
579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|POF|0|0|0|100|IKR|3302|2544|lyfalmen|V0107|2530|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||760||760|2544||2|0|E|0|||0
579972|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|BLS|0|0|0|100|XEU|13667|9648|lyfalmen|V0111|6315|2|100|0|100,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Eplerenón||5921||5921|9648||1|0|E|0|||0
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|LBK|0|0|0|100|DKK|7947|12436|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7947||7947|12436||1|0||0|||0
580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|0|0|FKD|0|0|0|100|DKK|9856|15064|lyfalmen|||1|8|0||Vistor hf|Fresenius Kabi Deutschland GmbH|Docetaxel||9856||9856|15064||1|H|0|0|||0
580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|G|0|FEL|0|0|0|100|DKK|3738|6643|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3738||3738|6643||1|0|G|0|||0
580713|R03AL1201|Enerzair Breezhaler|innönddu|||30|stk|1|stsk.þ|114 mcg/46 mcg/136mcg|R03AL12|01.01.2021||R|0|0|0|G|0|NEP|0|0|0|100|DKK|8139|12700|lyfalmen|||1|30|0||Vistor hf|Novartis Europharm Limited|Indacaterol, glycopyrronium bromide, mometasone||8139||8139|12700||1|0|G|0|||0
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|BAM|0|0|1|100|SEK|1485|3542|lyfalmen|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1485||1485|3542||2|0|0|0|||0
581379|C08CA0106|Amlodipin Medical Valley|töflur|10|mg|112|stk|1|þpakki||C08CA01|01.04.2020||R|1|0|0|G|0|VAL|0|0|0|100|XEU|2625|2472|lyfalmen|V0057|2472|2|112|0|224,0000|Acare ehf|Medical Valley Invest AB|Amlódipín||708||708|2472||2|0|G|0|||0
581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|G|0|SAO|0|0|0|100|XEU|3014|5646|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3014||3014|5646||2|0|G|0|||0
581474|N02BA5105|Treo Hindbær|freyðit|550|mg|20|stk|1|tfílát|500+50 mg|N02BA51|01.06.2020||L|0|0|0|0|0|MDK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Icepharma hf|Mylan Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2|0||0|||0
581661|N02CC0406|Rizatriptan Alvogen|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|G|0|POF|0|0|0|100|XEU|3304|6046|lyfalmen|||2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||3304||3304|6046||2|0|G|0|||0
581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|45283|lyfalmen|||2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||33214||33214|45283||2|0|G|0|||0
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|ANI|1|0|0|100|XEU|13328|25456|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13328||13328|25456||2|0||2|||0
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|G|0|NEL|0|0|0|100|DKK|2240|4581|lyfalmen|V0669|3893|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||2240||2240|4581||1|0|G|0|||0
582004|L01EX0801|Lenvima|hylki|4|mg|30|stk|1|þpakki||L01EX08|01.12.2018||R|0|0|1|0|0|SIE|0|1|0|100|SEK|228659|290899|lyfsjukr|||1|30|0||Eisai AB|Eisai GmbH|Lenvatinib||228659||228659|290899||1|0|L|0|||0
582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Meloxícam||||4185|8110||2|0||0|||0
582096|N03AF0203|Oxcarbazepin Jubilant|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.11.2018||R|1|0|0|G|0|JUB|0|0|0|100|DKK|3952|6787|lyfalmen|V0972|6787|2|100|0|30,0000|Acare ehf|Jubilant Pharmaceuticals nv|Oxkarbazepín||3843||3843|6787||2|0|G|0|||0
582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|1|G|0|FBA|0|0|0|100|SEK|16412|24087|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||16412||16412|24087||3|0|G|0|||0
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|GEH|0|0|0|100|NOK|21757|30792|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Iohexol||21757||21757|30792||2|H|0|0|||0
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|17720|25888|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Iohexol||17720||17720|25888||2|H|0|0|||0
582611|A10BJ0601|Ozempic|stl|1|mg|3|ml|1|áfpen|+4 einnota nálar|A10BJ06|01.01.2019||R|0|0|0|0|0|NON|0|0|0|100|DKK|18238|26601|lyfalmen|||1|3|0|27,2727|Vistor hf|Novo-Nordisk|Semaglutide||18238||18238|26601||1|0|E|0|||0
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|53161|70512|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Iohexol||53161||53161|70512||2|H|0|0|||0
582671|H02AB0912|Alkindi|kyrnhylk|5|mg|50|stk|1|glas|Kyrni í hylkjum sem á að opna|H02AB09|01.08.2019||R|1|0|0|G|0|DIU|0|0|1|100|SEK|72228|94628|lyfalmen|||1|50|0|8,3333|Diurnal Ltd.|Diurnal Europe B.V.|Hýdrókortisón||72228||72228|94628||2|0|G|0|||0
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|22124|31256|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||22124||22124|31256||2|H|0|0|||0
582981|G02BB0102|Ornibel|sk-innl|||3|stk|1|pakki|0,120 mg/0,015 mg/24 klst|G02BB01|01.06.2019||R|0|0|0|0|0|EXH|0|0|0|100|DKK|3499|5196|lyfalm11|V0983|5196|2|3|0|84,0000|Acare ehf|Exeltis Healthcare S.L.|Skeiðarinnleg með progestógeni og östrógeni||3129||3129|5196||2|0||0|||1
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|1|0|0|MEC|0|1|0|100|SEK|31195|42729|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||31195||31195|42729||2|0|L|0|||0
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|G|0|UPJ|0|0|0|100|DKK|1893|4103|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Upjohn EESV|Latanóprost||1893||1893|4103||1|0|G|0|||0
583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|45197|60439|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||45197||45197|60439||2|H|0|0|||0
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|G|0|MYL|0|0|0|100|SEK|1134|3059|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1134||1134|3059||2|0|G|0|||0
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|76328|99813|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||76328||76328|99813||2|H|0|0|||0
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|24182|33859|lyfalmen|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||24182||24182|33859||2|H|0|0|||0
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|38691|52210|lyfalmen|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||38691||38691|52210||2|H|0|0|||0
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|GEH|0|0|0|100|NOK|72545|95029|lyfalmen|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||72545||72545|95029||2|H|0|0|||0
583888|G04BD0807|Solifenacin Krka|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|4061|7087|lyfalmen|V0985|7087|2|30|0|60,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||4061||4061|7087||2|0|G|0|||0
583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|RAU|0|0|1|100|XEU|1919|4139|lyfalmen|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1919||1919|4139||2|0|0|0|||0
584306|J01EE0110|Cotrim|töflur|480|mg|30|stk|1|þpakki|80+400 mg|J01EE01|01.01.2021||R|1|0|0|0|0|TVB|0|0|1|100|XEU|1084|2990|lyfalmen|||2|30|0|7,5000|Actavis Pharmaceuticals Iceland ehf.|Teva B.V.|Súlfametoxazól og trímetóprím||||1084|2990||1|0|E|0|||0
584577|A04AD1202|Aprepitant Medical Valley|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.07.2019||R|1|0|0|G|0|VAL|0|0|1|100|XEU|7672|9302|lyfalmen|V0986|9302|2|3|0|1,7273|Acare ehf|Medical Valley Invest AB|Aprepitant||5670||5670|9302||2|0|G|0|||0
584738|N03AX1212|Gabapenstad|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1800|2943|lyfalmen|V0250|2943|2|120|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1050||1050|2943||2|0|G|0|||0
584834|N06AX2701|Spravato|nefúði|28|mg|28|mg|1|úðaílá|lausn|N06AX27|01.10.2020||R|0|1|0|0|0|JCI|0|1|0|100|SEK|31406|42996|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Esketamine||31406||31406|42996||1|H|L|1|30|dagar|0
584851|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.09.2020||R|1|0|0|G|0|TVI|0|0|0|100|XEU|574|2288|lyfalmen|V0448|2288|2|100|0|50,0000|Teva Pharma Iceland ehf|Teva B.V|Enalapríl||574||574|2288||1|0|G|0|||0
585283|S01ED5122|Fixopost|augndr|||0,2|ml|90|sk-ílá|50 mcg/ml + 5 mg/ml|S01ED51|01.01.2020||R|0|0|0|G|0|LTH|0|0|0|100|SEK|7139|11324|lyfalmen|||2|18|0|90,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||7139||7139|11324||1|0|G|0|||0
585287|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.07.2020||R|0|0|0|0|0|NEL|0|0|0|100|DKK|59167|78108|lyfalmen|V0727|78108|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||59167||59167|78108||1|0|E|0|||0
585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|0|0|MBV|0|1|0|100|DKK|493027|619699|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme B.V.|Pembrolizumab||493027||493027|619699||1|H|L|0|||0
585458|M02AA1502|Voltaren|hlaup|11,6|mg/g|75|g|1|túpa||M02AA15|01.11.2018||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|75|0||Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Díklófenak|||||||1|0||0|||0
585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|G|0|BOE|0|0|0|100|DKK|17327|25347|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17327||17327|25347||1|0|G|0|||0
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|LEP|0|0|1|100|DKK|5711|9359|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5711||5711|9359||1|0||0|||0
585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|G|0|VAL|0|0|1|100|IKR|2500|2186|lyfalmen|V0006|2186|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||500||500|2186||2|0|G|0|||0
585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|G|0|MYR|0|0|0|100|DKK|11465|17278|lyfalmen|||1|4|0|20,0000|Icepharma hf|Mylan IRE Healthcare Limited|Fondaparinux||11465||11465|17278||2|0|G|0|||0
585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|GPH|0|0|0|100|DKK|3869|6823|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3869||3869|6823||1|0||0|||0
585905|G04BD0807|Solifenacin Krka|filmhtfl|5|mg|100|stk|1|þpakki||G04BD08|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|11089|10720|lyfalmen|V0440|9877|2|100|0|100,0000|Krka Sverige AB|Krka d.d. Novo mesto|Sólífenacín||6700||6700|10720||2|0|G|0|||0
585914|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|128242|166008|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||128242||128242|166008||1|H|L|0|||0
586005|N03AX1212|Gabapenstad|hylki|400|mg|100|stk|1|þpakki|hart|N03AX12|01.07.2019||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1833|3150|lyfalmen|V0251|3150|2|100|0|22,2200|LYFIS ehf|STADA Arzneimittel AG|Gabapentín||1200||1200|3150||2|0|G|0|||0
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|G|0|HES|0|0|0|100|DKK|25972|36123|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||25972||25972|36123||1|0|G|0|||0
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|LEM|0|0|1|100|XEU|12073|18115|lyfalmen|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||12073||12073|18115||2|0|0|0|||0
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|0|0|MYE|0|1|1|100|DKK|302618|382883|lyfsjukr|||1|224|0|56,0000|Icepharma hf|Mylan Ireland Limited|Tobramýcín||302618||302618|382883||2|0|L|0|||0
586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|AEB|0|0|0|100|DKK|64838|85281|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||64838||64838|85281||1|0|E|0|||0
586579|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|110|stk|1|glas||N06AX16|01.08.2019||R|0|0|0|G|0|VAL|0|0|0|100|XEU|3018|2825|lyfalmen|V0335|2825|2|110|0|165,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||964||964|2825||2|0|G|0|||0
586627|N06AX1613|Venlafaxin Medical Valley|forðatfl|300|mg|30|stk|1|þpakki||N06AX16|01.11.2019||R|0|0|0|0|0|VAL|0|0|0|100|IKR|2358|4743|lyfalmen|||2|30|0|90,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2358||2358|4743||2|0|0|0|||0
586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2019||R|1|1|0|0|0|ATE|0|0|0|100|XEU|6411|3240|lyfalmen|V0815|3197|2|28|0|14,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Atomoxetín||1266||1266|3240||1|0|E|0|||0
586959|L01BC0207|Flúoróúracil Accord|stl/irl|50|mg/ml|100|ml|1|hgl||L01BC02|01.12.2019||R|0|0|0|0|0|AEE|0|0|0|100|XEU|4276|7383|lyfalmen|||2|100|0||Artasan ehf|Accord Healthcare B.V.|Flúóróúracíl||4276||4276|7383||1|H|0|0|||0
586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|G|0|BSM|0|0|0|100|DKK|27325|37834|lyfalmen|V0652|37833|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||27325|37834||1|0|G|0|||0
587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|G|0|ATE|0|0|1|100|XEU|4139|5948|lyfalmen|V0196|5948|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Celekoxíb||3233||3233|5948||1|0|G|0|||0
587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1|0||0|||0
587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|1|0|0|JAN|0|1|0|100|DKK|149703|192700|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||149703||149703|192700||1|0|L|0|||0
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|ATE|0|0|0|100|XEU|5993|9747|lyfalmen|||2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||5993||5993|9747||1|0|E|0|||0
587658|M05BA0606|Ibandronic acid WH|stl|3|mg|3|ml|1|áfspr||M05BA06|01.05.2018||R|0|1|0|0|0|WEH|0|0|0|100|IKR|11132|16820|lyfalmen|V0957|16820|2|3|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||11132||11132|16820||2|0|E|0|||0
587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|G|0|VAL|0|0|0|100|XEU|3992|6263|lyfalmen|V0081|6263|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||3462||3462|6263||2|0|G|0|||0
588134|L04AC1201|Kyntheum|stl|210|mg|1,5|ml|2|áf.spr||L04AC12|01.10.2018||R|0|0|1|0|0|OEL|0|1|0|100|DKK|157888|202880|lyfsjukr|||1|3|0|28,0000|Vistor hf|LEO Pharma A/S|Brodalumab||157888||157888|202880||1|0|L|0|||0
588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|1|0|0|G|0|WEH|0|0|0|100|XEU|6082|3375|lyfalmen|V0683|3375|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||1364||1364|3375||2|0|G|0|||0
588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|1|0|0|PEU|0|1|0|100|DKK|645273|809050|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Europe MA EEIG|Pegvisómant||645273||645273|809050||1|0|L|0|||0
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1800|3975|lyfalmen|V0461|3393|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1800||1800|3975||1|0|E|0|||0
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|G|0|ATE|0|0|0|100|XEU|16585|12230|lyfalmen|V0282|12009|2|100|0|100,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Olanzapín||7797||7797|12230||1|0|G|0|||0
589153|L01EC0201|Tafinlar|hylki|50|mg|120|stk|1|glas||L01EC02|01.11.2013||R|1|0|1|0|0|NEL|0|1|0|100|DKK|605546|759641|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafenib||605546||605546|759641||1|0|L|0|||0
589302|N02AX0213|Tramadol Krka|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.08.2019||R|1|0|0|G|0|KAN|0|0|0|100|IKR|3500|5214|lyfalmen|V0228|5214|2|100|0|50,0000|Krka Sverige AB|Krka d.d. Novo mesto|Tramadól||2700||2700|5214||2|0|G|1|30|dagar|0
589312|N03AX2201|Fycompa|mixtúra|0,5|mg/ml|340|ml|1|glas||N03AX22|01.10.2019||R|0|0|0|G|0|SIE|0|0|0|100|SEK|24583|34366|lyfalmen|||1|340|0|21,2500|Eisai AB|Eisai GmbH|Perampanel||24583||24583|34366||1|0|G|0|||0
589379|C10AA0509|Atorvastatin Xiromed|filmhtfl|10|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|G|0|MVX|0|0|0|100|IKR|2100|2870|lyfalmen|V0112|2870|2|105|0|52,5000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||997||997|2870||2|0|G|0|||0
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|ABC|0|0|0|100|SEK|10178|15507|lyfalmen|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10178||10178|15507||2|H|0|0|||0
589893|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.11.2019||R|1|1|0|0|0|SHS|0|0|0|100|DKK|4113|5572|lyfalmen|V0691|5572|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2960||2960|5572||1|0|E|1|30|dagar|0
590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|1|G|0|CLU|0|0|0|100|XEU|38565|52051|lyfalmen|V0984|27989|2|90|0|36,0000|Artasan ehf|Accord Healthcare S.L.U.|Síldenafíl||38565||38565|52051||1|0|G|0|||0
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2|0||0|||0
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|G|0|ATE|0|0|0|100|XEU|2835|4409|lyfalmen|V0041|3704|2|98|0|147,0000|Teva Pharma Iceland ehf|Actavis Group PTC ehf|Ísósorbíð mónónítrat||2115||2115|4409||1|0|G|0|||0
590825|L01XG0301|Ninlaro|hylki|2,3|mg|1|stk|3|þpakki|hvert hylki sérpakkað í þynnu|L01XG03|01.01.2019||R|0|0|1|0|0|TPA|0|1|0|100|DKK|784553|982275|lyfsjukr|||1|3|0||Vistor hf|Takeda Pharma A/S|Ixazomib||784553||784553|982275||1|0|L|0|||0
590845|N06AB0406|Citalopram STADA|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.01.2020||R|1|0|0|G|0|ASR|0|0|0|100|IKR|1600|3700|lyfalmen|V0317|3700|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Cítalópram||1600||1600|3700||2|0|G|0|||0
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|BOI|0|0|0|100|DKK|137171|177114|lyfalmen|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||137171||137171|177114||1|H|0|0|||0
591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|1|0|G|0|LVR|0|0|0|100|DKK|8790|13596|lyfalmen|V0347|13596|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8790||8790|13596||3|0|G|0|||0
591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|1|0|0|PEU|0|1|0|100|DKK|113001|147053|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Europe MA EEIG|Tofacitinib||113001||113001|147053||1|0|L|0|||0
591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|MAR|0|0|1|100|DKK|1917|4136|lyfalmen|V0561|3516|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1917||1917|4136||2|0||0|||0
591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|GPH|0|0|1|100|DKK|1077|2980|lyfalmen|V0168|2946|1|21|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1077||1077|2980||1|0|E|0|||0
591812|L01XC0204|Rixathon|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.05.2020||R|0|1|0|0|0|HSS|0|1|0|100|DKK|128242|166008|lyfsjukr|||2|50|0||Artasan ehf|Sandoz GmbH|Rítúxímab||128242||128242|166008||1|H|L|0|||0
592068|J01DD0402|Ceftriaxona Normon|sts|1000|mg|1|stk|1|hgl|+ 1 lykja með leysi.|J01DD04|01.06.2018||R|0|0|0|0|0|LNA|0|0|1|100|XEU|2261|4610|lyfalmen|||2|1|0|0,5000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftríaxón||2261||2261|4610|31.7.2021|2|0|0|0|||0
592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2308|3012|lyfalmen|V0825|3012|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1100||1100|3012||2|0|G|0|||0
592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3720|7228|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3720||3720|7228||1|0||0|||0
592961|H05BX0107|Cinacalcet STADA|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.12.2020||R|1|0|0|0|0|ASR|0|0|0|100|IKR|41798|43747|lyfalmen|V0722|43747|2|28|0|42,0000|LYFIS ehf|STADA Arzneimittel AG|Cinacalcet||32000||32000|43747||2|0||0|||0
592977|L01EX0401|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01EX04|01.07.2012||R|1|1|1|0|0|GEB|0|1|0|100|XEU|670060|837412|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetanib||668077||668077|837412||1|0|L|0|||0
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|882|2712|lyfalmen|||1|150|0|9,3750|Icepharma hf|Roche A.S.|Klónazepam||882||882|2712||2|0|G|2|450|töflur|0
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|G|0|ROA|0|0|0|100|DKK|1130|3053|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche A.S.|Klónazepam||1130||1130|3053||2|0|G|2|100|töflur|0
593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|G|0|WEH|0|0|0|100|XEU|7152|4465|lyfalmen|V0694|3861|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2156||2156|4465||2|0|G|0|||0
593527|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.05.2021||R|1|0|0|G|0|KNM|0|0|1|100|IKR|2548|3907|lyfalmen|V0826|3907|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1750||1750|3907||2|0|G|0|||0
593555|N03AX1610|Pregabalin Medical Valley|hylki|75|mg|70|stk|1|þpakki||N03AX16|01.06.2019||R|1|0|0|0|0|VAL|0|0|0|100|IKR|1556|3474|lyfalmen|V0686|2406|2|70|0|17,5000|Acare ehf|Medical Valley Invest AB|Pregabalín||1436||1436|3474||2|0|E|0|||0
594343|N02AE0104|Buprenorphine ratiopharm|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.06.2018|31.07.2021|R|0|0|0|G|0|RTH|0|0|0|100|IKR|3504|6321|lyfalmen|||2|4|0|11,2000|Alvogen|ratiopharm GmbH|Búprenorfín||2500||3504|6321||2|0|G|1|30|dagar|0
594709|C01CA1702|Midodrin Evolan|töflur|5|mg|50|stk|1|þpakki||C01CA17|01.05.2018||R|1|0|0|G|0|EVO|0|0|0|100|IKR|10293|13734|lyfalmen|V0969|10040|2|50|0|8,3333|LYFIS ehf|Evolan Pharma AB|midodrine||8890||8890|13734||2|0|G|0|||0
595176|C10AA0509|Atorvastatin Xiromed|filmhtfl|80|mg|105|stk|1|glas||C10AA05|01.08.2021||R|1|0|0|0|0|MVX|0|0|0|100|IKR|5142|8575|lyfalmen|V0115|8365|2|105|0|420,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||5142||5142|8575||2|0|E|0|||0
595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|G|0|APE|0|0|0|100|XEU|15205|22426|lyfalmen|V1031|22425|1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15205||15205|22426||1|0|G|0|||0
595364|N06BA0409|Methylphenidate STADA|hylki|20|mg|30|stk|1|glas|með breyttan losunarhraða|N06BA04|01.10.2020||R|1|1|0|0|0|ASR|0|0|0|100|IKR|3000|4870|lyfalmen|V0959|4529|2|30|0|20,0000|LYFIS ehf|STADA Arzneimittel AG|Metýlfenídat||2450||2450|4870||2|0|E|1|30|dagar|0
595455|A10BA0205|Metformin EQL|filmhtfl|500|mg|330|stk|1|glas||A10BA02|01.07.2020||R|1|0|0|G|0|EQL|0|0|0|100|IKR|2000|4251|lyfalmen|||2|330|0|82,5000|LYFIS ehf|EQL Pharma AB|Metformín||2000||2000|4251||2|0|G|0|||0
595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|1|0|0|PEU|0|1|0|100|DKK|18988|27633|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Europe MA EEIG|Storkuþáttur VIII||18988||18988|27633||1|0|L|0|||0
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|1|0|0|RAG|0|1|0|100|DKK|48101|64112|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||48101|64112||1|0|L|0|||0
596223|N07BA0153|Zonnic Pepparmint|munnhúði|1|mg/úðask|40|skammtar|1|glas||N07BA01|01.11.2018||L|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|40|0|1,3333|LYFIS ehf|Niconovum AB|Nikótín|||||||2|0||0|||0
596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|VEO|0|0|0|100|DKK|1227|2115|vetorma|||0|2|0||Icepharma hf|Vetoquinol S.A.|Febantel, Pyrantelembonat,Prazikvantel||1227||1227|2115||2|0||0|||0
597167|J01DD0206|Ceftazidima Normon|sts|2|g/hgl|50|hgl|1|pakki|50 lykjur Sjúkrahússpakkning|J01DD02|01.08.2020||R|0|0|0|0|0|LNA|0|0|1|100|XEU|90239|101630|lyfalmen|||2|50|0|25,0000|Williams & Halls efh|Laboratorios Normon, S.A.|Ceftazidím||77764||77764|101630||2|0|0|0|||0
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|PLS|0|0|1|100|DKK|1637|3751|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1637||1637|3751||1|0|E|0|||0
597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|0|0|BMS|0|1|0|100|DKK|526437|661251|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||526437||526437|661251||1|H|L|0|||0
597488|M03BX0107|Baclofen Sintetica í mænuvökva|irl|2|mg/ml|5|ml|1|lykja||M03BX01|01.06.2021||R|1|0|1|0|0|SIN|0|0|1|100|XEU|13796|17263|lyfalmen|||2|5|0|18,1800|Williams & Halls efh|Sintetica GmbH|Baklófen||11454||11454|17263||2|0|0|0|||0
597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|1|G|0|BNB|0|0|0|100|XEU|96171|124911|lyfalmen|||1|2|0|28,0900|Icepharma hf|Biogen Netherlands B.V.|Peginterferón beta-1a||96171||96171|124911||2|0|G|0|||0
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|TAE|0|0|1|100|IKR|||lyflausa|||0|30|0||Alvogen|Trimb Healthcare AB|Ekónazól|||||||2|0||0|||0
598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|G|0|ADI|0|0|0|100|SEK|2254|4600|lyfalmen|||1|100|0|33,3333|Abcur AB|Amdipharm Limited|Acetazólamíð||2254||2254|4600||2|0|G|0|||0
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2|0||0|||0
598859|M05BA0306|Pamidronatdinatrium Pfizer|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.02.2019||R|0|1|0|0|0|PLS|0|0|0|100|DKK|5080|8490|lyfalmen|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||5080||5080|8490||1|H|0|0|||0
598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|GCA|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare ApS|Nikótín|||||||1|0||0|||0
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|EKI|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Artasan ehf|Reckitt Benckiser H. (Scandinavia) A/S|Íbúprófen|||||2208||1|0||0|||0
599010|L01EK0101|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01EK01|01.05.2013||R|1|0|1|0|0|PEU|0|1|0|100|DKK|491249|617487|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Europe MA EEIG|Axitinib||491249||491249|617487||1|0|L|0|||0
599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|0|0|ATE|0|0|0|100|XEU|7361|11630|lyfalmen|||2|20|0||Teva Pharma Iceland ehf|Actavis Group PTC ehf|Oxalíplatín||7361||7361|11630||1|H|0|0|||0
599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|BIV|0|0|0|100|DKK|3517|6843|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||3517||3517|6843||1|0||0|||0
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|BVL|1|0|0|100|XEU|4184|8108|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4184||4184|8108||2|0||0|||0
599460|S01XA2024|Oculac án rotvarnar|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|G|0|CLA|0|0|0|100|XEU|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2497||1|0|G|0|||0
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|G|0|JAS|0|0|0|100|SEK|27371|37892|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||27371|37892||1|0|G|0|||0
599632|B01AA0303|Warfarin Teva|töflur|1|mg|100|stk|1|þpakki||B01AA03|01.01.2019||R|1|0|0|G|0|TVI|0|0|0|100|XEU|1224|3183|lyfalmen|||2|100|0|13,3333|Teva Pharma Iceland ehf|Teva B.V|Warfarín||1224||1224|3183||1|0|G|0|||0
599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|G|0|BLS|0|0|0|100|XEU|3386|3618|lyfalmen|V0334|2568|2|100|0|75,0000|Artasan ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1540||1540|3618||1|0|G|0|||0
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|0|0|EAG|0|0|0|100|NOK|109110|142214|lyfalmen|||1|5|0||Icepharma hf|GE Healthcare B.V.|Lofendýlat||109110||109110|142214||2|H|0|0|||0
957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22309|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22309||2|0||0|||0
957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3296|6035|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||3296||3296|6035||2|0||0|||0
968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|1918|4138|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1918||1918|4138||2|0||0|||0
968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27471|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27471||2|0||0|||0
968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5529|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5529||2|0||0|||0
968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6522|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6522||2|0||0|||0
970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|PAR|0|0|1|100|IKR|4187|7261|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||4187||4187|7261||2|0||0|||0
970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23513|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23513||2|0||0|||0
970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2095|4381|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||2095||2095|4381||2|0|E|0|||0
974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6143|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6143||2|0||0|||0
974792|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|2,5|mg/ml|100|ml|1|fl||C09AA01|01.07.2018||R|0|0|0|0|0|PAR|0|0|0|100|IKR|23568|33082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||23568||23568|33082||2|0||0|||0
974809|A01AC0002|Fluticasone propionate - forskriftarlyf|munnskol|0,1|mg/ml|300|ml|1|fl||A01AC|01.12.2018||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3962|6951|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3962|6951||2|0||0|||0
974825|D07XA0103|HTH krem - forskriftarlyf|krem|||30|g|1|túpa|4%/0,025%/1%|D07XA01|01.06.2019||R|0|0|0|0|0|PAR|0|0|1|100|IKR|3475|6281|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Hydrocortisone||3475||3475|6281||2|0|0|0|||0
974841|D10AD0104|Tretinoin - forskriftarlyf|krem|0,05|%|30|g|1|túpa||D10AD01|01.01.2020||R|0|0|0|0|0|PAR|0|0|0|100|IKR|2979|5598|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||2979||2979|5598||2|0|0|0|||0
980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|PAR|0|0|0|100|IKR|5245|8717|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||5245||5245|8717||2|0||0|||0
980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|PAR|0|0|1|100|IKR|16998|24894|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24894||2|0||0|||0
985145|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|10|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|9369|14393|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||9369||9369|14393||2|0|0|0|||0
985153|A07EA0102|Prednisolon - forskriftarlyf|eþ-stíll|20|mg|10|stk|1|pakki||A07EA01|01.01.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|10090|15386|lyfalmen|||0|10|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Prednisolone||10090||10090|15386||2|0|0|0|||0
985161|D10AD0104|Tretinoin - forskriftarlyf|krem|0,1|%|30|g|1|túpa||D10AD01|01.07.2021||R|0|0|0|0|0|PAR|0|0|0|100|IKR|3292|6029|lyfalmen|||0|30|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tretínóín||3292||3292|6029||2|0|0|0|||0